0001841761-22-000015.txt : 20220812 0001841761-22-000015.hdr.sgml : 20220812 20220811180604 ACCESSION NUMBER: 0001841761-22-000015 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 69 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220812 DATE AS OF CHANGE: 20220811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grove Collaborative Holdings, Inc. CENTRAL INDEX KEY: 0001841761 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-CATALOG & MAIL-ORDER HOUSES [5961] IRS NUMBER: 882840659 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40263 FILM NUMBER: 221157241 BUSINESS ADDRESS: STREET 1: 1301 SANSOME STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: (800) 231-8527 MAIL ADDRESS: STREET 1: 1301 SANSOME STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94111 FORMER COMPANY: FORMER CONFORMED NAME: Virgin Group Acquisition Corp. II DATE OF NAME CHANGE: 20210122 10-Q 1 grov-20220630.htm 10-Q grov-20220630
0001841761June 302022Q2falseP20DP30D00018417612022-01-012022-06-300001841761dei:FormerAddressMember2022-01-012022-06-300001841761us-gaap:CommonClassAMember2022-01-012022-06-300001841761us-gaap:WarrantMember2022-01-012022-06-300001841761us-gaap:CommonClassAMember2022-08-04xbrli:shares0001841761us-gaap:CommonClassBMember2022-08-0400018417612022-06-30iso4217:USD00018417612021-12-31iso4217:USDxbrli:shares0001841761us-gaap:CommonClassAMember2022-06-300001841761us-gaap:CommonClassAMember2021-12-310001841761us-gaap:CommonClassBMember2021-12-310001841761us-gaap:CommonClassBMember2022-06-3000018417612022-04-012022-06-3000018417612021-04-012021-06-3000018417612021-01-012021-06-300001841761srt:ScenarioPreviouslyReportedMemberus-gaap:ConvertiblePreferredStockMember2022-03-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMembersrt:ScenarioPreviouslyReportedMember2022-03-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2022-03-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2022-03-310001841761us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2022-03-310001841761srt:ScenarioPreviouslyReportedMember2022-03-310001841761srt:RestatementAdjustmentMemberus-gaap:ConvertiblePreferredStockMember2022-03-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMembersrt:RestatementAdjustmentMember2022-03-310001841761srt:RestatementAdjustmentMemberus-gaap:CommonStockMember2022-03-310001841761us-gaap:ConvertiblePreferredStockMember2022-03-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-03-310001841761us-gaap:CommonStockMember2022-03-310001841761us-gaap:AdditionalPaidInCapitalMember2022-03-310001841761us-gaap:RetainedEarningsMember2022-03-3100018417612022-03-310001841761us-gaap:ConvertiblePreferredStockMember2022-04-012022-06-300001841761us-gaap:CommonStockMember2022-04-012022-06-300001841761us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-04-012022-06-300001841761us-gaap:RetainedEarningsMember2022-04-012022-06-300001841761us-gaap:ConvertiblePreferredStockMember2022-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-06-300001841761us-gaap:CommonStockMember2022-06-300001841761us-gaap:AdditionalPaidInCapitalMember2022-06-300001841761us-gaap:RetainedEarningsMember2022-06-300001841761us-gaap:CommonClassBMembergrov:TwoThousandAndTwentyTwoEquityIncentivePlanMember2022-06-16xbrli:pure0001841761srt:ScenarioPreviouslyReportedMemberus-gaap:ConvertiblePreferredStockMember2021-03-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2021-03-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2021-03-310001841761us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2021-03-310001841761srt:ScenarioPreviouslyReportedMember2021-03-310001841761srt:RestatementAdjustmentMemberus-gaap:ConvertiblePreferredStockMember2021-03-310001841761srt:RestatementAdjustmentMemberus-gaap:CommonStockMember2021-03-310001841761us-gaap:ConvertiblePreferredStockMember2021-03-310001841761us-gaap:CommonStockMember2021-03-310001841761us-gaap:AdditionalPaidInCapitalMember2021-03-310001841761us-gaap:RetainedEarningsMember2021-03-3100018417612021-03-310001841761us-gaap:CommonStockMember2021-04-012021-06-300001841761us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001841761us-gaap:RetainedEarningsMember2021-04-012021-06-300001841761us-gaap:ConvertiblePreferredStockMember2021-06-300001841761us-gaap:CommonStockMember2021-06-300001841761us-gaap:AdditionalPaidInCapitalMember2021-06-300001841761us-gaap:RetainedEarningsMember2021-06-3000018417612021-06-300001841761srt:ScenarioPreviouslyReportedMemberus-gaap:ConvertiblePreferredStockMember2021-12-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMembersrt:ScenarioPreviouslyReportedMember2021-12-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2021-12-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2021-12-310001841761us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2021-12-310001841761srt:ScenarioPreviouslyReportedMember2021-12-310001841761srt:RestatementAdjustmentMemberus-gaap:ConvertiblePreferredStockMember2021-12-310001841761srt:RestatementAdjustmentMemberus-gaap:CommonStockMember2021-12-310001841761us-gaap:ConvertiblePreferredStockMember2021-12-310001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2021-12-310001841761us-gaap:CommonStockMember2021-12-310001841761us-gaap:AdditionalPaidInCapitalMember2021-12-310001841761us-gaap:RetainedEarningsMember2021-12-310001841761us-gaap:ConvertiblePreferredStockMember2022-01-012022-06-300001841761us-gaap:CommonStockMember2022-01-012022-06-300001841761us-gaap:AdditionalPaidInCapitalMember2022-01-012022-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-01-012022-06-300001841761us-gaap:RetainedEarningsMember2022-01-012022-06-300001841761srt:ScenarioPreviouslyReportedMemberus-gaap:ConvertiblePreferredStockMember2020-12-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2020-12-310001841761srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001841761us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2020-12-310001841761srt:ScenarioPreviouslyReportedMember2020-12-310001841761srt:RestatementAdjustmentMemberus-gaap:ConvertiblePreferredStockMember2020-12-310001841761srt:RestatementAdjustmentMemberus-gaap:CommonStockMember2020-12-310001841761us-gaap:ConvertiblePreferredStockMember2020-12-310001841761us-gaap:CommonStockMember2020-12-310001841761us-gaap:AdditionalPaidInCapitalMember2020-12-310001841761us-gaap:RetainedEarningsMember2020-12-3100018417612020-12-310001841761us-gaap:CommonStockMember2021-01-012021-06-300001841761us-gaap:AdditionalPaidInCapitalMember2021-01-012021-06-300001841761us-gaap:RetainedEarningsMember2021-01-012021-06-300001841761us-gaap:SalesRevenueNetMemberus-gaap:SupplierConcentrationRiskMembergrov:FiveSuppliersMember2021-04-012021-06-300001841761us-gaap:SalesRevenueNetMemberus-gaap:SupplierConcentrationRiskMembergrov:FiveSuppliersMember2022-04-012022-06-300001841761us-gaap:SalesRevenueNetMemberus-gaap:SupplierConcentrationRiskMembergrov:FiveSuppliersMember2022-01-012022-06-300001841761us-gaap:SalesRevenueNetMemberus-gaap:SupplierConcentrationRiskMembergrov:FiveSuppliersMember2021-01-012021-06-300001841761grov:GroveBrandsMember2022-04-012022-06-300001841761grov:GroveBrandsMember2021-04-012021-06-300001841761grov:GroveBrandsMember2022-01-012022-06-300001841761grov:GroveBrandsMember2021-01-012021-06-300001841761grov:ThirdPartyProductsMember2022-04-012022-06-300001841761grov:ThirdPartyProductsMember2021-04-012021-06-300001841761grov:ThirdPartyProductsMember2022-01-012022-06-300001841761grov:ThirdPartyProductsMember2021-01-012021-06-300001841761grov:DeferredRevenueMember2022-06-300001841761us-gaap:OtherCurrentLiabilitiesMember2022-06-300001841761grov:DeferredRevenueMember2021-12-310001841761us-gaap:OtherCurrentLiabilitiesMember2021-12-310001841761grov:DeferredRevenueMember2022-01-012022-06-300001841761us-gaap:OtherCurrentLiabilitiesMember2022-01-012022-06-300001841761us-gaap:ShippingAndHandlingMember2022-01-012022-06-300001841761us-gaap:ShippingAndHandlingMember2021-04-012021-06-300001841761grov:FulfillmentLaborMember2022-01-012022-06-300001841761grov:FulfillmentLaborMember2021-04-012021-06-300001841761us-gaap:ShippingAndHandlingMember2022-04-012022-06-300001841761us-gaap:ShippingAndHandlingMember2021-01-012021-06-300001841761grov:FulfillmentLaborMember2022-04-012022-06-300001841761grov:FulfillmentLaborMember2021-01-012021-06-3000018417612022-06-1600018417612022-06-162022-06-160001841761us-gaap:CommonClassBMember2022-06-160001841761us-gaap:CommonClassBMember2022-06-162022-06-160001841761grov:ReverseRecapitalizationTrancheOneMemberus-gaap:CommonClassAMember2022-06-162022-06-160001841761grov:ReverseRecapitalizationTrancheOneMemberus-gaap:CommonClassAMember2022-06-160001841761us-gaap:CommonClassAMembergrov:ReverseRecapitalizationTrancheTwoMember2022-06-162022-06-160001841761us-gaap:CommonClassAMembergrov:ReverseRecapitalizationTrancheTwoMember2022-06-160001841761us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2021-12-072021-12-070001841761us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2021-12-070001841761grov:CorvinaHoldingsLimitedMembergrov:TrancheOneSharesMember2022-03-312022-03-310001841761us-gaap:CommonClassAMember2022-03-312022-03-310001841761grov:CorvinaHoldingsLimitedMemberus-gaap:CommonClassAMembergrov:TrancheTwoSharesMember2022-03-310001841761grov:CorvinaHoldingsLimitedMemberus-gaap:CommonClassAMembergrov:TrancheTwoSharesMember2022-03-312022-03-310001841761grov:CorvinaHoldingsLimitedMemberus-gaap:CommonClassAMembergrov:TrancheTwoSharesMember2022-06-300001841761grov:CorvinaHoldingsLimitedMemberus-gaap:CommonClassAMembergrov:TrancheTwoSharesMember2022-01-012022-06-300001841761grov:CorvinaHoldingsLimitedMemberus-gaap:CommonClassAMember2022-03-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-06-300001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-06-300001841761us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761us-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Membergrov:AdditionalShareMember2022-06-300001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Membergrov:AdditionalShareMember2022-06-300001841761us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalShareMember2022-06-300001841761us-gaap:FairValueMeasurementsRecurringMembergrov:AdditionalShareMember2022-06-300001841761grov:EarnOutShareMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300001841761grov:EarnOutShareMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-06-300001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761grov:EarnOutShareMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761grov:PublicWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300001841761grov:PublicWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-06-300001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761grov:PublicWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761grov:PrivatePlacementWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-06-300001841761grov:PrivatePlacementWarrantMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-06-300001841761us-gaap:FairValueInputsLevel3Membergrov:PrivatePlacementWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761grov:PrivatePlacementWarrantMemberus-gaap:FairValueMeasurementsRecurringMember2022-06-300001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001841761us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001841761us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001841761us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001841761us-gaap:FairValueMeasurementsRecurringMember2021-12-310001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001841761us-gaap:FairValueInputsLevel3Membergrov:AdditionalShareMember2022-01-012022-06-300001841761us-gaap:FairValueInputsLevel3Membergrov:AdditionalShareMember2021-12-310001841761us-gaap:FairValueInputsLevel3Membergrov:AdditionalShareMember2022-06-300001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-06-300001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2021-12-310001841761grov:EarnOutShareMemberus-gaap:FairValueInputsLevel3Member2022-06-300001841761grov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel2Member2021-12-310001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2021-12-310001841761grov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel2Member2022-01-012022-06-300001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-06-300001841761grov:PrivatePlacementWarrantMemberus-gaap:FairValueInputsLevel2Member2022-06-300001841761grov:PublicWarrantMemberus-gaap:FairValueInputsLevel1Member2022-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2021-12-310001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-01-012022-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Membersrt:ScenarioPreviouslyReportedMember2022-06-300001841761srt:RestatementAdjustmentMembergrov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMemberus-gaap:FairValueInputsLevel3Member2022-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMember2022-04-012022-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMember2021-04-012021-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMember2022-01-012022-06-300001841761grov:ConvertiblePreferredStockWarrantLiabilityMember2021-01-012021-06-300001841761grov:SiliconValleyBankMemberus-gaap:RevolvingCreditFacilityMember2022-06-300001841761grov:SiliconValleyBankMemberus-gaap:RevolvingCreditFacilityMember2021-12-310001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndEquitySecurityMember2022-06-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndEquitySecurityMember2021-12-310001841761grov:AtelMembergrov:AtelLoanFacilityTrancheThreeMember2022-06-300001841761grov:AtelMembergrov:AtelLoanFacilityTrancheThreeMember2021-12-310001841761grov:AtelMembergrov:AtelLoanFacilityTrancheFourMember2022-06-300001841761grov:AtelMembergrov:AtelLoanFacilityTrancheFourMember2021-12-310001841761grov:SiliconValleyBankMemberus-gaap:RevolvingCreditFacilityMembergrov:LoanAndSecurityAgreementMember2016-12-310001841761us-gaap:PrimeRateMembergrov:GrowthCapitalAdvanceMembergrov:SiliconValleyBankMembergrov:LoanAndSecurityAgreementMember2016-12-310001841761us-gaap:LetterOfCreditMembergrov:SiliconValleyBankMembergrov:LoanAndSecurityAgreementMember2016-12-310001841761grov:AmendmentToTheLoanAndSecurityAgreementMembergrov:SiliconValleyBankMemberus-gaap:RevolvingCreditFacilityMember2021-04-012021-04-300001841761us-gaap:LetterOfCreditMembergrov:AmendmentToTheLoanAndSecurityAgreementMembergrov:SiliconValleyBankMember2021-04-300001841761grov:AmendmentToTheLoanAndSecurityAgreementMembergrov:SiliconValleyBankMemberus-gaap:RevolvingCreditFacilityMember2021-04-300001841761grov:AmendmentToTheLoanAndSecurityAgreementMembergrov:SiliconValleyBankMemberus-gaap:RevolvingCreditFacilityMember2022-06-300001841761grov:AmendmentToTheLoanAndSecurityAgreementMembergrov:SiliconValleyBankMembersrt:ScenarioForecastMemberus-gaap:RevolvingCreditFacilityMember2023-03-310001841761grov:AmendmentToTheLoanAndSecurityAgreementMember2021-04-012021-06-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndSecurityAgreementMember2021-04-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:TrancheOneMembergrov:MezzanineLoanAndSecurityAgreementMember2021-04-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:TrancheTwoMembergrov:MezzanineLoanAndSecurityAgreementMember2021-09-300001841761grov:TrancheThreeMembergrov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndSecurityAgreementMember2021-12-310001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndSecurityAgreementMember2021-04-012021-04-300001841761grov:MezzanineLoanAndSecurityAgreementMembergrov:SiliconValleyBankMember2021-04-300001841761grov:MezzanineLoanAndSecurityAgreementMembergrov:HerculesCapitalIncMember2021-04-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembersrt:MinimumMember2022-05-310001841761grov:SiliconValleyBankAndHerculesCapitalIncMembersrt:MaximumMember2022-05-310001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndSecurityAgreementMember2022-06-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndSecurityAgreementMembersrt:MinimumMember2022-06-300001841761grov:SiliconValleyBankAndHerculesCapitalIncMembergrov:MezzanineLoanAndSecurityAgreementMembersrt:MaximumMember2022-06-300001841761grov:TrancheThreeMembergrov:AtelLoanFacilityMembergrov:AtelMember2022-06-300001841761grov:AtelLoanFacilityMembergrov:AtelMembergrov:TrancheFourMember2022-06-300001841761grov:AtelLoanFacilityTrancheFourMember2022-06-300001841761grov:AtelLoanFacilityTrancheThreeMember2022-06-300001841761us-gaap:StandbyLettersOfCreditMember2022-06-300001841761us-gaap:StandbyLettersOfCreditMember2021-12-310001841761grov:SeriesSeedPreferredStockMember2021-12-310001841761us-gaap:SeriesAPreferredStockMember2021-12-310001841761us-gaap:SeriesBPreferredStockMember2021-12-310001841761us-gaap:SeriesCPreferredStockMember2021-12-310001841761grov:SeriesC1PreferredStockMember2021-12-310001841761us-gaap:SeriesDPreferredStockMember2021-12-310001841761grov:SeriesD1PreferredStockMember2021-12-310001841761grov:SeriesD2PreferredStockMember2021-12-310001841761us-gaap:SeriesEPreferredStockMember2021-12-310001841761us-gaap:CommonStockMember2022-06-160001841761us-gaap:CommonClassAMember2022-06-16grov:vote0001841761grov:PrivatePlacementWarrantMember2022-06-300001841761grov:PublicWarrantMember2022-06-300001841761grov:PublicWarrantMemberus-gaap:SubsequentEventMemberus-gaap:CommonClassAMember2022-07-160001841761grov:PublicWarrantMemberus-gaap:SubsequentEventMemberus-gaap:CommonClassAMembersrt:MinimumMember2022-07-160001841761grov:PublicWarrantMemberus-gaap:SubsequentEventMemberus-gaap:CommonClassAMembersrt:MaximumMember2022-07-160001841761us-gaap:CommonClassAMembergrov:TwoThousandAndSixteenEquityIncentivePlanMember2022-06-300001841761us-gaap:CommonClassBMembergrov:TwoThousandAndSixteenEquityIncentivePlanMember2022-06-300001841761us-gaap:CommonClassAMembergrov:TwoThousandAndSixteenEquityIncentivePlanMember2021-12-310001841761us-gaap:CommonClassBMembergrov:TwoThousandAndSixteenEquityIncentivePlanMember2021-12-310001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMemberus-gaap:CommonClassAMember2022-06-300001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMemberus-gaap:CommonClassBMember2022-06-300001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMemberus-gaap:CommonClassAMember2021-12-310001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMemberus-gaap:CommonClassBMember2021-12-310001841761grov:TwoThousandAndSixteenEquityIncentivePlanMember2022-04-300001841761grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember2022-06-300001841761srt:ScenarioPreviouslyReportedMember2021-01-012021-12-310001841761srt:RestatementAdjustmentMember2021-12-3100018417612021-01-012021-12-310001841761us-gaap:StockCompensationPlanMember2022-01-012022-06-300001841761us-gaap:StockCompensationPlanMember2021-01-012021-06-300001841761grov:RestrictedCommonStockMembersrt:ScenarioPreviouslyReportedMember2021-12-310001841761grov:RestrictedCommonStockMembersrt:RestatementAdjustmentMember2021-12-310001841761grov:RestrictedCommonStockMember2021-12-310001841761grov:RestrictedCommonStockMember2022-01-012022-06-300001841761grov:RestrictedCommonStockMember2022-06-300001841761srt:MinimumMember2021-04-012021-06-300001841761srt:MaximumMember2021-04-012021-06-300001841761srt:MinimumMember2021-01-012021-06-300001841761srt:MaximumMember2021-01-012021-06-300001841761grov:MarketBasedStockOptionsMember2021-02-012021-02-280001841761grov:MarketBasedStockOptionsMember2021-02-280001841761grov:PerformanceBasedRestrictedStockUnitsMembersrt:ScenarioPreviouslyReportedMember2021-12-310001841761srt:RestatementAdjustmentMembergrov:PerformanceBasedRestrictedStockUnitsMember2021-12-310001841761grov:PerformanceBasedRestrictedStockUnitsMember2021-12-310001841761grov:PerformanceBasedRestrictedStockUnitsMember2022-01-012022-06-300001841761grov:PerformanceBasedRestrictedStockUnitsMember2022-06-300001841761us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001841761grov:SixtyDaysMembergrov:EquityAwardModificationsMember2022-01-012022-06-300001841761grov:EquityAwardModificationsMembergrov:OneYearMember2022-01-012022-06-300001841761grov:TwoYearsMembergrov:EquityAwardModificationsMember2022-01-012022-06-300001841761grov:TenYearsMembergrov:EquityAwardModificationsMember2022-01-012022-06-300001841761grov:EquityAwardModificationsMember2022-04-012022-06-300001841761grov:EquityAwardModificationsMember2022-01-012022-06-300001841761us-gaap:ConvertiblePreferredStockMember2022-04-012022-06-300001841761us-gaap:ConvertiblePreferredStockMember2021-04-012021-06-300001841761us-gaap:ConvertiblePreferredStockMember2022-01-012022-06-300001841761us-gaap:ConvertiblePreferredStockMember2021-01-012021-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-04-012022-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2021-04-012021-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2022-01-012022-06-300001841761grov:ContingentlyRedeemableConvertibleCommonStockMember2021-01-012021-06-300001841761us-gaap:EmployeeStockOptionMember2022-04-012022-06-300001841761us-gaap:EmployeeStockOptionMember2021-04-012021-06-300001841761us-gaap:EmployeeStockOptionMember2022-01-012022-06-300001841761us-gaap:EmployeeStockOptionMember2021-01-012021-06-300001841761us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300001841761us-gaap:RestrictedStockUnitsRSUMember2021-04-012021-06-300001841761us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-06-300001841761us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-06-300001841761grov:ConvertiblePreferredStockWarrantsMember2022-04-012022-06-300001841761grov:ConvertiblePreferredStockWarrantsMember2021-04-012021-06-300001841761grov:ConvertiblePreferredStockWarrantsMember2022-01-012022-06-300001841761grov:ConvertiblePreferredStockWarrantsMember2021-01-012021-06-300001841761us-gaap:WarrantMember2022-04-012022-06-300001841761us-gaap:WarrantMember2021-04-012021-06-300001841761us-gaap:WarrantMember2022-01-012022-06-300001841761us-gaap:WarrantMember2021-01-012021-06-300001841761grov:PrivateAndPublicPlacementWarrantsMember2022-04-012022-06-300001841761grov:PrivateAndPublicPlacementWarrantsMember2021-04-012021-06-300001841761grov:PrivateAndPublicPlacementWarrantsMember2022-01-012022-06-300001841761grov:PrivateAndPublicPlacementWarrantsMember2021-01-012021-06-300001841761grov:EarnOutShareMember2022-04-012022-06-300001841761grov:EarnOutShareMember2021-04-012021-06-300001841761grov:EarnOutShareMember2022-01-012022-06-300001841761grov:EarnOutShareMember2021-01-012021-06-300001841761grov:SharesSubjectToRepurchaseMember2022-04-012022-06-300001841761grov:SharesSubjectToRepurchaseMember2021-04-012021-06-300001841761grov:SharesSubjectToRepurchaseMember2022-01-012022-06-300001841761grov:SharesSubjectToRepurchaseMember2021-01-012021-06-300001841761us-gaap:SubsequentEventMember2022-07-182022-07-18
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________
FORM 10-Q
_____________________________________
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2022
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number 001-40263
_____________________________________
Grove Collaborative Holdings, Inc.
(Exact name of registrant as specified in its charter)
_____________________________________
Delaware88-2840659
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
1301 Sansome Street
San Francisco, California 94111
Tel.: (800) 231-8527
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Virgin Group Acquisition Corp. II
65 Bleecker Street, 6th Floor
New York, New York 10012
(Former Name or Former Address, if Changed Since Last Report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A common stock, par value $0.0001GROVNew York Stock Exchange
Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per shareGROV.WSNew York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days. Yes x No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
x
Smaller reporting company
x
Emerging growth company
x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes o No x

The registrant had outstanding 43,101,881 shares of Class A common stock and 119,767,876 shares of Class B common stock as of August 4, 2022.
1

Table of Contents
Page





2


CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This quarterly report on Form 10-Q (this "Form 10-Q), including, without limitation, statements under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations," includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). Generally, statements that are not historical facts, including statements concerning Grove Collaborative Holdings, Inc. (the “Company,” “we,” “us,” or “our”) possible or assumed future actions, business strategies, events, or results of operations, are forward-looking statements. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "may," "will," "potential," "projects," "predicts," "continue," or "should," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations.

The forward-looking statements contained in this Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, without limitation, those factors described under Part II, Item 1A: "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws. These risks and others described under Part II, Item 1A: "Risk Factors" may not be exhaustive.

By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this Form 10-Q. In addition, even if our results or operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in this Form 10-Q, those results or developments may not be indicative of results or developments in subsequent periods.
3

Part I - Financial Information
Item 1. Financial Statements
Grove Collaborative Holdings, Inc.
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
June 30,
2022
December 31,
2021
(Unaudited)
Assets
Current assets:
Cash and cash equivalents $132,393 $78,376 
Inventory, net53,494 54,453 
Prepaid expenses and other current assets7,491 8,104 
Total current assets193,378 140,933 
Property and equipment, net15,831 15,932 
Operating lease right-of-use assets19,581 21,214 
Other long-term assets1,249 4,394 
Total assets$230,039 $182,473 
Liabilities, Convertible Preferred Stock and Stockholders’ Deficit
Current liabilities:
Accounts payable$17,714 $21,346 
Accrued expenses40,830 20,651 
Deferred revenue12,575 11,267 
Operating lease liabilities, current3,788 3,550 
Other current liabilities854 1,650 
Debt, current22,708 10,750 
Total current liabilities98,469 69,214 
Debt, noncurrent43,694 56,183 
Operating lease liabilities, noncurrent18,106 20,029 
Derivative liabilities
76,686  
Other long-term liabilities1,562 5,408 
Total liabilities238,517 150,834 
Commitments and contingencies (Note 7)
Convertible preferred stock, $0.0001 par value – 100,000,000 and 115,527,580 shares authorized at June 30, 2022 and December 31, 2021, respectively; no and 114,795,034 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively
 487,918 
Stockholders’ deficit:
Common stock - Class A shares, $0.0001 par value – 600,000,000 shares authorized at June 30, 2022 and no shares authorized at December 31, 2021; 38,513,779 and no shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively;
       Class B shares, $0.0001 par value – 200,000,000 and 194,046,918 shares authorized at June 30, 2022 and December 31, 2021, respectively; 124,355,978 and 9,368,167 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively
16 1 
Additional paid-in capital564,343 33,863 
Accumulated deficit(572,837)(490,143)
Total stockholders’ deficit(8,478)(456,279)
Total liabilities, convertible preferred stock and stockholders’ deficit$230,039 $182,473 
The accompanying notes are an integral part of these condensed consolidated financial statements.
4

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
(In thousands, except share and per share amounts)
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Revenue, net$79,279 $99,023 $169,758 $201,243 
Cost of goods sold40,322 49,957 88,064 99,985 
Gross profit38,957 49,066 81,694 101,258 
Operating expenses:
Advertising17,898 22,516 50,691 58,152 
Product development5,922 5,688 12,162 10,850 
Selling, general and administrative57,895 46,971 108,865 94,509 
Operating loss(42,758)(26,109)(90,024)(62,253)
Interest expense 2,285 1,096 4,372 2,059 
Loss on extinguishment on debt 1,027  1,027 
Change in fair value of Additional Shares liability2,015  2,015  
Change in fair value of Earn-Out liability(17,345) (17,345) 
Change in fair value of Public and Private Placement Warrants liability(1,180) (1,180) 
Other expense, net 6,775 268 4,783 1,044 
Interest and other expense (income), net(7,450)2,391 (7,355)4,130 
Loss before provision for income taxes(35,308)(28,500)(82,669)(66,383)
Provision for income taxes2 16 25 28 
Net loss$(35,310)$(28,516)$(82,694)$(66,411)
Net loss per share attributable to common stockholders, basic and diluted$(1.06)$(3.97)$(3.86)$(9.13)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted33,384,292 7,182,025 21,419,222 7,277,677 
The accompanying notes are an integral part of these condensed consolidated financial statements.
5

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit
(In thousands)
Convertible Preferred Stock (1)
Contingently Redeemable Convertible Common Stock (1)
Common Stock (1)
Additional
Paid-In
Capital
Accumulated
Deficit
Total
Stockholders’ Deficit
SharesAmountSharesAmountSharesAmount
Balances at March 31, 202297,611 $487,918 2,350 $27,473 8,040 $1 $38,660 $(537,527)$(498,866)
Recapitalization17,184 — 400 — 1,415 — — — — 
Balances at March 31, 2022114,795 487,918 2,750 27,473 9,455 1 38,660 (537,527)(498,866)
Issuance of preferred stock and common stock upon net exercise of warrants168 989 — — 156 — — — — 
Conversion of preferred stock warrant liability to common stock warrants— — — — — — 2,182 — 2,182 
Convertible preferred stock and contingently redeemable common stock conversion(114,963)(488,907)(2,750)(27,473)118,205 12 516,368 — 516,380 
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs
— — — — 20,921 2 79,979 — 79,981 
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination— — — — — — (93,196)— (93,196)
Issuance of Earn-Out Shares— — — — 14,000 1 — — 1 
Issuance of Class A common stock issued to employees, net of withholding taxes — — — — 32 — (96)— (96)
Issuance of common stock upon exercise of stock options— — — — 118 — 162 — 162 
Repurchase of early exercise of options— — — — (17)— — — — 
Stock-based compensation— — — — — — 20,284 — 20,284 
Net loss— — — — — — — (35,310)(35,310)
Balances at June 30, 2022 (Unaudited) $  $ 162,870 $16 $564,343 $(572,837)$(8,478)
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
6

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit
(In thousands)
Convertible Preferred Stock (1)
Common Stock (1)
Additional
Paid-In
Capital
Accumulated DeficitTotal
Stockholders’
Deficit
SharesAmountSharesAmount
Balances at March 31, 202197,611 $487,918 7,329 $1 $19,402 $(392,142)$(372,739)
Recapitalization17,184 — 1,290 — — — — 
Balance at March 31, 2021114,795 487,918 8,619 1 19,402 (392,142)(372,739)
Issuance of common stock for services— — 4 — 49 — 49 
Issuance of common stock upon exercise of stock options— — 216 — 227 — 227 
Vesting of early exercise of options— — — — 221 — 221 
Issuance of common stock warrants— — — — 1,622 — 1,622 
Stock-based compensation— — — — 3,861 — 3,861 
Net loss— — — — — (28,516)(28,516)
Balances at June 30, 2021 (Unaudited)114,795 $487,918 8,839 $1 $25,382 $(420,658)$(395,275)
(1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
7

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit
(In thousands)
Convertible Preferred Stock (1)
Contingently Redeemable Convertible Common Stock (1)
Common Stock (1)
Additional
Paid-In
Capital
Accumulated
Deficit
Total
Stockholders’ Deficit
SharesAmountSharesAmountSharesAmount
Balances at December 31, 202197,611 $487,918  $ 7,966 $1 $33,863 $(490,143)$(456,279)
Recapitalization17,184 — — — 1,402 — — — — 
Balances at December 31, 2021114,795 487,918   9,368 1 33,863 (490,143)(456,279)
 Issuance of preferred stock and common stock upon net exercise of warrants 168 989 — — 156 — — — — 
Conversion of preferred stock warrant liability to common stock warrants— — — — — — 2,182 — 2,182 
Convertible preferred stock and contingently redeemable common stock conversion (114,963)(488,907)(2,750)(27,473)118,205 12 516,368 — 516,380 
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs
— — — — 20,921 2 79,979 — 79,981 
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination— — — — — — (93,196)— (93,196)
Issuance of Earn-Out Shares— — — — 14,000 1 — — 1 
Issuance of Class A common stock issued to employees, net of withholding taxes — — — — 32 — (96)— (96)
Issuance of convertible common stock — — 2,750 27,473 — — — — — 
Issuance of common stock upon exercise of stock options — — — — 205 — 333 — 333 
Vesting of early exercised options — — — — — — 125 — 125 
Repurchase of early exercise of options — — — — (17)— — — — 
Stock-based compensation — — — — — — 24,785 — 24,785 
Net loss — — — — — — — (82,694)(82,694)
Balances at June 30, 2022 (Unaudited) $  $ 162,870 $16 $564,343 $(572,837)$(8,478)
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
8

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit
(In thousands)
Convertible Preferred Stock (1)
Common Stock (1)
Additional Paid-In CapitalAccumulated
Deficit
Total Stockholders’ Deficit
SharesAmountSharesAmount
Balances at December 31, 202097,611 $487,918 7,200 $1 $14,605 $(354,247)$(339,641)
Recapitalization17,1841,268— 
Balances at December 31, 2020114,795487,9188,468114,605(354,247)(339,641)
Issuance of common stock for services4 49 49 
Issuance of common stock upon exercise of stock options— — 522 — 517 — 517 
Vesting of early exercise of options— — — — 1,245 — 1,245 
Repurchase of early exercised options— — (155)— — — — 
Issuance of common stock warrants1,622 1,622 
Stock-based compensation— — — — 7,344 — 7,344 
Net loss— — — — — (66,411)(66,411)
Balances at June 30, 2021 (Unaudited)114,795 $487,918 8,839 $1 $25,382 $(420,658)$(395,275)
(1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.

The accompanying notes are an integral part of these condensed consolidated financial statements.
9

Grove Collaborative Holdings, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
(In thousands)
Six Months Ended June 30,
20222021
Cash Flows from Operating Activities
Net loss$(82,694)$(66,411)
Adjustments to reconcile net loss to net cash used in operating activities:
Remeasurement of convertible preferred stock warrant liability(1,616)1,308 
Stock-based compensation24,534 7,269 
Depreciation and amortization2,864 2,337 
Changes in fair value of derivative liabilities(16,510) 
Transaction costs allocated to derivative liabilities upon Business Combination6,673  
Non-cash interest expense312 313 
Inventory reserve1,693 1,719 
Loss on extinguishment of debt 1,027 
Other non-cash expenses139 387 
Changes in operating assets and liabilities:
Inventory(734)(11,320)
Prepaids and other assets613 (3,059)
Accounts payable(3,495)(3,426)
Accrued expenses525 7,327 
Deferred revenue1,308 1,788 
Operating lease right-of-use assets and liabilities(52)45 
Other liabilities302 (1,103)
Net cash used in operating activities(66,138)(61,799)
Cash Flows from Investing Activities
Purchase of property and equipment(2,610)(2,845)
Net cash used in investing activities(2,610)(2,845)
Cash Flows from Financing Activities
Proceeds from issuance of common stock upon Closing of Business Combination97,100  
Proceeds from issuance of contingently redeemable convertible common stock27,500  
Payment of transaction costs related to the Closing of the Business Combination and convertible preferred stock issuance costs(1,267)(340)
Proceeds from the issuance of debt 25,000 
Repayment of debt(562)(21,165)
Payment of debt extinguishment (2,499)
Payment of debt issuance costs(211)(375)
Proceeds from exercise of stock options, net of withholding taxes paid related to common stock issued to employees237 525 
Repurchase of common stock(32)(297)
Net cash provided by financing activities122,765 849 
Net increase (decrease) in cash and cash equivalents54,017 (63,795)
Cash and cash equivalents at beginning of period78,376 176,523 
Cash and cash equivalents at end of period $132,393 $112,728 
Supplemental Disclosure
Cash paid for taxes$61 $52 
Cash paid for interest3,052 1,299 
10


Supplemental Disclosure of Non-Cash Investing and Financing Activities
Transaction costs, convertible preferred stock and contingently redeemable convertible common stock issuance costs included in accounts payable and accrued liabilities$21,435 $291 
Purchases of property and equipment included in accounts payable and accrued liabilities    122 139 
Initial measurement of common stock warrants recorded as debt fees 1,622 
Net exercise of preferred stock warrants989  
Conversion of contingently redeemable convertible common stock and convertible preferred stock to common stock516,365  
Assumption of derivative liabilities upon Business Combination93,196  
Reclassification of Grove's preferred stock warrant liability to additional paid-in capital2,182  
Vesting of early exercised stock options125 1,245 
The accompanying notes are an integral part of these condensed consolidated financial statements.
11


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements
(Unaudited)

1.    Description of Business

Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world, and we plan to become 100% plastic-free by 2025. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016.

On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”).

The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing.

Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 3, Recapitalization for additional details.
2.    Summary of Significant Accounting Policies
Basis of Presentation and Liquidity

The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should
12


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
be read in conjunction with Legacy Grove’s financial statements and accompanying notes as of and for the year ended December 31, 2021 (the “audited financial statements”) that were included in the Company’s Proxy Statement/Prospectus filed with the SEC on May 17, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2022 and the results of operations for the three and six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other future interim or annual period.

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business. The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $572.8 million as of June 30, 2022. The Company’s existing sources of liquidity as of June 30, 2022 include cash and cash equivalents of $132.4 million. Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock and contingently redeemable convertible common stock and the incurrence of debt. Upon the Closing of the Business Combination, the Company received $80.0 million in cash proceeds, net of transaction costs. The Company believes the Business Combination eliminated the substantial doubt about the Company’s ability to continue as a going concern from at least one year after the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.

Emerging Growth Company
The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.

Comprehensive Loss
Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.

Significant Accounting Policies

Except for the addition of the Business Combination and related derivative liabilities, there have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, Summary of Significant Accounting Policies, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2021.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement warrants, the fair value of Earn-Out liabilities, and Additional Shares related to the Backstop Subscription Agreement and stock-based compensation expense. Actual
13


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.
The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.

Concentration of Risks
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
The Company depends on a limited number of vendors to supply products sold by the Company. For the three and six months ended June 30, 2022 and 2021, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases.

Revenue Recognition
The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. 
The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.
In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.
A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the
14


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.
The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).
At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. The Company records a refund reserve based on historical refund patterns. As of June 30, 2022 and December 31, 2021 the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was $0.1 million.
Disaggregation of Revenue
The following table sets forth revenue by product type (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Revenue, net:
Grove Brands $38,216 $47,469 $85,064 $99,754 
Third-party products41,063 51,554 84,694 101,489 
Total revenue, net$79,279 $99,023 $169,758 $201,243 
Contractual Liabilities
The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. Contractual liabilities included in deferred revenue and other current liabilities were $12.6 million and $0.3 million, respectively, as of June 30, 2022 and $11.3 million and $0.3 million, respectively, as of December 31, 2021. The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the six months ended June 30, 2022 that was previously included in deferred revenue and other current liabilities as of December 31, 2021 was $9.1 million and $0.2 million, respectively.

15


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
Customer Referral Credits
The Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase. The liability for customer referral credits was $0.1 million as of June 30, 2022 and December 31, 2021 and is included within other current liabilities in the condensed consolidated balance sheets.

Fulfillment Costs
Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative expenses in the condensed consolidated statements of operations. For the three months ended June 30, 2022 and 2021, the Company recorded fulfillment costs of $20.3 million and $23.6 million, respectively, which included $12.8 million and $13.8 million in shipping and handling expenses, respectively, and $4.5 million and $5.8 million in Fulfillment Labor, respectively. For the six months ended June 30, 2022 and 2021, the Company recorded fulfillment costs of $44.7 million and $48.8 million, respectively, which included $27.1 million and $28.9 million in shipping and handling expenses, respectively, and $11.1 million and $12.1 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors.

Warrant Liabilities

The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.
16


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)

3.    Recapitalization

As discussed in Note 1, Description of Business, on the Closing Date, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination, including the Backstop Tranche 2 shares, and proceeds from the PIPE investment (as defined below). The Company recorded $23.8 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were allocated on a relative fair value basis between the issuance of common stock, Public and Private Placement Warrants, Grove Earn-Out Shares, Downside Protection feature and Backstop Warrants (as defined below). Direct and incremental transaction costs allocated to equity-classified instruments have been recorded within equity as an offset against proceeds upon accounting for the consummation of the Business Combination in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net in the condensed consolidated statements of operations. The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows. On the Closing Date, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. See Note 8, Convertible Preferred Stock and Note 9, Common Stock and Warrants for additional details of the Company's stockholders' deficit prior to and subsequent to the Business Combination.

All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of approximately 1.1760, each outstanding restricted stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760.

Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant.

The Merger was accounted for as a reverse recapitalization with Legacy Grove as the accounting acquirer and VGAC II as the acquired company for accounting purposes. Legacy Grove was determined to be the accounting acquirer since Legacy Grove’s shareholders prior to the business combination had the greatest voting interest in the combined entity, Legacy Grove's shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Legacy Grove comprises all of the ongoing operations, and Legacy Grove's senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these condensed consolidated financial statements represents the accounts of Legacy Grove. Net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Legacy Grove.

Earn-Out

At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of New Grove Class B Common Stock (“Earn-Out Shares”), which will vest (i) with respect to 7,000,173 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,999,787 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Mergers (the “Earn-Out Period”).



17


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)

If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.

If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and it will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of June 30, 2022, the Company did not meet any Earn-Out thresholds.

PIPE Investment

On December 7, 2021, concurrently with the execution of the Merger Agreement, VGAC II entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 8,707,500 shares of the Company’s Class A common stock at $10.00 per share for aggregate gross proceeds of $87,075,000 (the “PIPE Investment”). 8,607,500 shares of the Company’s Class A common stock have been issued for aggregate proceeds of $86,075,000, which consummated concurrently with the closing to the Business Combination.

Backstop Financing

On March 31, 2022, VGAC II entered into the Subscription Agreement (the “Backstop Subscription Agreement”) with Corvina Holdings Limited (the “Backstop Investor”) and Legacy Grove. As part of the Subscription Agreement, the Backstop Investor subscribed for and purchased 2,338,352 shares of Legacy Grove Common Stock (the “Backstop Tranche 1 Shares”) for aggregate proceeds of $27,500,000. The Company initially classified the Backstop Tranche 1 Shares as mezzanine (or temporary) equity on its balance sheet because the Backstop Tranche 1 Shares were contingently redeemable upon the occurrence of certain events not solely within the control of the Company that allow for the effective redemption of such shares in cash at the option of the holder. Upon Closing of the Business Combination, the Backstop Tranche 1 Shares were converted into 2,750,000 shares of Class A Common Stock and the Tranche 1 Share were no longer contingently redeemable. The Company has classified these shares in permanent equity on its balance sheet at June 30, 2022.

In addition, the Backstop Investor agreed to subscribe for and purchase, on the closing date of the Business Combination, certain shares of New Grove class A common stock at a purchase price of $10.00 per share (“Backstop Tranche 2 Shares”) for aggregate gross proceeds in an amount equal to (x) $22.5 million minus (y) the amount of aggregate cash remaining in VGAC II’s trust account, after deducting any amounts paid to VGAC II shareholders who exercise their redemption rights in connection with the Business Combination. The Company issued to the Backstop Investor, as of immediately following the closing of the Mergers, 1,671,524 Backstop Tranche 2 Shares for aggregate proceeds of $16,715,240.

The Backstop Subscription Agreement also provides that the Company will issue additional shares of Class A common stock to the Backstop Investor for Backstop Tranche 1 Shares and Backstop Tranche 2 Shares if the volume weighted average price of Class A common stock is less than $10.00 during the 10 trading days commencing on the first trading date after the Company’s first quarterly earnings call for the fiscal quarter ended June 30, 2022 (“Additional Shares”).

As part of the Backstop Subscription Agreement, the Company issued to the Backstop Investor 3,875,028 warrants to purchase New Grove Class A Common Stock (each warrant exercisable to purchase one share of New Grove Class A Common Stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. The Backstop Warrants were recorded in equity on the Company’s balance sheet at June 30, 2022.
18


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
4.    Fair Value Measurements and Fair Value of Financial Instruments
The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.

The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exception discussed in Note 9, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 by level within the fair value hierarchy (in thousands):
June 30, 2022
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$129,171 $ $ $129,171 
Total$129,171 $ $ $129,171 
Financial Liabilities:
Additional Shares$ $ $17,355 17,355 
Earn-Out Shares  53,136 53,136 
Public Warrants3,381   3,381 
Private Placement Warrants 2,814  2,814 
Total$3,381 $2,814 $70,491 $76,686 
19


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
December 31, 2021
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$77,771 $ $ $77,771 
Total$77,771 $ $ $77,771 
Financial Liabilities:
Convertible preferred stock warrant liability$ $ $4,787 $4,787 
Total$ $ $4,787 $4,787 
There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented.

Additional Shares

At closing of the Mergers, the Company recorded a liability of $15.3 million related to the potential issuance of the Additional Shares related to the Backstop Subscription Agreement. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations.

The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):

Balance at December 31, 2021$ 
Assumption of Additional Shares liability15,340 
Change in fair value2,015 
Balance at June 30, 2022$17,355 
Earn-Out Shares

At Closing of the Mergers, certain Earn-Out Shares were accounted for as a liability totaling $70.5 million. Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations.

The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):

Balance at December 31, 2021$ 
Assumption of Earn-Out liability70,481 
Change in fair value(17,345)
Balance at June 30, 2022$53,136 












20


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)

Private Placement and Public Warrant Liabilities

As of June 30, 2022, the Company has Private Placement and Public Warrants defined and discussed in Note 9, Common Stock and Warrants. Such warrants are measured at fair value on a recurring basis.

The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands):

Private Placement WarrantsPublic Warrants
Balance at December 31, 2021$ $ 
Assumption of Private Placement and Public Warrants3,350 4,025 
Changes in fair value(536)(644)
Balance at June 30, 2022$2,814 $3,381 

Convertible Preferred Stock Warrant Liability
The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands):
Balance at December 31, 2021$4,787 
Change in fair value(1,616)
Net exercise of preferred stock warrants(989)
Balance before reclassification at June 30, 20222,182 
Reclassification to additional paid-in capital(2,182)
Balance at June 30, 2022$ 

The Company recorded a loss on remeasurement of preferred stock warrant liability of $0.3 million and $0.4 million for the three months ended June 30, 2022 and 2021, respectively, and a gain of $1.6 million and a loss of $1.3 million on remeasurement of preferred stock warrant liability for the six months ended June 30, 2022 and 2021, respectively. With the closing of the Business Combination, unexercised preferred stock warrants are converted into warrants of the Company to purchase shares of common stock and the preferred stock warrant liability is reclassified to additional paid-in capital.

21


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
5.    Accrued Expenses
Accrued expenses consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Inventory purchases$3,468 $4,659 
Compensation and benefits1,744 2,072 
Advertising costs3,527 2,363 
Fulfillment costs1,147 1,120 
Sales taxes1,537 1,812 
Transaction costs21,399 1,846 
Other accrued expenses8,008 6,779 
Total accrued expenses$40,830 $20,651 
        
6.    Debt
The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Silicon Valley Bank Loan Revolver$5,947 $5,947 
Silicon Valley Bank and Hercules Mezzanine Term Loan59,263 59,237 
Atel Loan Facility Draw 31,009 1,489 
Atel Loan Facility Draw 4183 260 
Total debt66,402 66,933 
Less: debt, current(22,708)(10,750)
Total debt, noncurrent$43,694 $56,183 
Silicon Valley Bank Loan Facility
In December 2016, the Company entered into a loan and security agreement (the “SVB Loan Facility”) with Silicon Valley Bank (“SVB”). The terms of the SVB Loan Facility, as amended and restated, provided for: (i) a revolving line of credit not to exceed $25.0 million (“Loan Revolver”), (ii) growth capital advance (“Term Loan”) of $3.9 million and (iii) a letter of credit sublimit of $6.0 million. The Term Loan had a maturity date in December 2022 and bore interest at Prime Rate per annum, payable monthly. The Loan Revolver borrowing capacity was limited to 60% of eligible inventory balances.
In April 2021, the Company entered into an amendment to the SVB Loan Facility, which incurs a facility fee of 0.20% per annum assessed on the daily average undrawn portion of revolving line of credit. In addition, the Loan Revolver letter of credit sublimit increased to $10.0 million and the Loan Revolver borrowing capacity increased to 65% of eligible inventory balances. The Loan Revolver borrowing capacity is reduced by outstanding letters of credit and credit available to the Company from certain credit card facilities, which amounted to $3.1 million and $1.5 million, respectively as of June 30, 2022. The amended Loan Revolver bears an interest rate equal to the greater of prime rate or 3.25% per annum and matures on March 31, 2023. Interest on the Loan Revolver is payable monthly in arrears.
In April 2021, all of the Company’s outstanding amounts under the SVB Term Loan were refinanced directly through the SVB and Hercules Loan Facility (see below). The Company determined the refinance represented an extinguishment of the SVB Term Loan and recorded a loss on extinguishment of $1.0 million during the three months ended June 30, 2021.
The SVB Loan Facility is collateralized by substantially all of the Company’s assets on a first priority basis and contains customary events of default. The SVB Loan Facility includes affirmative, negative, and financial covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted
22


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends, or repurchase stock, subject to customary exceptions. The SVB Loan Facility contains certain financial covenants which requires the Company to maintain minimum liquidity of $45.0 million. Minimum liquidity is defined as the sum of the aggregate amount of unrestricted and unencumbered cash deposited with SVB plus amounts available to be drawn under the loan revolver, as adjusted for any outstanding standby letters of credit issued by SVB.
As of June 30, 2022, the Company was in compliance with all covenants and had $5.9 million outstanding under the revolving line of credit, with an effective interest rate of 5.00%.
Silicon Valley Bank and Hercules Loan Facility
In April 2021, the Company entered into a Mezzanine Loan and Security Agreement (“SVB and Hercules Loan Facility”) with SVB and Hercules Capital, Inc. (“Hercules”). The availability period runs from the effective date until June 30, 2022, provides for advances of up to $60.0 million. In April 2021, the Company drew $25.0 million, which it used to directly settle the amounts outstanding under the SVB Term Loan. In September and December 2021, the Company drew down the remaining additional borrowings of $25.0 million and $10.0 million, respectively. The SVB and Hercules Loan Facility bears an annual interest at the greater of 8.75% or prime plus 5.5%, payable monthly. The principal repayment period commences on November 1, 2022 and continues for 30 monthly installments with an additional final payment equal to 6.75% of the aggregate term loan advances. SVB and Hercules have committed to fund 51.0% and 49.0%, respectively, of all draws made under the SVB and Hercules Loan Facility.

In May 2022, as part of the Closing of the Business Combination, the Company entered into an amendment with SVB and Hercules Loan Facility which increased the final payment from 6.75% to 8.75% of the aggregate term loan advances.
The SVB and Hercules Loan Facility is collateralized on a second priority basis, subordinate to the SVB Loan Facility, by substantially all of the Company’s assets and contains affirmative and negative covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends or repurchase stock, subject to customary exceptions. The SVB and Hercules Loan Facility does not include any financial covenants, but does contain a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, SVB and Hercules have been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that SVB and Hercules would exercise the subjective acceleration clause is remote.
As of June 30, 2022, the Company had an aggregate of $60.0 million outstanding under the SVB and Hercules Loan Facility, excluding unamortized debt issuance cost, with effective interest rates ranging from 14.26% to 17.31%. As of June 30, 2022, the Company was in compliance with all covenants.
Atel Loan Facility
In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default.
As of June 30, 2022, the Company had $1.0 million outstanding on its third draw and $0.2 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.
7.    Commitments and Contingencies
Merchandise Purchase Commitments
As of June 30, 2022 and December 31, 2021, the Company had obligations to purchase $27.0 million and $36.1 million, respectively, of merchandise.
23


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
Letters of Credit
The Company had irrevocable standby letters of credit in the amount of $3.1 million as of June 30, 2022 and December 31, 2021 related to the Company’s operating leases. The letters of credit have expiration dates through January 2029.
Contingencies
The Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.
8.    Convertible Preferred Stock
The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data):
Original
Issue Price
Shares
Authorized
Shares
Outstanding
Net Carrying
Value
Liquidation
Preference 
Series Seed$0.5245 9,693,116 9,693,115 $3,943 $5,084 
Series A0.5245 14,130,360 14,069,657 5,240 7,379 
Series B1.2450 12,689,363 12,563,418 15,545 15,642 
Series C2.4144 15,635,550 15,324,913 36,917 37,000 
Series C-13.1669 8,554,106 8,554,106 27,003 27,090 
Series D7.0135 20,196,682 19,961,423 136,618 140,000 
Series D-19.0731 5,314,209 5,314,209 48,146 48,216 
Series D-26.1850 14,551,371 14,551,370 89,638 90,000 
Series E8.4672 14,762,823 14,762,823 124,868 125,000 
Total115,527,580 114,795,034 $487,918 $495,411 
Conversion

At the closing of the Business Combination, all series of convertible preferred stock of Legacy Grove were converted on an as-converted basis to the Company’s Class B common stock at an exchange ratio of approximately 1.1760. As of June 30, 2022, no shares of convertible preferred stock were outstanding.
24


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
9.    Common Stock and Warrants

Prior to the Business Combination, Legacy Grove had one class of authorized common stock (Class B common stock). The outstanding shares of Legacy Grove common stock is presented on the consolidated balance sheet and on the statements of convertible preferred stock, contingently redeemable convertible common stock and stockholders’ deficit for the year ended December 31, 2021.

Merger Transaction

On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each common stock, par value $0.0001 per share (other than Backstop Tranche 1 Shares), preferred stock, outstanding options (whether vested or unvested), restricted stock units (whether vested or unvested) and warrants of Legacy Grove was canceled and converted into a comparable number of awards (i) that consisted of either the rights to receive or acquire shares of the Company’s Class B common stock, par value $0.0001 per share, as determined by the exchange ratio, and (ii) the right to receive a number of the Company’s Earn-Out shares. Each Backstop Tranche 1 Shares issued to the Backstop Investor pursuant to the Backstop Subscription Agreement was canceled and converted into the right to receive a number of shares of the Company’s Class B common stock equal to the exchange ratio, which were immediately exchanged on a one-for-one basis for shares of the Company’s Class A common stock). The exchange ratio is approximately 1.1760.

On June 16, 2022, in connection with the closing of the Business Combination, the Company amended and restated its certificate of incorporation to authorize 900,000,000 shares, consisting of (a) 800,000,000 shares of common stock, including (i) 600,000,000 shares of Class A common stock, and (ii) 200,000,000 shares of Class B common stock, and (b) 100,000,000 shares of preferred stock.

The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to number of voting rights. Holders of Class A common stock are entitled to one vote per share and holders of Class B common stock are entitled to ten votes per share. Each share of Class B common stock is convertible into one share of Class A common stock any time at the option of the holder, and is automatically converted into one share of Class A common stock upon transfer (except for certain permitted transfers). Once converted into Class A common stock, the Class B common stock will not be reissued. The Company’s Board of Directors has the authority to issue shares of the Preferred Stock in one or more series and to determine the voting rights, designations, powers, preferences, other rights and restrictions of each such series of shares. As of June 30, 2022, no shares of preferred stock were issued and outstanding.

Class A Common Stock Warrants

As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assumed 6,700,000 Private Placement Warrants for Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation.

Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets and amounted to $76.7 million as of June 30, 2022.
25


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
As of June 30, 2022, the following Warrants were outstanding:

Warrant TypeSharesExercise Price
Public Warrants8,050,000 $11.50 
Private Placement Warrants6,700,000 $11.50 

Public Warrants

The Public Warrants become exercisable into shares of Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments.

The Company may redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any twenty trading days within the thirty trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.

Private Placement Warrants

The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. At Closing, the Company assumed 6,700,000 Private Placement Warrants.
26


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
Reserved for Issuance

The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:
June 30, 2022December 31, 2021
Class A Common StockClass B Common StockClass A Common StockClass B Common Stock
Convertible preferred stock   115,287,015 
Convertible preferred stock warrants   735,760 
Private Placement Warrants6,700,000    
Public Warrants8,050,000    
Backstop Warrants3,875,028    
Common Stock Warrants 923,857  688,349 
Outstanding Stock Options9,323,547 15,312,140  27,882,520 
Outstanding Restricted Stock Units4,517,208 1,184,158  1,777,183 
Remaining Shares available for issuance under 2016 Equity Incentive Plan   1,070,974 
Remaining Shares available for issuance under 2022 Equity Incentive Plan24,544,031    
Shares available for issuance under 2022 Employee Stock Purchase Plan3,274,070    
Total shares of common stock reserved60,283,884 17,420,155  147,441,801 
27


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
10.    Stock-Based Compensation
Equity Incentive Plan

In 2016, Legacy Grove adopted the 2016 Equity Incentive Plan (the “2016 Plan”). The Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by the Board of Directors. In April 2022, the Company’s Board of Directors authorized an increase in the number of shares available for issuance under the 2016 Plan by 3,500,000. In addition, all equity awards of Legacy Grove that were issued under the 2016 Plan were converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each of Legacy Grove’s equity awards were converted into an option to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760. As of the effective date of the 2022 Plan, no further stock awards have been or will be granted under the 2016 Plan.

In June 2022, the stockholders of the Company approved the Grove Collaborative Holdings, Inc. 2022 Stock Incentive Plan (the “2022 Plan”). The Plan provides for the granting of stock-based awards to eligible participants, specifically officers, other employees, non-employee directors, consultants, independent contractors under terms and provisions established by the Board of Directors.

The 2022 Plan authorizes the issuance of Class A common stock of up to 24,555,528. The number of shares available shall increase annually on the first day of each calendar year, beginning with calendar year ending December 31, 2023 and continuing until (and including) calendar year December 31 2032, with annual increases equal to lesser of (i) 5% of the number of shares of Class A and Class B common stock issued and outstanding on December 31 of the immediately preceding fiscal year, and (ii) an amount determined by the Board.
Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
Options Outstanding
Number of Options Weighted–Average Exercise PriceWeighted-Average Remaining Contractual Life (years)Aggregate Intrinsic Value
Balance – December 31, 202123,708,957 $3.05 7.99$125,429 
Recapitalization4,173,563 (0.46)
Balance – December 31, 202127,882,520 2.59 7.99125,429 
Exercised(205,337)1.60 
Cancelled/forfeited(3,041,496)3.44 
Balance – June 30, 202224,635,687 2.53 7.4254,818 
Options vested and exercisable – June 30, 202215,742,548 $1.81 6.87$44,349 
The weighted-average grant date fair value of options granted during the six months ended June 30, 2021 was $4.41 per share. No options were granted during the six months ended June 30, 2022. The total grant date fair value of options that vested during the six months ended June 30, 2022 and 2021 was $7.8 million and $6.0 million, respectively. The aggregate intrinsic value of options exercised during the six months ended June 30, 2022 and 2021 was $1.1 million and $2.3 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options.
Early Exercise of Employee Options
The Company allows certain employees to exercise options granted under the Plan prior to vesting in exchange for shares of restricted common stock. The unvested shares, upon termination of employment, are subject to repurchase by the Company at the original purchase price. The proceeds are recorded in other current liabilities in the consolidated balance sheets at the time of the early exercise of stock options and reclassified to common stock and additional paid-in capital as the Company’s repurchase right lapses (i.e., as the underlying stock options vest). No and 11,025 shares of common stock were issued due to early exercise of unvested stock options during the six months
28


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
ended June 30, 2022 and 2021. As of June 30, 2022 and December 31, 2021, the aggregate price of the restricted common stock subject to repurchase was zero and $0.2 million, respectively. A summary of the restricted common stock is as follows:
Number of Options Weighted–Average Exercise Price
Outstanding and unvested as of December 31, 202169,513 $2.25 
Recapitalization12,237 (0.33)
Outstanding and unvested as of December 31, 202181,750 1.92 
Vested(65,211)1.92 
Repurchase of early exercise(16,539)1.92 
Outstanding and unvested as of June 30, 2022 $ 

Determination of Fair Value
The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
Three Months Ended June 30, 2021Six Months Ended June 30, 2021
Fair value of common stock
$5.86 – $6.45
$5.06 – $6.45
Expected term (in years)
5.036.28
5.006.28
Volatility
62.33% – 63.66%
62.33% – 75.19%
Risk-free interest rate
0.81% – 1.16%
0.50% – 1.16%
Dividend yield
Market-Based Stock Options

In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of awards vest upon valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for the six months ended June 30, 2022 which was principally related to service periods completed prior to the Business Combination. As of June 30, 2022, the market-based vesting criteria had not been met.
29


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
Performance-Based Restricted Stock Units
Performance-based restricted stock units activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
Number of shares Weighted–Average Grant Date Fair Value Per Share
Unvested – December 31, 20211,511,191 $8.62 
Recapitalization265,992 (1.29)
Unvested – December 31, 20211,777,183 7.33 
Granted4,748,063 6.98 
Vested(593,971)6.93 
Cancelled/forfeited(823,880)6.71 
Balance – June 30, 20225,107,395 6.71 
Vested but unissued – June 30, 2022593,971 $6.93 

RSUs granted under the 2016 Plan contain vesting conditions based on continuous service and the occurrence of a specified liquidity event, which is considered a performance condition. The performance condition is satisfied upon the consummation of (i) an initial underwritten public offering of the Company’s common stock; (ii) a change in control event, or (iii) a merger, consolidation or similar transaction in which the Company’s common stock outstanding immediately preceding such transaction are converted or exchanged into securities that are publicly-traded on an established exchange (the “Liquidity Event”), provided that the Liquidity Event occurs prior to the fifth anniversary of the grant date and the recipient continues to provide service to the Company on such date. The Company satisfied the performance condition on June 16, 2022 with the Closing of the Business Combination. Accordingly, the Company started recognizing stock compensation expense in the three months ended June 30, 2022 using the accelerated attribution method from the grant date. The total cumulative catch up expense related to prior periods recognized for the RSUs was $11.9 million. The vested but unissued RSUs will be issued to the common stockholders in November 2022 upon the termination of the Lock-Up Period, as defined in Section 7.10 of the Company’s Bylaws. There are no other contingencies for the issuance of these RSUs other than passage of time.
Equity Award Modifications

During the six months ended June 30, 2022, the Company modified options held by former and existing employees to extend the post termination exercise period of the awards from 60 days to 1, 2 or 10 years after termination, as well as accelerated the vesting of RSUs. The modifications resulted in modification expenses of $0.6 million and $1.7 million during the three and six months ended June 30, 2022, respectively.

Stock-Based Compensation Expense
For the three months ended June 30, 2022 and 2021, the Company recognized a total of $20.1 million and $3.8 million of stock-based compensation expense, respectively. For the six months ended June 30, 2022 and 2021, the Company recognized a total of $24.5 million and $7.3 million of stock-based compensation expense, respectively. Stock-based compensation expense was predominately recorded in selling, general and administrative expenses in the statements of operations for each period presented. As of June 30, 2022, the total unrecognized compensation expense related to unvested options and RSUs was $47.4 million, which the Company expects to recognize over an estimated weighted average period of 2.6 years.
30


Grove Collaborative Holdings, Inc.
Notes to Condensed Consolidated Financial Statements (continued)
(Unaudited)
11.    Net Loss Per Share Attributable to Common Stockholders
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Convertible preferred stock 115,287,015  115,287,015 
Contingently redeemable convertible common stock    
Common stock options24,635,687 27,646,468 24,635,687 27,646,468 
Restricted stock units5,107,395  5,107,395  
Convertible preferred stock warrants 735,760  735,760 
Common stock warrants923,857 974,350 923,857 974,350 
Private and Public Placement Warrants14,750,000  14,750,000  
Earn-Out Shares13,999,960  13,999,960  
Shares subject to repurchase 320,589  320,589 
Total Net loss per share attributable to common stockholders, basic and diluted59,416,899 144,964,182 59,416,899 144,964,182 
12.    Subsequent Events
On July 18, 2022, Grove entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with an affiliate of Yorkville Advisors Global, LP (“Yorkville”), enabling the Company to sell up to $100 million of shares of Class A common stock to Yorkville at the Company’s request during the 36 months following the execution of the Purchase Agreement, subject to certain conditions. As of August 11, 2022, the conditions precedent allowing the Company to sell shares under the Purchase Agreement have not yet been met.

31


Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our Registration Statement filed on May 17, 2022, including the audited financial statements of Grove Collaborative, Inc. (referred to as “Legacy Grove” herein) as of December 31, 2019, 2020 and 2021 and Management's Discussion and Analysis of Financial Condition and Results of Operations included therein, as well as the accompanying unaudited condensed consolidated financial statements and notes thereto included in this Form 10-Q.

In addition to historical information, this discussion and analysis contains forward-looking statements. These forward-looking statements are subject to risks and uncertainties, including those discussed in the section titled “Risk Factors” of this Form 10-Q, that could cause actual results to differ materially from historical results or anticipated results. Unless the context otherwise requires, references in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” to the "Grove," “we,” “us,” and “our” refer to Grove Collaborative Holding, Inc., a Delaware corporation formerly known as Virgin Group Acquisition Corp. II., and its consolidated subsidiary. References to Virgin Group Acquisition Corp. II. or "VGAC II" refer to the Company prior to the consummation of the Business Combination.
OVERVIEW

Grove Collaborative Holdings, Inc., formally Virgin Group Acquisition Corp. II is a digital-first, sustainability-oriented consumer products innovator. We use our connection with consumers to create and curate authentic, disruptive brands and products. Grove builds natural products that perform as well as or better than many leading CPG brands (both conventional and natural), while being healthier for consumers and the planet.
Our omnichannel distribution strategy enables us to reach consumers where they want to shop. We operate an online direct-to-consumer website and mobile application (“DTC platform”) where we both sell our Grove-owned brands (“Grove Brands”) and partner with other leading natural and mission-based CPG brands, providing consumers the best selection of curated products across many categories and brands.

Grove is a public benefit corporation and a Certified B Corporation, meaning we adhere to third party standards for prioritizing social, environmental, and community wellbeing. We have a history of doing well by doing good, which is supported by our flywheel: as we have grown, our product development capabilities and data have improved. Over the long term, we believe that improved innovation grows both topline and expands margins as our innovation tends to be both market expanding and margin accretive. Since inception, we have grown rapidly and invested heavily in building out both our ecommerce platform and Grove Brands, and over this period we have operated at a loss and have an accumulated deficit of $572.8 million as of June 30, 2022. We anticipate that we will continue to incur losses in the future as we continue to invest in advertising and other strategic initiatives planned for future growth and as a result, we will need additional capital resources to fund our operations. Refer to Liquidity, Capital Resources and Requirements below for more information.
Reorganization
In March 2022, due to the ongoing impact of the pandemic, current market headwinds, and the steadfast commitment to building a sustainable business, we implemented a company-wide reorganization which included a reduction in our workforce of approximately 17% of corporate employees to reduce operating expenses and strengthen key strategic areas across the business. In connection with the reorganization, we recorded charges totaling $1.6 million in the six months ended June 30, 2022.
Business Combination

On June 16, 2022 (the “Closing Date”), we consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Grove Collaborative, Inc. (“Legacy Grove”) (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following
32

the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc. (together with the Merger and the Domestication, the “Business Combination”).

On December 7, 2021, concurrently with the execution of the Merger Agreement, VGAC II entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 8,707,500 shares of Class A Common Stock at $10.00 per share for aggregate gross proceeds of $87,075,000 (the “PIPE Investment”). 8,607,500 shares of Class A Common Stock has been issued for aggregate proceeds of $86,075,000, which consummated concurrently with the closing to the Business Combination.

On March 31, 2022, VGAC II entered into the a Subscription Agreement with Corvina Holdings Limited (the “Backstop Investor”), where the Backstop Investor agreed to purchase, on the closing date of the Business Combination, certain shares of Class A Common Stock at a purchase price of $10.00 per share (“Backstop Tranche 2 Shares”) for aggregate gross proceeds in an amount equal to (x) $22.5 million minus (y) the amount of aggregate cash remaining in VGAC II’s trust account, after deducting any amounts paid to VGAC II shareholders who exercise their redemption rights in connection with the Business Combination.

We completed the Business Combination and PIPE Investment on June 16, 2022, pursuant to which we received total gross proceeds of $97.1 million, including proceeds from the issuance of Backstop Tranche 2 Shares.
Key Factors Affecting Our Operating Performance
We believe that the growth of our business and our future success are dependent on many factors. While each of these factors presents significant opportunities for us, they also pose important challenges that we must successfully address to enable us to sustain the growth of our business and improve our operations while staying true to our mission, including those discussed below and in the section entitled “Risk Factors”.
Ability To Grow our Brand Awareness
Our brand is integral to the growth of our business and is essential to our ability to engage with our community. Our performance will depend on our ability to attract new customers and encourage consumer spending across our product portfolio. We believe the core elements of continuing to grow our awareness, and thus increase our penetration, are highlighting our products’ qualities of being natural, sustainable and effective, the efficacy of our marketing efforts and the success of our continued retail rollout. Beyond preserving the integrity of our brand, our performance will depend on our ability to augment our reach and increase the number of consumers aware of Grove and our product portfolio.
Ability to Continue to Innovate in Products and Packaging
Our continued product innovation is integral to our future growth. We have successfully developed and launched over 500 individual products in recent years. The research, development, testing and improvement has been led by our R&D team, which includes experienced chemists and formulators, who work closely with our Sustainability team. These new and innovative products, as well as our focus on environmentally responsible packaging, have been key drivers of our value proposition to date. An important element of our product development strategy is our ability to engage directly with customers through our DTC platform to assess demand and market preferences. To the extent our customers increasingly access our products through retail channels, we will need to innovate our modalities of customer engagement to maintain this important feedback loop. Our continued success in research and development and ability to assess customer needs and develop sustainable and effective products will be central to attracting and retaining consumers in the future and to growing our market penetration and our impact on human and environmental health.
Ability to Expand our Retail Distribution
We have a significant opportunity to expand our distribution in retail channels, both broadening our partner reach and introducing our products across more doors, as well as deepening our retail distribution in terms of the number of individual products. Our success and speed of doing so will impact our financial performance. We will pursue partnerships with a wide variety of retailers, including big-box retailers, online retailers, grocery stores, drugstores and specialty retailers. Our ability to execute this strategy will depend on a number of factors, such as retailers’ satisfaction with the sales and profitability of our products. In the near-term, retail expansion will require partnerships with retailers on launches and we may choose to invest in promotions to drive sales and awareness over time. To the extent we are successful in retail expansion over the next several years, we expect to see potential negative effects on gross margins resulting from the retail
33

cost structure to be approximately offset by savings in fulfillment costs driven by bulk shipping to retailers versus individualized fulfillment to consumers, through our fulfillment centers.
Cost-Efficient Acquisition of New Customers and Retention of Existing Customers on our DTC Platform
Our ability to attract new customers is a key factor for our future growth. To date we have successfully acquired new customers through many online and offline marketing channels. As a result, revenue has increased each year since our launch through fiscal 2021. In recent periods, changes in the algorithms used for targeting and purchasing online advertising, changes to privacy and online tracking, supply and demand dynamics in the market, and other factors have caused the cost of marketing on these channels to increase consistently. Failure to effectively adapt to changes in online marketing dynamics or otherwise to attract customers on a cost- efficient basis would adversely impact our path to profitability and operating results. We have several initiatives underway that we believe may lower marketing and customer acquisition cost, but these may not be successful and our inability to drive success in new marketing initiatives would adversely impact our profitability and operating results.
In 2020, new customer acquisition, customer acquisition cost, average order value, promotion rates, and growth in order volume by cohort were favorably impacted to a substantial degree by the onset of the COVID-19 pandemic. This was driven both by the increasing use of DTC platform by customers sheltering in place and by substantially higher demand for many of our product categories, especially personal care and household paper and cleaning products. After several years of annual revenue growth, our revenues in the three months and six months ended June 30, 2022 were approximately 20% and 16%, lower than in the prior year comparative periods, respectively, reflecting the challenges that the industry faces as a result of customers buying behaviors reverting to pre-pandemic levels. While we continue to believe that there are long term growth trends in the zero-waste industry and that we will be able to continue to grow our business in the long run, post-pandemic consumer behavior patterns and macro-economic factors will continue to be a risk to our business and will adversely impact our financial performance.
The future activity level and profitability of our DTC customer base will depend on our ability to continue to offer a compelling value proposition to consumers including strong selection, pricing, customer service, smooth and compelling web and mobile app experience, fast and reliable fulfillment, and curation within natural and sustainable products. Our success is also dependent on our ability to maintain relevance with our consumers on a regular basis through high performing products and a consumer-friendly refill and fulfillment process, and most importantly to provide consumers with products that consistently outperform their expectations. Our ability to execute on these key value-driving areas for consumers, and to remain competitive and compelling in a post-pandemic landscape, are necessary for our future growth. Failure to achieve these things would materially impact our operating results and financial performance.
Ability to Drive Operating Efficiency and Leverage as We Scale
We believe we are in the early stages of realizing a substantial opportunity to transform the consumer products industry into a force for human and environmental good by relentlessly creating and curating planet- first, high-performance brands and products. We have made substantial operating and capital expenditures to build our operations for this opportunity and believe that realization will require sustained levels of investment for the foreseeable future. To achieve profitability over the longer term, we will need to leverage economies of scale in sourcing our products, generating brand awareness, acquiring customers, creating operating leverage over headcount and other overhead, and fulfilling orders. Our retail strategy is designed, in part, to help accelerate achievement of this scale, as we leverage the retail presence of our partners and minimize the fulfillment costs associated with our DTC platform and create new revenue streams for our product development efforts. However, we believe that maintaining our DTC presence will remain a key driver of our product innovation and customer satisfaction strategies and serves the need of an important and growing group of consumers that wants to shop online. If we are unable to achieve sufficient operating leverage in our business, we may need to curtail our expenditures, which would in turn compromise our prospects for growth and or negatively impact our ability to operate profitably.
Impact of COVID-19
The global COVID-19 pandemic has impacted and will continue to impact our operating results, financial condition and cash flows.
We have implemented a number of measures to protect the health and safety of our workforce. These measures include substantial modifications to employee travel, employee work locations, and virtualization or cancellation of in-person meetings, among other modifications. In our fulfillment centers, as well as for the staff employees who work in our
34

offices, we are following the guidance from public health officials and applicable government agencies, including implementation of enhanced cleaning measures, social distancing guidelines and the wearing of masks.
During the height of the COVID-19 outbreak in Q2 and Q3 2020, we perceived a marked increase in the attention and demand for our products, especially personal care and household paper and cleaning products. At the same time, the pandemic caused significant uncertainty in the overall business environment, including risks to business continuity in our fulfillment centers, as well as in inbound freight and inventory supply disruptions. We navigated this situation by significantly reducing our expenses for paid customer acquisition, while investing in the health and safety of our employees.
The inventory supply challenges adversely affected revenue due to an above-average out-of-stock rate. We responded to this and the ongoing challenges in global logistics by temporarily building up an increased level of inventory that can absorb more unpredictability within our inbound freight procurement processes. We continue to work with our existing manufacturing, logistics and other supply chain partners to ensure our ability to service our customers. We recognize that the COVID-19 pandemic may impact the global supply chain in ways that negatively impact our ability to source our products and the cost at which we are able to source products. While we have a number of efforts in place to ensure we maintain strong service levels for our consumers, if we are unable to navigate cost inflation and supply chain disruptions it will have a material impact on our operating results and financial performance.
We believe that the COVID-19 pandemic led to an increase in revenue and profitability leading to better operating results in 2020. The positive drivers were the increase in unpaid new customer acquisition, in general a more favorable customer marketing environment with lower advertising cost, a reduced need for promotion, and a higher activity level of our existing customer base. These factors drove up both revenue and profitability and more than offset the operational and inventory challenges which we successfully navigated. As COVID restrictions were lifted and to the extent the pandemic continues to subside, the rate of growth experienced in 2020 did not continue into 2021, and in the six months ended June 30, 2022, our revenues were approximately 16% lower than the prior year comparative period.
The COVID-19 pandemic may have other adverse effects on our business, operations, and financial results and condition, including, among other things, adverse impacts on labor availability, our fulfillment center operations, supply chain and logistics disruptions, consumer behaviors, and on the overall economy, including recent high inflation levels impacting consumer spending. While most areas of the United States have reduced most or all COVID-19 restrictions, as the pandemic continues and if new outbreaks emerge, there remains uncertainty regarding the magnitude and duration of the economic and social effects of the COVID-19 pandemic, and therefore we cannot predict the full extent of the positive or negative impacts the pandemic will have on our business, operations, and financial results and condition in future periods. In particular, the positive trends on our operating results relating to changes in consumer behaviors relating to the pandemic that we have generally seen in 2020 did not continue into all of 2021, started declining in the later part of 2021, and could continue to decline in future periods.
Even after the COVID-19 pandemic subsides, we may experience materially adverse impacts to our business as a result of its economic impact. For additional discussion of COVID-19-related risks, see section entitled “Risk Factors”.
Key Operating and Financial Metrics
In addition to our financial statements, included elsewhere in this Form 10-Q, we assess the performance of our overall business based on the following metrics and measures, including identifying trends, formulating financial projections, making strategic decisions, assessing operational efficiencies and monitoring our business.
Over the coming years, we expect to grow our omnichannel presence both in core assortment, adjacent categories and channels.

We believe that the future of CPG brand building and consumer demand is omnichannel. Our DTC platform remains a core part of our strategy and customer value proposition in addition to providing key data and customer feedback driving our innovation process. We kicked off our expansion into brick and mortar retail in April 2021 with the launch of a curated assortment of Grove Co. products at Target, and recently announced entry into Kohl’s, Meijer, and Giant Eagle. As we aim to continue our leadership in both omnichannel and sustainability, we will aggressively expand our presence into physical retail over the next few years to reach more consumers no matter where they shop.
35

Our current operating metrics reflect our core strategic focus on growing our Grove Brands omnichannel presence and revenue, as well as our key DTC platform metrics.
Three Months Ended
June 30,
Six Months Ended
June 30,
(in thousands, except DTC Net Revenue Per Order and percentages)
2022
2021
2022
2021
Financial and Operating Data
Grove Brands % Net Revenue
48 %48 %50 %50 %
DTC Total Orders
1,315 1,694 2,874 3,480 
DTC Active Customers
1,564 1,733 1,564 1,733 
DTC Net Revenue Per Order
$58 $56 $57 $56 
Grove Brands % Net Revenue
We define Grove Brands % Net Revenue as total net revenue across all channels attributable to Grove Brands, including: Grove Co., Honu, Peach, Rooted Beauty, Grove Co. Paper (“previously named Seedling”) and Superbloom divided by our total net revenue. On our DTC Platform, our total net revenue includes revenue from both Grove Brands and third-party brands that we carry, whereas for our retail sales total net revenues is comprised exclusively of revenue from Grove Brand products. We view Grove Brands % Net Revenue as a key indicator of the success of our product innovation and growth strategy, and customers’ acceptance of our products.
DTC Total Orders
We determine our number of DTC Total Orders by counting the number of customer orders submitted through our website and mobile applications that have been shipped within the period. The metric includes orders that have been refunded, excludes reshipments of customer orders for any reason including damaged and missing products, and excludes retail orders. Refunded orders are included in DTC Total Orders as we believe this provides more meaningful order management performance metrics, including fulfillment cost efficacy and refund rates. Changes in DTC Total Orders in a reporting period capture both the inflow of new customers, changes in order frequency of existing customers and customer attrition. We view the number of Total DTC Orders as a key indicator of trends in our DTC platform, and our future success in this channel will depend in part on our ability to drive growth through new customer acquisition and by increasing existing customer engagement. In the three and six months ended June 30, 2022, DTC Total Orders declined due to softness in retention as the economy continues to emerge from the COVID-19 pandemic and due to our reduction in advertising spend. We expect this trend to continue at least into 2023.
DTC Active Customers
As of the last day of each reporting period, we determine our number of DTC Active Customers by counting the number of individual customers who submitted orders through our DTC platform, and for whom an order has shipped, at least once during the preceding 364-day period. The change in active customers in a reporting period captures both the inflow of new customers as well as the outflow of customers who have not made a purchase in the last 364 days. We view the number of active customers as one of the key indicators of our growth of our DTC channel. In the three and six months ended June 30, 2022, DTC Active Customers declined due to continued softness in retention as the economy continues to emerge from the COVID-19 pandemic and due to our reduction in advertising spend.
DTC Net Revenue Per Order
We define DTC Net Revenue Per Order as our DTC Total Net Revenue in a given reporting period, divided by the DTC Total Orders in that period. We view DTC Net Revenue per Order as a key indicator of the performance of our DTC business. DTC Net Revenue Per Order increased slightly in the three and six months ended June 30, 2022 compared to the prior year comparative periods.
Non-GAAP Financial Measures: Adjusted EBITDA and Adjusted EBITDA Margin
We prepare and present our financial statements in accordance with U.S. GAAP (“GAAP”). In addition, we believe that Adjusted EBITDA, when taken together with our financial results presented in accordance with GAAP, provides meaningful supplemental information regarding our operating performance and facilitates internal comparisons of our historical operating performance on a more consistent basis by excluding certain items that may not be indicative of our business, results of operations or outlook. For these reasons, management uses Adjusted EBITDA in evaluating our
36

operating performance and resource allocation and forecasting. As such, we believe Adjusted EBITDA provides investors with additional useful information in evaluating our performance.

We calculate adjusted EBITDA as net loss, adjusted to exclude: (1) stock-based compensation expense; (2) depreciation and amortization; (3) remeasurement of convertible preferred stock warrant liability; (4) changes in fair values of Additional Shares, Earn-out Shares and Public and Private Placement Warrant liabilities; (5) transaction costs allocated to derivative liabilities upon Business Combination; (6) interest expense; (7) provision for income taxes, (8) restructuring expenses and (9) loss on extinguishment on debt. We define Adjusted EBITDA Margin as Adjusted EBITDA divided by revenue. Because Adjusted EBITDA excludes these elements that are otherwise included in our GAAP financial results, this measure has limitations when compared to net loss determined in accordance with GAAP. Further, Adjusted EBITDA is not necessarily comparable to similarly titled measures used by other companies. For these reasons, investors should not consider Adjusted EBITDA in isolation from, or as a substitute for, net loss determined in accordance with GAAP.
The following table presents a reconciliation of net loss, the most directly comparable financial measure stated in accordance with GAAP, to adjusted EBITDA, for each of the periods presented.
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Reconciliation of Net Loss to Adjusted EBITDA
(in thousands)
Net loss$(35,310)$(28,516)$(82,694)$(66,411)
Stock-based compensation
20,074 3,809 24,534 7,269 
Depreciation and amortization
1,454 1,209 2,864 2,337 
Remeasurement of convertible preferred stock warrant liability
270 376 (1,616)1,308 
Change in fair value of Additional Shares liability2,015 — 2,015 — 
Change in fair value of Earn-Out liability(17,345)— (17,345)— 
Change in fair value of Public and Private Placement Warrants liability(1,180)— (1,180)— 
Transaction costs allocated to derivative liabilities upon Business Combination6,673 — 6,673 — 
Interest expense
2,285 1,096 4,372 2,059 
Restructuring expenses
— — 1,636 — 
Loss on extinguishment on debt— 1,027 — 1,027 
Provision for income taxes
16 25 28 
Total Adjusted EBITDA
$(21,062)$(20,983)$(60,716)$(52,383)
Net loss margin
(44.5)%(28.8)%(48.7)%(33.0)%
Adjusted EBITDA margin
(26.6)%(21.2)%(35.8)%(26.0)%
Components of Results of Operations
Revenue, Net
We generate revenue primarily from the sale of both third-party and our Grove Brands products through our DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by our recurring shipment recommendation engine, and featured products that appear in marketing on-site, in emails and on our mobile app. Most customers purchase a combination of products recommended by us based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. We also generate revenue from the sale of our Grove Brands products to the retail channel.
We recognize revenue from the sale of our products through our DTC platform net of discounts, sales tax, customer service credits and estimated refunds. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities.
37

Cost of Goods Sold
Cost of goods sold consists of the product costs of merchandise, inbound freight costs, vendor allowances, costs associated with inventory shrinkage and damages and inventory write-offs and related reserves.
Gross Profit and Gross Margin
Gross profit represents revenue less cost of goods sold. Gross margin is gross profit expressed as a percentage of revenue. We generally record higher gross margins associated with sales of Grove Brands products compared to sales of third-party products. To help induce first-time customers to purchase on our DTC platform, we generally offer higher discounts and free product offerings, and as a result our overall margins can be adversely affected in periods of rapid new customer acquisition. Our gross margin also fluctuates from period to period based on promotional activity, product and channel mix, the timing of promotions and launches, and in-bound transportation rates, among other factors. Our gross profit and gross margin may not be comparable with that of other retailers because we include certain fulfillment related costs in selling, general, and administrative expenses while other retailers may include these expenses in cost of merchandise sold.
Operating Expenses
Our operating expenses consist of advertising, product development, and selling, general and administrative expenses.
Advertising

Advertising expenses are expensed as incurred and consist primarily of our customer acquisition costs associated with online advertising, as well as advertising on television, direct mail campaigns and other media. Costs associated with the production of advertising are expensed when the first advertisement is shown. We expect advertising costs to decrease from the 2021 fiscal year as a result of cash flow and customer acquisition cost management.
Product Development
Product development expenses relate to the product and packaging innovation in our Grove Brands product lines and costs related to the ongoing support and maintenance of the Company’s proprietary technology, including the Company’s DTC platform, as well as amortization of capitalized internally developed software. Product development expenses consist primarily of personnel-related expenses, including salaries, bonuses, benefits and stock-based compensation expense. Product development costs also include allocated facilities, equipment, depreciation and overhead costs. We expect product development costs to be consistent from 2021 as a percentage of revenue as we balance our investments in the expansion of our product line, innovative packaging and product improvements with revenue growth.
Selling, General and Administrative

Selling, general and administrative expenses consist primarily of compensation and benefit costs for personnel involved in general corporate functions, including stock-based compensation expense, and certain fulfillment costs, as further outlined below. Selling, general and administrative expenses also include the allocated facilities, equipment, depreciation and overhead costs, marketing costs including qualified cost of credits issued through our referral program, costs associated with our customer service operation, costs of environmental offsets. While selling, general and administrative expenses have increased in recent periods as a result of activities related to the Business Combination and becoming a public company, we expect selling, general and administrative expense to decrease in the future, as we scale our fulfillment costs by adjusting capacity to changes in order volumes and our selling and administrative infrastructure, which will offset additional costs associated with operating as a public company.
Fulfillment costs represent those costs incurred in operating and staffing our fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packing and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packing materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative expenses in the statements of operations. We expect fulfillment costs to increase in the future on a per order basis primarily from shipping rate increases from our carriers.
Interest and Other Expense (Income), Net
Interest expense consists primarily of interest expense associated with our debt financing arrangements.
38


Other expense (income), net consists primarily of losses or gains on remeasurement of our convertible preferred stock warrant liabilities, changes in fair values of Additional Shares, Earn-Out Shares and Public and Private Placement Warrant liabilities, and transaction costs allocated to derivative liabilities upon Business Combination. These changes in fair value may fluctuate significantly in future periods primarily due to fluctuations in the fair value of our common stock.
Provision for Income Taxes
We account for income taxes under the asset and liability method, whereby deferred tax assets and liabilities are determined based on the difference between the financial statement and income tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. We recognize the benefits of tax-return positions in the financial statements when they are more likely than not to be sustained by the taxing authority, based on the technical merits at the reporting date. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments, and which may not accurately forecast actual outcomes. We recognize interest and penalties related to unrecognized tax benefits, if any, as income tax expense.
39

Results of Operations
The following table sets forth our results of operations for each period presented:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
(in thousands)
Revenue, net$79,279 $99,023 $169,758 $201,243 
Cost of goods sold40,322 49,957 88,064 99,985 
Gross profit38,957 49,066 81,694 101,258 
Operating expenses:
Advertising17,898 22,516 50,691 58,152 
Product development5,922 5,688 12,162 10,850 
Selling, general and administrative57,895 46,971 108,865 94,509 
Operating loss(42,758)(26,109)(90,024)(62,253)
Interest expense 2,285 1,096 4,372 2,059 
Loss on extinguishment on debt— 1,027 — 1,027 
Change in fair value of Additional Shares liability2,015 — 2,015 — 
Change in fair value of Earn-Out liability(17,345)— (17,345)— 
Change in fair value of Public and Private Placement Warrants liability(1,180)— (1,180)— 
Other expense, net 6,775 268 4,783 1,044 
Interest and other expense (income), net(7,450)2,391 (7,355)4,130 
Loss before provision for income taxes(35,308)(28,500)(82,669)(66,383)
Provision for income taxes16 25 28 
Net loss$(35,310)$(28,516)$(82,694)$(66,411)
The following table sets forth our statements of operations data expressed as a percentage of revenue:
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
(as a percentage of revenue)
Revenue, net100 %100 %100 %100 %
Cost of goods sold51 50 52 50 
Gross profit49 50 48 50 
Operating expenses:
Advertising23 23 30 29 
Product development
Selling, general and administrative73 47 64 47 
Operating loss(54)(26)(53)(31)
Interest expense
Loss on extinguishment on debt— — 
Change in fair value of Additional Shares liability— — 
Change in fair value of Earn-Out liability(22)— (10)— 
Change in fair value of Public and Private Placement Warrants liability(1)— (1)— 
Other expense, net — 
Interest and other expense (income), net(9)(4)
Loss before provision for income taxes(45)(29)(49)(33)
Provision for income taxes— — — — 
Net loss(45)%(29)%(49)%(33)%
40

Comparisons of the Three Months and Six Months Ended June 30, 2022 and June 30, 2021
Revenue, Net
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%

(in thousands)
Revenue, net:
Grove Brand$38,216 $47,469 $(9,253)(19)%$85,064 $99,754 $(14,690)(15)%
Third-party product41,063 51,554 (10,491)(20)%84,694 101,489 (16,795)(17)%
Total revenue, net$79,279 $99,023 $(19,744)(20)%$169,758 $201,243 $(31,485)(16)%
Revenue decreased by $19.7 million, or 20%, and $31.5 million, or 16% for the three and six months ended June 30, 2022, respectively, as compared to the three and six months ended June 30, 2021, primarily driven by a decrease in DTC Total Orders caused by a reduction in DTC Active Customers. We believe the decline in 2022 is due to continued softness in retention as the economy continues to emerge from the COVID-19 pandemic and due to our reduction in advertising spend, partially offset by increases in DTC Net Revenue Per Order.

Cost of Goods Sold and Gross Profit
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Cost of goods sold$40,322 $49,957 $(9,635)(19)%$88,064 $99,985 $(11,921)(12)%
Gross profit 38,957 49,066 (10,109)(21)%81,694 101,258 (19,564)(19)%
Gross margin49 %50 %(1)%48 %50 %(2)%
Cost of goods sold decreased by $9.6 million, or 19%, for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021, and decreased by $11.9 million, or 12%, for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021, primarily due to an overall decrease in DTC Total Orders.

Gross margin in the three months and six months ended June 30, 2022 decreased by 40 and 219 basis points, respectively, compared to the three months and six months ended June 30, 2021 primarily due to higher discounts offered to new and existing customers due to a less favorable environment as the COVID-19 pandemic subsides and an increase in in-bound freight costs.
Operating Expenses
Advertising Expenses
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Advertising
$17,898 $22,516 $(4,618)(21)%$50,691 $58,152 $(7,461)(13)%
Advertising expenses decreased by $4.6 million, or 21%, for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021, primarily due to our cash flow and customer acquisition cost management. Online advertising expenses decreased by $9.5 million. This was offset by an increase of $1.1 million in costs associated with the
41

production of advertising and $2.3 million in other advertising campaigns, including advertising focused specifically to attract retail consumers for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021.
Advertising expenses decreased by $7.5 million, or 13%, for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021, primarily due to our cash flow and customer acquisition cost management. Online advertising expenses decreased by $18.3 million. This was offset by an increase of $3.2 million in costs associated with the production of advertising, $1.5 million increase in television advertising expenses, and $5.5 million in other advertising campaigns, including advertising focused specifically to attract retail consumers for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021.
Product Development Expenses
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Product development
$5,922 $5,688 $234 %$12,162 $10,850 $1,312 12 %

Product development expenses increased by $0.2 million, or 4% for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021, primarily due to $1.0 million catch up of stock based compensation related expense due to the Company going public thereby meeting the performance vesting condition and $0.3 million increase in amortization of internally developed software, offset by $1.0 million decrease in salaries primarily from a reduction in headcount as a result of the company-wide reorganization that occurred in March 2022.

Product development expenses increased by $1.3 million, or 12% for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021, primarily due to $1.0 million catch up of stock based compensation related expense due to the Company going public thereby meeting the performance vesting condition, $0.6 million increase in restructuring related expenses as a result of the company-wide reorganization and $0.5 million increase in amortization of internally developed software, offset by $0.5 million decrease in salaries and benefit primarily from a reduction in headcount as a result of the company-wide reorganization that occurred in March 2022.
Selling, General and Administrative Expenses
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Selling, general and administrative
$57,895 $46,971 $10,924 23 %$108,865 $94,509 $14,356 15 %

Selling, general and administrative expenses increased by $10.9 million, or 23% for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021. The increase was primarily driven by an increase of $14.6 million in stock based compensation due to catch up of expense for the Company’s restricted stock units and certain stock options as a result of meeting the performance vesting condition when the Company went public, including $0.6 million related to equity award modification expenses. Fulfillment costs decreased by $3.3 million, including $1.0 million decrease in shipping and handling expenses and a $1.3 million decrease in Fulfillment Labor. The decrease in shipping and handling expenses was driven by a decrease in the volume of orders partially offset by an increase in carrier rates. The decrease in Fulfillment Labor was due to decrease in the volume of orders and efficiencies gained, partially offset by expanded investments in wages and benefits for fulfillment members. Facilities expenses and other general and administrative expenses, excluding stock-based compensation, decreased by $0.4 million, primarily due to decrease in corporate salaries and benefits primarily from a reduction in headcount as a result of the company-wide reorganization, partially offset by an increase in costs related to being a public company.

Selling, general and administrative expenses increased by $14.4 million, or 15% for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021. The increase was primarily driven by an increase of $15.7
42

million in stock based compensation partially due to catch up of expense for the Company’s restricted stock units and certain stock options as a result of meeting the performance vesting condition when the Company went public, including $1.7 million related to equity award modification expenses as a result of the company-wide reorganization. Fulfillment costs decreased by $4.1 million, including $1.8 million decrease in shipping and handling expenses and a $1.0 million decrease in Fulfillment Labor. The decrease in shipping and handling expenses was driven by a decrease in the volume of orders partially offset by an increase in carrier rates. The decrease in Fulfillment Labor was due to decrease in the volume of orders, offset by expanded investments in wages and benefits for fulfillment members and efficiencies gained. In addition, facilities expenses and other general and administrative expenses, excluding stock-based compensation, increased by $2.8 million, primarily due to increased corporate salaries and benefits, including $1.0 million in restructuring related expenses as a result of the company-wide reorganization, and an increase in costs related to being a public company.
Interest expense
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Interest expense
$2,285 $1,096 $1,189 108 %$4,372 $2,059 $2,313 112 %

Interest expense increased by $1.2 million, or 108% and $2.3 million, or 112% for the three and six months ended June 30, 2022 as compared to the three and six months ended June 30, 2021 primarily due to draws under the SVB and Hercules Term Loan in the second half of 2021. See the section titled “Liquidity and Capital Resources — Loan Facilities” below for further details.
Loss on extinguishment of debt

Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Loss on extinguishment of debt
$— $1,027 $1,027 *$— $1,027 $1,027 *
______________
* Percentage change not meaningful.

Loss on extinguishment of debt resulted from refinancing of certain of our loan facilities during the six months ended June 30, 2021. See the section titled “Liquidity and Capital Resources—Loan Facilities” below for further details.
Other expense (income), net
Three Months Ended
June 30,
Change Six Months Ended
June 30,
Change
20222021Amount %20222021Amount%
(in thousands)
Change in fair value of Additional Shares liability$2,015 $— $2,015 *$2,015 $— $2,015 *
Change in fair value of Earn-Out liability(17,345)— (17,345)*(17,345)— (17,345)*
Change in fair value of Public and Private Placement Warrants liability(1,180)— (1,180)*(1,180)— (1,180)*
Other expense, net $6,775 $268 $6,507 *$4,783 $1,044 $3,739 *
______________
* Percentage change not meaningful.
43


The change in the fair value of Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants liability for the three and six months ended June 30, 2022 was driven by the decrease in our stock price from the Closing of the Business Combination to June 30, 2022.

Other expense, net increased by $6.5 million for the three months ended June 30, 2022 as compared to the three months ended June 30, 2021 primarily due to a $6.7 million expense related to transaction costs that were allocated to liability classified derivative liabilities as a result of the Company going public.

Other expense, net increased by $3.7 million for the six months ended June 30, 2022 as compared to the six months ended June 30, 2021, primarily due to a $6.7 million expense related to transaction costs that were allocated to liability classified derivative liabilities as a result of the Company going public partially offset by a $2.9 million gain on remeasurement of preferred stock warrant liability.
44

Liquidity, Capital Resources and Requirements

As of June 30, 2022, we had $132.4 million of cash and cash equivalents, an accumulated deficit of approximately $572.8 million, working capital of $94.9 million and incurred negative cash flows from operating activities of $66.1 million for the six months ended June 30, 2022. To date, we have funded our operations principally through convertible preferred stock and contingently redeemable convertible common stock financings, the incurrence of debt and the Closing of the Business Combination. We received cash proceeds, net of transaction costs from the Closing of the Business Combination on June 16, 2022 of $80.0 million. We have total outstanding indebtedness of $66.4 million as of June 30, 2022. On July 18, 2022, we entered into the Purchase Agreement, whereby we have the right, but not the obligation, to sell to the Selling Holder up to $100.0 million of our shares of common stock at our request until July 18, 2025, subject to certain conditions.

Management believes that currently available resources will provide sufficient funds to enable the Company to meet its obligations for at least one year past the date these condensed consolidated financial statements are available to be issued. We anticipate that we will continue to incur operating losses and generate negative cash flows from operations in the future as we continue to invest in advertising and other strategic incentives planned for future growth. Cash from operations could also be affected by our customers and other risks detailed in the section of our titled “Risk Factors.” As a result, we will need additional capital resources to execute strategic initiatives and fund our operations, prior to achieving break even or positive operating cashflow. We expect to continue to opportunistically seek access to additional funds by utilizing the Purchase Agreement, through additional public or private equity offerings or debt financings, through partnering or other strategic arrangements, through the exercise of certain of our warrants, or a combination of the foregoing. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.

Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide, including the trading price of common stock. To the extent that we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution. Debt financing arrangements may require us to pledge certain assets or enter into covenants that could restrict our operations or our ability to pay dividends or other distributions on our common stock or incur further indebtedness. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. In addition, our Class A Common Stock trading price may not exceed the respective exercise prices of our Public Warrants, Private Placement Warrants and/or our Legacy Grove Warrants before the respective warrants expire, and therefore we may not receive any proceeds from the exercise of warrants to fund our operations. If we are unable to raise additional capital when desired, our business, results of operations, and financial condition would be materially and adversely affected.


45

Contractual Obligations and Other Commitments
Our most significant contractual obligations relate to our loan facilities, purchase commitments on inventory and operating lease obligations on our fulfillment centers and corporate offices. As of June 30, 2022, we had $27.0 million of enforceable and legally binding inventory purchase commitments predominantly due within one year. For information on our contractual obligations for operating leases, please see “Leases” in Note 7 of the Notes to our audited financial statements as of and for the years ended December 31, 2019, 2020 and 2021 included in the proxy statement/consent solicitation statement/prospectus filed with the SEC on May 16, 2022.
Loan Facilities
Silicon Valley Bank Loan Facilities
In December 2016, we entered into a loan and security agreement (the “SVB Loan Facility”) with Silicon Valley Bank (“SVB”). The terms of the SVB Loan Facility, as amended and restated, provided for: (i) a revolving line of credit not to exceed $25.0 million (“Loan Revolver”), (ii) growth capital advance (“Term Loan”) of $3.9 million and (iii) a letter of credit sublimit of $6.0 million. The Term Loan had a maturity date in December 2022 and bore interest at Prime Rate, payable monthly. The Loan Revolver borrowing capacity was limited to 60% of eligible inventory balances.
In April 2021, we entered into an amendment to the SVB Loan Facility. The terms of the amendment provided for the Loan Revolver letter of credit sublimit to increase to $10.0 million and an increased borrowing capacity to 65% of eligible inventory balances. The Loan Revolver borrowing capacity is reduced by outstanding letters of credit and credit available to the Company from certain credit card facilities, which amounted to $3.1 million and $1.5 million, respectively, as of December 31, 2021. The Loan Revolver incurs a facility fee of 0.20% per annum assessed on the daily average undrawn portion of revolving line of credit. The amended Loan Revolver bears an interest rate equal to the greater of prime rate or 3.25% and matures on March 31, 2023. Interests on the Loan Revolver is payable monthly in arrears. In April 2021, all of our outstanding borrowings under the SVB Term Loan were refinanced directly through the SVB and Hercules Loan Facility (see below).
The SVB Loan Facility is collateralized by substantially all of our assets on a first priority basis and contains customary events of default and covenants that restrict our ability to, among other things, incur additional indebtedness, other than permitted indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends, or repurchase stock, subject to customary exceptions. The SVB Loan Facility contains a financial covenant which requires us to maintain minimum liquidity of $45.0 million. Minimum liquidity is defined as the sum of the aggregate amount of unrestricted and unencumbered cash deposited with SVB plus amounts available to be drawn under the loan revolver, as adjusted for any outstanding standby letters of credit issued by SVB.
As of June 30, 2022, we were in compliance with all covenants and had $5.9 million outstanding under the Loan Revolver. The effective interest rate is 5.00% on the revolving line of credit.
Silicon Valley Bank and Hercules Loan Facility
In April 2021, we entered into a Mezzanine Loan and Security Agreement (“SVB and Hercules Loan Facility”) with SVB and Hercules Capital, Inc. (“Hercules”). The SVB and Hercules Loan Facility provides for a draw period, which runs from the effective date until March 31, 2022, for advances of up to $60.0 million. In April 2021, we drew $25.0 million, which was used to directly settle the amounts outstanding under the SVB Term Loan and the Triplepoint Loan Facility (see below). In September and December 2021, we drew down the remaining additional borrowings of $25.0 and $10.0 million, respectively, on the SVB and Hercules Loan Facility. The SVB and Hercules Loan Facility bears interest at the greater of 8.75% or prime plus 5.5%, payable monthly. The principal repayment period commences on November 1, 2022 and continues for 30 monthly installments with an additional final payment equal to 6.75% of the aggregate term loan advances. SVB and Hercules have committed to fund 51.0% and 49.0%, respectively, of all draws made under the SVB and Hercules Loan Facility.

In May 2022, as part of the Closing of the Business Combination, the Company entered into an amendment with SVB and Hercules Loan Facility to increase the final payment from 6.75% to 8.75% of the aggregate term loan advances. Total fees paid for the amendment, including bank legal fees was $0.2 million.
The SVB and Hercules Loan Facility is collateralized on a second priority basis, subordinate to the SVB Loan Facility, by substantially all of our assets and contains restrictive covenants that are substantially similar to the SVB Loan Facility. The SVB and Hercules Loan Facility does not include any financial covenants, but does contain a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business,
46

operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, we have provided SVB and Hercules with periodic financial statements and projections to facilitate their ongoing assessment company performance. We believe the likelihood that SVB and Hercules would exercise the subjective acceleration clause is remote.
As of June 30, 2022, we owe an aggregate of $60.0 million outstanding under the SVB and Hercules Loan Facility with effective interest rates ranging from 14.26% to 17.31%. As of June 30, 2022, we were in compliance with all covenants under the SVB and Hercules Loan Facility.
Atel Loan Facility
In July 2018, we entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) to fund purchases of machinery and warehouse equipment that are held as collateral under the Atel Loan Facility.
As of June 30, 2022, we had an aggregate of $1.2 million outstanding borrowing under the Atel Loan Facility through two separate loan draws that will be fully repaid in April 2023, and May 2023, respectively. As of June 30, 2022, we were in compliance with all of our covenants under the Atel Loan Facility.
47

Cash Flows
The following table summarizes our cash flows for the periods presented:
Six Months Ended
June 30,
20222021
(in thousands)
Net cash used in operating activities$(66,138)$(61,799)
Net cash used in investing activities(2,610)(2,845)
Net cash provided by financing activities122,765 849 
Net increase (decrease) in cash and cash equivalents$54,017 $(63,795)

Operating Activities
Net cash used in operating activities increased by $4.3 million for the six months ended June 30, 2022 compared to June 30, 2021, primarily attributable to an increase in net loss of $16.3 million. The increase in net loss was primarily driven by a decrease in net revenue resulting from decreased DTC Total Orders and DTC Active Customers. This was offset by a cash inflow related to changes in operating assets and liabilities of $8.2 million, from decreases in inventory and prepaids and other assets, offset by increase in accrued expenses due to timing of invoices from and payments to our vendors and suppliers and a $3.7 million increase in non-cash charges including an increase of stock based compensation expense of $17.3 million offset by a decrease in fair value of derivative liabilities of $16.5 million.
Investing Activities
Net cash used in investing activities of $2.6 million and $2.8 million for the six months ended June 30, 2022 and 2021, respectively was due to purchases of property and equipment.
Financing Activities
Net cash provided by financing activities of $122.8 million for the six months ended June 30, 2022 primarily consisted of proceeds of $97.1 million from issuance of common stock upon the Closing of the Business Combination, including proceeds from PIPE financing, and proceeds from issuance of contingently redeemable convertible common stock of $27.5 million, partially offset by $1.3 million payment of transaction issuance costs.
Net cash provided by financing activities of $0.8 million for the six months ended June 30, 2021 primarily consisted of proceeds from issuance of debt of $25.0 million, offset by repayment of debt of $21.2 million, payment of debt extinguishment of $2.5 million, payment of debt issuance costs of $0.4 million.
Off-Balance Sheet Arrangements
We did not have during the periods presented, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
Critical Accounting Estimates
Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with GAAP. The preparation of our financial statements and related disclosures requires us to make estimates, assumptions and judgments that can have a significant impact on the amounts reported in those financial statements and accompanying notes. We believe that the estimates, assumptions and judgments involved in the accounting policies described below have the greatest potential impact on our financial statements and, therefore, we consider these to be our critical accounting policies. Accordingly, we evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions and conditions. Our significant accounting policies are described in Note 2 to our audited financial statements as of and for the years ended December 31, 2019, 2020 and 2021 included in the proxy statement/consent solicitation statement/prospectus filed with the SEC on May 16, 2022, with the addition of Earn-Out Share Liability and Additional Share Liability below.
48


Earn-Out Share Liability
At the closing of the Business Combination, certain Legacy Grove shareholders were issued an aggregate of 13,999,960 shares of Grove Class B Common Stock (“Earn-Out Shares”). Such shares are subject to vesting and forfeitures based upon certain triggering events that can occur during a period of ten years following the closing of the Business Combination (the “Earn-Out Period”). The triggering events that will result in the vesting of the Grove Earn-Out Shares during the Earn-Out Period are the following:

• 7,000,173 shares will vest if the share price of New Grove Class A Common Stock is greater than or equal to $12.50 over any 20 trading days within any consecutive 30 trading day period during the Earn-Out Period;

• 6,999,787 shares will vest, including the shares subject to the $12.50 threshold if not previously vested, if the share price of New Grove Class A Common Stock is greater than or equal to $15.00 over any 20 trading days within any 30 consecutive trading day period during the Earn-Out Period; and

• If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.

If, at any time prior to the expiration of the Earn-Out Period, any holder of Grove Earn-Out Shares forfeits all or any portion of such holder’s Grove options and restricted stock units, all unvested Grove Earn-Out Shares issued to such holder with respect to any such awards shall be automatically forfeited to the Company and distributed to the other holders of Legacy Grove securities as of immediately prior to the closing of the Business Combination on a pro rata basis.

Earn-Out shares which are subject to a service condition are accounted for under ASC 718. See Note 3—Recapitalization and Note 4— Fair Value Measurements and Fair Value of Financial Instruments.

Earn-Out Shares which are not subject to service conditions were accounted for as liability classified instruments in accordance with ASC 815-40, as such shares were not solely indexed to the common stock of the Company and the events that determine the number of Earn-Out Shares required to vest include events that are not solely indexed to the fair value of common stock of the Company. Such Earn-Out Shares will be measured at fair value at each reporting date until they are settled or meet the criteria for equity classification, and changes in the fair value will be recorded in the unaudited condensed consolidated statements of operations. The fair value of the Earn-Out Shares liability is estimated using the Monte Carlo simulation of the stock prices based on historical and implied market volatility of a peer group of public companies.

The Company has historically been a private company and has limited company-specific historical and implied volatility information. Accordingly, the volatility assumption used in the model is subjective and requires significant management judgment. Management estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments that will be recorded in the Company’s unaudited condensed consolidated statements of operations.

Additional Shares Liability
At closing of the Business Combination and in connection with the Backstop Subscription Agreement, Legacy Grove committed to issue additional shares of Grove Class A Common Stock to the Backstop Investor if the volume weighted average price of Grove Class A Common Stock is less than $10.00 during the 10 trading days commencing on the first trading day after New Grove’s first quarterly earnings call for the fiscal quarter ending June 30, 2022 (“Additional Shares”). The Backstop Investor shall be entitled to receive additional Grove Class A Common Shares equal to the lesser of (i) the product of (x) the sum of (1) the Grove Class B Common Shares issued to Subscriber at the Business Combination Closing pursuant to the Business Combination Agreement as consideration for the Tranche 1 Shares and (2) the Tranche 2 Shares multiplied by (y) a fraction, (A) the numerator of which is $10.00 (as adjusted for any stock split, reverse stock split or similar adjustment following the Business Combination Closing) minus the Measurement Period VWAP, and (B) the denominator of which is the Measurement Period VWAP and (ii) the number of Post-Combination VGAC Shares outstanding as of immediately following the Business Combination Closing.


49

The Additional Shares are accounted for as a liability classified instrument under ASC 480 as the fair value of the obligation to issue the Additional Shares varies inversely to the fair value of the Company’s common stock. The Additional Shares liability will be measured at each reporting date until settled. Change in the fair value will be recorded in the unaudited condensed consolidated statements of operations.

The Company has historically been a private company and has limited company-specific historical and implied volatility information. Accordingly, the volatility assumption used in the model is subjective and requires significant management judgment. Management estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments that will be recorded in the Company’s unaudited condensed consolidated statements of operations.

Inventories
Inventory is recorded at the lower of weighted average cost and net realizable value. The cost of inventory consists of merchandise costs and in-bound freight, net of any vendor allowances. Inventory valuation requires us to make judgments, based on currently available information, about the likely method of disposition, such as through sales to individual customers or liquidations, and expected recoverable values of each disposition category. We record inventory reserves based on the excess of the carrying value or average cost over the amount we expect to realize from the ultimate sale of the inventory.
Stock-Based Compensation
We recognize the cost of share-based awards granted to employees and non-employees based on the estimated grant-date fair value of the awards.
For stock option awards with service only vesting conditions, we recognize expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. We estimate the grant-date fair value of the stock option awards with service only vesting conditions using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model utilizes inputs and assumptions which involve inherent uncertainties and generally require significant judgment. As a result, if factors or expected outcomes change and significantly different assumptions or estimates are used, our stock-based compensation could be materially different. Significant inputs and assumptions include:
Fair value of Common Stock – As our common stock is not currently publicly traded, the fair value of our underlying common stock was determined by our board of directors based upon a number of objective and subjective factors, as described in the section titled “—Common Stock Valuation” below.
Expected Term – Our expected term represents the period that our stock-based awards are expected to be outstanding and is determined using the simplified method (based on the mid-point between the vesting date and the end of the contractual term).
Expected Volatility – Because we are privately held and there is no active trading market for our common stock, the expected volatility was estimated based on the average volatility for publicly traded companies that we consider to be comparable, over a period equal to the expected term of the stock option grants.
Risk-Free Interest Rate – The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of option.
Expected Dividend – We have never paid dividends on our common stock and has no plans to pay dividends on our common stock. Therefore, we used an expected dividend yield of zero.
For restricted stock unit (“RSU”) awards with performance vesting conditions, we evaluate the probability of achieving the performance vesting condition at each reporting date. We begin to recognize expense for RSUs with performance vesting conditions using an accelerated attribution method on June 16, 2022 when the performance condition was met. The fair value of RSU awards is determined using the price of our common stock on the grant date, as determined by our board of directors.
For awards with both market and service vesting conditions, we recognize expense over the derived service period using an accelerated attribution method. The fair value of stock option awards with both market and performance conditions is estimated using multifactor Monte Carlo simulations. The Monte Carlo simulation model incorporates the probability of satisfying a market condition and utilizes inputs and assumptions which involve inherent uncertainties and
50

generally require significant judgment, including our stock price, contractual terms, maturity and risk-free interest rates, as well as volatility.
Common Stock Valuation
Given the absence of a public market of our common stock, and in accordance with the American Institute of Certified Public Accountants, Valuation of Privately-Held-Company Equity Securities Issued as Compensation, our board of directors exercises significant judgment and considers numerous factors to determine the best estimate of fair value of our common stock, including the following:
independent third-party valuations of our common stock;
the rights, preferences and privileges of our redeemable convertible preferred stock relative to our common stock;
our operating results, financial position and capital resources;
our stage of development and current business conditions and projections, including the introduction of new products;
the lack of marketability of our common stock;
the hiring of key personnel and the experience of our management;
the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company given the prevailing market conditions;
and the nature and history of our business;
industry trends and competitive environment;
trends in consumer spending, including consumer confidence; and
the overall economic, regulatory and capital market conditions.
For common stock valuations performed prior to March 31, 2022, we performed valuations of our common stock that took into account the factors described above. We primarily used a combination of the market and income approach to determine the equity value of our business. The income approach estimates equity value based on the expectation of future cash flows that a company will generate. These future cash flows, and an assumed terminal value, are discounted to their present values using a discount rate based on a weighted-average cost of capital that reflects the risks inherent in the cash flows. The market approach estimates equity value based on a comparison of the subject company to comparable public companies in a similar line of business. From the comparable companies, a representative market value multiple is determined and then applied to the subject company’s financial forecasts to estimate the value of the subject company. The resulting common stock value is then discounted by a non-marketability factor. Public company trading revenue multiple comparisons provide a quantitative analysis that our board of directors’ reviews in addition to the qualitative factors described above in order to determine the fair value of our common stock.
Application of these approaches involves the use of estimates, judgment, and assumptions that are highly complex and subjective, such as those regarding our expected future revenue, expenses, and future cash flows, discount rates, market multiples, the selection of comparable companies and the probability of possible future events. Changes in any or all of these estimates and assumptions or the relationships between those assumptions impact our valuations as of each valuation date and may have a material impact on the valuation of our common stock.

For the common stock valuation performed as of March 31, 2022, we used the Backstop Subscription Agreement as an initial indication of value of our common stock, as this was an arms-length length transaction with a sophisticated investor. Our common share value was modified and iterated so that the aggregate value of each component of the transactions contemplated by the Backstop Subscription Agreement summed to the total consideration paid by the investor. When determining the value of each component, we assumed maximum redemptions of common stock prior to the Mergers, based on redemption rates of companies that have recently become a public company through a SPAC transaction (i.e. Inspirato Incorporated and Sonder Holdings Inc.). We also assumed 100% probability that the Mergers would occur because, in connection with the execution with the Backstop Subscription Agreement, we waived the condition to the consummation of the Mergers requiring that the aggregate cash proceeds from VGAC II’s trust account, together with the proceeds from the issuance and sale of an aggregate of 8,707,500 shares of New Grove Class A Common Stock at a price
51

of $10.00 from certain investors, equal no less than $175,000,000 (after deducting any amounts paid to VGAC II shareholders that exercise their redemption rights in connection with the Business Combination).
For valuations after the Business Combination, our board of directors will determine the fair value of each share of underlying common stock based on the closing price of our common stock as reported on the date of grant. Future expense amounts for any particular period could be affected by changes in our assumptions or market conditions.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. Controls and Procedures
Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate to allow timely decisions regarding required disclosure. The Company evaluated, with the participation of the current chief executive officer and chief financial officer (the “Company’s Certifying Officers”), the effectiveness of the Company’s disclosure controls and procedures as of June 30, 2022, pursuant to Rule 13a-15(b) under the Exchange Act. Based on this evaluation, the Company’s Certifying Officers concluded that, at June 30, 2022, our disclosure controls and procedures were effective at the reasonable assurance level.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the six months ended June 30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Limitations on the Effectiveness of Controls
The Company does not expect that its disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
52

Part II - Other Information
Item 1. Legal Proceedings
From time to time, we are subject to various claims, charges and litigation matters that arise in the ordinary course of business. We believe these actions are a normal incident of the nature and kind of business in which we are engaged. While it is not feasible to predict the outcome of these matters with certainty, we do not believe that any asserted or unasserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations or prospects.
As noted below in “Item 1A. Risk Factors”, the Consumer Protection Division of the Santa Clara County District Attorney’s Office, in conjunction with other county and city prosecutors, is currently investigating our automatic renewal practices, and the Federal Trade Commission is currently investigating our billing and automatic renewal practices. As of the date of this filing, no legal proceeding has commenced regarding these investigations.
Item 1A. Risk Factors

Investing in our securities involves risks. Before you make a decision to buy our securities, in addition to the risks and uncertainties discussed above under “Cautionary Note Regarding Forward-Looking Statements,” you should carefully consider the specific risks set forth herein. If any of these risks actually occur, it may materially harm our business, financial condition, liquidity and results of operations. As a result, the market price of our securities could decline, and you could lose all or part of your investment. Additionally, the risks and uncertainties described in this prospectus or any amendment or supplement to this prospectus are not the only risks and uncertainties that we face. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may become material and adversely affect our business.

Risks Related to Our Business

We rely on consumer discretionary spending, which may be adversely affected by economic downturns and other macroeconomic conditions or trends.

Our business depends on consumer discretionary spending. Some of the factors that may negatively influence consumer spending include high levels of unemployment; higher consumer debt levels; reductions in net worth, declines in asset values, and related market uncertainty; home foreclosures and reductions in home values; fluctuating interest rates and credit availability; global pandemics, including the COVID-19 pandemic and the loosening of restrictions as the pandemic conditions improve; fluctuating fuel and other energy costs; fluctuating commodity prices; the high rate of inflation and general uncertainty regarding the overall future political and economic environment. Furthermore, any increases in consumer discretionary spending during times of crisis may be temporary, such as those related to government stimulus programs or remote-work environments, and consumer spending may decrease when those programs or circumstances end. In addition, economic conditions in certain regions may be affected by natural disasters, such as hurricanes, tropical storms, earthquakes, and wildfires; other public health crises; and other major unforeseen events. Consumer purchases of discretionary items, including the merchandise that we offer, generally decline during recessionary periods or periods of economic uncertainty, when disposable income is reduced or when there is a reduction in consumer confidence. Any decline in consumer discretionary spending could negatively impact our revenue, which could have a material adverse effect on our business, financial condition and results of operations.

Our significant growth may not be indicative of our future growth and, if we continue to grow rapidly, we may not be able to effectively manage our growth or evaluate our future prospects. If we fail to effectively manage our future growth, our business could be adversely affected.

We have experienced significant growth since our launch in 2012. For example, our revenue grew from approximately $7 million in 2016 to $384 million in the year ended December 31, 2021. This growth has placed significant demands on our management, financial, operational, technological and other resources. The anticipated growth and expansion of our business depends on a number of factors, including our ability to increase awareness of our brand and successfully compete with other companies; price our products effectively so that we are able to attract new consumers and expand sales to our existing consumers; expand distribution to new retail partners; continue to innovate and introduce new products; maintain and improve our technology platform supporting our e-commerce business; expand our supplier and fulfillment capacities; expand internationally; and maintain quality control over our product offerings.

Such growth and expansion of our business places significant demands on our management and operations teams and requires significant additional resources, financial and otherwise, to meet our needs, which may not be available in a cost-
53

effective manner, or at all. We expect to continue to expend substantial resources on marketing efforts to increase brand awareness; product innovation and development; technology platform maintenance and improvements to support sales; and general administration, including increased finance, legal, and accounting expenses associated with being a public company.

These investments may not result in the growth of our business. Even if these investments do result in the growth of our business, if we do not effectively manage our growth, we may not be able to execute on our business plan, respond to competitive pressures, take advantage of market opportunities, satisfy consumer requirements or maintain high-quality product offerings, any of which could adversely affect our business, financial condition, results of operations and prospects. You should not rely on our historical rate of revenue growth as an indication of our future performance or the rate of growth which we may experience in any new category or from international expansion.

In addition, to support continued growth, we must effectively integrate, develop and motivate a large number of new employees while maintaining our corporate culture. We face significant competition for personnel. To attract top talent, we must offer competitive compensation and benefits packages before we can validate the productivity of new employees. We may also need to increase our employee compensation levels to remain competitive in attracting and retaining talented employees. Additionally, we may not be able to hire new employees quickly enough to meet our needs. The risks associated with a rapidly growing workforce will be particularly acute to the extent we expand into new product categories and markets outside of the United States. If we fail to effectively manage our hiring needs or successfully integrate new hires, our efficiency, ability to meet forecasts and employee morale, productivity and retention could suffer, which could have an adverse effect on our business, financial condition, results of operations and prospects.

We are also required to manage numerous relationships with vendors and other third parties. Further growth of our operations, vendor base, fulfillment centers, information technology systems or internal controls and procedures may not be adequate to support our operations. If we are unable to manage the growth of our organization effectively, our business, financial condition, results of operations and prospects may be adversely affected.

Our quarterly operating results fluctuate, which could cause our stock price to decline.

Our quarterly operating results fluctuate for a variety of reasons, many of which are beyond our control. Our revenue has fluctuated for a variety of reasons, including as a result of adverse market conditions due to the COVID-19 pandemic and the associated imposition and easing of restrictions on retail and travel opportunities; the seasonality of market transactions; our success in attracting new and maintaining relationships with existing retail and ecommerce partners; our success in executing on our strategy and the impact of any changes in our strategy; the timing and success of product launches, including new products that we may introduce; the success of our marketing efforts; general market conditions; disruptions or defects in our technology platform, such as privacy or data security breaches, errors in our software or other incidents that impact the availability, reliability, or performance of our platform; the impact of competitive developments and our response to those developments; supply chain issues; and our ability to recruit and retain employees. Historically, we have realized a higher portion of our net revenues in the first quarter when customers are focused on improving their lifestyle and quality of living, which we believe makes our products and marketing messages particularly appealing, and a lower portion of our net revenues in the fourth quarter when many customers are focused on holiday shopping. In addition, our operating expenses fluctuate from period to period, in part in anticipation of their seasonality.

Fluctuations in our quarterly operating results may cause those results to fall below our financial guidance or other projections, or the expectations of analysts or investors, which could cause the price of our common stock to decline. Fluctuations in our results could also cause other problems, including, for example, analysts or investors changing their models for valuing our common stock, particularly post-pandemic. We could experience short-term liquidity issues, our ability to retain or attract key personnel may diminish, and other unanticipated issues may arise.

We believe that our quarterly operating results may vary in the future and that period-to-period comparisons of our operating results may not be meaningful. For example, our overall historical growth rate and the impacts of the COVID-19
pandemic may have overshadowed the effect of seasonal variations on our recent historical operating results. Any seasonal effects may change or become more pronounced over time, which could also cause our operating results to fluctuate. You should not rely on the results of any given quarter as an indication of future performance.

We have incurred significant losses since inception, we expect to incur losses in the future, and we may not be able to generate sufficient revenue to achieve and maintain profitability.

Grove has incurred significant losses since its inception. For the years ended December 31, 2021 and December 31, 2020, Grove incurred net losses of $136 million and $72 million, respectively. As of June 30, 2022, Grove had an accumulated deficit of $573 million.

54

We expect to continue to incur significant expenses and operating losses for the foreseeable future as we broaden our customer base, develop our brick-and-mortar retail distribution platform and expand our sales to third-party ecommerce channels, enhance our existing online direct-to-consumer website and mobile application, continue to expand research and development efforts grow the product assortment offered by our Grove-owned brands, acquire or create additional Grove-owned brands, and hire additional employees to support our growth. Historically, Grove has devoted most of its financial and other resources on sales and marketing, including a significant expansion of our marketing team and budget; continued expansion of our business; research and development related to our products; and general administration expenses, including legal, accounting and other expenses. We may not succeed in increasing our revenues, which historically have been reliant on our online direct-to-consumer website and mobile application, in a manner that will be sufficient to offset these higher expenses. Any failure to increase our revenues as we implement initiatives to grow our business could prevent us from achieving profitability. We cannot be certain that we will be able to achieve profitability on a quarterly or annual basis. If we are unable to address these risks and difficulties as we encounter them, our business, financial condition and results of operations may suffer.

We will require additional financing to achieve our goals, and a failure to obtain this necessary capital when needed could force us to delay, limit, reduce our investments in advertising and other strategic initiatives planned for future growth.

We expect to continue to incur significant expenses and operating losses for the foreseeable future as we broaden our customer base, develop our brick-and-mortar retail distribution platform and expand our sales to third-party ecommerce channels, enhance our existing online direct-to-consumer website and mobile application, continue to expand research and development efforts grow the product assortment offered by our Grove Brands, acquire or create additional Grove Brands, and hire additional employees to support our growth.

We believe that our existing cash and cash equivalents will be sufficient to fund our planned operations for at least the next 12 months from the date of this registration statement. However, our operating plan may change as a result of many factors, and we may need additional funds sooner than planned.

In July 2022, we entered into a Standby Equity Purchase Agreement (the “Equity Purchase Agreement”) with YA II PN, Ltd. (“Yorkville”), whereby we have the right, but not the obligation, to sell to Yorkville up to $100.0 million of our shares of common stock at our request until July 18, 2025, subject to certain conditions. We expect to continue to opportunistically seek access to additional funds by utilizing the Equity Purchase Agreement, through additional public or private equity offerings or debt financings, through partnering or other strategic arrangements, or a combination of the foregoing, additional funds may not be available when we need them on terms that are acceptable to us, or at all. To the extent that we raise additional capital by issuing equity securities, our stockholders may experience substantial dilution. Debt financing arrangements may require us to pledge certain assets or enter into covenants that could restrict our operations or our ability to pay dividends or other distributions on our common stock or incur further indebtedness. Our ability to raise additional capital may be adversely impacted by potential worsening global economic conditions and the recent disruptions to and volatility in the credit and financial markets in the United States and worldwide, including the trading price of common stock. If adequate funds are not available to us on a timely basis, we may be required to delay, limit, reduce our investments in advertising and other strategic initiatives planned for future growth, which could have a material adverse effect on our business, results of operations, financial condition, and prospects.

We may not be able to compete successfully.

The markets in which we compete are evolving rapidly and intensely competitive, and we face a broad array of competitors from many different industry sectors.

Our business includes a variety of product types and delivery channels. Our current and potential competitors include: (1) companies that sell household and personal care products online and in physical stores; (2) physical, e-commerce, and omnichannel retailers, vendors, distributors, and manufacturers of the products we offer and sell to consumers; and (3) web search engines, comparison shopping websites, social networks, and other online and app-based means of discovering, using, or acquiring goods, either directly or in collaboration with other retailers. We compete based on various product attributes, including sustainability, price, and quality.

We compete with producers of household and personal care products and e-commerce and traditional sales outlets for these products. Some of our competitors are also our partners and we distribute their products. In addition, there is a risk that our emerging retail distribution partnerships will erode the success of our DTC e-commerce business. Some of our current and potential competitors have longer histories, larger fulfillment infrastructures, better established wholesale and retail distribution networks, faster shipping times, lower-cost shipping, lower operating costs, larger consumer bases, and greater control over inputs critical to our business such as financial, marketing, institutional and other resources, and larger consumer bases than we do. They may secure better terms from suppliers, adopt more aggressive pricing, pursue restrictive
55

distribution agreements that restrict our access to supply, direct consumers to their own offerings instead of ours, and devote more resources to research and development, technology, infrastructure, fulfillment, and marketing and develop products or services that are similar to ours or that achieve greater market acceptance. The Internet facilitates competitive entry and comparison shopping, which enhances the ability of new, smaller, or lesser-known businesses to compete against us. Our business is subject to rapid change, the development of new business models and the entry of new and well-funded competitors. Other companies also may enter into business combinations or alliances that strengthen their competitive positions.

Competition in the natural and sustainable consumer products market presents an ongoing threat to the success of our business.

The number of companies entering the natural and sustainable consumer products market with offerings similar to ours continues to increase. We believe that our ability to compete depends upon many factors both within and beyond our control, including the size of our customer base; the timing and market acceptance of products, including the developments and enhancements to those products and services that we or our competitors offer; customer service and support efforts, selling and marketing efforts, ease of use, performance, price and reliability of the products and services that we and our competitors develop, and our brand strength relative to our competitors. Some of our current and potential competitors have longer operating histories and greater financial, technical, marketing and other resources than we do. These factors may allow our competitors to respond more quickly or efficiently than we can to new or emerging technologies. These competitors may engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies, which may allow them to build larger customer bases than ours or greater market acceptance than us.

We must find sustainable solutions that support our brand and long-term growth.

Our vision to grow our business will require us to innovate and develop more sustainable ways of doing business. In a world where resources are scarce and demand for them continues to increase, it is critical that we succeed in reducing our resource consumption and converting to sustainably sourced supplies. In doing this, we are dependent on the efforts of partners and various certification bodies. There can be no assurance that we will be successful developing sustainable business solutions and our failure to do so could limit our growth and profit potential and damage our corporate reputation.

Today, Grove is completely plastic neutral, which means that for every ounce of plastic that we ship to our customers, we, through our partner rePurpose Global, collect and retire the same amount of nature bound plastic pollution. To quantify the amount of plastic we ship to our customers, we weigh and record the amount of plastic in every Grove Brand product we sell, and receive data on plastic weight from the makers of third-party products sold on our platform. Using these numbers, we calculate how much plastic we send in each order. Furthermore, Grove has a stated goal of our products being plastic-free by 2025. If Grove is unable to remain plastic neutral or unable to meet our goal of our products being plastic-free by 2025, our brand reputation may suffer. Not only is there a risk around finding appropriate replacement materials, but due to high demand, the cost of alternative packaging materials could significantly increase in the foreseeable future and this could impact our business performance. Similarly, the cost associated with collecting and recycling nature bound plastic could significantly increase in the foreseeable future and this could impact our business performance.

If we fail to cost-effectively acquire new consumers or retain our existing consumers, our business could be adversely affected.

Our success depends on our ability to attract new customers and engage existing customers cost-effectively. To acquire and engage customers, we must, among other things, promote and sustain our platform, provide high-quality products, user experiences, and customer service. If customers do not perceive our e-commerce service or products to be reliable, sustainable and of high quality, if we fail to introduce new and improved products and services, or if we introduce new products or services that are not favorably received by the market, we may not be able to attract or retain customers.

We have historically acquired a significant number of our customers through digital advertising on social media channels owned by Facebook that may, along with other social media platforms we may engage in the future, terminate their agreements with us at any time or introduce factors beyond our control, such as such as adjustments to algorithms that may decrease user engagement or negatively affect our ability to reach a broad audience; increase pricing; and change their policies which may have the effect of delaying or preventing our advertising through these channels, all of which could impact our ability to attract new customers.

We have recently introduced marketing initiatives designed to acquire customers through increased search engine optimization, streaming digital video services, and linear television. These new acquisition channels may not perform as
56

well as our historical social media advertising channels. Our efforts to diversify customer acquisition channels may not be effective, which could negatively affect our results of operations.

Customer acquisition costs may fluctuate and rise on the channels that have been successful for us historically and on new channels that we are introducing. Rising costs may limit our ability to expand or maintain or acquisition efforts which could negatively affect our results of operations.

Changes to our DTC business designed to attract new customers and retain existing customers, including, but not limited to expanded shopping personalization, non-subscription options, and user generated and editorial content may not perform as well as our historical DTC platform which could negatively impact our results of operations.

Other factors may reduce our ability to acquire, maintain and further engage with customers, including the effectiveness of our marketing efforts and other expenditures we make to continue to acquire new customers and
maintain and increase engagement with existing customers; system updates to app stores and advertising platforms; changes in search algorithms by search engines; the development of new search engines or social media sites that reduce traffic on existing search engines and social media sites; and consumer behavior changes as a result of the
COVID-19 pandemic, or otherwise.

In addition, we believe that many of our new customers originate from word-of-mouth and other non-paid referrals from existing customers, including referral discounts and gift giving, so we must ensure that our existing customers remain loyal and continue to derive value from our products and services in order to continue receiving those referrals. Consequently, if our efforts to satisfy our existing customers are not successful, we may not be able to attract new customers.

Moreover, consumer preferences may change, and customers may not purchase through our marketplace as frequently or spend as much with us as historically has been the case. As a result of these potential changes, the revenue generated from customer transactions may not be as high as revenue generated from transactions historically.

We must expend resources to maintain consumer awareness of our brand, build brand loyalty and generate interest in our products. Our marketing strategies and channels will evolve and our efforts may or may not be successful.

To remain competitive and expand and keep market share for our products across our various channels, we need to increase our marketing and advertising spending. Substantial advertising and promotional expenditures may be required to maintain or improve our brand’s market position or to introduce new products to the market, and we are increasingly engaging with more traditional media, such as television and web-based streaming services, which may not prove successful. An increase in our marketing and advertising efforts may not maintain our current reputation, lead to increased brand awareness, or attract new customers. If we are unable to maintain and promote a favorable perception of our brand and products on a cost-effective basis, our business, financial condition, results of operations and prospects could be adversely affected.

Our brand and reputation may be diminished due to real or perceived quality, safety, efficacy or environmental impact issues with our products, which could have an adverse effect on our business, financial condition, results of operations and prospects.

We believe our consumers rely on us to provide them with clean, sustainable, well-designed, and effective products. Any loss of confidence on the part of consumers in our products or the ingredients used in our products, whether related to actual or perceived product contamination or product safety or quality failures, environmental impacts, or inclusion of prohibited ingredients, or ingredients that are perceived to be “toxic”, could tarnish the image of our brand and could cause consumers to choose other products. Allegations of contamination or other adverse effects on product safety or efficacy or suitability for use by a particular consumer or on the environment, even if untrue, may require us to expend significant time and resources responding to such allegations and could, from time to time, result in a recall of a product from any or all of the markets in which the affected product was distributed. Any such issues or recalls could negatively affect our ability to achieve or maintain profitability and brand image.

If our products are found to be, or perceived to be, defective or unsafe, or if they otherwise fail to meet our consumers’ expectations, our relationships with consumers could suffer, the appeal of our brand could be diminished, we may need to recall some of our products and/or become subject to regulatory action, and we could lose sales or market share or become subject to boycotts or liability claims. In addition, safety or other defects in our competitors’ products or products using the Grove name in other consumer categories, could reduce consumer confidence in or demand for our own products if consumers view them to be similar. Any such adverse effect could be exacerbated by our market positioning as a purveyor of clean, sustainable, well-designed, and effective products and may significantly reduce our brand value. Issues
57

regarding the safety, efficacy, quality or environmental impact of any of our products, regardless of the cause, may have an adverse effect on our brand, reputation and operating results.

Further, our customers may engage with us online through social media platforms by providing feedback and public commentary about all aspects of our business. Information concerning us, whether accurate or not, may be posted on social media platforms at any time and may have a disproportionately adverse impact on our brand, reputation, or business. The harm may be immediate without affording us an opportunity for redress or correction and could have a material adverse effect on our business, results of operations, financial condition, and prospects.

Failure to introduce new products that meet the expectations of our customers may adversely affect our ability to continue to grow.

We have a limited history introducing new products and services to our customers. New potential products and services may fail at any stage of development or commercialization, including after launch, and if we determine that any of our current or future products are unlikely to succeed, we may abandon them without any return on our investment. In addition, any unsuccessful effort may adversely affect our brand and reputation. If our efforts to attract new customers and engage existing customers with new and enhanced products are unsuccessful or if such efforts are more costly than we expect, our business may be harmed and our potential for growth may be impaired.

The COVID-19 global pandemic and related government, private sector and individual consumer responsive actions may adversely affect our business operations, employee availability, financial performance, liquidity and cash flow for an unknown period of time.

The outbreak of COVID-19 was declared a pandemic by the World Health Organization and continues to spread in the U.S., Canada, and in many other countries globally. Related government and private sector responsive actions have adversely affected, and may continue to adversely affect, our business operations. It is impossible to predict the effect and ultimate impact of the COVID-19 pandemic, as the situation continues to evolve and variant strains of the virus have led to increased uncertainty. The COVID-19 pandemic has disrupted the global supply chain and may cause disruptions to our operations if a significant number of employees are ill, quarantined or if they are otherwise limited in their ability to work at our locations or travel. Any worsening of the COVID-19 pandemic, including the unknown potential impact of variant strains, and any future actions in response to the COVID-19 pandemic by federal, state or local authorities, including those that order the shutdown of non-essential businesses or limit the ability of our employees to travel to work, could impact our ability to take or fulfill our customers’ orders and operate our business. If surges related to the COVID-19 pandemic or any future pandemics outpace our capacity or occur at unexpected times, we may be unable to fully meet our customers’ demands for our products.

As a result of the COVID-19 pandemic, many of our personnel are working remotely and it is possible that this could have a negative impact on the execution of our business plans and operations. If a natural disaster, power outage, connectivity issue, or other event occurred that impacted our employees’ ability to work remotely, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The increase in remote working may also result in consumer privacy, IT security and fraud concerns, increase our exposure to potential wage and hour issues, and decrease the cohesiveness of our teams and our ability to maintain our corporate culture. We may experience increased costs as we prepare our facilities for a safe return to work environment and experiment with hybrid work models.

Plans to open new fulfillment centers or to expand the capacity of our existing fulfillment centers over the next few years may also be delayed or made more costly by the continuing spread of COVID-19 and variant strains. Disruptions to the operations of our fulfillment centers and delays or increased costs in the expansion of our fulfillment center capacity may negatively impact our financial performance and slow our future growth.

Quantifying the adverse impact of the COVID-19 pandemic is difficult given the pervasive disruptions and changes to society that it has caused. At the onset of the pandemic, we incurred approximately $600,000 in costs associated with additional cleaning and sanitization measures such as sanitation stations, supplies, and installation of disinfecting lights. In early 2020, we also reduced our marketing spending because of the economic uncertainty associated with the pandemic, potentially resulting in a reduction of our new customer acquisition since new customer acquisition is primarily driven by our marketing activities. As the pandemic has continued, its disruption has spread to our shipping, supply chain and labor, along with inflation resulting from the pandemic. For example, from fiscal year 2020 into 2021, we experienced an increase of approximately 10% in wages for employees at our fulfillment centers due to labor shortages and macroeconomic trends in labor markets, and increased inbound shipping rates that reduced margins on our Grove-owned brands by approximately 200 basis points. These costs have continued to increased from 2022 compared to 2021. As a result of supply chain disruptions and increased shipping costs, we are also placing orders with our suppliers further in advance, which negatively impacts our cash flow. While we believe some of these upward cost trends have stabilized, others may continue to increase in the future which may result in further adverse financial impacts.
58


At the same time, the COVID-19 pandemic drove a surge in demand for direct-to-consumer businesses such as ours. Early in the pandemic, we saw substantial growth in our customer base and orders, particularly for certain cleaning products, as consumers have opted for ecommerce solutions rather than in-person shopping, but the pandemic also caused many customers to over-purchase and cancel their subscriptions. As the COVID-19 pandemic and restrictions related thereto wind down, we have begun to experience a softening of demand compared to the COVID-19 pandemic surge as consumers return to “normal” shopping activities.

The uncertainty around the duration of business disruptions and the extent of the spread of the virus in the U.S. and to other areas of the world will likely continue to adversely impact the national or global economy and negatively impact consumer spending. Any of these outcomes could have a material adverse impact on our business, financial condition, operating results and ability to execute and capitalize on our strategies. The full extent of the COVID-19 pandemic’s impact on our operations and financial performance depends on future developments that are uncertain and unpredictable, including the duration and spread of the pandemic, its impact on capital and financial markets and any new information that may emerge concerning the severity of the virus, its spread to other regions as well as the actions taken to contain it, among others. The COVID-19 pandemic has adversely affected our business operations, costs of doing business, availability of labor, access to inventory, supply chain operations and financial results since the start of the pandemic and will continue to adversely affect our business for a period of time that is currently unknown.

We have pursued and intend to pursue acquisitions to expand our business, and if any of those acquisitions are unsuccessful, our business may be harmed.

Our strategy includes the expansion of our business through the acquisition of other businesses, products or technologies, or through strategic alliances. Acquisitions involve numerous risks, including the possibility that we will pay more than the value we derive from the acquisitions which could result in future non-cash impairment charges, and incremental operating losses; difficulties in integration of the operations, technologies and products of the acquired companies, which may require significant attention of our management that otherwise would be available for the ongoing development of our business; the assumption of certain known and unknown liabilities of the acquired companies; difficulties in retaining key relationships with employees, customers, collaborators, vendors and suppliers of the acquired company; and in the case of acquisitions outside of the jurisdictions where we currently operate, the need to address the particular economic, currency, political, and regulatory risks associated with specific countries, particularly those related to our collection of sensitive data, regulatory approvals, and tax management, which may result in significant additional costs or management overhead for our business. Failure to successfully address any of these or other unforeseen challenges would adversely affect our business.

We may experience damage or destruction to our distribution centers, which may harm our business, results of operations and financial condition.

Our distribution centers, as well as our headquarters, are located in areas that have a history of natural disasters, including severe weather events, rendering our distribution centers vulnerable to damage. Any large-scale damage, to or catastrophic loss of, products stored in our distribution centers due to natural disasters or man-made disasters such as arson, theft, power disruptions, computer viruses, data security breaches or terrorism, could result in the reduction in value of our inventory and a significant disruption in our business. Further, natural disasters such as earthquakes, hurricanes, tornadoes, fires, floods and other adverse weather and climate conditions; unforeseen health crises, such as pandemics and epidemics, political crises, such as terrorist attacks, war and other political instability (including, for example, cyberattacks or other attacks carried out by Russia following its invasion of Ukraine in February 2022); or other catastrophic events, could disrupt our operations in any of our offices, our remote workforce and distribution centers. For example, in March 2020, we temporarily closed our corporate offices to slow the spread of COVID-19 and protect our employees. Such closures have slowed and may in the future slow or temporarily halt our operations and harm our business, results of operations and financial condition.

We are dependent on our management team, and the loss of one or more key employees or groups could harm our business and prevent us from implementing our business plan in a timely manner.

Our success depends substantially upon the continued services of our executive officers and other key members of management, particularly our Chief Executive Officer. From time to time, there may be changes in our executive management team resulting from the hiring or departure of executives. Such changes in our executive management team may be disruptive to our business. We do not have employment agreements with any our executive officers or key management personnel and, therefore, they could terminate their employment with us at any time. We do not maintain key person life insurance policies on any of our employees. The loss of one or more of our key employees or groups could seriously harm our business.

59

Labor-related matters, including labor disputes, may adversely affect our operations.

None of our employees are currently represented by a union. If our employees decide to form or affiliate with a union, we cannot predict the negative effects such future organizational activities will have on our business and operations. If we were to become subject to work stoppages, we could experience disruption in our operations, including delays in merchandising operations and shipping, and increases in our labor costs, which could harm our business, results of operations and financial condition.

If we cannot successfully manage the unique challenges presented by international markets, we may not be successful in expanding our operations outside of the United States.

We offer our products and services in the contiguous United States. Although international expansion is part of our strategy, we may never pursue international expansion and may not be successful if we do so. We would be subject to a variety of risks inherent in doing business internationally, including political, social and/or economic instability; risks related to governmental regulations in foreign jurisdictions and unexpected changes in regulatory requirements and enforcement; fluctuations in currency exchange rates; higher levels of credit risk and payment fraud; enhanced difficulties of integrating any foreign acquisitions; burdens of complying with a variety of foreign laws; lesser protection for intellectual property rights in some countries; difficulties in staffing and managing global operations and the increased travel, infrastructure and legal compliance costs associated with operating from international locations and subsidiaries; different regulations and practices with respect to employee/employer relationships, existence of workers’ councils and labor unions, and other challenges caused by distance, language, and cultural differences; compliance with statutory equity requirements; and management of tax consequences and compliance.

Our business, including our costs and supply chain, is subject to risks associated with sourcing, manufacturing, warehousing, distribution, infrastructure and logistics to third-party providers, and the loss of any of our key suppliers or logistical service providers could negatively impact our business.

All of the products we offer are supplied or manufactured by a limited number of third-party suppliers and manufacturers, and as a result, we may be subject to price fluctuations or supply disruptions. Our operating results would be negatively impacted by increases in the costs of our products, and we have no guarantees that costs will not rise. In addition, as we expand into new categories and product types, we expect that we may not have strong purchasing power in these new areas, which could lead to higher costs than we have historically seen in our current categories. We may not be able to pass increased costs on to consumers, which could adversely affect our operating results. Moreover, in the event of a significant disruption in the supply of the materials used to manufacture the products we offer, we and the vendors that we work with might not be able to locate alternative suppliers of materials of comparable quality at an acceptable price. Furthermore, our reliance on suppliers and manufacturers outside of the United States, the number of third parties with whom we transact and the number of jurisdictions to which we sell complicates our efforts to comply with customs duties and excise taxes; any failure to comply could adversely affect our business.

In addition, products and merchandise we receive from manufacturers and suppliers may not be of sufficient quality or free from damage, or such products may be damaged during shipping, while stored in our warehouse fulfillment centers or with third-party ecommerce or retail customers or when returned by consumers. We may incur additional expenses and our reputation could be harmed if consumers and potential consumers believe that our products do not meet their expectations, are not properly labeled or are damaged. Quality control problems could also result in regulatory action, such as FDA Warning Letters, restrictions on importation, product liability litigation, product seizures, products of inferior quality or product stock outages or shortages, harming our sales and creating inventory write-downs for unusable products.

We purchase significant amounts of product from a limited number of suppliers with limited supply capabilities. There can be no assurance that our current suppliers will be able to accommodate our anticipated growth or continue to supply current quantities at preferential prices. In the past, we have experienced supply shortages of certain goods that have resulted in lost sales. We generally do not maintain long-term supply contracts with any of our suppliers and any of our suppliers could discontinue selling to us at any time. An inability of our existing suppliers to provide materials in a timely or cost-effective manner could impair our growth and have an adverse effect on our business, financial condition, results of operations and prospects.

We rely or may rely on SaaS technologies from third parties in order to operate critical functions of our business, including financial management services, payment processing, customer relationship management services, website platform services, ecommerce services, email services, supply chain services and data storage services. If these services become unavailable due to extended outages or interruptions or because they are no longer available on commercially reasonable terms or prices or for any other reason, or if we fail to migrate successfully to new services, our expenses could increase, our ability to manage our finances could be interrupted, our processes for managing sales of our offerings and supporting our consumers could be impaired, our ability to communicate with our suppliers could be weakened and our
60

ability to access or save data stored to the cloud may be impaired until equivalent services, if available, are identified, obtained and implemented, all of which could have an adverse effect on our business, financial condition, results of operations and prospects.

We utilize cloud services from third-party data center facilities operated by AWS. Any damage to, failure of or interference with our cloud service that is hosted by us, AWS or by third-party providers we may utilize in the future, whether as a result of our actions, actions by the third-party data centers, actions by other third parties, or acts of God, could result in interruptions in our cloud service and/or the loss of our or our customers’ data, including personal information. Impairment of, or interruptions in, our cloud services may subject us to claims and litigation and adversely affect our ability to attract new customers. Our business will also be harmed if our customers and potential customers believe our services are unreliable. Additionally, any limitation of the capacity of our data centers could impede our ability to scale, onboard new customers or expand the usage of existing customers, which could adversely affect our business, financial condition and results of operations. While we have some disaster recovery arrangements in place, our preparations may not be adequate to account for disasters or similar events that may occur in the future and may not effectively permit us to continue operating in the event of any problems with respect to our systems or those of our third-party data centers or any other third-party facilities. Our disaster recovery and data redundancy measures may be inadequate, and our business interruption insurance may not be sufficient to compensate us for the losses that could occur.

If any of our key suppliers becomes insolvent, ceases or significantly reduces its operations or experiences financial distress, or if any environmental, economic or other outside factors impact their operations, our operations could be substantially disrupted. If we are unable to identify or enter into distribution relationships with new suppliers or to replace the loss of any of our existing suppliers, we may experience a competitive disadvantage, our business may be disrupted and our business, financial condition, results of operations and prospects could be adversely affected.

If our third-party suppliers and manufacturers do not comply with ethical business practices or with applicable laws and regulations, our reputation, business, financial condition, results of operations and prospects could be harmed.

We continually seek to expand our base of suppliers, especially as we identify new products that necessitate new or additional materials. We also require our new and existing suppliers to meet our ethical and business partner standards. Suppliers may also have to meet governmental and industry standards and any relevant standards required by our consumers, which may require additional investment and time on behalf of suppliers and us.

Our reputation and our consumers’ willingness to purchase our products depend in part on our suppliers’, manufacturers’, and retail partners’ compliance with ethical employment practices, such as with respect to child labor, wages and benefits, forced labor, discrimination, safe and healthy working conditions, and with all legal and regulatory requirements relating to the conduct of their businesses. We do not exercise control over our suppliers, manufacturers, and retail partners and cannot guarantee their compliance with ethical and lawful business practices. If our suppliers, manufacturers, or retail partners fail to comply with applicable laws, regulations, safety codes, employment practices, human rights standards, quality standards, environmental standards, production practices, or other obligations, norms, or ethical standards, our reputation and brand image could be harmed, and we could be exposed to litigation, investigations, enforcement actions, monetary liability, and additional costs that would harm our reputation, business, financial condition, results of operations and prospects.

If we or our distribution partners do not successfully optimize, operate and manage the expansion of the capacity of our warehouse fulfillment centers, our business, financial condition, results of operations and prospects could be adversely affected.

We operate warehouse fulfillment centers located in Reno, Nevada, Elizabethtown, Pennsylvania, and St. Peters, Missouri. If we do not optimize and operate our warehouse fulfillment centers successfully and efficiently, it could result in excess or insufficient fulfillment capacity, an increase in costs or impairment charges or harm our business in other ways. In addition, if we do not have sufficient fulfillment capacity or experience a problem fulfilling orders in a timely manner, our consumers may experience delays in receiving their purchases, which could harm our reputation and our relationship with our consumers.

We have designed and established our own fulfillment center infrastructure, including customizing inventory and package handling software systems, which is tailored to meet the specific needs of our business. If we continue to add fulfillment and warehouse capabilities, add new businesses or categories with different fulfillment requirements or change the mix in products that we sell, our fulfillment network will become increasingly complex and operating it will become more challenging. Failure to successfully address such challenges in a cost-effective and timely manner could impair our ability to timely deliver purchases to our consumers and merchandise inventory to our retail and ecommerce partners, and
61

could have an adverse effect on our reputation and ultimately, our business, financial condition, results of operations and prospects.

If we grow faster than we anticipate, we may exceed our fulfillment center capacity sooner than we anticipate, we may experience problems fulfilling orders in a timely manner or our consumers may experience delays in receiving their purchases, which could harm our reputation and our relationships with our consumers. In such event, we would need to increase our capital expenditures generally and in a shorter time frame than anticipated. Our ability to expand our fulfillment center capacity, including our ability to secure suitable facilities and recruit qualified employees, have been and may in the future be adversely affected by the COVID-19 pandemic and related governmental orders. Many of the expenses and investments with respect to our fulfillment centers are fixed, and any expansion of such fulfillment centers will require additional investment of capital. We expect to incur higher capital expenditures in the future for our fulfillment center operations as our business continues to grow.

Shipping is a critical part of our business and any changes in our shipping arrangements or any interruptions in shipping could adversely affect our operating results.

We rely on several vendors for our shipping requirements. If we are not able to negotiate acceptable pricing and other terms with these vendors or if they experience performance problems or other difficulties, it could negatively impact our operating results and our consumer experience. Rising shipping costs and the imposition of surcharges from time to time could negatively impact our operating results. In addition, our ability to receive inbound inventory and ship products to consumers and retailers may be negatively affected by inclement weather, fire, flood, power loss, earthquakes, labor disputes, acts of war or terrorism, trade embargoes, customs and tax requirements and similar factors. For example, the recent invasion of Ukraine by Russia in February 2022 could increase disruptions in shipping or our supply chain. We are also subject to risks of damage or loss during delivery by our shipping vendors. If our products are not delivered in a timely fashion or are damaged or lost during delivery, our consumers could become dissatisfied and cease shopping on our site or retailer or third-party ecommerce sites that carry our products, which could have an adverse effect on our business, financial condition, operating results and prospects.

Risks associated with the outsourcing of our fulfillment process and other technology-related functions could materially and adversely affect our business, financial condition, and results of operations.

We have also outsourced portions of our fulfillment process, as well as certain technology-related functions, to third-party service providers. Specifically, we rely on third parties in a number of foreign countries and territories, we are dependent on third-party vendors for credit card processing, and we use third-party hosting and networking providers to host our sites. The failure of one or more of these entities to provide the expected services on a timely basis, or at all, or at the prices we expect, or the costs and disruption incurred in changing these outsourced functions to be performed under our management and direct control or that of a third party, could have an adverse effect on our business, financial condition, results of operations and prospects. We are not party to long-term contracts with some of our retail and ecommerce partners, and upon expiration of these existing agreements, we may not be able to renegotiate the terms on a commercially reasonable basis, or at all.

We are subject to risks related to online payment methods, including third-party payment processing-related risks.

We currently accept payments using a variety of methods, including credit card, debit card, and gift cards. As we offer new payment options to consumers, we may be subject to additional regulations, compliance requirements, fraud and other risks. We also rely on third parties to provide payment processing services, and for certain payment methods, we pay interchange and other fees, which may increase over time and raise our operating costs and affect our ability to achieve or maintain profitability. We are also subject to payment card association operating rules and certification requirements, including the Payment Card Industry Data Security Standard, or PCI-DSS, and rules governing electronic funds transfers, which could change or be reinterpreted to make it difficult or impossible for us to comply. If we (or a third party processing payment card transactions on our behalf) suffer a security breach affecting payment card information, we may have to pay onerous and significant fines, penalties and assessments arising out of the major card brands’ rules and regulations, contractual indemnifications or liability contained in merchant agreements and similar contracts, and we may lose our ability to accept payment cards for payment for our goods and services, which could materially impact our operations and financial performance.

Furthermore, as our business changes, we may be subject to different rules under existing standards, which may require new assessments that involve costs above what we currently pay for compliance. As we offer new payment options to consumers, including by way of integrating emerging mobile and other payment methods, we may be subject to additional regulations, compliance requirements and fraud. If we fail to comply with the rules or requirements of any provider of a payment method we accept, if the volume of fraud in our transactions limits or terminates our rights to use payment methods we currently accept, or if a data breach occurs relating to our payment systems, we may, among other
62

things, be subject to fines or higher transaction fees and may lose, or face restrictions placed upon, our ability to accept credit card payments from consumers or facilitate other types of online payments. In addition, our customers could lose confidence in certain payment types, which may result in a shift to other payment types or potential changes to our payment systems that may result in higher costs.

We also occasionally receive orders placed with fraudulent data and we may ultimately be held liable for the unauthorized use of a cardholder’s card number in an illegal activity and be required by card issuers to pay charge-back fees. Charge-backs result not only in our loss of fees earned with respect to the payment, but also leave us liable for the underlying money transfer amount. If our charge-back rate becomes excessive, card associations also may require us to pay fines or refuse to process our transactions. In addition, we may be subject to additional fraud risk if third-party service providers or our employees fraudulently use consumer information for their own gain or facilitate the fraudulent use of such information. Overall, we may have little recourse if we process a criminally fraudulent transaction. If we fail to adequately control fraudulent credit card transactions, we may face civil liability, diminished public perception of our security measures, and significantly higher credit card-related costs, each of which could harm our business, results of operations and financial condition.

We have only recently expanded to offer our own branded products in retail stores and our inability to secure, maintain and increase our presence in retail stores could adversely impact our revenue.

Our omnichannel strategy includes selling our products through third-party ecommerce and retail partners (including their websites). Our retail operations were established in 2021 and include sales to retail stores and their related websites. The success of our business is largely dependent on our continuing development of strong relationships with major retail chains. Prior to our recently announced partnerships with Kohl’s, Meijer and Giant Eagle, our only retail partnership has been with Target, and our experience operating through the retail channel is extremely limited. Factors that could affect our ability to maintain or expand our sales and our current or any future retail distribution partners include: failure to accurately identify the needs of our customers; a lack of customer acceptance of new products or product expansions; unwillingness of our retail distribution partners and customers to attribute premium value to our new or existing products or product expansions relative to competing products; failure to obtain floor space from retail distribution partners, new, well-received product introductions by competitors; damage to our relationships with our retail distribution partners due to brand or reputational harm; delays or defaults on our retail distribution partners’ payment obligations to us; and store closures, decreased foot traffic, recession or other adverse effects resulting from public health crises such as the current COVID-19 pandemic (or other future pandemics or epidemics).

The loss of our relationship with Target or other current or future large retail partner could have a significant impact on our revenue. In addition, we may be unable to secure adequate shelf space in new markets, or any shelf space at all, until we develop relationships with the retailers that operate in such markets. We may not be successful in developing those relationships. Consequently, growth opportunities through our retail operations may be limited and our revenue, business, financial condition, results of operations and prospects could be adversely affected if we are unable to successfully establish relationships with other retailers in new or current markets. To date, our retail sales have not comprised a significant percentage of our total revenue.

We also face competition to display our products on store shelves and obtain optimal presence on those shelves. Due to the intense competition for limited shelf space, retailers are in a position to negotiate favorable terms of sale, including price discounts, allowances and product return policies. To the extent we increase discounts or allowances in an effort to secure shelf space, our operating results could be adversely affected. We may not be able to increase or sustain our volume of retail shelf space or offer retailers price discounts sufficient to overcome competition. As a result, our retail distribution channels may not continue to grow and may shrink, and our sales and results of operations could be adversely affected. In addition, many of our competitors have significantly greater financial, manufacturing, marketing, management and other resources than we do, and may have greater name recognition, a more established distribution network and a larger base of wholesale customers and distributors. Furthermore, our retail sales, to the extent successful, may compete with and erode our DTC business. If we are unable to address these challenges, our business may be adversely affected.

We may be unable to adequately obtain, maintain, protect, defend and enforce our intellectual property rights.

Our ability to compete effectively is dependent in part upon our ability to obtain, maintain, protect, defend and enforce our intellectual property and other proprietary rights, including our proprietary technology. We establish and protect our intellectual property and proprietary rights, including our proprietary information and technology, through a combination of confidentiality procedures and other contractual provisions, as well as through patent, trademark, copyright, trade secret and other intellectual property laws in the United States and similar laws in certain other jurisdictions. However, the steps we take to obtain, maintain, protect, defend and enforce our intellectual property and proprietary rights may be inadequate. There can be no assurance that these protections will be available in all cases or will be adequate to
63

prevent our competitors or other third parties from copying, reverse engineering, accessing or otherwise obtaining and using our technology, intellectual property or proprietary rights or solutions without our permission.

We pursue the registration of certain aspects of our intellectual property in the U.S. and other countries. We are seeking to protect certain aspects of our intellectual property in an increasing number of jurisdictions, a process that is expensive and time-consuming and may not be successful or which we may not pursue in every jurisdiction in which we conduct business. As we apply to register our unregistered trademarks in the U.S. and other countries, our applications may not be allowed for registration in a timely fashion or at all, and our registered trademarks may not be maintained or enforced. In addition, third parties may oppose our trademark and service mark applications or trademark registrations, or otherwise challenge our use of the trademarks and service marks. In certain countries outside of the U.S., trademark registration is required to enforce trademark rights. If we do not secure registrations for our trademarks, we may encounter more difficulty in enforcing them against third parties than we otherwise would. We also may not be able to acquire or maintain appropriate domain names in all countries in which we do business. Furthermore, regulations governing domain names may not protect our trademarks and similar proprietary rights. We may be unable to prevent third parties from acquiring domain names that are similar to, infringe upon, or diminish the value of our intellectual property.

We have six registered patents worldwide, 13 patent applications filed and two patent applications pending through the Patent Cooperation Treaty. We cannot offer any assurances about which, if any, patents will issue from our applications, the breadth of any such patents, or whether any issued patents will be found invalid and unenforceable or will be threatened by third parties. Any successful opposition to these patents or any other patents owned by or, if applicable in the future, licensed to us could deprive us of rights necessary for the successful commercialization of products that we may develop. Since patent applications in the United States and most other countries are confidential for a period of time after filing, we cannot be certain that we were the first to file on the technologies covered in several of the patent applications related to our technologies or products. Furthermore, a derivation proceeding can be provoked by a third party, or instituted by the U.S. Patent and Trademark Office (USPTO), to determine who was the first to invent any of the subject matter covered by the patent claims of our applications.

Enforcement of our intellectual property rights may be difficult and may require considerable resources. We are not always able to discover or determine the extent of any unauthorized use of our intellectual property. Moreover, the steps we take to protect our intellectual property do not always adequately protect our rights or prevent third parties from infringing or misappropriating our proprietary rights. We also cannot be certain that others will not independently develop or otherwise acquire equivalent or superior technology or other intellectual property rights. In addition, any of our intellectual property rights may be challenged or circumvented by others or invalidated or held unenforceable through administrative process or litigation in the U.S. or in foreign jurisdictions.

In addition, the laws of some foreign countries do not protect intellectual property rights to the same level of protection as the laws of the U.S., and we may encounter difficulties in protecting and defending such rights in foreign jurisdictions. To the extent we expand our international activities, our exposure to unauthorized copying and use of our intellectual property and proprietary information may increase. Consequently, we may not be able to prevent third parties from infringing on our intellectual property in all countries outside the U.S., or from selling or importing products made using our intellectual property in and into the U.S. or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and may also export infringing products to territories where we have patent protection, but enforcement of patents and other intellectual protection is not as strong as that in the U.S. These products may compete with our products and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.

As we move into new markets and expand our products or services offerings, incumbent participants in such markets may assert their intellectual property and other proprietary rights against us as a means of slowing our entry into such markets or as a means to extract substantial license and royalty payments from us. In addition, our agreements with some of our customers, suppliers or other entities with whom we do business requires us to defend or indemnify these parties to the extent they become involved in infringement claims, including the types of claims described above. As a result, we could incur significant costs and expenses that could adversely affect our business, operating results or financial condition.

Third parties may knowingly or unknowingly infringe our intellectual property and proprietary rights, third parties may challenge our intellectual property and proprietary rights, pending and future patent, copyright, trademark and other applications may not be approved and we may not be able to prevent infringement without incurring substantial expense. If the protection of our proprietary rights is inadequate to prevent use or appropriation by third parties, the value of our brand and other intangible assets may be diminished and competitors may be able to more effectively mimic our service and methods of operations. With respect to any intellectual property rights claim, we may have to seek a license to continue practices found to be in violation of a third parties rights, which may not be available on reasonable terms and may significantly increase our operating expenses. A license to continue such practices may not be available to us at all.

64

Litigation may be necessary to enforce our intellectual property rights, protect our trade secrets, or determine the validity and scope of the proprietary rights of others. Any litigation of this nature, regardless of outcome or merit, may be time-consuming and could incur substantial costs and expenses, substantial liability for damages, or could require us to stop our development and commercialization efforts for our products and services. Our efforts to enforce our intellectual property and proprietary rights might be met with defenses, counterclaims and countersuits attacking the validity and enforceability of our intellectual property and proprietary rights, and if such defenses, counterclaims or countersuits are successful, we could lose valuable intellectual property and proprietary rights. Furthermore, many of our current and potential competitors may be in a position to dedicate substantially greater resources to enforce their intellectual property and proprietary rights than us. Accordingly, despite our efforts, we may not be able to prevent third parties from infringing, misappropriating or otherwise violating our intellectual property and proprietary rights. Additionally, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation.

Moreover, the outcome of any such litigation might not be favorable to us, even when our rights have been infringed, misappropriated or otherwise violated. If we do not prevail, we may be required to pay significant money damages, suffer losses of significant revenues, be prohibited from using the relevant systems, processes, technologies or other intellectual property (temporarily or permanently), be required to cease offering certain products or services, incur significant license, royalty or technology development expenses, or be required to comply with other unfavorable terms. Even if we were to prevail, such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, operating results or financial condition. We may also be required to enter into license agreements that may not be available on commercially reasonable terms or at all. In addition, although in some cases a third party may have agreed to indemnify us for such costs, such an indemnifying party may refuse or be unable to uphold its contractual obligations. In other cases, insurance may not cover potential claims of this type adequately or at all, and we may be required to pay monetary damages, which may be significant.

We rely on trademark, copyright, and patent law, trade secret protection, and confidentiality and/or license agreements with our employees, customers, and others to protect our proprietary rights.

We rely and expect to continue to rely on a combination of confidentiality, invention assignment and other agreements with our employees, consultants and third parties with whom we have relationships and who may have access to confidential or patentable aspects of our research and development output, as well as trademark, copyright, patent and trade secret protection laws, to protect our proprietary rights. However, any of these parties may breach their agreements with us and disclose information improperly. In addition, we cannot guarantee that we have entered into such agreements with each party that has or may have had access to our proprietary information, know-how and trade secrets or each party that has developed intellectual property on our behalf. Moreover, no assurance can be given that these agreements will be effective in controlling access to, distribution, use, misuse, misappropriation, reverse engineering or disclosure of our proprietary information, know-how and trade secrets, platform or confidential information. Further, these agreements may not prevent our competitors from independently developing technologies that are substantially equivalent or superior to our offerings. These agreements may be insufficient or breached, and we may not have adequate remedies for any such breach. Additionally, such agreements may not effectively prevent unauthorized access to or unauthorized use, disclosure, misappropriation or reverse engineering of, our confidential information, intellectual property, or technology. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret or know-how is difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, trade secrets and know-how can be difficult to protect and some courts inside and outside the U.S. are less willing or unwilling to protect trade secrets and know-how. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us, and our competitive position would be materially and adversely harmed.

Additionally, individuals not subject to invention assignment agreements may make adverse ownership claims to our current and future intellectual property. For example, we may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets or other intellectual property as an inventor or co-inventor. Ownership disputes may arise, for example, from conflicting obligations of employees, consultants or others who are involved in developing our future products and services.

We may be subject to claims that our employees, consultants or independent contractors have wrongfully used or disclosed confidential information of third parties or that our employees have wrongfully used or disclosed alleged trade secrets of their former employers.

We employ, and expect to employ in the future, individuals who were previously employed at universities or other companies, including our competitors or potential competitors. We may be subject to claims that our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed trade secrets or other proprietary information of their former employers or other third parties, or to claims that we have improperly used or obtained such
65

trade secrets. Litigation may be necessary to defend against these claims. In defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or key personnel, which could adversely impact our business. Even if we are successful in defending against these claims, litigation could result in substantial costs and be a distraction to management and other employees.

Indemnity provisions in various agreements to which we are party potentially expose us to substantial liability for infringement, misappropriation or other violation of intellectual property rights.

Our agreements with our customers and other third parties may include indemnification provisions under which we agree to indemnify or otherwise be liable to them for losses suffered or incurred as a result of claims of infringement, misappropriation or other violation of intellectual property rights or other liabilities relating to or arising from our products, our acts or omissions under such agreements or other contractual obligations. Some of these indemnity agreements provide for uncapped liability and some indemnity provisions survive termination or expiration of the applicable agreement. As we continue to grow, the possibility of infringement claims and other intellectual property rights claims against us may increase. For any intellectual property rights indemnification claim against us or our customers, we will incur significant legal expenses and may have to pay damages, settlement fees, license fees or stop using products or technology found to be in violation of the third party’s rights. Large indemnity payments could harm our business, financial condition and results of operations.

Although we attempt to contractually limit our liability with respect to such indemnity obligations, we are not always successful and we may still incur substantial liability related to them. We may be required to cease use of certain functions of our platform or cease selling certain products as a result of any such claims. Any dispute with a customer or other third party with respect to such indemnification obligations could have adverse effects on our relationship with such customer or other third party and other existing or current and prospective customers, subject us to costly and time-consuming litigation, expensive remediation and licenses, divert management attention and financial resources, reduce demand for our products and adversely affect our brand, reputation, business, financial conditions and results of operations. In addition, although we carry general liability insurance, our insurance may not be adequate to indemnify us for all liability that may be imposed or otherwise protect us from liabilities or damages with respect to claims alleging compromises of customer data, and any such coverage may not continue to be available to us on acceptable terms or at all.

We must successfully maintain, scale and upgrade our information technology systems, and our failure to do so could have an adverse effect on our business, financial condition, results of operations and prospects.

We have identified the need to significantly expand, scale and improve our information technology systems and personnel to support recent and expected future growth. As such, we are in the process of implementing, and will continue to invest in and implement, significant modifications and upgrades to our information technology systems and procedures, including replacing legacy systems with successor systems, making changes to legacy systems or acquiring new systems with new functionality, hiring employees with information technology expertise and building new policies, procedures, training programs and monitoring tools. There are inherent costs and risks associated with replacing and changing these systems, including impairment of our ability to fulfill customer orders, potential disruption of our internal control structure, substantial capital expenditures, additional administration and operating expenses, the need to acquire and retain sufficiently skilled personnel to implement and operate the new systems, demands on management time, the introduction of errors or vulnerabilities and other risks and costs of delays or difficulties in transitioning to or integrating new systems into our current systems. These implementations, modifications and upgrades may not result in productivity improvements at a level that outweighs the costs of implementation, or at all. Additionally, difficulties with implementing new technology systems, delays in our timeline for planned improvements, significant system failures, or our inability to successfully modify our information systems to respond to changes in our business needs may cause disruptions in our business operations and could have an adverse effect on our business, financial condition, results of operations and prospects.

If we (or our vendors) are unable to protect against or adequately respond to mitigate the impacts of a service interruption, data corruption, or cybersecurity attack, our operations could be disrupted, our reputation may be harmed and we could face significant costs to remediate the incident and defend against claims by business partners, customers, or regulators. Such security breaches or other cybersecurity incidents may harm our reputation and expose us to loss of consumers and business.

We rely on information technology networks and systems and data processing (some of which are managed by third-party service providers) to market, sell and deliver our products and services, to fulfill orders, to collect, receive, store, generate, use, transfer, disclose, make accessible, protect, secure, dispose of, share and otherwise process personal information, confidential or proprietary information, financial information and other information, to manage a variety of business processes and activities, for financial reporting purposes, to operate our business, process orders and to comply with regulatory, legal and tax requirements. These information technology networks and systems, and the processing they perform, may be susceptible to damage, disruptions or shutdowns, software or hardware vulnerabilities, security incidents,
66

ransomware attacks, unauthorized activity and access, malicious code (such as malware, viruses and worms), acts of vandalism, employee or contractor theft, misplaced or lost data, fraud, misconduct or misuse, social engineering attacks and denial of service attacks, supply-side attacks, phishing and spear phishing attacks, organized cyberattacks, programming or human errors, failures during the process of upgrading or replacing software, databases or components, power outages, fires, natural disasters, hardware failures, telecommunication failures, user errors or catastrophic events, any of which could result in the loss or disclosure of confidential customer information or our own proprietary information, software, methodologies and business information.

In addition, due to the COVID-19 pandemic, our personnel are often working remotely and relying on their own computers, routers and other equipment, which may pose additional data security risks to networks, systems and data. Any material disruption of our networks, systems or data processing activities, or those of our third-party service providers, could disrupt our ability to undertake, and cause a material adverse impact to our business, reputation and financial condition. If our information technology networks and systems or data processing (or those of our third-party service providers) suffers damage, security breaches, vulnerabilities, disruption or shutdown (including, for example, cyberattacks or other attacks on global networking infrastructure carried out by Russia following its invasion of Ukraine in February 2022), and we do not effectively resolve the issues in a timely manner, we could experience a material adverse impact to our business, reputation and financial condition. Our DTC and ecommerce operations are critical to our business and our financial performance. Our website serves as an effective extension of our marketing strategies by exposing potential new consumers to our brand, product offerings and enhanced content. Due to the importance of our website and DTC operations, any material disruption of our networks, systems or data processing activities related to our websites and DTC operations could reduce DTC sales and financial performance, damage our brand’s reputation and materially adversely impact our business.

The recovery systems, security protocols, network protection mechanisms and other security measures that we have integrated into our systems, networks and physical facilities, which are designed to protect against, detect and minimize security breaches, may not be adequate to prevent or detect service interruption, system failure data loss or theft, or other material adverse consequences. We and our third-party service providers regularly defend against and respond to cybersecurity incidents. No security solution, strategy, or measures can address all possible security threats or block all methods of penetrating a network or otherwise perpetrating a security incident, and our incident response procedures may be inadequate to fully contain, mitigate, or remediate a data security incident. Moreover, notwithstanding any contractual rights or remedies we may have, because we do not control our third-party service providers, including their security measures and their processing of data, we cannot ensure the integrity or security of measures they take to protect customer information and prevent data loss.

The risk of unauthorized circumvention of our security measures or those of our third-party providers, has been heightened by the increased use of the Internet and telecommunications technologies (including mobile and other connected devices) to conduct financial and other business transactions, advances in computer and software capabilities and the increasing sophistication of hackers who employ complex techniques, including without limitation, the theft or misuse of personal and financial information, counterfeiting, “phishing” or social engineering incidents, ransomware, extortion, publicly announcing security breaches, account takeover attacks, denial or degradation of service attacks, malware, fraudulent payment and identity theft. Because the techniques used by hackers change frequently, we may be unable to anticipate these techniques or implement adequate preventive measures. Our applications, systems, networks, software and physical facilities could have material vulnerabilities, be breached, or personal or confidential information could be otherwise compromised due to employee error or malfeasance, such as where third parties fraudulently induce our personnel or our consumers to disclose information or user names and/or passwords, or otherwise compromise the security of our networks, systems and/or physical facilities. Third-party criminals regularly attempt to exploit vulnerabilities in, or obtain unauthorized access to, platforms, software, applications, systems, networks, sensitive information, and/or physical facilities utilized by us or our vendors. Improper access to our systems or databases could result in the theft, publication, deletion or modification of personal information, confidential or proprietary information, financial information and other information. An actual or perceived breach of our security systems or those of our third-party service providers may require notification under applicable data privacy regulations or contractual obligations, or for consumer relations or publicity purposes, which could result in reputational harm, costly litigation (including class action litigation), material contract breaches, liability, settlement costs, loss of sales, regulatory scrutiny, actions or investigations, a loss of confidence in our business, systems and processing, a diversion of management’s time and attention, and significant fines, penalties, assessments, fees and expenses.

As is common in the digital world we operate in, we and our third-party service providers have experienced occasional security incidents involving unauthorized access to our account credentials; however, all such incidents have been remediated and we are not aware of any of significant impact resulting from such incidents. While we regularly defend against and respond to cybersecurity threats and attacks, our efforts to contain, mitigate and remediate a data security incident may not be successful, resulting in unexpected interruptions, delays, cessation of service, negative publicity, and other harm to our business and our competitive position. The costs to respond to a significant security breach
67

or security vulnerability, including to provide breach notification where required, can be substantial. We may have to notify stakeholders of security breaches, which may harm our reputation and expose us to loss of consumers and business. Breach notification can lead to negative publicity, may cause our consumers to lose confidence in the effectiveness of our security measures, and could require us to expend significant capital and other resources to respond to and/or alleviate problems caused by the actual or perceived security breach. A security breach could lead to claims by our consumers or ecommerce or retail customers, or other relevant stakeholders that we have failed to comply with our legal or contractual obligations. As a result, we could be subject to legal action or our consumers or ecommerce or retail customers could end their relationships with us. There can be no assurance that any limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages. We could be required to fundamentally change our business activities and practices in response to a security breach or related regulatory actions or litigation, which could have an adverse effect on our business. We may not have, or in the future be able to obtain, adequate insurance coverage for security incidents or breaches, including fines, judgments, settlements, penalties, costs, attorney fees and other impacts that arise out of incidents or breaches. Any incidents may result in loss of, or increased costs of, our cybersecurity insurance. We also cannot ensure that our existing insurance coverage will continue to be available on acceptable terms or will be available in sufficient amounts to cover one or more large claims related to a security incident or breach, or that the insurer will not deny coverage as to any future claim. If the impact of a security incident or breach or the successful assertion of one or more large claims against us exceeds our available insurance coverage or results in changes to our insurance policies (including premium increases or the imposition of large deductible or co-insurance requirements), it could have an adverse effect on our business, financial condition, reputation and results of operations.

We use open source software in our platform, which may subject us to additional risks and harm our intellectual property.

We use open source software in our platform and expect to continue to use open source software in the future. There are risks and uncertainties regarding the proper interpretation of and compliance with open source software licenses. Some open source software licenses require those who distribute open source software as part of their own software product to publicly disclose all or part of the source code to such software product or to make available any derivative works of the open source code on unfavorable terms or at no cost, and we may be subject to such terms. Consequently, there is a risk that the owners of the copyrights in such open source software may claim that the open source licenses governing their use impose certain conditions or restrictions on our ability to use the software that we did not anticipate. Such owners may seek to enforce the terms of the applicable open source license, including by demanding release of the source code for the open source software, derivative works of such software, or, in some cases, our proprietary source code that uses or was developed using such open source software. These claims could also result in litigation, subject us to significant damages, require us to purchase costly third-party licenses, require us to devote additional research and development resources to change our products or discontinue the sale of our proprietary products, any of which could result in reputational harm and would be disruptive to our business. In addition, if the license terms for the open source software we utilize change, we may be forced to re-engineer our platform or incur additional costs to comply with the changed license terms or to replace the affected open source software. Furthermore, if we were to combine our proprietary platform with open source software in a certain manner, we could, under certain of the open source licenses, be required to release the source code of our proprietary platform to the public or offer our platform to users at no cost. This could allow our competitors to create similar platforms with lower development effort and time and ultimately could result in a loss of sales for us.

In addition to risks related to license requirements, usage of open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide warranties or assurance of title or controls on origin of the software. There is typically no support available for open source software, and we cannot ensure that the authors of such open source software will implement or push updates to address security risks or will not abandon further development and maintenance.

Although we have implemented policies and tools to regulate the use and incorporation of open source software into our platform, we cannot be certain that we have not incorporated open source software in our platform in a manner that is inconsistent with such policies. Therefore, we may inadvertently use open source in a manner that we do not intend or that could expose us to claims for breach of contract or intellectual property infringement, misappropriation or other violation. Any of the foregoing could have a material adverse effect on our business, financial condition, prospects and results of operations.

The actual or perceived failure by us or our vendors to comply with applicable privacy and data protection laws, regulations or industry standards could have an adverse effect on our business, financial condition, results of operations and prospects.

We collect, store, share, use, retain, safeguard, transfer, analyze and otherwise process, and our vendors process on our behalf, personal information, confidential information and other information necessary to provide and deliver our products through our e-commerce channel to operate our business, for legal and marketing purposes, and for other
68

business-related purposes. Collection and use of this information might raise privacy and data protection concerns, which could negatively impact our business. Data privacy and information security has become a significant issue in the United States, countries in Europe, and in many other countries. The legal and regulatory framework for privacy and security issues is rapidly evolving and is expected to increase our compliance costs and exposure to liability. There are numerous federal, state, local, and international laws, orders, codes, rules, regulations and regulatory guidance regarding privacy, information security and processing (which we collectively refer to as “Data Protection Laws”), the number and scope of which is changing, subject to differing applications and interpretations, and which may be inconsistent among jurisdictions, or in conflict with other rules, laws or obligations (which we collectively refer to as “Data Protection Obligations”). Therefore, the regulatory framework for privacy and data protection worldwide is, and is likely to remain, uncertain and complex for the foreseeable future, and our actual or perceived failure to address or comply with applicable Data Protection Laws and Data Protection Obligations could have an adverse effect on our business, financial condition, results of operations and prospects. We also expect that there will continue to be new Data Protection Laws and Data Protection Obligations, and we cannot yet determine the impact such future Data Protection Laws and Data Protection Obligations may have on our business. Any significant change to Data Protection Laws and Data Protection Obligations, including without limitation, regarding the manner in which the express or implied consent of consumers for processing is obtained, could increase our costs and require us to modify our operations, possibly in a material manner, which we may be unable to complete and may limit our ability to store and process consumer data and operate our business.

We are or may also be subject to the terms of our external and internal privacy and security policies, codes, representations, certifications, industry standards, publications and frameworks (which we collectively refer to as “Privacy Policies”) and contractual obligations to third parties related to privacy, information security and processing, including contractual obligations to indemnify and hold harmless third parties from the costs or consequences of non-compliance with Data Protection Laws or Data Protection Obligations.

We may not be successful in achieving compliance if our employees, partners or vendors do not comply with applicable Data Protection Laws, Privacy Policies and Data Protection Obligations. If we or our vendors fail (or are perceived to have failed) to comply with applicable Data Protection Laws, Privacy Policies and Data Protection Obligations, or if our Privacy Policies are, in whole or part, found to be inaccurate, incomplete, deceptive, unfair, or misrepresentative of our actual practices, our business, financial condition, results of operations and prospects could be adversely affected.

In the United States, our obligations include rules and regulations promulgated under the authority of the Federal Trade Commission, the Electronic Communications Privacy Act, the Computer Fraud and Abuse Act, the California Consumer Privacy Act (the “CCPA”) and other state and federal laws relating to privacy and data security. The CCPA, which took effect on January 1, 2020, requires companies that process information of California residents to make new disclosures to consumers about their data collection, use and sharing practices, allows consumers to opt out of the sale of personal information with third parties and prohibits covered businesses from discriminating against California residents (for example, charging more for services) for exercising any of their rights under the CCPA. The law also provides a private right of action and statutory damages for certain data breaches that result in the loss of personal information. This private right of action is expected to increase the likelihood of, and risks associated with, data breach litigation. However, it remains unclear how various provisions of the CCPA will be interpreted and enforced. Therefore, the CCPA may increase our compliance costs and potential liability.

In addition, California voters recently approved the California Privacy Rights Act of 2020 (the “CPRA”) that goes into effect on January 1, 2023. The CPRA will significantly modify the CCPA, and will impose additional data protection obligations on companies doing business in California, potentially resulting in further complexity. The law will, among other things, give California residents the ability to limit the use of their sensitive information, provide for penalties for CPRA violations concerning California residents under the age of 16, and establish a new California Privacy Protection Agency to implement and enforce the law. The effects of this legislation are potentially far-reaching and may impact our business. Some observers have noted that the CCPA could mark the beginning of a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our business, financial condition, results of operations and prospects.

Other jurisdictions in the United States have already passed or are considering laws similar to the CCPA, with potentially greater penalties and more rigorous compliance requirements relevant to our business. Many state legislatures have already adopted legislation that regulates how businesses operate online, including measures relating to privacy, data security, data breaches and the protection of sensitive and personal information. For example, on March 2, 2021, Virginia enacted the Virginia Consumer Data Protection Act (the “CDPA”), a comprehensive privacy statute that shares similarities with the CCPA, CPRA, and legislation proposed in other states. The CDPA will require us to incur additional costs and expenses in an effort to comply with it before it becomes effective on January 1, 2023. June 2021, Colorado also enacted a similar law, the Colorado Privacy Act (the “CPA”), which becomes effective on July 1, 2023. Many other states are currently considering proposed comprehensive data privacy legislation and all 50 states have passed at least some form of
69

data privacy legislation (for example, all 50 states have enacted laws requiring disclosure of certain personal data breaches). At the federal level, the United States Congress is also considering various proposals for comprehensive federal data privacy legislation and, while no comprehensive federal data privacy law currently exists, we are subject to applicable existing federal laws and regulations, such as the rules and regulations promulgated under the authority of the Federal Trade Commission, which regulates unfair or deceptive acts or practices, including with respect to data privacy and security. These state statutes, and other similar state or federal laws, may require us to modify our data processing practices and policies and incur substantial compliance-related costs and expenses.

We rely on a variety of marketing techniques and practices, including email and social media marketing, online targeted advertising, cookie-based processing, and postal mail to sell our products and services and to attract new consumers, and we, and our vendors, are subject to various current and future Data Protection Laws and Data Protection Obligations that govern marketing and advertising practices. Governmental authorities continue to evaluate the privacy implications inherent in the use of third-party “cookies” and other methods of online tracking for behavioral advertising and other purposes, such as by regulating the level of consumer notice and consent required before a company can employ cookies or other electronic tracking tools or the use of data gathered with such tools. Additionally, some providers of consumer devices, web browsers and application stores have implemented, or announced plans to implement, means to make it easier for Internet users to prevent the placement of cookies or to block other tracking technologies, require additional consents, or limit the ability to track user activity, which could if widely adopted result in the use of third-party cookies and other methods of online tracking becoming significantly less effective. Laws and regulations regarding the use of these cookies and other current online tracking and advertising practices or a loss in our ability to make effective use of services that employ such technologies could increase our costs of operations and limit our ability to acquire new consumers on cost-effective terms, which, in turn, could have an adverse effect on our business, financial condition, results of operations and prospects.

Government regulation of the Internet and ecommerce is evolving, and unfavorable changes or failure by us to comply with these regulations could have an adverse effect on our business, financial condition, results of operations and prospects.

We are subject to general business regulations and laws as well as regulations and laws specifically governing the Internet and ecommerce, including consumer protection regulations that regulate retailers and govern the promotion and sale of merchandise. Existing and future regulations and laws could impede the growth of the Internet, ecommerce or mobile commerce, which could in turn adversely affect our growth. These regulations and laws may involve taxes, tariffs, privacy and data security, anti-spam, content protection, electronic contracts and communications, consumer protection, sales practices, subscription programs and Internet neutrality. It is not clear how existing laws governing issues such as property ownership, sales and other taxes and consumer privacy apply to the Internet as the vast majority of these laws were adopted prior to the advent of the Internet and do not contemplate or address the unique issues raised by the Internet or ecommerce. It is possible that general business regulations and laws, or those specifically governing the Internet or ecommerce, may be interpreted and applied in a manner that is inconsistent from one jurisdiction to another and may conflict with other rules or our practices. We cannot be sure that our practices have complied, comply or will comply fully with all such laws and regulations. Any failure, or perceived failure, by us to comply with any of these laws or regulations could result in damage to our reputation, a loss in business and proceedings or actions against us by governmental entities, customers, suppliers or others. Any such proceeding or action could hurt our reputation, force us to spend significant amounts in defense of these proceedings, distract our management, increase our costs of doing business, decrease the use of our website and mobile applications by customers and suppliers and may result in the imposition of monetary liabilities and burdensome injunctions that could, for example, require changes to our business practices. We may also be contractually liable to indemnify and hold harmless third parties from the costs or consequences of noncompliance with any such laws or regulations. As a result, adverse developments with respect to these laws and regulations could have an adverse effect on our business, financial condition, results of operations and prospects.

Advertising inaccuracies or product mislabeling may have an adverse effect on our business by exposing us to lawsuits, product recalls or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings.

Many products that we sell are labeled and advertised with claims as to their origin, ingredients or health, wellness, environmental or other benefits, including, by way of example, the use of the term “natural”, “organic”, “clean conscious”, or “sustainable”, or similar synonyms or implied statements relating to such benefits. Grove’s brand as a whole is marketed using similar environmental language. The Federal Trade Commission’s (FTC) Guides For The Use Of Environmental Marketing Claims, or the “Green Guides,” or “Green Guides,” provide guidance on how to use environmental marketing claims, provide specific guidance for certain terms (e.g. “recyclable”), and recommend against using unqualified statements about environmental benefits such as “eco-friendly”. Although the FDA and the USDA each have issued statements regarding the appropriate use of the word “natural,” there is no single, U.S. government regulated definition of the term
70

“natural” for use in the consumer and personal care industry. This is also true for many other claims common in the clean conscious product industry.

Consumer class actions, actions from industry groups such as the National Advertising Division of the Better Business Bureau, and public enforcement actions have been brought against numerous companies that market “natural,” “sustainable,” or other ecologically conscious products or ingredients, asserting false, misleading and deceptive advertising and labeling claims.

These suits often identify ingredients or components of a product for which certain marketing claims may not be fully accurate, and claim that their presence in the product renders the statements false and deceptive. For example, some actions concerning “natural” claims have focused on the presence of genetically modified and/or synthetic ingredients or components in products, including synthetic forms of otherwise natural ingredients.

Many of our products are subject to regulatory enforcement:
The FDA regulates product labels and other product claims for the consumer products subject to its jurisdiction and has the authority to challenge product labels and claims that it believes are
non-compliant or false or misleading, through the use of a variety of enforcement tools (e.g., Warning Letters, untitled letters, and seizure actions). In limited circumstances, the FDA has taken regulatory action against products labeled “natural” but that nonetheless contain synthetic ingredients or components.
The FTC has the authority to challenge claims made in product advertising and requires that such claims are adequately substantiated prior to use. The FTC similarly has enforcement tools that it uses to challenge advertising claims that it deems non-compliant with the law.
The USDA enforces federal standards for organic production and use of the term “organic” on product labeling. These laws prohibit a company from selling or labeling products as organic unless they are produced and handled in accordance with the applicable federal law. Failure to comply with these requirements may subject us to liability or regulatory enforcement. Consumers may also pursue state law claims challenging use of the organic label as being intentionally mislabeled or misleading or deceptive to consumers.
In addition, certain products, including the disinfectant products, we sell may require approval from and registration with the EPA and state regulatory agencies prior to sale. Products that expressly or impliedly claim to control microorganisms that pose a threat to human health may be subject by additional regulatory scrutiny and need to be supported by additional efficacy data. Should we advertise or market these regulated products with claims that are not permitted by the terms of their registration or are otherwise false or misleading, the EPA and states may be authorized to take enforcement action to prevent the sale or distribution of disinfectant products.

State and local enforcers also have the authority to prosecute false advertising cases, including relating to environmental marketing claims. Current and potential competitors may make similar claims, which may result in litigation and inquiries from state and federal regulators and governments.

Should we become subject to actions regarding our branding or product marketing, consumers may avoid purchasing products from us or seek alternatives, even if the basis for the claim is unfounded. Moreover, any regulatory or government enforcement actions may trigger class action lawsuits under state consumer protection laws.

Adverse publicity about these matters may discourage consumers from buying our products. The cost of defending against any such claims could be significant and we may incur substantial costs remediating product claims in labeling and advertising if we are unsuccessful in defending such actions. Any loss of confidence on the part of consumers in the truthfulness of our labeling, advertising or ingredient claims would be difficult and costly to overcome and may significantly reduce our brand value. Any of these events could adversely affect our reputation and brand and decrease our sales, which could have an adverse effect on our business, financial condition, results of operations and prospects.

False or misleading marketing claims concerning a product’s registration or its efficacy may also create the risk for challenges under federal or state law.





71

We may become subject to product liability claims, which could harm our reputation, financial condition, and liquidity if we are not able to successfully defend or insure against such claims.

Selling consumer product goods and personal care products involves inherent legal and other risks, and there is increasing governmental scrutiny of, and public awareness regarding, product safety. Such products are highly regulated by numerous government agencies.

Some of the products we sell or manufacture expose us to product liability claims relating to personal injury or illness, death, or environmental or property damage, and can require product recalls or other actions. Third parties who sell products using our services also expose us to product liability claims. Although we maintain liability insurance, we cannot be certain that our coverage will be adequate for liabilities actually incurred or that insurance will continue to be available to us on economically reasonable terms, or at all. In addition, some of our agreements with our vendors and sellers do not indemnify us from product liability.

Adverse reactions, including illnesses, injury or death related to ingredients, allergens, or foreign material contamination in our products or other product safety incidents or efficacy failures with our products, or involving our suppliers, could result in the disruption or discontinuance of sales of these products or our relationships with such suppliers, or otherwise result in increased operating costs, regulatory enforcement actions (e.g., seizure), and harm to our reputation.

Shipment of adulterated, misbranded or expired products, even if inadvertent or the fault of a third-party supplier, can result in criminal or civil liability. Such incidents could also expose us to product liability, negligence or other lawsuits, including consumer class action lawsuits. Any claims brought against us may exceed or be outside the scope of our existing or future insurance policy coverage or limits. Any judgment against us that is more than our policy limits or not covered by our policies or not subject to insurance would have to be paid from our cash reserves, which would reduce our capital resources.

The occurrence of adverse reactions, ineffectiveness or other safety incidents associated with our products could also adversely affect the price and availability of affected ingredients or products, resulting in higher costs, disruptions in supply and a reduction in our sales. Furthermore, any safety, contamination, defects, or regulatory noncompliance issues, whether or not caused by our actions, could compel us, our suppliers, our retail or ecommerce customers, or our consumers, depending on the circumstances, to conduct a recall in accordance with requests from the FDA, the Consumer Product Safety Commission, or CPSC, the USDA, the U.S. Environmental Protection Agency, or EPA, or other federal, state or local authorities. Product recalls could result in significant losses due to their costs, the destruction of product inventory, lost sales due to the unavailability of the product for a period of time and potential loss of existing retail or ecommerce partners or consumers, negative publicity and a potential negative impact on our ability to attract new consumers due to negative consumer experiences or because of an adverse impact on our brand and reputation. The costs of a recall could be outside the scope of our existing or future insurance policy coverage or limits.

Companies that sell consumer and personal care products have also been subject to targeted, large-scale tampering as well as to opportunistic, individual product tampering, and we, like any such company, could be a target for product tampering. Forms of tampering could include the introduction of foreign material, chemical contaminants and pathological organisms into products, as well as product substitution. Governmental regulations require companies like us to analyze, prepare and implement mitigation strategies specifically to address tampering designed to inflict widespread public health harm. If we do not adequately address the possibility, or any actual instance, of product tampering, we could face possible seizure or recall of our products and the imposition of civil or criminal sanctions, which could have an adverse effect on our business, financial condition, results of operations and prospects.

We are subject to a number of other laws and regulations, which could impact our business.

We are subject to a broad range of federal, state, local, and foreign laws and regulations intended to protect public and worker health and safety, natural resources, the environment and consumers. Our operations are subject to regulation by the Occupational Safety and Health Administration (“OSHA”), the FDA, the CPSC, the USDA, the FTC, EPA, and by various other federal, state, local and foreign authorities regarding the manufacture, processing, packaging, storage, sale, order fulfillment, advertising, labeling, import and export of our products. In addition, we and our manufacturing partners are subject to additional regulatory requirements, including environmental, health and safety laws and regulations administered by the EPA, state, local and foreign environmental, health and safety legislative and regulatory authorities and the National Labor Relations Board, covering such areas as discharges and emissions to air and water, the use, management, disposal and remediation of, and human exposure to, hazardous materials and wastes, and public and worker health and safety, and Current Good Manufacturing Practice requirements, or GMPs, enforced by the FDA.

72

In addition, as the provider of products with a subscription-based element, a variety of laws and regulations govern the ability of users to cancel subscriptions and auto-payment renewals. California’s automatic renewal law in particular has been the basis for both consumer class actions and government enforcement.

Violations of or liability under any of these laws and regulations may result in administrative, civil or criminal fines, penalties or sanctions against us, revocation or modification of applicable permits, licenses or authorizations, environmental, health and safety investigations or remedial activities, voluntary or involuntary product recalls, warning or untitled letters or cease and desist orders against operations that are not in compliance, among other things. Such laws and regulations generally have become more stringent over time and may become more so in the future, and we may incur (directly, or indirectly through our manufacturing partners) material costs to comply with current or future laws and regulations or in any required product recalls. For example, in just the last year or so, California, New York, Illinois, Delaware, and Colorado all enacted more robust requirements for subscription programs.

Liabilities under, and/or costs of compliance, and the impacts on us of any non-compliance, with or investigations under any such laws and regulations could have an adverse effect on our business, financial condition, results of operations and prospects. For example, the Consumer Protection Division of the Santa Clara County District Attorney’s Office, in conjunction with other county and city prosecutors, is currently investigating our automatic renewal practices, and the Federal Trade Commission is currently investigating our billing and automatic renewal practices. We may be subject to future claims under auto-payment renewal laws and regulations that could have a material adverse effect on our business. In addition, changes in the laws and regulations to which we are subject, or in the prevailing interpretations of such laws and regulations by courts and enforcement authorities, could impose significant limitations and require changes to our business, which may increase our compliance expenses, make our business more costly and less efficient to conduct, and compromise our growth strategy, which could have an adverse effect on our business, financial condition, results of operations and prospects.

Our products are also subject to state laws and regulations, such as California’s Proposition 65 (“Prop 65”), which requires a specific warning on any product that causes an exposure to a substance listed by the State of California as known to cause cancer or birth defects, unless the exposure is below the warning level. We have in the past been subject to lawsuits brought under Prop 65, and if we fail to comply with Prop 65 in the future, it may result in lawsuits and regulatory enforcement that could have a material adverse effect on our reputation, business, financial condition, results of operations and prospects. Further, the inclusion of warnings on our products to comply with Prop 65 could also reduce overall consumption of our products or leave consumers with the perception (whether or not valid) that our products do not meet their health and wellness needs, all of which could adversely affect our reputation, business, financial condition, results of operations and prospects.

These developments, depending on the outcome, could have an adverse effect on our reputation, business, financial condition, results of operations and prospects.

Changes in existing laws or regulations or related official guidance, or the adoption of new laws or regulations or guidance, may increase our costs and otherwise adversely affect our business, financial condition, results of operations and prospects.

The regulatory environment in which we operate has changed in the past and could change significantly and adversely in the future. For example, in December 2009, the FTC substantially revised its Guides Concerning the Use of Endorsements and Testimonials in Advertising (“Endorsement Guides”) to eliminate a safe harbor principle that formerly recognized that advertisers could publish consumer testimonials that conveyed truthful but extraordinary results from using the advertiser’s product as long as the advertiser clearly and conspicuously disclosed that the endorser’s results were not typical. Similarly, in 2012, the FTC announced revisions to its Green Guides discussed above, which assist advertisers in avoiding the dissemination of false or deceptive environmental claims for their products. The Green Guides revisions introduced new and proscriptive guidance regarding advertisers’ use of product certifications and seals of approval, “recyclable” claims, “renewable materials” claims, “carbon offset” claims and other environmental benefit claims. In October 2021, California passed a new environmental marketing law banning recyclability claims unless a product and/or its packaging meets specifically enumerated benchmarks focused on the practical realities of the recycling process; the benchmarks, which have not yet been enumerated, may be more stringent than those currently imposed by the FTC’s Green Guides.

Although we strive to adapt our marketing efforts to evolving legal and regulatory requirements and related guidance, we may not always anticipate or timely identify changes in regulation or official guidance that could impact our business, with the result that we could be subjected to litigation and enforcement actions that could adversely affect our business, financial condition, results of operations and prospects. Future changes in laws, regulations, and related official agency guidance, such as the Endorsement Guides and Green Guides (or state automatic renewal laws, discussed above), could also introduce new restrictions that impair our ability to market our products effectively and place us at a competitive
73

disadvantage with competitors who, for example, depend less than we do on environmental marketing claims and social media influencer relationships.

Moreover, any change in laws, regulations or guidance relating to manufacturing, advertising, labeling or packaging for our products may lead to an increase in costs or interruptions in production, either of which could adversely affect our business, financial condition, results of operations and prospects. New or revised government laws, regulations or guidelines could result in additional compliance costs and, in the event of non-compliance, civil remedies, including fines, injunctions, withdrawals, recalls or seizures and confiscations, as well as potential criminal sanctions, any of which could have an adverse effect on our business, financial condition, results of operations and prospects.

Failure by our network of retail and ecommerce partners, suppliers or manufacturers to comply with product safety, environmental or other laws and regulations, or with the specifications and requirements of our products, may disrupt our supply of products and adversely affect our business.

If our network of retail and ecommerce partners, suppliers or manufacturers fail to comply with environmental, health and safety or other laws and regulations, or face allegations of non-compliance, their operations may be disrupted and our reputation could be harmed. Additionally, our retail and ecommerce partners, suppliers and manufacturers are required to maintain the quality of our products and to comply with our standards and specifications. In the event of actual or alleged non-compliance, we might be forced to find alternative retail or ecommerce partners, suppliers or manufacturers and we may be subject to lawsuits and/or regulatory enforcement actions related to such non-compliance by the suppliers and manufacturers. As a result, our supply of products could be disrupted or our costs could increase, which could adversely affect our business, financial condition, results of operations and prospects. The failure of any partner or manufacturer to produce products that conform to our standards could adversely affect our reputation in the marketplace and result in product recalls, product liability claims, government or third-party actions and economic loss. For example, a manufacturer’s failure to meet GMPs, could result in the delivery of a product that is subject to a product recall, product liability litigation, or government investigations and enforcement. Additionally, actions we may take to mitigate the impact of any disruption or potential disruption in our supply of materials or finished inventory, including increasing inventory in anticipation of a potential supply or production interruption, could have an adverse effect on our business, financial condition, results of operations and prospects.

Our status as a public benefit corporation and a Certified B Corporation may not result in the benefits that we anticipate.

We are a public benefit corporation incorporated under Delaware law. As a public benefit corporation we are required to balance the financial interests of our stockholders with the best interests of those stakeholders materially affected by our conduct, including particularly those affected by the specific benefit purposes set forth in our Charter. In addition, there is no assurance that the expected positive impact from being a public benefit corporation will be realized. Accordingly, being a public benefit corporation and complying with our related obligations could negatively impact our ability to provide the highest possible return to our stockholders.

As a public benefit corporation, we are required to disclose to stockholders a report at least biennially on our overall public benefit performance and on our assessment of our success in achieving our specific public benefit purpose. If we are not timely or are unable to provide this report, or if the report is not viewed favorably by parties doing business with us or regulators or others reviewing our credentials, our reputation and status as a public benefit corporation may be harmed.

While not required by Delaware law or the terms of our Charter, we have elected to have our social and environmental performance, accountability and transparency assessed against the proprietary criteria established by an independent non-profit organization. As a result of this assessment, we have been designated as a “Certified B Corporation,” which refers to companies that are certified as meeting certain levels of social and environmental performance, accountability and transparency. The standards for Certified B Corporation certification are set by an independent organization and may change over time. Currently, we are required to recertify as a Certified B Corporation once every three years, with our next certification required by October 20, 2023. Our reputation could be harmed if we lose our status as a Certified B Corporation, whether by our choice or by our failure to continue to meet the certification requirements, if that failure or change were to create a perception that we are more focused on financial performance and are no longer as committed to the values shared by Certified B Corporations. Likewise, our reputation could be harmed if our publicly reported Certified B Corporation score declines.

As a public benefit corporation, our duty to balance a variety of interests may result in actions that do not maximize stockholder value.

As a public benefit corporation, our board of directors has a duty to balance (i) the pecuniary interest of our stockholders, (ii) the best interests of those materially affected by our conduct and (iii) specific public benefits identified in
74

our charter documents. In balancing these interests, our board of directors may take actions that do not maximize stockholder value. Any benefits to stockholders resulting from our public benefit purposes may not materialize within the timeframe we expect or at all and may have negative effects. For example: we may choose to revise our policies in ways that we believe will be beneficial to our stakeholders, including customers, suppliers, employees and local communities, even though the changes may be costly; we may be influenced to pursue programs and services to demonstrate our commitment to the communities to which we serve even though there is no immediate return to our stockholders; or in responding to a possible proposal to acquire the Company, our board of directors may be influenced by the interests of our stakeholders, including suppliers, crew members and local communities, whose interests may be different from the interests of our stockholders.

We may be unable or slow to realize the benefits we expect from actions taken to benefit our stakeholders, including suppliers, crew members and local communities, which could adversely affect our business, financial condition and results of operations, which in turn could cause our stock price to decline.

As a public benefit corporation, we may be subject to increased derivative litigation concerning our duty to balance stockholder and public benefit interests, the occurrence of which may have an adverse impact on our financial condition and results of operations.

As a Delaware public benefit corporation, our stockholders (if they, individually or collectively, own at least 2% of our outstanding capital stock or shares having at least $2 million in market value (whichever is less)) are entitled to file a derivative lawsuit claiming that our directors failed to balance stockholder and public benefit interests. This potential liability does not exist for traditional corporations. Therefore, we may be subject to the possibility of increased derivative litigation, which would require the attention of management and, as a result, may adversely impact management’s ability to effectively execute our strategy. Any such derivative litigation may be costly and have an adverse impact on our financial condition and results of operations.

We and our directors and executive officers may be subject to litigation for a variety of claims, which could harm our reputation and adversely affect our business, results of operations and financial condition.

In the ordinary course of business, we may face allegations, lawsuits, and regulatory inquiries, audits, and investigations regarding labor and employment, wage and hour, consumer protection, commercial, antitrust, alleged securities law violations or other investor claims, claims that our employees or independent contractors have wrongfully disclosed or we have wrongfully used proprietary information of our employees’ or independent contractors’ former employers and other matters, data privacy, security, consumer protection, and intellectual property infringement, acquisitions, or business practices. The number and significance of these potential claims and disputes may increase as our business expands. Further, our general liability insurance may not cover all potential claims made against us or be sufficient to indemnify us for all liability that may be imposed. Any claim against us, regardless of its merit, could be costly, divert management’s attention and operational resources, and harm our reputation.

Our directors and executive officers may also be subject to litigation. The limitation of liability and indemnification provisions that are included in our amended and restated Charter, our amended and restated bylaws and indemnification agreements that we entered into with our directors and executive officers provide that we will indemnify our directors and officers to the fullest extent permitted by Delaware law and may discourage stockholders from bringing a lawsuit against our directors and executive officers for breach of their fiduciary duties. Such provisions may also reduce the likelihood of derivative litigation against our directors and executive officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder’s investment may be harmed to the extent that we pay the costs of settlement and damage awards against our directors and executive officers as required by these indemnification provisions. We have obtained insurance policies under which, subject to the limitations of the policies, coverage is provided to our directors and executive officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or executive officer, including claims relating to public securities matters, and to us with respect to payments that may be made by us to these directors and executive officers pursuant to our indemnification obligations or otherwise as a matter of law. These insurance policies may not cover all potential claims made against our directors and executive officers, may not be available to us in the future at a reasonable rate and may not be adequate to indemnify us for all liability that may be imposed. As litigation is inherently unpredictable, we cannot assure you that any potential claims or disputes will not harm our business, results of operations and financial condition.

The results of regulatory proceedings, litigation, claims, and audits cannot be predicted with certainty, and determining reserves for pending litigation and other legal, regulatory and audit matters requires significant judgment. Regardless of the outcome of any litigation, the litigation itself can have an adverse impact on us because of legal costs, diversion of management resources and other factors.


75

Risks Relating to Ownership of Company Securities

The price of our Class A Common Stock and our warrants may be volatile.

The price of our Class A Common Stock and our warrants may fluctuate due to a variety of factors, including:
changes in the industries in which we and our customers operate;
variations in our operating performance and the performance of our competitors in general;
material and adverse impact of the COVID-19 pandemic on the markets and the broader global economy;
actual or anticipated fluctuations in our quarterly or annual results of operation;
publication of research reports by securities analysts about us or our competitors or our industry;
the public’s reaction to our press releases, our other public announcements, and our filings with the SEC;
our failure or the failure of our competitors to meet analysts’ projections or guidance that we or our competitors may give to the market;
additions and departures of key personnel;
changes in laws and regulations affecting our business;
commencement of, or involvement in, litigation involving us;
changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;
the volume of shares of our Class A Common Stock available for public sale;
sales of shares of our Class A Common Stock by the PIPE Investors; and
general economic and political conditions such as recessions, interest rates, fuel prices and general inflationary pressures, foreign currency fluctuations, international tariffs, social, political, and economic risks, and acts of war or terrorism.

These market and industry factors may materially reduce the market price of our Class A Common Stock and our warrants regardless of our operating performance.

Warrants are or may become exercisable for shares of our common stock, and additional shares of our common stock may become issuable, which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.

Outstanding Public Warrants and Private Placement Warrants to purchase an aggregate of 14,750,000 shares of Class A Common Stock may become exercisable in accordance with the terms of the warrant agreement governing those securities with an exercise price of $11.50 per share. However, there is no guarantee that the Public Warrants or the Private Placement Warrants will ever be in the money prior to their expiration, and as such, the Public Warrants and the Private Placement Warrants may expire worthless. See below risk factor, “The Public Warrants may never be in the money, and they may expire worthless and the terms of the Public Warrants may be amended in a manner adverse to a holder if holders of at least 65% of the then-outstanding Public Warrants approve of such amendment.

Outstanding warrants to purchase an aggregate of 923,857 shares of Class B Common Stock may become exercisable in accordance with the terms of the warrant agreements governing those securities, the forms of which have been filed as Exhibit 4.5 through Exhibit 4.12 of the Company’s Current Report on Form 8-K filed with the SEC on June 23, 2022. The exercise prices of the Legacy Grove Warrants are set forth in such warrant agreements, as subsequently adjusted pursuant to the Business Combination.

Outstanding Backstop Warrants to purchase an aggregate of 3,875,028 shares of Class A Common Stock are exercisable in accordance with the terms of the Backstop Subscription Agreement governing those securities with an exercise price of $0.01 per share.

Pursuant to the Backstop Subscription Agreement, we may be required to issue additional shares of Class A Common Stock to the Backstop Investor if the volume weighted average price of our Class A Common Stock is less than $10.00 during the 10 trading days commencing on the first trading day after our first quarterly earnings call for the fiscal quarter ending June 30, 2022 (“Additional Shares”).
76

To the extent any of the Public Warrants, Private Placement Warrants, Legacy Grove Warrants or Backstop Warrants are exercised, and/or the Additional Shares are issued, additional shares of Class A Common Stock will be issued or become issuable, as applicable, which will or could result in dilution to the holders of Class A Common Stock and an increase in the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market or the fact that such warrants may be exercised or shares be issued, as applicable, could adversely affect the prevailing market prices of Class A Common Stock.

The Public Warrants may never be in the money, and they may expire worthless and the terms of the Public Warrants may be amended in a manner adverse to a holder if holders of at least 65% of the then-outstanding public warrants approve of such amendment.

The Public Warrants were issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or correct any mistake, but requires the approval by the holders of at least 65% of the then-outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants. Accordingly, we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 65% of the then-outstanding Public Warrants approve of such amendment. Although our ability to amend the terms of the Public Warrants with the consent of at least 65% of the then-outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the Warrants, convert the Warrants into cash, shorten the exercise period, or decrease the number of shares of Class A Common Stock purchasable upon exercise of a Warrant.

We may redeem unexpired Public Warrants prior to their exercise at a time that is disadvantageous to holders of the Public Warrants, thereby making the Public Warrants worthless.

We have the ability to redeem outstanding Public Warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of the Class A Common Stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations, and the like) for any 20 trading days within a 30-trading-day period ending on the third trading day prior to the date we send the notice of redemption to the warrant holders. If and when the Public Warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding Public Warrants could force holders of Public Warrants to: (i) exercise the Public Warrants and pay the exercise price therefor at a time when it may be disadvantageous for such holder to do so; (ii) sell the Public Warrants at the then-current market price when the holder of such Public Warrant might otherwise wish to hold their Public Warrants; or (iii) accept the nominal redemption price which, at the time the outstanding Public Warrants are called for redemption, is likely to be substantially less than the market value of such Public Warrants.

In addition, we may redeem the Public Warrants at any time after they become exercisable and prior to their expiration at a price of $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their Public Warrants prior to redemption for a number of Class A Common Stock determined based on the redemption date and the fair market value of our Class A Common Stock. The value received upon exercise of the Public Warrants (1) may be less than the value the holders would have received if they had exercised their Public Warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the Public Warrants. None of the Private Placement Warrants will be redeemable by us, subject to certain circumstances, so long as they are held by the Sponsor or its permitted transferees.

Our dual-class structure may impact the stock price of our Class A Common Stock.

We cannot predict whether our dual-class structure will result in a lower or more volatile market price of our Class A Common Stock or in adverse publicity or other adverse consequences. For example, certain index providers have announced restrictions on including companies with multiple-class share structures in certain of their indices. In July 2017, FTSE Russell and S&P Dow Jones announced that they would cease to allow most newly-public companies utilizing dual or multi-class capital structures to be included in their indices. Affected indices include the Russell 2000 and the S&P 500, S&P MidCap 400, and S&P SmallCap 600, which together make up the S&P Composite 1500. Beginning in 2017, MSCI, a leading stock index provider, opened public consultations on their treatment of no-vote and multi-class structures and temporarily barred new multi-class listings from certain of its indices; however, in October 2018, MSCI announced its decision to include equity securities “with unequal voting structures” in its indices and to launch a new index that specifically includes voting rights in its eligibility criteria. Under the announced policies, our dual-class capital structure makes us ineligible for inclusion in certain indices, and as a result, mutual funds, exchange-traded funds, and other investment vehicles that attempt to passively track those indices will not invest in our Class A Common Stock. These policies are still fairly new and it is unclear what effect, if any, they will have on the valuations of publicly traded
77

companies excluded from the indices, but it is possible that they may depress these valuations compared to those of other similar companies that are included. Because of our dual-class structure, we will likely be excluded from certain of these indices and we cannot assure you that other stock indices will not take similar actions. Given the sustained flow of investment funds into passive strategies that seek to track certain indices, exclusion from stock indices would likely preclude investment by many of these funds and could make shares of our Class A Common Stock less attractive to other investors. As a result, the market price of shares of our Class A Common Stock could be adversely affected.

We are an emerging growth company within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to “emerging growth companies,” this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.

We are an “emerging growth company” within the meaning of the Securities Act, as modified by the JOBS Act, and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not “emerging growth companies” including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We will remain an emerging growth company under the JOBS Act until the earliest of (a) December 31, 2026, (b) the last date of our fiscal year in which we have total annual gross revenue of at least $1.07 billion, (c) the date on which we are deemed to be a “large accelerated filer” under the rules of the SEC with at least $700.0 million of outstanding securities held by non-affiliates or (d) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the previous three years. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

We may incur debt or assume contingent or other liabilities or dilute our stockholders in connection with acquisitions or strategic alliances.

We may issue equity securities to pay for future acquisitions or strategic alliances, which could be dilutive to existing stockholders. We may also incur debt or assume contingent or other liabilities in connection with acquisitions and strategic alliances, which could impose restrictions on our business operations and harm our operating results. Further, any additional equity financing, debt financing, or credit facility used for such acquisitions may not be on favorable terms, and any such financing or facility may place restrictions on our business. In addition, to the extent that the economic benefits associated with any of our acquisitions diminish in the future, we may incur incremental operating losses, and we may be required to record additional write downs of goodwill, intangible assets or other assets associated with such acquisitions, which would adversely affect our operating results.

Future sales, or the perception of future sales, by us or our stockholders in the public market could cause the market price for our Class A Common Stock to decline.

The sale of shares of our Class A Common Stock in the public market, or the perception that such sales could occur, could harm the prevailing market price of shares of our Class A Common Stock. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.

78

As any restrictions on resale end, the market price of our Class A Common Stock could drop significantly if the holders of these shares sell them or are perceived by the market as intending to sell them. These factors could also make it more difficult for us to raise additional funds through future offerings of our Class A Common Stock or other securities.

In addition, Class A Common Stock reserved for future issuance under our equity incentive plans will become eligible for sale in the public market once those shares are issued, subject to provisions relating to various vesting agreements, lock-up provisions, and, in some cases, limitations on volume and manner of sale applicable to affiliates under Rule 144, as applicable. As of June 30, 2022, the aggregate number of shares of Class A Common Stock reserved for future issuance under our Incentive Equity Plan is 24,544,031. The Compensation Committee of the Board may determine the exact number of shares to be reserved for future issuance under our equity incentive plans at its discretion. We will file one or more registration statements on Form S-8 under the Securities Act to register shares of Class A Common Stock or securities convertible into or exchangeable for shares of Class A Common Stock issued pursuant to our Equity Incentive Plan. Any such Form S-8 registration statements will automatically become effective upon filing. Accordingly, shares registered under such registration statements will be available for sale in the open market.

The NYSE may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.

Currently, our Class A Common Stock and Public Warrants are publicly traded on the NYSE under the symbols GROV and GROV.WS, respectively. We cannot assure you that our securities will continue to be listed on the NYSE. In order to continue listing our securities on the NYSE, we must maintain certain financial, distribution and share price levels. Generally, we must maintain a minimum number of holders of our securities (400 public holders). If the NYSE delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including:
a limited availability of market quotations for our securities;
reduced liquidity for our securities;
a determination that our Class A Common Stock is a “penny stock” which will require brokers trading in our Class A Common Stock to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities;
a limited amount of news and analyst coverage; and
a decreased ability to issue additional securities or obtain additional financing in the future.
The National Securities Markets Improvement Act of 1996, which is a federal statute, prevents or preempts the states from regulating the sale of certain securities, which are referred to as “covered securities.” Since our Class A Common Stock and Public Warrants are listed on the NYSE, they are covered securities. Although the states are preempted from regulating the sale of our securities, the federal statute does allow the states to investigate companies if there is a suspicion of fraud, and, if there is a finding of fraudulent activity, then the states can regulate or bar the sale of covered securities in a particular case. If we were no longer listed on the NYSE, our securities would not be covered securities and we would be subject to regulation in each state in which we offer our securities.

Because there are no current plans to pay cash dividends on our Class A Common Stock for the foreseeable future, holders of our Class A Common Stock may not receive any return on investment unless such holders sells their Class A Common Stock for a price greater than that which such holder paid for it.

We intend to retain future earnings, if any, for future operations, expansion and debt repayment and there are no current plans to pay any cash dividends for the foreseeable future. The declaration, amount and payment of any future dividends on shares of the Class A Common Stock will be at the sole discretion of our Board. Our Board may take into account general and economic conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax, and regulatory restrictions, implications on the payment of dividends by us to our stockholders or by our subsidiaries to us and such other factors as our Board may deem relevant. In addition, our ability to pay dividends is limited by covenants of our existing and outstanding indebtedness and may be limited by covenants of any future indebtedness we incur. As a result, holders of our Class A Common Stock may not receive any return on an investment in our Class A Common Stock unless such holder sells the Class A Common Stock for a price greater than that which such holder paid for it.



79

If securities analysts do not publish research or reports about our business or if they downgrade our stock or our sector, our stock price and trading volume could decline.

The trading market for our Class A Common Stock will rely in part on the research and reports that industry or financial analysts publish about the us or our business. We will not control these analysts. If one or more of the analysts who do cover us downgrade our stock or industry, or the stock of any of our competitors, or publish inaccurate or unfavorable research about our business, the price of our stock could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, we could lose visibility in the market, which in turn could cause our stock price or trading volume to decline.

We will incur significant increased expenses and administrative burdens as a public company, which could have an adverse effect on its business, financial condition and results of operations.

Following the consummation of the Business Combination, we now face increased legal, accounting, administrative and other costs and expenses as a public company that we did not incur as a private company. The Sarbanes-Oxley Act of 2002 or the Sarbanes-Oxley Act, including the requirements of Section 404, to the extent applicable to us, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the PCAOB and the securities exchanges, impose additional reporting and other obligations on public companies. Compliance with public company requirements may increase costs and make certain activities more time consuming. It may also be more expensive to obtain director and officer liability insurance.

Delaware law and our governing documents contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.

Our governing documents and the DGCL contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by the Board and therefore depress the trading price of our Class A Common Stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of the Board or taking other corporate actions. Among other things, our governing documents include provisions regarding:
a classified board of directors;
the dual-class structure that provides for Class B Common Stock being entitled to ten votes per share;
the ability of the Board to issue shares of preferred stock, including “blank check” preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;
the limitation of the liability of, and the indemnification of, our directors and officers;
the requirement that a special meeting of stockholders may only be called by a majority of the entire Board, the Chairman of the Board, or our Chief Executive Officer, which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors;
controlling the procedures for the conduct and scheduling of Board and stockholder meetings;
the ability of the Board to amend the Bylaws, which may allow the Board to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the Bylaws to facilitate an unsolicited takeover attempt; and
advance notice procedures with which stockholders must comply to nominate candidates to the Board or to propose matters to be acted upon at a stockholders’ meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in the Board, and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of us.
These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in the Board or management, that stockholders may consider to be in their best interests.




80

Our Charter designates a state or federal court located within the State of Delaware as the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers, stockholders, employees, or agents.

Our Charter provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on behalf of us, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, employee, or agent of the Company to us or our stockholders, (iii) any action arising pursuant to any provision of the DGCL or our Charter or Bylaws (as either may be amended from time to time), or (iv) any action asserting a claim against us governed by the internal affairs doctrine. The forgoing provisions do not apply to any claims arising under the Securities Act and, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States will be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act.

These choice of forum provisions in our Charter may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies’ charter documents has been challenged in legal proceedings. It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find the choice of forum provision contained in our Charter to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
On June 16, 2022, Grove Collaborative issued Class A Common Stock to certain qualified institutional buyers and accredited investors that agreed to purchase such shares in connection with the Business Combination for aggregate gross proceeds of $86,075,000.

The foregoing securities were issued in transactions not involving an underwriter and not requiring registration under Section 5 of the Securities Act of 1933, as amended, in reliance on the exemption afforded by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder as a transaction by an issuer not involving a public offering without any form of general solicitation or general advertising.
Item 3. Defaults Upon Senior Securities
None
Item 4. Mine Safety Disclosures
None
Item 5. Other Information
None
Item 6. Exhibits
(a) Exhibits.
81

Exhibit
Number
Description
3.1
3.2
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
4.9
4.10
4.11
4.12
10.1
10.2
10.3
10.4
10.5
82

Exhibit
Number
Description
10.6
10.7
10.8+
10.9+
10.10+
10.11+
10.12+
10.13+
10.14+
10.15†
10.16
10.17
10.18
10.19
10.20
83

Exhibit
Number
Description
10.21
10.22
10.23*
10.24*
31.1*
31.2*
32.1*
101.INS*Inline Instance Document.
101.SCHInline Taxonomy Extension Schema Document.
101.CAL*Inline Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline Taxonomy Extension Label Linkbase Document.
101.PRE*Inline Taxonomy Extension Presentation Linkbase Document.
104*Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*    Filed herewith.
+    Indicates management contract or compensatory plan or arrangement.
†    Schedules and exhibits to this Exhibit omitted pursuant to Regulation S-K Item 601(b)(2). The Registrant agrees to furnish supplementally a copy of any omitted schedule of exhibit to the SEC upon request.
††    The Registrant has redacted provisions or terms of this Exhibit pursuant to Regulation S-K Item 601(b)(10)(iv). The Registrant agrees to furnish an unredacted copy of the Exhibit to the SEC upon its request.
84

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: August 11, 2022GROVE COLLABORATIVE HOLDINGS, INC.
By:/s/ Sergio Cervantes
Name:Sergio Cervantes
Title:Chief Financial Officer

85
EX-10.23 2 ex10232022eipexecrsuagt.htm RSU AGREEMENT Document
Exhibit 10.23

EXECUTIVE VERSION

GROVE COLLABORATIVE HOLDINGS, INC.
2022 EQUITY AND INCENTIVE PLAN
Restricted Stock Unit Award Notice
[Name of Executive]


You have been awarded a restricted stock unit award with respect to shares of Class A Common Stock of Grove Collaborative Holdings, Inc., a Delaware corporation (the “
Company”), pursuant to the terms and conditions of the Grove Collaborative Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) and the Restricted Stock Unit Award Agreement (together with this Award Notice, the “Agreement”). Copies of the Plan and the Restricted Stock Unit Award Agreement are attached hereto. Capitalized terms not defined herein shall have the meanings specified in the Plan or the Agreement.
Restricted Stock Units:
You have been awarded a restricted stock unit award with respect to [____] Shares, par value $0.0001 per share, subject to adjustment as provided in the Plan.
Grant Date:
[_________]
Vesting Schedule:
Except as otherwise provided in the Plan, the Agreement or any other agreement between the Company or any of its Subsidiaries and Holder in effect as of the Grant Date, the Award shall vest [_____________], if, and only if, you are, and have been, continuously (except for any absence for vacation, leave, etc. in accordance with the Company’s or its Subsidiaries’ policies): (i) employed by the Company or any of its Subsidiaries; (ii) serving as a Non-Employee Director; or (iii) providing services to the Company or any of its Subsidiaries as an advisor or consultant, in each case, from the date of this Agreement through and including the applicable vesting date.




Tax Withholding:
IMPORTANT INFORMATION REGARDING ACCEPTANCE OF AWARD AND SELL TO COVER TAX WITHHOLDING PAYMENT METHOD

By accepting this Award, to the greatest extent permitted under the Plan and applicable law, any withholding obligations for applicable Tax-Related Items (as defined in the Agreement) will be satisfied through the sale of a number of Shares subject to the Award as determined in accordance with the Tax Withholding section of the Agreement and the remittance of the cash proceeds of such sale to the Company (a “Sell to Cover”).  Under the Agreement, the Company is authorized and directed by you to make payment from the cash proceeds of this sale directly to the appropriate taxing authorities in an amount equal to the withholding obligation for Tax-Related Items.  

You represent and warrant that (i) you have carefully reviewed this Restricted Stock Unit Award Notice and the Tax Withholding section of the Agreement, (ii) on the date you accept this Award, you are not aware of any material, nonpublic information with respect to the Company or any securities of the Company, are not subject to any legal, regulatory or contractual restriction that would prevent Agent (as defined in the Agreement) from conducting sales, do not have, and will not attempt to exercise, authority, influence or control over any sales of Shares effected by the Agent pursuant to the Agreement, and are entering into the Agreement in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1 (regarding trading of the Company's securities on the basis of material nonpublic information) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and (iii) it is your intent that this election comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c) under the Exchange Act.

GROVE COLLABORATIVE HOLDINGS, INC.

By: ______________________________
Name:
Title:



Acknowledgment, Acceptance and Agreement:
By signing below and returning this Award Notice to Grove Collaborative Holdings, Inc., I hereby accept the Award granted to me and acknowledge and agree to be bound by the terms and conditions of this Award Notice, the Agreement and the Plan.

__________________________________ Date: [_____________]
Executive





GROVE COLLABORATIVE HOLDINGS, INC.
2022 EQUITY AND INCENTIVE PLAN

RESTRICTED STOCK UNIT AWARD AGREEMENT

Grove Collaborative, Holdings Inc., a Delaware corporation (the “Company”), hereby grants to the individual (the “Holder”) named in the award notice attached hereto (the “Award Notice”) as of the date set forth in the Award Notice (the “Grant Date”), pursuant to the provisions of the Grove Collaborative Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”), a restricted stock unit award (the “Award”) with respect to the number of shares of the Company’s Class A Common Stock, par value $0.0001 per share (“Stock”), set forth in the Award Notice, upon and subject to the restrictions, terms and conditions set forth in the Plan and this agreement (the “Agreement”). Capitalized terms not defined herein shall have the meanings specified in the Plan.

1. Award Subject to Acceptance of Agreement. The Award shall be null and void unless the Holder accepts this Agreement by executing the Award Notice in the space provided therefor and returning an original execution copy of the Award Notice to the Company or electronically accepting this Agreement within the Holder’s stock plan account with the Company’s stock plan administrator according to the procedures then in effect.

2. Rights as a Stockholder. The Holder shall not be entitled to any privileges of ownership with respect to the shares of Stock subject to the Award unless and until, and only to the extent, such shares become vested pursuant to Section 3 hereof and the Holder becomes a stockholder of record with respect to such shares. The Award includes a right to dividend equivalents equal to the value of any dividends paid on the Stock for which the dividend record date occurs between the Grant Date and the date the Award is settled or forfeited. Subject to vesting, each dividend equivalent entitles the Holder to receive the equivalent cash value of any such dividends paid on the number of shares of Stock underlying the Award that are outstanding during such period. Dividend equivalents will be accrued (without interest) and will be subject to the same conditions as the shares of Stock to which they are attributable, including, without limitation, the vesting conditions, the provisions governing the time and form of settlement of the Award.
3. Restriction Period and Vesting.

3.1. Service-Based Vesting Condition. Except as otherwise provided in this Section 3, the Award shall vest in accordance with the vesting schedule set forth in the Award Notice. The period of time prior to the full vesting of the Award shall be referred to herein as the “Restriction Period.”

3.2. Termination of Employment.

(a) Termination of Employment Due to Death or Disability. If the Holder’s employment with the Company terminates prior to the end of the Restriction Period by reason of the Holder’s death or termination by the Company due to Disability, then in any such case, the Award shall be 100% vested upon such termination of employment.

(b) Termination of Employment Other Than Due to Death or Disability. If the Holder’s employment with the Company terminates prior to the end of the Restriction Period and prior to a Change in Control for any reason other than death or termination by the Company due to Disability, then the Award shall be immediately and automatically forfeited by the Holder and cancelled by the Company.



3.3. Change in Control.

(a) Vesting of Award Not Assumed. In the event of a Change in Control prior to the end of the Restriction Period pursuant to which the Award is not effectively assumed or continued by the surviving or acquiring corporation in such Change in Control (as determined by the Board or Committee, with appropriate adjustments to the number and kind of shares, in each case, that preserve the value of the shares subject to the Award and other material terms and conditions of the outstanding Award as in effect immediately prior to the Change in Control), the Award shall vest in its entirety as of the date of the Change in Control.

(b) Vesting of Award Assumed. In the event of a Change in Control prior to the end of the Restriction Period pursuant to which the Award is effectively assumed or continued by the surviving or acquiring corporation in such Change in Control (as determined by the Board or Committee, with appropriate adjustments to the number and kind of shares, in each case, that preserve the value of the shares subject to the Award and other material terms and conditions of the outstanding Award as in effect immediately prior to the Change in Control) and (i) the Holder remains continuously employed through the end of the Restriction Period or (ii) the Company terminates the Holder’s employment without Cause or the Holder resigns for Good Reason within 24 months following such Change in Control, in any such case, the Award shall become fully vested as of the end of the Restriction Period or, if earlier, the Holder’s termination of employment. If, following a Change in Control, the Holder experiences a termination of employment other than as set forth in Section 3.2(a) or this Section 3.3(b), the Award shall be immediately and automatically forfeited by the Holder and cancelled by the Company.

3.4. Definitions.

(a) Cause. For purposes of this Award, (i) “Cause” shall have the meaning assigned to such term in any written employment or similar agreement between the Company or any of its Subsidiaries and the Holder in effect on the Grant Date or (ii) if Holder is not party to an employment or similar agreement in effect on the Grant Date which defines “Cause,” then “Cause” shall mean: (A) the Holder’s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (B) the Holder’s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (C) the Holder’s intentional, material violation of any contract or agreement between the Holder and the Company or of any statutory duty owed to the Company; (D) the Holder’s unauthorized use or disclosure of the Company’s confidential information or trade secrets; or (E) the Holder’s gross, or material deliberate, misconduct. The determination that a termination of the Holder’s employment is either for Cause or without Cause will be made by the Company (or, in the event the Holder is subject to Section 16 of the Exchange Act, the Committee), in its sole discretion. Any determination by the Company (or, if applicable, the Committee) that the Holder’s employment was terminated with or without Cause for the purposes of this Award shall have no effect upon any determination of the rights or obligations of the Company or the Holder for any other purpose.

(b) Disability. For purposes of this Award, “Disability” shall mean the inability of the Holder to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than twelve (12) months as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Company (or, in the event the Holder is subject to Section 16 of the Exchange Act, the Committee) on the basis of such medical evidence as the Company (or, in the event the Holder is subject to Section 16 of the Exchange Act, the Committee) deems warranted under the circumstances.




(c) Good Reason. For purposes of this Award, (i) “Good Reason” shall have the meaning assigned to such term in any written employment or similar agreement between the Company or any of its Subsidiaries and the Holder in effect on the Grant Date or (ii) if Holder is not party to an employment or similar agreement in effect on the Grant Date which defines “Good Reason,” then “Good Reason” shall mean Holder's voluntary termination following: (A) a material reduction in the Holder’s base salary; (B) a material reduction in the Holder’s authority, duties or responsibilities, provided, however, that a change in job position (including a change in title) shall not be deemed a “material reduction” unless the Holder’s new authority, duties or responsibilities are substantially reduced from the prior authority, duties or responsibilities; or (C) a relocation of the Holder’s principal place of employment that results in an increase in the Holder’s one-way driving distance by more than ten (10) miles from the Holder’s then current principal residence. In order to resign for Good Reason, the Holder must provide written notice of the event giving rise to Good Reason to the Company's Chief Executive Officer (or, in the event the Holder is subject to Section 16 of the Exchange Act, the Board) within thirty (30) days after the condition arises, allow the Company thirty (30) days to cure such condition, and if the Company fails to cure the condition within such period, the Holder’s resignation from all positions the Holder then held with the Company must be effective not later than thirty (30) days after the end of the Company’s cure period.

4. Issuance or Delivery of Shares. Subject to Section 6.13 and except as otherwise provided for herein, within 30 days after the vesting of the Award, the Company shall issue or deliver, subject to the conditions of this Agreement, the vested shares of Stock to the Holder (the date such shares of Stock are issued to the Holder, the “Issuance Date”). Such issuance or delivery shall be evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company. The Company shall pay all original issue or transfer taxes and all fees and expenses incident to such issuance or delivery, except as otherwise provided in Section 6. Prior to the issuance to the Holder of the shares of Stock subject to the Award, the Holder shall have no direct or secured claim in any specific assets of the Company or in such shares of Stock, and will have the status of a general unsecured creditor of the Company.

5. Transfer Restrictions and Investment Representation.

5.1. Non-Transferability of Award. The Award may not be transferred by the Holder other than by will or the laws of descent and distribution or pursuant to beneficiary designation procedures approved by the Company. Except to the extent permitted by the foregoing sentence, the Award may not be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, hypothecate, encumber or otherwise dispose of the Award, the Award and all rights hereunder shall immediately become null and void.

5.2. Investment Representation. The Holder hereby covenants that (a) any sale of any share of Stock acquired upon the vesting of the Award shall be made either pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Securities Act”), and any applicable state securities laws, or pursuant to an exemption from registration under the Securities Act and such state securities laws and (b) the Holder shall comply with all regulations and requirements of any regulatory authority having control of or supervision over the issuance of the shares and, in connection therewith, shall execute any documents which the Committee shall in its sole discretion deem necessary or advisable.

6. Additional Terms and Conditions of Award.

6.1. Withholding Taxes.




(a) Responsibility for Tax-Related Items. The Holder acknowledges that, regardless of any action the Company takes with respect to any or all income tax, social insurance, payroll tax, fringe benefit tax, payment on account or other tax-related withholding (“Tax-Related Items”), the ultimate liability for all Tax-Related Items is and remains the Holder’s responsibility and may exceed the amount actually withheld by the Company. The Holder further acknowledges that the Company (i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of this Award, including the grant of the Award, the vesting and settlement of the Restricted Stock Units, the delivery or sale of any shares of Stock and the issuance of any dividends, and (ii) does not commit to and is under no obligation to structure the terms of the grant or any aspect of this Award to reduce or eliminate the Holder’s liability for Tax-Related Items or achieve any particular tax result. The Holder acknowledges and agrees that the Holder will not make any claim against the Company, or any of its officers, directors, employees or affiliates for Tax-Related Items arising from this Award or the Holder’s other compensation. Further, if the Holder is subject to Tax-Related Items in more than one jurisdiction, the Holder acknowledges that the Company may be required to withhold or account for Tax-Related Items in more than one jurisdiction.

(b) Method of Tax Withholding. Prior to the relevant taxable or tax withholding event, as applicable, the Holder agrees to make adequate arrangements satisfactory to the Company to satisfy all Tax-Related Items.  Specifically, pursuant to Section 6.1(d) below, the Holder has agreed to a “same day sale” commitment with a broker-dealer that is a member of the Financial Industry Regulatory Authority (a “FINRA Dealer”) whereby the Holder has (except as provided in Section 6.1(e) below) agreed to sell a portion of the shares of Stock to be delivered in connection with this Award to satisfy any withholding obligations for Tax-Related Items and whereby the FINRA Dealer has committed to forward the proceeds necessary to satisfy any withholding obligations for Tax-Related Items directly to the Company.  If, for any reason, such “same day sale” commitment pursuant to Section 6.1(d) does not result in sufficient proceeds to satisfy any withholding obligations for Tax-Related Items, the Holder authorizes the Company, or its agents, at their discretion, to satisfy the Company’s withholding obligations with regard to all Tax-Related Items by one or a combination of the following: (i) withholding from the Holder’s wages or other cash compensation paid to the Holder by the Company; (ii) withholding a number of shares of Stock having a fair market value determined by the Company as of the date of the relevant taxable or tax withholding event, as applicable, that are otherwise deliverable to the Holder upon settlement; provided, however, that to the extent necessary to qualify for an exemption from application of Section 16(b) of the Exchange Act, if applicable, such share withholding procedure be subject to the express prior approval of the Committee; or (iii) causing the Holder to tender a cash payment (which may be in the form of a check, electronic wire transfer or other method permitted by the Company).

(c) Withholding Rate. Depending on the withholding method, the Company may withhold or account for Tax-Related Items by considering applicable minimum statutory withholding amounts or other applicable withholding rates, including maximum applicable rates, in which case the Holder may receive a refund of any over-withheld amount in cash and will have no entitlement to the Stock equivalent. If the obligation for Tax-Related Items is satisfied by withholding in shares of Stock, for tax purposes, the Holder is deemed to have been issued the full number of shares of Stock subject to the vested Restricted Stock Units notwithstanding that a number of the shares of Stock are held back solely for the purpose of paying the Tax-Related Items.

(d) Authorization of Same Day Sale. The Holder hereby acknowledges and agrees to the following:




(i) The Holder hereby appoints Fidelity Workplace Services LLC (or any successor agent determined by the Company) as the Holder’s agent (the “Agent”), and authorizes the Agent to:
    
(1) Sell on the open market at the then-prevailing market price(s), on the Holder’s behalf, as soon as practicable on or after each date on which shares of Stock underlying the Holder’s Restricted Stock Units vest and are issued on the Issuance Date, the number (rounded up to the next whole number) of the shares of Stock to be delivered to the Holder in connection with the vesting of those shares sufficient to generate proceeds to cover (1) the satisfaction of the Tax-Related Items arising from the vesting of the Award and the related issuance of shares of Stock to the Holder, and (2) all applicable fees and commissions due to, or required to be collected by, the Agent with respect thereto;

(2) Remit directly to the Company the proceeds necessary to satisfy the Tax-Related Items;

(3) Retain the amount required to cover all applicable fees and commissions due to, or required to be collected by, the Agent, relating directly to the sale of the shares of Stock referred to in clause (1) above; and

(4) Remit any remaining funds to the Holder.

(ii) The Holder hereby authorizes the Company and the Agent to cooperate and communicate with one another to determine the number of shares of Stock underlying my Restricted Stock Units that must be sold pursuant to this Section 6.1(d).

(iii) The Holder acknowledges that the Agent is under no obligation to arrange for the sale of Stock at any particular price under this Section 6.1(d) and that the Agent may effect sales as provided in this Section 6.1(d) in one or more sales and that the average price for executions resulting from bunched orders may be assigned to the Holder’s account. The Holder further acknowledges that the Holder will be responsible for all brokerage fees and other costs of sale associated with this Section 6.1(d), and the Holder agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sales. In addition, the Holder acknowledges that it may not be possible to sell shares of Stock as provided by in this Section 6.1(d) due to (i) a legal or contractual restriction applicable to the Holder or the Agent, (ii) a market disruption, (iii) rules governing order execution priority on the national exchange where the Stock may be traded or (iv) applicable law restricting such sale. In the event of the Agent’s inability to sell shares of Stock, the Holder will continue to be responsible for the timely payment to the Company of all Tax-Related Items that are required by applicable laws and regulations to be withheld.

(iv) The Holder acknowledges that regardless of any other term or condition of this Section 6.1(d), the Agent will not be liable to the Holder for (a) special, indirect, punitive, exemplary, or consequential damages, or incidental losses or damages of any kind, or (b) any failure to perform or for any delay in performance that results from a cause or circumstance that is beyond its reasonable control.

(v) The Holder hereby agrees to execute and deliver to the Agent any other agreements or documents as the Agent reasonably deems necessary or appropriate to carry out the purposes and intent of this Section 6.1(d). The Agent is a third-party beneficiary of this Section 6.1(d).

(vi) This Section 6.1(d) shall terminate not later than the date on which all Tax-Related Items arising in connection with the Award have been satisfied.




(vii) The Holder hereby authorizes the Company to appoint a successor Agent should the above-named entity in (i) above (or its successor) resign as Agent or be replaced by the Company.

(e) The Holder agrees to pay to the Company any amount of Tax-Related Items that the Company may be required to withhold or account for as a result of the Holder’s participation in the Plan that cannot be satisfied by the means previously described. The Holder acknowledges and agrees that the Company may refuse to issue or deliver the shares of Stock, or the proceeds of the sale of shares of Stock, if the Holder fails to comply with the Holder’s obligations in connection with the Tax-Related Items.

(f) The Holder represents and warrants that (i) the Holder has carefully reviewed this Agreement including, without limitation, the provisions set forth in Section 6.1(d), (ii) on the date the Holder accepts this Award, he or she is not aware of any material, nonpublic information with respect to the Company or any securities of the Company, is not subject to any legal, regulatory or contractual restriction that would prevent Agent from conducting sales, does not have, and will not attempt to exercise, authority, influence or control over any sales of Stock effected by the Agent pursuant to this Agreement, and is entering into this Agreement and any such election in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b5-1 (regarding trading of the Company's securities on the basis of material nonpublic information) under the Exchange Act, and (iii) it is the Holder’s intent that this election comply with the requirements of Rule 10b5-1(c)(1) under the Exchange Act and be interpreted to comply with the requirements of Rule 10b5-1(c) under the Exchange Act.

6.2. Compliance with Applicable Law. The Award is subject to the condition that if the listing, registration or qualification of the shares of Stock subject to the Award upon any securities exchange or under any law, or the consent or approval of any governmental body, or the taking of any other action is necessary or desirable as a condition of, or in connection with, the delivery of shares hereunder, the shares of Stock subject to the Award shall not be delivered, in whole or in part, unless such listing, registration, qualification, consent, approval or other action shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company agrees to use reasonable efforts to effect or obtain any such listing, registration, qualification, consent, approval or other action.

6.3. Award Confers No Rights to Continued Employment. In no event shall the granting of the Award or its acceptance by the Holder, or any provision of the Agreement or the Plan, give or be deemed to give the Holder any right to continued employment by the Company, any Subsidiary or any affiliate of the Company or affect in any manner the right of the Company, any Subsidiary or any affiliate of the Company to terminate the employment of any person at any time.

6.4. Decisions of Board or Committee. The Board or the Committee shall have the right to resolve all questions which may arise in connection with the Award. Any interpretation, determination or other action made or taken by the Board or the Committee regarding the Plan or this Agreement shall be final, binding and conclusive.

6.5. Successors. This Agreement shall be binding upon and inure to the benefit of any successor or successors of the Company and any person or persons who shall, upon the death of the Holder, acquire any rights hereunder in accordance with this Agreement or the Plan.

6.6. Notices. All notices, requests or other communications provided for in this Agreement shall be made, if to the Company, to Grove Collaborative Holdings, Inc., Attn: Chief Legal Officer, 1301 Sansome Street, San Francisco, California 94111, and if to the Holder, to the



last known mailing address of the Holder contained in the records of the Company. All notices, requests or other communications provided for in this Agreement shall be made in writing either (a) by personal delivery, (b) by facsimile or electronic mail with confirmation of receipt, (c) by mailing in the United States mails or (d) by express courier service. The notice, request or other communication shall be deemed to be received upon personal delivery, upon confirmation of receipt of facsimile or electronic mail transmission or upon receipt by the party entitled thereto if by United States mail or express courier service; provided, however, that if a notice, request or other communication sent to the Company is not received during regular business hours, it shall be deemed to be received on the next succeeding business day of the Company.

6.7. Governing Law. This Agreement, the Award and all determinations made and actions taken pursuant hereto and thereto, to the extent not governed by the laws of the United States, shall be governed by the laws of the State of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws.

6.8. Agreement Subject to the Plan. This Agreement is subject to the provisions of the Plan and shall be interpreted in accordance therewith. In the event that the provisions of this Agreement and the Plan conflict, the Plan shall control. The Holder hereby acknowledges receipt of a copy of the Plan.

6.9. Entire Agreement. This Agreement and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Holder with respect to the subject matter hereof, and may not be modified adversely to the Holder’s interest except by means of a writing signed by the Company and the Holder.

6.10. Partial Invalidity. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof and this Agreement shall be construed in all respects as if such invalid or unenforceable provision was omitted.

6.11. Amendment and Waiver. The Company may amend the provisions of this Agreement at any time; provided that an amendment that would adversely affect the Holder’s rights under this Agreement shall be subject to the written consent of the Holder. No course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding effect or enforceability of this Agreement.
6.12    Counterparts. The Award Notice may be executed in two counterparts, each of which shall be deemed an original and both of which together shall constitute one and the same instrument.

6.13. Compliance With Section 409A of the Code. This Award is intended to be exempt from or comply with Section 409A of the Code, and shall be interpreted and construed accordingly, and each payment hereunder shall be considered a separate payment for purposes of Section 409A of the Code. To the extent this Agreement provides for the Award to become vested and be settled upon the Holder’s termination of employment, the applicable shares of Stock shall be transferred to the Holder or his or her beneficiary upon the Holder’s “separation from service,” within the meaning of Section 409A of the Code; provided that if the Holder is a “specified employee,” within the meaning of Section 409A of the Code, then to the extent the Award constitutes nonqualified deferred compensation, within the meaning of Section 409A of the Code, such shares of Stock shall be transferred to the Holder or his or her beneficiary upon the earlier to occur of (i) the six-month anniversary of such separation from service and (ii) the date of the Holder’s death.

6.14    Protected Rights. Nothing in this Agreement or otherwise is intended to, or does, prohibit the Holder from (i) filing a charge or complaint with, providing truthful



information to, or cooperating with an investigation being conducted by a governmental agency (such as the U.S. Equal Employment Opportunity Commission, another other fair employment practices agency, the U.S. National Labor Relations Board, the U.S. Department of Labor, or the U.S. Securities and Exchange Commission (the “SEC”)); (ii) engaging in other legally-protected activities; (iii) giving truthful testimony or making statements under oath in response to a subpoena or other valid legal process or in any legal proceeding; (iv) otherwise making truthful statements as required by law or valid legal process; or (v) disclosing a trade secret in confidence to a governmental official, directly or indirectly, or to an attorney, if the disclosure is made solely for the purpose of reporting or investigating a suspected violation of law.  Accordingly, the Holder shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In the event the Holder files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Holder may disclose the trade secret(s) of the Company to the Holder’s attorney and use the trade secret information in the court proceeding, if the Holder (i) files any document containing the trade secret under seal; and (ii) does not disclose the trade secret, except pursuant to court order.  In accordance with applicable law, and notwithstanding any other provision of the Plan or this Agreement, nothing in the Plan, this Agreement or any of any policies or agreements of the Company or any affiliate applicable to the Holder (i) impedes the Holder’s right to communicate with the SEC or any other governmental agency about possible violations of federal securities or other laws or regulations or (ii) requires the Holder to provide any prior notice to the Company or its affiliates or obtain their prior approval before engaging in any such communications.


EX-10.24 3 ex10242022eipexecoptionagt.htm OPTION AGREEMENT Document

Exhibit 10.24
EXECUTIVE VERSION


Grove Collaborative Holdings, Inc.
2022 Equity And Incentive Plan
OPTION AWARD NOTICE
[Name of Optionee]

You have been awarded a stock option award with respect to shares of Class A Common Stock of Grove Collaborative Holdings, Inc., a Delaware corporation (the “Company”), pursuant to the terms and conditions of the Grove Collaborative Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”) and the Stock Option Agreement (together with this Award Notice, the “Agreement”). Copies of the Plan and the Stock Option Agreement are attached hereto. Capitalized terms not defined herein shall have the meanings specified in the Plan or the Agreement.
 
Option:
  
You have been awarded a Nonqualified Stock Option to purchase from the Company [            ] Shares, par value $0.0001 per share, subject to adjustment as provided in the Plan, subject to adjustment as provided in Section 4.2 of the Agreement.
Option Date:
  
[                    ]
Exercise Price:
  
$[        ] per share, subject to adjustment as provided in Section 4.2 of the Agreement.
Vesting Schedule:
  
Except as otherwise provided in the Plan, the Agreement or any other agreement between the Company or any of its Subsidiaries and Optionee in effect on the Option Date, the Option shall vest [____________], if, and only if, you are, and have been, continuously (except for any absence for vacation, leave, etc. in accordance with the Company’s or its Subsidiaries’ policies): (i) employed by the Company or any of its Subsidiaries; (ii) serving as a Non-Employee Director; or (iii) providing services to the Company or any of its Subsidiaries as an advisor or consultant, in each case, from the date of this Agreement through and including the applicable vesting date.
Expiration Date:
  
Except to the extent earlier terminated pursuant to Section 2.2 of the Agreement or earlier exercised pursuant to Section 2.2 of the Agreement, the Option shall terminate at 5:00 p.m., U.S. Pacific time, on the ten-year anniversary of the Option Date; providedhowever, if such date occurs during any period when the Optionee is prohibited from trading in securities of the Company during a period when the exercise of the Option would violate applicable securities laws (a “Blackout Period”), then the period during which the Option is exercisable shall be extended to the date that is 30 days after the expiration of such Blackout Period, to the extent permitted by Section 409A of the Code.




GROVE COLLABORATIVE HOLDINGS, INC.
By: 
Name: 
Title:


Acknowledgment, Acceptance and Agreement:
By signing below and returning this Award Notice to Grove Collaborative Holdings, Inc., I hereby acknowledge receipt of the Agreement and the Plan, accept the Option granted to me and agree to be bound by the terms and conditions of this Award Notice, the Agreement and the Plan.
 
 
Optionee
 
Date


Signature Page to Stock Option Agreement


EXECUTIVE VERSION
GROVE COLLABORATIVE HOLDINGS, INC. 
2022 EQUITY AND INCENTIVE PLAN 

Stock Option Agreement

Grove Collaborative Holdings, Inc., a Delaware corporation (the “Company”), hereby grants to the individual (“Optionee”) named in the award notice attached hereto (the “Award Notice”) as of the date set forth in the Award Notice (the “Option Date”), pursuant to the provisions of the Grove Collaborative Holdings, Inc. 2022 Equity and Incentive Plan (the “Plan”), an option to purchase from the Company the number of shares of the Company’s Class A Common Stock, par value $0.0001 per share (“Common Stock”), set forth in the Award Notice at the price per share set forth in the Award Notice (the “Exercise Price”) (the “Option”), upon and subject to the terms and conditions set forth below, in the Award Notice and in the Plan. Capitalized terms not defined herein shall have the meanings specified in the Plan.

1. Option Subject to Acceptance of Agreement. The Option shall be null and void unless Optionee shall accept this Agreement by executing the Award Notice in the space provided therefor and returning an original execution copy of the Award Notice to the Company (or electronically accepting this Agreement within the Optionee’s stock plan account with the Company’s stock plan administrator according to the procedures then in effect).

2. Time and Manner of Exercise of Option.

2.1.    Maximum Term of Option. In no event may the Option be exercised, in whole or in part, after the expiration date set forth in the Award Notice (the “Expiration Date”).

2.2.    Vesting and Exercise of Option. The Option shall become vested and exercisable in accordance with the vesting schedule set forth in the Award Notice (the “Vesting Schedule”). The period of time prior to the full vesting of the Option shall be referred to herein as the “Vesting Period.” The Option shall be vested and exercisable following a termination of Optionee’s employment according to the following terms and conditions:

(a)    Termination due to Death or Disability. If Optionee’s employment with the Company terminates prior to the end of the Vesting Period by reason of Optionee’s death or a termination by the Company due to Disability, then in either such case, the Option shall be 100% vested as of the date of termination, and the Option may thereafter be exercised by Optionee or Optionee’s executor, administrator, legal representative, guardian or similar person until and including the earlier to occur of (i) the date which is one year after the date of termination of employment and (ii) the Expiration Date.

(b)    Termination other than for Cause, Death or Disability. Subject to Section 2.2(d), if Optionee’s employment with the Company terminates prior to the end of the Vesting Period by reason of a termination of Optionee’s employment (i) by the Company for any reason other than for Cause, death or Disability or (ii) by the Optionee for any reason, the Option, only to the extent vested on the effective date of such termination of employment, may thereafter be exercised by Optionee until and including the earlier to occur of (i) the date which is ninety (90) days after the date of such termination of employment and (ii) the Expiration Date.

(c)    Termination for Cause. If Optionee’s employment with the Company terminates by reason of the Company’s termination of Optionee’s employment for Cause, then the Option, whether or not vested, shall terminate immediately upon such termination of employment.




(d)    Change in Control.

(i)    In the event of a Change in Control prior to the end of the Vesting Period pursuant to which the Option is not effectively assumed or continued by the surviving or acquiring corporation in such Change in Control (as determined by the Board or Committee, with appropriate adjustments to the number and kind of shares, in each case, that preserve the intrinsic value and other material terms and conditions of the outstanding Option as in effect immediately prior to the Change in Control and in accordance with Section 409A of the Code), the Option shall be 100% vested immediately prior to such Change in Control.

(ii)    In the event of a Change in Control prior to the end of the Vesting Period pursuant to which the Option is effectively assumed or continued by the surviving or acquiring corporation in such Change in Control (as determined by the Board or Committee, with appropriate adjustments to the number and kind of shares, in each case, that preserve the intrinsic value and other material terms and conditions of the outstanding Option as in effect immediately prior to the Change in Control and in accordance with Section 409A of the Code) and the Company terminates Optionee’s employment without Cause or Optionee resigns for Good Reason within 24 months following such Change in Control, the Option shall be 100% vested upon such termination of employment, and the Option may thereafter be exercised by Optionee until and including the earlier to occur of (i) the date which is one year after the date of termination of employment and (ii) the Expiration Date.

(e)    Termination of Option During Blackout Period. If the Option shall expire under Section 2.2 during any period when the exercise of the Option would violate applicable securities laws (each, a “Blackout Period”), then the period during which the Option is exercisable shall be extended to the date that is 30 days after the expiration of such Blackout Period, to the extent permitted by Section 409A of the Code.

(f)    Definitions.

(i)    Cause. For purposes of this Option, (i) “Cause” shall have the meaning assigned to such term in any written employment or similar agreement between the Company or any of its Subsidiaries and the Optionee in effect on the Option Date or (ii) if Optionee is not party to an employment or similar agreement in effect on the Option Date which defines “Cause,” then “Cause” shall mean: (A) the Optionee’s commission of any felony or any crime involving fraud, dishonesty or moral turpitude under the laws of the United States or any state thereof; (B) the Optionee’s attempted commission of, or participation in, a fraud or act of dishonesty against the Company; (C) the Optionee’s intentional, material violation of any contract or agreement between the Optionee and the Company or of any statutory duty owed to the Company; (D) the Optionee’s unauthorized use or disclosure of the Company’s confidential information or trade secrets; or (E) the Optionee’s gross, or material deliberate, misconduct. The determination that a termination of the Optionee’s employment is either for Cause or without Cause will be made by the Company (or, in the event the Optionee is subject to Section 16 of the Exchange Act, the Committee), in its sole discretion. Any determination by the Company (or, if applicable, the Committee) that the Optionee’s employment was terminated with or without Cause for the purposes of this Option shall have no effect upon any determination of the rights or obligations of the Company or the Optionee for any other purpose.

(ii)    Disability. For purposes of this Option, “Disability” shall mean the inability of the Optionee to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than twelve (12) months as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the



Company (or, in the event the Option is subject to Section 16 of the Exchange Act, the Committee) on the basis of such medical evidence as the Company (or, in the event the Option is subject to Section 16 of the Exchange Act, the Committee) deems warranted under the circumstances.

(iii)    Good Reason. For purposes of this Option, (i) “Good Reason” shall have the meaning assigned to such term in any written employment or similar agreement between the Company or any of its Subsidiaries and the Optionee in effect on the Option Date or (ii) if Optionee is not party to an employment or similar agreement in effect on the Option Date which defines “Good Reason,” then “Good Reason” shall mean Optionee's voluntary termination following: (A) a material reduction in the Optionee’s base salary; (B) a material reduction in the Optionee’s authority, duties or responsibilities, provided, however, that a change in job position (including a change in title) shall not be deemed a “material reduction” unless the Optionee’s new authority, duties or responsibilities are substantially reduced from the prior authority, duties or responsibilities; or (C) a relocation of the Optionee’s principal place of employment that results in an increase in the Optionee’s one-way driving distance by more than ten (10) miles from the Optionee’s then current principal residence. In order to resign for Good Reason, the Optionee must provide written notice of the event giving rise to Good Reason to the Company's Chief Executive Officer (or, in the event the Optionee is subject to Section 16 of the Exchange Act, the Board) within thirty (30) days after the condition arises, allow the Company thirty (30) days to cure such condition, and if the Company fails to cure the condition within such period, the Optionee’s resignation from all positions the Optionee then held with the Company must be effective not later than thirty (30) days after the end of the Company’s cure period.

2.3.    Method of Exercise. Subject to the limitations set forth in this Agreement, the Option, to the extent vested, may be exercised by Optionee (a) by delivering to the Company an exercise notice in the form prescribed by the Company specifying the number of whole shares of Common Stock to be purchased and by accompanying such notice with payment therefor in full (or by arranging for such payment to the Company’s satisfaction) either (i) in cash, (ii) to the extent permitted by the Committee, by delivery to the Company (either actual delivery or by attestation procedures established by the Company) of shares of Common Stock having an aggregate Fair Market Value, determined as of the date of exercise, equal to the aggregate purchase price payable pursuant to the Option by reason of such exercise, (iii) to the extent permitted by the Committee, by authorizing the Company to withhold whole shares of Common Stock which would otherwise be delivered having an aggregate Fair Market Value, determined as of the date of exercise, equal to the amount necessary to satisfy such obligation, (iv) except as may be prohibited by applicable law, in cash by a broker-dealer acceptable to the Company to whom Optionee has submitted an irrevocable notice of exercise or (v) by a combination of (i), (ii) and (iii), and (b) by executing such documents as the Company may reasonably request. No share of Common Stock or certificate representing a share of Common Stock shall be issued or delivered until the full purchase price therefor and any withholding taxes thereon, as described in Section 4.1, have been paid.

2.4.    Termination of Option. In no event may the Option be exercised after it terminates as set forth in this Section 2.4. The Option shall terminate, to the extent not earlier terminated pursuant to Section 2.2 or exercised pursuant to Section 2.3, on the Expiration Date. Upon the termination of the Option, the Option and all rights hereunder shall immediately become null and void.

3. Transfer Restrictions and Investment Representations.

3.1.    Non-Transferability of Option. The Option may not be transferred by Optionee other than by will or the laws of descent and distribution or pursuant to beneficiary designation procedures approved by the Company. Except to the extent permitted by the



foregoing sentence, (i) during Optionee’s lifetime the Option is exercisable only by Optionee or Optionee’s legal representative, guardian or similar person and (ii) the Option may not be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law or otherwise) or be subject to execution, attachment or similar process. Upon any attempt to so sell, transfer, assign, pledge, hypothecate, encumber or otherwise dispose of the Option, the Option and all rights hereunder shall immediately become null and void.

3.2.    Investment Representation. Optionee hereby represents and covenants that (a) any shares of Common Stock purchased upon exercise of the Option will be purchased for investment and not with a view to the distribution thereof within the meaning of the Securities Act of 1933, as amended (the “Securities Act”), unless such purchase has been registered under the Securities Act and any applicable state securities laws; (b) any subsequent sale of any such shares shall be made either pursuant to an effective registration statement under the Securities Act and any applicable state securities laws, or pursuant to an exemption from registration under the Securities Act and such state securities laws; and (c) if requested by the Company, Optionee shall submit a written statement, in a form satisfactory to the Company, to the effect that such representation (x) is true and correct as of the date of any purchase of any shares hereunder or (y) is true and correct as of the date of any sale of any such shares, as applicable. As a further condition precedent to any exercise of the Option, Optionee shall comply with all regulations and requirements of any regulatory authority having control of or supervision over the issuance or delivery of the shares and, in connection therewith, shall execute any documents which the Board or the Committee shall in its sole discretion deem necessary or advisable.

4. Additional Terms and Conditions.

4.1.    Withholding Taxes. (a)    As a condition precedent to the issuance of Common Stock following the exercise of the Option, Optionee shall, upon request by the Company, pay to the Company in addition to the purchase price of the shares, such amount as the Company determines is required, under all applicable federal, state, local or other laws or regulations, to be withheld and paid over as income or other withholding taxes (the “Required Tax Payments”) with respect to such exercise of the Option. If Optionee shall fail to advance the Required Tax Payments after request by the Company, the Company may, in its discretion, deduct any Required Tax Payments from any amount then or thereafter payable by the Company to Optionee.

(b)    Optionee may elect to satisfy his or her obligation to advance the Required Tax Payments by any of the following means: (i) a cash payment to the Company; (ii) to the extent permitted by the Committee, delivery to the Company (either actual delivery or by attestation procedures established by the Company) of previously owned whole shares of Common Stock having an aggregate Fair Market Value, determined as of the date on which such withholding obligation arises (the “Tax Date”), equal to the Required Tax Payments; (iii) to the extent permitted by the Committee, authorizing the Company to withhold whole shares of Common Stock which would otherwise be delivered to Optionee upon exercise of the Option having an aggregate Fair Market Value, determined as of the Tax Date, equal to the Required Tax Payments; (iv) except as may be prohibited by applicable law, a cash payment by a broker-dealer acceptable to the Company to whom Optionee has submitted an irrevocable notice of exercise or (v) any combination of (i), (ii) and (iii). Shares of Common Stock to be delivered or withheld may not have a Fair Market Value in excess of the amount determined by applying the maximum individual statutory tax rate in the Optionee’s jurisdiction; provided that the Committee shall be permitted to limit the number of shares so delivered or withheld to a lesser number if necessary, as determined by the Committee, to avoid adverse accounting consequences; providedhowever, that if a fraction of a share of Common Stock would be required to satisfy the maximum individual statutory rate in the Optionee’s jurisdiction, then the number of shares of Common Stock to be delivered or withheld may be rounded up to the next



nearest whole share of Common Stock. No share of Common Stock or certificate representing a share of Common Stock shall be issued or delivered until the Required Tax Payments have been satisfied in full.

4.2.    Adjustment. In the event of any equity restructuring (within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation—Stock Compensation or any successor or replacement accounting standard) that causes the per share value of shares of Common Stock to change, such as a stock dividend, stock split, spinoff, rights offering or recapitalization through an extraordinary cash dividend, the number and class of securities subject to the Option and the Exercise Price shall be equitably adjusted by the Committee, such adjustment to be made in accordance with Section 409A of the Code. In the event of any other change in corporate capitalization, including a merger, consolidation, reorganization, or partial or complete liquidation of the Company, such equitable adjustments described in the foregoing sentence may be made as determined to be appropriate and equitable by the Committee to prevent dilution or enlargement of rights of participants. The decision of the Committee regarding any such adjustment shall be final, binding and conclusive.

4.3.    Compliance with Applicable Law. The Option is subject to the condition that if the listing, registration or qualification of the shares subject to the Option upon any securities exchange or under any law, or the consent or approval of any governmental body, or the taking of any other action is necessary or desirable as a condition of, or in connection with, the purchase or issuance of shares hereunder, the Option may not be exercised, in whole or in part, and such shares may not be issued, unless such listing, registration, qualification, consent, approval or other action shall have been effected or obtained, free of any conditions not acceptable to the Company. The Company agrees to use reasonable efforts to effect or obtain any such listing, registration, qualification, consent, approval or other action.

4.4.    Issuance or Delivery of Shares. Upon the exercise of the Option, in whole or in part, the Company shall issue or deliver, subject to the conditions of this Agreement, the number of shares of Common Stock purchased against full payment therefor. Such issuance shall be evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company. The Company shall pay all original issue or transfer taxes and all fees and expenses incident to such issuance, except as otherwise provided in Section 4.1.

4.5.    Option Confers No Rights as Stockholder. Optionee shall not be entitled to any privileges of ownership with respect to shares of Common Stock subject to the Option unless and until such shares are purchased and issued upon the exercise of the Option, in whole or in part, and Optionee becomes a stockholder of record with respect to such issued shares. Optionee shall not be considered a stockholder of the Company with respect to any such shares not so purchased and issued.

4.6.    Option Confers No Rights to Continued Employment. In no event shall the granting of the Option or its acceptance by Optionee, or any provision of this Agreement or the Plan, give or be deemed to give Optionee any right to continued employment by the Company, any Subsidiary or any affiliate of the Company or affect in any manner the right of the Company, any Subsidiary or any affiliate of the Company to terminate the employment of any person at any time.

4.7.    Decisions of Board or Committee. The Board or the Committee shall have the right to resolve all questions which may arise in connection with the Option or its exercise. Any interpretation, determination or other action made or taken by the Board or the Committee regarding the Plan or this Agreement shall be final, binding and conclusive.




4.8.    Successors. This Agreement shall be binding upon and inure to the benefit of any successor or successors of the Company and any person or persons who shall, upon the death of Optionee, acquire any rights hereunder in accordance with this Agreement or the Plan.

4.9.    Notices. All notices, requests or other communications provided for in this Agreement shall be made, if to the Company, to Grove Collaborative Holdings, Inc., Attn: Chief Legal Officer, 1301 Sansome Street, San Francisco, California 94111, and if to Optionee, to the last known mailing address of Optionee contained in the records of the Company. All notices, requests or other communications provided for in this Agreement shall be made in writing either (a) by personal delivery, (b) by facsimile or electronic mail with confirmation of receipt, (c) by mailing in the United States mails or (d) by express courier service. The notice, request or other communication shall be deemed to be received upon personal delivery, upon confirmation of receipt of facsimile or electronic mail transmission or upon receipt by the party entitled thereto if by United States mail or express courier service; providedhowever, that if a notice, request or other communication sent to the Company is not received during regular business hours, it shall be deemed to be received on the next succeeding business day of the Company.

4.10.    Governing Law. This Agreement, the Option and all determinations made and actions taken pursuant hereto and thereto, to the extent not governed by the Code or the laws of the United States, shall be governed by the laws of the State of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws.

4.11.    Agreement Subject to the Plan. This Agreement is subject to the provisions of the Plan and shall be interpreted in accordance therewith. In the event that the provisions of this Agreement and the Plan conflict, the Plan shall control. The Optionee hereby acknowledges receipt of a copy of the Plan.

4.12.    Entire Agreement. This Agreement and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by means of a writing signed by the Company and the Optionee.

4.13.    Partial Invalidity. The invalidity or unenforceability of any particular provision of this Agreement shall not affect the other provisions hereof and this Agreement shall be construed in all respects as if such invalid or unenforceable provisions were omitted.

4.14.    Amendment and Waiver. The provisions of this Agreement may be amended or waived only by the written agreement of the Company and the Optionee, and no course of conduct or failure or delay in enforcing the provisions of this Agreement shall affect the validity, binding effect or enforceability of this Agreement.

4.15.    Counterparts. The Award Notice may be executed in two counterparts, each of which shall be deemed an original and both of which together shall constitute one and the same instrument.

4.16    Protected Rights. Nothing in this Agreement or otherwise is intended to, or does, prohibit the Optionee from (i) filing a charge or complaint with, providing truthful information to, or cooperating with an investigation being conducted by a governmental agency (such as the U.S. Equal Employment Opportunity Commission, another other fair employment practices agency, the U.S. National Labor Relations Board, the U.S. Department of Labor, or the U.S. Securities and Exchange Commission (the “SEC”)); (ii) engaging in other legally-protected activities; (iii) giving truthful testimony or making statements under oath in response to a subpoena or other valid legal process or in any legal proceeding; (iv) otherwise making truthful



statements as required by law or valid legal process; or (v) disclosing a trade secret in confidence to a governmental official, directly or indirectly, or to an attorney, if the disclosure is made solely for the purpose of reporting or investigating a suspected violation of law.  Accordingly, the Optionee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made (A) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In the event the Optionee files a lawsuit for retaliation by the Company for reporting a suspected violation of law, the Optionee may disclose the trade secret(s) of the Company to the Optionee’s attorney and use the trade secret information in the court proceeding, if the Optionee (i) files any document containing the trade secret under seal; and (ii) does not disclose the trade secret, except pursuant to court order.  In accordance with applicable law, and notwithstanding any other provision of the Plan or this Agreement, nothing in the Plan, this Agreement or any of any policies or agreements of the Company or any affiliate applicable to the Optionee (i) impedes the Optionee’s right to communicate with the SEC or any other governmental agency about possible violations of federal securities or other laws or regulations or (ii) requires the Optionee to provide any prior notice to the Company or its affiliates or obtain their prior approval before engaging in any such communications.




EX-31.1 4 exhibit311.htm EX-31.1 Document

Exhibit 31.1

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Stuart Landesberg, certify that:

1.     I have reviewed this Quarterly Report on Form 10-Q of Grove Collaborative Holdings, Inc.;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.     The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date: August 11, 2022By:/s/ Stuart Landesberg
Stuart Landesberg
Chief Executive Officer


EX-31.2 5 exhibit312.htm EX-31.2 Document

Exhibit 31.2

CERTIFICATION PURSUANT TO
RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,
AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Sergio Cervantes, certify that:

1.     I have reviewed this Quarterly Report on Form 10-Q of Grove Collaborative Holdings, Inc.;

2.     Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.     Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.     The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)    Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)    Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.     The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



Date: August 11, 2022By:/s/ Sergio Cervantes
Sergio Cervantes
Chief Financial Officer


EX-32.1 6 exhibit321.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Grove Collaborative Holdings, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stuart Landesberg, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.     The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 11, 2022By:/s/ Stuart Landesberg
Stuart Landesberg
Chief Executive Officer
In connection with the Quarterly Report of Grove Collaborative Holdings, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Sergio Cervantes, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
1.     The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 11, 2022By:/s/ Sergio Cervantes
Sergio Cervantes
Chief Financial Officer




EX-101.SCH 7 grov-20220630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1402401 - Statement - Condensed Consolidated Balance Sheets - Parenthetical (Details) link:presentationLink link:calculationLink link:definitionLink 1003003 - Statement - Condensed Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 1004004 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 1005005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit - Parenthetical (Details) link:presentationLink link:calculationLink link:definitionLink 1006006 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 2102102 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2107103 - Disclosure - Recapitalization link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Recapitalization - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2109104 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2310302 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 2412406 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2413407 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 2414408 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 2115105 - Disclosure - Accrued Expenses link:presentationLink link:calculationLink link:definitionLink 2316303 - Disclosure - Accrued Expenses (Tables) link:presentationLink link:calculationLink link:definitionLink 2417409 - Disclosure - Accrued Expenses - Schedule of Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 2118106 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2319304 - Disclosure - Debt and Convertible Preferred Stock and Common Stock Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 2420410 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2421411 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2122107 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 2423412 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:calculationLink link:definitionLink 2124108 - Disclosure - Convertible Preferred Stock link:presentationLink link:calculationLink link:definitionLink 2325305 - Disclosure - Convertible Preferred Stock (Tables) link:presentationLink link:calculationLink link:definitionLink 2426413 - Disclosure - Convertible Preferred Stock - Temporary Equity (Details) link:presentationLink link:calculationLink link:definitionLink 2427414 - Disclosure - Convertible Preferred Stock - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2128109 - Disclosure - Common Stock and Warrants link:presentationLink link:calculationLink link:definitionLink 2329306 - Disclosure - Common Stock and Warrants (Tables) link:presentationLink link:calculationLink link:definitionLink 2430415 - Disclosure - Common Stock and Warrants - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2431416 - Disclosure - Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) link:presentationLink link:calculationLink link:definitionLink 2432417 - Disclosure - Common Stock and Warrants - Schedule of Reserved for Issuance (Details) link:presentationLink link:calculationLink link:definitionLink 2133110 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2334307 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2435418 - Disclosure - Stock-Based Compensation - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2436419 - Disclosure - Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2437420 - Disclosure - Stock-Based Compensation - Schedule of Restricted Common Stock (Details) link:presentationLink link:calculationLink link:definitionLink 2438421 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 2439422 - Disclosure - Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) link:presentationLink link:calculationLink link:definitionLink 2140111 - Disclosure - Net Loss Per Share Attributable to Common Stockholders link:presentationLink link:calculationLink link:definitionLink 2341308 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) link:presentationLink link:calculationLink link:definitionLink 2442423 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 2143112 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 2444424 - Disclosure - Subsequent Events (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 grov-20220630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 9 grov-20220630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 10 grov-20220630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Revision of Prior Period [Axis] Revision of Prior Period [Axis] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Additional Shares Additional Share [Member] Additional Share Entity Address, Postal Zip Code Entity Address, Postal Zip Code Reverse Recapitalization Tranche Reverse Recapitalization Tranche [Axis] Reverse Recapitalization Tranche Proceeds from issuance of contingently redeemable convertible common stock Proceeds from Issuance of Redeemable Convertible Common Stock Proceeds from Issuance of Redeemable Convertible Common Stock Reverse Recapitalization Tranche [Domain] Reverse Recapitalization Tranche [Domain] Reverse Recapitalization Tranche [Domain] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Common stock warrant, shares reserved for future issuance (in shares) Common Stock Warrant, Shares Reserved for Future Issuance Common Stock Warrant, Shares Reserved for Future Issuance Debt Instrument [Axis] Debt Instrument [Axis] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Remeasurement of convertible preferred stock warrant liability Adjustment of Convertible Preferred Stock Warrant Liability Adjustment of Convertible Preferred Stock Warrant Liability Vesting of early exercise of options Stock Vesting of Early Exercise During Period, Shares Stock Vesting of Early Exercise During Period, Shares Additional paid-in capital Additional Paid in Capital Silicon Valley Bank and Hercules Mezzanine Term Loan Silicon Valley Bank and Hercules Capital Inc [Member] Silicon Valley Bank and Hercules Capital Inc Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Series D Series D Preferred Stock [Member] Statistical Measurement [Domain] Statistical Measurement [Domain] Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs Stock Issued During Period, Value, Reverse Recapitalization Stock Issued During Period, Value, Reverse Recapitalization Issuance of common stock upon exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Payment Arrangement [Abstract] Five Suppliers Five Suppliers [Member] Five Suppliers Conversion of preferred stock warrant liability to common stock warrants Convertible preferred stock and contingently redeemable common stock conversion Stock Issued During Period, Value, Conversion of Convertible Securities Temporary equity, shares outstanding (in shares) Temporary equity, balances at beginning of period (in shares) Temporary equity, balances at ending of period (in shares) Temporary Equity, Shares Outstanding Net loss Net loss Net Income (Loss) Attributable to Parent Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total Net loss per share attributable to common stockholders, basic and diluted (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Subsequent Event Type [Axis] Subsequent Event Type [Axis] Temporary Equity [Line Items] Temporary Equity [Line Items] Changes in fair value Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Private and Public Placement Warrants Private and Public Placement Warrants [Member] Private and Public Placement Warrants Reverse recapitalization, percentage of voting interests acquired Reverse Recapitalization, Percentage of Voting Interests Acquired Reverse Recapitalization, Percentage of Voting Interests Acquired Equity Component [Domain] Equity Component [Domain] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Scenario [Axis] Scenario [Axis] Vesting rights, percentage Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Initial measurement of common stock warrants recorded as debt fees Initial Measurement of Common Stock Warrants Recorded as Debt Fees Initial Measurement of Common Stock Warrants Recorded as Debt Fees Earn-Out Shares Earn-Out Share [Member] Earn-Out Share Ten Years Ten Years [Member] Ten Years Fair Value Measurement Fair Value Measurement, Policy [Policy Text Block] Share-based payment arrangement, plan modification, incremental cost Share-Based Payment Arrangement, Plan Modification, Incremental Cost Plan Name [Axis] Plan Name [Axis] Agreement [Domain] Agreement [Domain] Agreement [Domain] Standby Letters of Credit Standby Letters of Credit [Member] Supplemental Disclosure Supplemental Cash Flow Information [Abstract] Plan Name [Domain] Plan Name [Domain] Statement of Cash Flows [Abstract] Long-term line of credit Long-Term Line of Credit Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Day Period Reverse Recapitalization, Contingent Consideration, Liability, Earnout Period, Threshold Trading Day Period Options, outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Original issue price (in dollars per share) Shares Issued, Price Per Share Award Type [Axis] Award Type [Axis] Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Other non-cash expenses Other Noncash Expense Operating lease liabilities, current Operating Lease, Liability, Current Schedule of Restricted Common Stock Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Deferred Revenue Deferred Revenue [Member] Deferred Revenue Debt, noncurrent Total debt, noncurrent Long-Term Debt, Excluding Current Maturities Total liabilities Liabilities Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Sale of stock, consideration available on transaction Sale of Stock, Consideration Available on Transaction Sale of Stock, Consideration Available on Transaction Increase (Decrease) in Temporary Equity [Roll Forward] Increase (Decrease) in Temporary Equity [Roll Forward] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Post Termination Exercise Period [Domain] Post Termination Exercise Period [Domain] Post Termination Exercise Period [Domain] Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Weighted–Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Forfeited and expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-based compensation arrangement by share-based payment award, options, grant date, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value Transaction costs allocated to derivative liabilities upon Business Combination Transaction Costs Allocated to Derivative Liabilities Upon Business Combination Transaction Costs Allocated to Derivative Liabilities Upon Business Combination Contract with customer, refund liability, current Contract with Customer, Refund Liability, Current Transaction costs Transaction Costs, Current Transaction Costs, Current Outstanding and unvested, beginning of period (in dollars per share) Outstanding and unvested, ending of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Debt Debt Disclosure [Text Block] Stock-Based Compensation Compensation and Employee Benefit Plans [Text Block] Product and Service [Domain] Product and Service [Domain] Entity Shell Company Entity Shell Company Class B Common Stock Common Class B [Member] Post Termination Exercise Period [Axis] Post Termination Exercise Period [Axis] Post Termination Exercise Period Accrued expenses Increase (Decrease) in Accrued Liabilities Tranche [Axis] Tranche [Axis] Tranche Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation Liquidation Preference  Temporary Equity, Liquidation Preference Subsequent Event Subsequent Event [Member] Revenue Benchmark Revenue Benchmark [Member] Document Period End Date Document Period End Date Private placement warrant, shares reserved for future issuance (in shares) Private Placement Warrant, Shares Reserved for Future Issuance Private Placement Warrant, Shares Reserved for Future Issuance Advertising costs Accrued Advertising, Current Convertible Preferred Stock Convertible preferred stock Convertible Preferred Stock [Member] Total assets Assets Debt Disclosure [Abstract] Earnings Per Share [Abstract] Sales taxes Sales and Excise Tax Payable, Current Tranche Type [Domain] Tranche Type [Domain] Tranche Type [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Accrued expenses Accrued expenses Accrued Liabilities, Current Debt, current Debt, current Long-Term Debt, Current Maturities Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Accounting Policies [Abstract] Stockholders’ deficit: Stockholders' Equity Note [Abstract] Market-based Stock Options Market-based Stock Options [Member] Market-based Stock Options Tranche Four Tranche Four [Member] Tranche Four Compensation and benefits Employee-related Liabilities, Current #REF! Temporary equity, balances at beginning of period Temporary equity, balances at ending of period Net Carrying Value Temporary Equity, Carrying Amount, Attributable to Parent Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Net Loss Per Share Attributable to Common Stockholders Earnings Per Share [Text Block] Customer [Axis] Customer [Axis] Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Share-based compensation arrangement by share-based payment award, options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Award Type [Domain] Award Type [Domain] Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Loss on extinguishment of debt Gain (Loss) on Extinguishment of Debt Series C Series C Preferred Stock [Member] Public Warrants Public Warrant [Member] Public Warrant Convertible preferred stock warrant, shares reserved for future issuance (in shares) Convertible Preferred Stock Warrant, Shares Reserved for Future Issuance Convertible Preferred Stock Warrant, Shares Reserved for Future Issuance Gross profit Gross Profit Entity Registrant Name Entity Registrant Name Issuance of preferred stock and common stock upon net exercise of warrants (in shares) Stock Issued During Period, Shares, New Issues Temporary equity, shares authorized (in shares) Temporary Equity, Shares Authorized Subsequent Events Subsequent Events [Text Block] Supplier Concentration Risk Supplier Concentration Risk [Member] Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Fulfillment costs Accrued Fulfillment Costs, Current Accrued Fulfillment Costs, Current Entity Address, City or Town Entity Address, City or Town Atel Loan Facility Atel Loan Facility [Member] Atel Loan Facility Operating Expenses [Abstract] Operating Expenses [Abstract] Contingently redeemable convertible common stock Contingently Redeemable Convertible Common Stock [Member] Contingently Redeemable Convertible Common Stock Contract with customer, referral credit, current Contract with Customer, Referral Credit, Current Contract with Customer, Referral Credit, Current Minimum Minimum [Member] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Inventory reserve Inventory Write-down Commitments and Contingencies Disclosure [Abstract] Fair Value Measurements and Fair Value of Financial Instruments Fair Value Disclosures [Text Block] Share price (in dollars per share) Share Price Trading Symbol Trading Symbol Entity File Number Entity File Number Shares subject to repurchase Shares Subject to Repurchase [Member] Shares Subject to Repurchase Backstop warrant, shares reserved for future issuance (in shares) Backstop Warrant, Shares Reserved for Future Issuance Backstop Warrant, Shares Reserved for Future Issuance Product development Research and Development Expense Options vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Sixty Days Sixty Days [Member] Sixty Days Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Restricted stock units Restricted Stock Units (RSUs) [Member] Entity Information [Line Items] Entity Information [Line Items] Series E Series E Preferred Stock [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Customer Referral Credits Customer Referral Credits [Policy Text Block] Customer Referral Credits Use of Estimates Use of Estimates, Policy [Policy Text Block] Cash equivalents: Cash and Cash Equivalents, Fair Value Disclosure Class of warrants or rights warrants issued during period (in shares) Class of Warrants or Rights Warrants Issued During Period Class of Warrants or Rights Warrants Issued During Period Series Seed Series Seed Preferred Stock [Member] Series Seed Preferred Stock Accounts payable Increase (Decrease) in Accounts Payable Class of warrants redemption notice period Class of Warrants Redemption Notice Period Class of Warrants Redemption Notice Period Balance at December 31, 2021 Balance at June 30, 2022 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Convertible preferred stock and contingently redeemable common stock conversion Temporary Equity, Conversion of Stock, Amount Converted Temporary Equity, Conversion of Stock, Amount Converted Subsequent Events [Abstract] Prime Rate Prime Rate [Member] Concentration risk, percentage Concentration Risk, Percentage Corvina Holdings Limited Corvina Holdings Limited [Member] Corvina Holdings Limited Assumption of Private Placement and Public Warrants Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Purchases Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Purchases Payment of debt extinguishment Payment for Debt Extinguishment or Debt Prepayment Cost Credit Facility [Domain] Credit Facility [Domain] Outstanding stock option, shares reserved for future issuance (in shares) Outstanding Stock Option, Shares Reserved for Future Issuance Outstanding Stock Option, Shares Reserved for Future Issuance Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Net loss per share attributable to common stockholders, basic (in dollars per share) Earnings Per Share, Basic Repurchase of early exercise (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Repurchase of Early Exercise Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Repurchase of Early Exercise Class of warrant or right redemption threshold consecutive trading days Class of Warrant or Right Redemption Threshold Consecutive Trading Days Class of Warrant or Right Redemption Threshold Consecutive Trading Days Concentration Risk Type [Domain] Concentration Risk Type [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares) Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance Total stockholders’ deficit Balances at beginning of period Balances at ending of period Stockholders' Equity Attributable to Parent Cancelled/forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Entity Interactive Data Current Entity Interactive Data Current Sale of stock, number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Money market funds Money Market Funds [Member] Accumulated
Deficit Retained Earnings [Member] Common Stock Common Stock [Member] Issuance of Class A common stock issued to employees, net of withholding taxes Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Convertible preferred stock warrants Convertible Preferred Stock Warrants [Member] Convertible Preferred Stock Warrants Repurchase of common stock Payments for Repurchase of Common Stock Minimum liquidity to be maintained Minimum Liquidity To Be Maintained Minimum Liquidity To Be Maintained Class of Stock [Axis] Class of Stock [Axis] Transaction costs, convertible preferred stock and contingently redeemable convertible common stock issuance costs included in accounts payable and accrued liabilities Transaction Costs Incurred but Not yet Paid Transaction Costs Incurred but Not yet Paid Statement [Table] Statement [Table] Net exercise of preferred stock warrants Warrants Exercised, Preferred Stock Warrants Exercised, Preferred Stock Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Debt instrument, interest rate, effective percentage Debt Instrument, Interest Rate, Effective Percentage Schedule of Performance-based Restricted Stock Units Activity Schedule of Nonvested Performance-Based Units Activity [Table Text Block] Document Quarterly Report Document Quarterly Report Reverse recapitalization, contingent consideration, liability (in shares) Reverse Recapitalization, Contingent Consideration, Shares Reverse Recapitalization, Contingent Consideration, Shares Letter of Credit Letter of Credit [Member] Temporary equity, shares issued (in shares) Temporary Equity, Shares Issued Current assets: Assets, Current [Abstract] Class of warrants or rights redemption price per unit (in dollars per share) Class of Warrants or Rights Redemption Price Per Unit Class of Warrants or Rights Redemption Price Per Unit Operating lease liabilities, noncurrent Operating Lease, Liability, Noncurrent Temporary equity, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Statistical Measurement [Axis] Statistical Measurement [Axis] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Purchase agreement, equity interests issuable, not yet issued, transaction period Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period Tranche Three Tranche Three [Member] Tranche Three Accumulated deficit Retained Earnings (Accumulated Deficit) Equity Components [Axis] Equity Components [Axis] Scenario [Domain] Scenario [Domain] Private Placement Warrants Private Placement Warrant [Member] Private Placement Warrant Fair Value, Recurring Fair Value, Recurring [Member] Percentage of aggregate term loan advance increase Long Term Debt Commitment By Lender Long Term Debt Commitment By Lender Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Comprehensive Loss Comprehensive Income, Policy [Policy Text Block] Revision of Prior Period [Domain] Revision of Prior Period [Domain] Document Fiscal Year Focus Document Fiscal Year Focus Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Statement [Line Items] Statement [Line Items] Outstanding and unvested, beginning of period (in shares) Outstanding and unvested, ending of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2016 Equity Incentive Plan Two Thousand and Sixteen Equity Incentive Plan [Member] Two Thousand and Sixteen Equity Incentive Plan Debt instrument, frequency of periodic payment Debt Instrument, Frequency of Periodic Payment Interest and other expense (income), net Nonoperating Income (Expense) Variable Rate [Domain] Variable Rate [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling, general and administrative Selling, General and Administrative Expense Entity Addresses, Address Type [Axis] Entity Addresses, Address Type [Axis] Temporary Equity Temporary Equity [Table Text Block] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Series A Series A Preferred Stock [Member] Purchase agreement, equity interests issuable, not yet issued Purchase Agreement, Equity Interests Issuable, Not Yet Issued Purchase Agreement, Equity Interests Issuable, Not Yet Issued Tranche One Tranche One [Member] Tranche One Document Transition Report Document Transition Report Local Phone Number Local Phone Number Share-Based Payment Arrangement, Option, Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Operating loss Operating Income (Loss) Inventory Increase (Decrease) in Inventories Shipping and Handling Shipping and Handling [Member] Sale of stock, number of shares available in transaction (in shares) Sale of Stock, Number of Shares Available in Transaction Sale of Stock, Number of Shares Available in Transaction Reclassification of Grove's preferred stock warrant liability to additional paid-in capital Reclassification of Preferred Stock Warrant Liability to Equity Reclassification of Preferred Stock Warrant Liability to Equity Prepaids and other assets Increase (Decrease) in Prepaid Expense and Other Assets Common stock, shares outstanding (in shares) Balances at beginning of period (in shares) Balances at ending of period (in shares) Common Stock, Shares, Outstanding Other Current Liabilities Other Current Liabilities [Member] Repurchase of early exercised options (in shares) Stock Repurchased During Period, Shares Atel Loan Facility Draw 4 Atel Loan Facility Tranche Four [Member] Atel Loan Facility Tranche Four Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Provision for income taxes Income Tax Expense (Benefit) Number of warrant or right, entitles to purchase (in shares) Number of Warrant or Right, Entitles to Purchase Number of Warrant or Right, Entitles to Purchase Series B Series B Preferred Stock [Member] Income Statement [Abstract] Income Statement [Abstract] Share-based compensation arrangement by share-based payment award, options, grants in period, gross Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of trading days after the closing of business combination Reversed Recapitalization, Number of Trading Days Commencing Reversed Recapitalization, Number of Trading Days Commencing Schedule of Reverse Recapitalization [Line Items] Schedule of Reverse Recapitalization [Line Items] Schedule of Reverse Recapitalization [Line Items] Address Type [Domain] Address Type [Domain] Additional Paid-In Capital Additional Paid-in Capital [Member] Tranche Type [Axis] Tranche Type [Axis] Tranche Type Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Cost of goods sold Cost of Goods and Services Sold Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value Assumption of derivative liabilities upon Business Combination Liabilities Assumed Expected term (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Hercules Capital Inc Hercules Capital Inc [Member] Hercules Capital Inc Public warrant, shares reserved for future issuance (in shares) Public Warrant, Shares Reserved for Future Issuance Public Warrant, Shares Reserved for Future Issuance Common stock - Class A shares, $0.0001 par value – 600,000,000 shares authorized at June 30, 2022 and no shares authorized at December 31, 2021; 38,513,779 and no shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively; Class B shares, $0.0001 par value – 200,000,000 and 194,046,918 shares authorized at June 30, 2022 and December 31, 2021, respectively; 124,355,978 and 9,368,167 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively Common Stock, Value, Issued Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Mezzanine Loan And Equity Security Mezzanine Loan And Equity Security [Member] Mezzanine Loan And Equity Security Warrant Liabilities Warrant Liabilities [Policy Text Block] Warrant Liabilities Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Fulfillment Labor Fulfillment Labor [Member] Fulfillment Labor Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Contingencies Commitments and Contingencies, Policy [Policy Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Recapitalization Reverse Recapitalization [Text Block] Reverse Recapitalization Lender [Axis] Lender [Axis] Lender Private Placement Private Placement [Member] 2022 Equity Incentive Plan Two Thousand and Twenty Two Equity Incentive Plan [Member] Two Thousand and Twenty Two Equity Incentive Plan Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Issuance of preferred stock and common stock upon net exercise of warrants (in shares) Temporary Equity, Stock Issued During Period, Shares, New Issues Temporary Equity, Stock Issued During Period, Shares, New Issues Growth Capital Advance Growth Capital Advance [Member] Growth Capital Advance Agreement [Axis] Agreement [Axis] Agreement Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Conversion of preferred stock warrant liability to common stock warrants Issuance of common stock warrants Adjustments to Additional Paid in Capital, Warrant Issued Current liabilities: Liabilities, Current [Abstract] Proceeds from exercise of stock options, net of withholding taxes paid related to common stock issued to employees Proceeds from Stock Options Exercised Proceeds from the issuance of debt Proceeds from Issuance of Long-Term Debt Common stock, shares issued (in shares) Common Stock, Shares, Issued Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases Assumption Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases Tranche Two Tranche Two [Member] Tranche Two Deferred revenue Contractual liabilities Contract with Customer, Liability, Current Share-based compensation arrangement by share-based payment award, annual percent of shares increase Share-based Compensation Arrangement by Share-based Payment Award, Annual Percent of Shares Increase Share-based Compensation Arrangement by Share-based Payment Award, Annual Percent of Shares Increase Purchases of property and equipment included in accounts payable and accrued liabilities Capital Expenditures Incurred but Not yet Paid Fulfillment Costs Fulfillment Costs [Policy Text Block] Fulfillment Costs Balance at December 31, 2021 Balance at June 30, 2022 Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Amendment Flag Amendment Flag Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Temporary Equity, by Class of Stock [Table] Temporary Equity, by Class of Stock [Table] Debt instrument, face amount Debt Instrument, Face Amount Entity Current Reporting Status Entity Current Reporting Status Other current liabilities Other Liabilities, Current Other long-term assets Other Assets, Noncurrent Convertible preferred stock, shares reserved for future issuance (in shares) Convertible Preferred Stock, Shares Reserved for Future Issuance Share redemption trigger price (in dollars per share) Share Redemption Trigger Price Share Redemption Trigger Price Mezzanine Loan and Security Agreement Mezzanine Loan and Security Agreement [Member] Mezzanine Loan and Security Agreement Atel Atel [Member] Atel Credit card outstanding Credit Card Outstanding Credit Card Outstanding Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Share-based compensation arrangement by share-based payment award, fair value of shares subject to repurchase obligation Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value of Shares Subject to Repurchase Obligation Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value of Shares Subject to Repurchase Obligation Line of credit facility, unused capacity, commitment fee percentage Line of Credit Facility, Unused Capacity, Commitment Fee Percentage Series D-2 Series D-2 Preferred Stock [Member] Series D-2 Preferred Stock Counterparty Name [Axis] Counterparty Name [Axis] Options outstanding, beginning of period (in shares) Options outstanding, ending of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days Basis of Presentation and Liquidity Basis of Accounting, Policy [Policy Text Block] Property and equipment, net Property, Plant and Equipment, Net Entities [Table] Entities [Table] Repayment of debt Repayments of Long-Term Debt Changes in fair value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Common stock options Share-Based Payment Arrangement, Option [Member] Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Change in fair value of Public and Private Placement Warrants liability Fair Value Adjustment of Warrants, Public and Private Fair Value Adjustment of Warrants, Public and Private Issuance of common stock upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Cancelled/forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Total debt Long-Term Debt Other expense, net Other Nonoperating Income (Expense) Balance Sheet Location [Axis] Balance Sheet Location [Axis] Sale of stock (in dollars per share) Sale of Stock, Price Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Reverse recapitalization, transaction costs net Reverse Recapitalization, Transaction Costs Net Reverse Recapitalization, Transaction Costs Net Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Maximum Maximum [Member] Third-party products Third-party Products [Member] Third-party Products Class A Common Stock Common Class A [Member] Share-Based Payment Arrangement Share-Based Payment Arrangement [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Deferred revenue Increase (Decrease) in Contract with Customer, Liability Total current assets Assets, Current Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization [Table] Schedule of Reverse Recapitalization Tranche One Shares Tranche One Shares [Member] Tranche One Shares Cash paid for taxes Income Taxes Paid, Net Contract with customer, liability, revenue recognized Contract with Customer, Liability, Revenue Recognized Entity Small Business Entity Small Business Schedule of Stockholders' Equity Note, Warrants or Rights Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Lender [Domain] Lender [Domain] Lender [Domain] Common Stock and Warrants Stockholders' Equity Note Disclosure [Text Block] Measurement Frequency [Domain] Measurement Frequency [Domain] Share-based compensation arrangement by Share-based payment award, shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Revenues [Abstract] Revenues [Abstract] Restricted Common Stock Restricted Common Stock [Member] Restricted Common Stock Share-based payment arrangement, nonvested award, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $7.1 million transaction costs (in shares) Stock Issued During Period, Shares, Reverse Recapitalization Stock Issued During Period, Shares, Reverse Recapitalization Proceeds from issuance of common stock upon Closing of Business Combination Proceed from Issuance of Common Stock, Reverse Recapitalization Proceed from Issuance of Common Stock, Reverse Recapitalization Number of Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Non-cash interest expense Paid-in-Kind Interest Other long-term debt Other Long-Term Debt Options, outstanding, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Equity Award Modifications Equity Award Modifications [Member] Equity Award Modifications Title of 12(b) Security Title of 12(b) Security Fair value of common stock (in dollars per share) Share based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value of Common Stock Share based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value of Common Stock Vested but unissued (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period, Weighted Average Grant Date Fair Value Operating lease right-of-use assets and liabilities Increase (Decrease) in Operating Right of Use Asset Increase (Decrease) in Operating Right of Use Asset Payables and Accruals [Abstract] Subsequent Event [Line Items] Subsequent Event [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Business Combination and Asset Acquisition [Abstract] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Class of Stock [Line Items] Class of Stock [Line Items] Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Payment of debt issuance costs Payments of Debt Issuance Costs Two Years Two Years [Member] Two Years Previously Reported Previously Reported [Member] Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination Adjustment to Additional Paid in Capital, Earn-out Liability Upon Reverse Recapitalization Adjustment to Additional Paid in Capital, Earn-out Liability Upon Reverse Recapitalization Liabilities, Convertible Preferred Stock and Stockholders’ Deficit Liabilities and Equity [Abstract] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Forfeited and expired (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Conversion of contingently redeemable convertible common stock and convertible preferred stock to common stock Conversion Of Redeemable Convertible Preferred Stock To Common Stock Conversion Of Redeemable Convertible Preferred Stock To Common Stock Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Inventory, net Inventory, Net Accounts payable Accounts Payable, Current Convertible preferred stock warrant liability Convertible Preferred Stock Warrant Liability [Member] Convertible Preferred Stock Warrant Liability Grove Brands Grove Brands [Member] Grove Brands Description of Business Nature of Operations [Text Block] Convertible Preferred Stock Convertible Preferred Stock [Text Block] Convertible Preferred Stock Entity Filer Category Entity Filer Category Common stock warrants Warrant [Member] Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Weighted-Average Remaining Contractual Life (years) Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term [Abstract] Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term Reverse Recapitalization Tranche Two Reverse Recapitalization Tranche Two [Member] Reverse Recapitalization Tranche Two Options vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Number of shares converted Number of Shares Converted Number of Shares Converted Stock-based compensation expense Share-Based Payment Arrangement, Expense Commitments and contingencies (Note 7) Commitments and Contingencies Recapitalization exchange ratio Reverse Recapitalization, Exchange Ratio Reverse Recapitalization, Exchange Ratio Security Exchange Name Security Exchange Name Options outstanding, beginning of period (in dollars per share) Options outstanding, ending of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Vesting of early exercised stock options Vesting of Early Exercised Stock Options Vesting of Early Exercised Stock Options Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Number of days after the completion of an initial business combination Number of Days After the Completion of an Initial Business Combination Number of Days After the Completion of an Initial Business Combination Letters of credit outstanding, amount Letters of Credit Outstanding, Amount Issuance of common stock for services Stock Issued During Period, Value, Issued for Services Reverse Recapitalization Tranche One Reverse Recapitalization Tranche One [Member] Reverse Recapitalization Tranche One Schedule of Reserved for Issuance Schedule of Reserved for Issuance [Table Text Block] Schedule of Reserved for Issuance Schedule of Debt Schedule of Debt [Table Text Block] Revenue, net Total revenue, net Revenue from Contract with Customer, Excluding Assessed Tax Reverse Recapitalization [Abstract] Reverse Recapitalization Convertible preferred stock and contingently redeemable common stock conversion (in shares) Stock issued during period, shares, conversion of convertible securities (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Issuance of convertible common stock Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock Former Address Former Address [Member] Fulfillment cost Fulfillment Costs Fulfillment Costs Total shares of common stock reserved (in shares) Common Stock, Capital Shares Reserved for Future Issuance Cover [Abstract] Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Level 3 Fair Value, Inputs, Level 3 [Member] One Year One Year [Member] One Year Issuance of Earn-Out Shares Stock Issued During Period, Value, Earn-Out Shares Stock Issued During Period, Value, Earn-Out Shares Series C-1 Series C-1 Preferred Stock [Member] Series C-1 Preferred Stock Forecast Forecast [Member] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger Issuance of Earn-Out Shares (in shares) Stock Issued During Period, Earn-Out Shares Stock Issued During Period, Earn-Out Shares Total liabilities, convertible preferred stock and stockholders’ deficit Liabilities and Equity Convertible preferred stock and contingently redeemable common stock conversion (in shares) Temporary Equity, Conversion of Stock, Shares Converted Temporary Equity, Conversion of Stock, Shares Converted Number of votes Number of Votes Number of Votes Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Tranche Two Shares Tranche Two Shares [Member] Tranche Two Shares Repurchase of early exercise (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Repurchase of Early Exercise in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Repurchase of Early Exercise in Period Reverse recapitalization, aggregate gross proceeds amount Reverse Recapitalization, Aggregate Gross Proceeds Amount Reverse Recapitalization, Aggregate Gross Proceeds Amount Series D-1 Series D-1 Preferred Stock [Member] Series D-1 Preferred Stock Reverse recapitalization, contingent consideration, liability, earnout period Reverse Recapitalization, Contingent Consideration, Earnout Period Reverse Recapitalization, Contingent Consideration, Earnout Period Organization, Consolidation and Presentation of Financial Statements [Abstract] Level 2 Fair Value, Inputs, Level 2 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value Accrued Expenses Accounts Payable and Accrued Liabilities Disclosure [Text Block] Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation [Table Text Block] Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation Net loss per share attributable to common stockholders, diluted (in dollars per share) Earnings Per Share, Diluted Sale of Stock [Domain] Sale of Stock [Domain] Payment of transaction costs related to the Closing of the Business Combination and convertible preferred stock issuance costs Payments of Stock Issuance Costs Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Changes in fair value of derivative liabilities Fair Value Adjustment of Warrants Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current Entity Ex Transition Period Entity Ex Transition Period Issuance of common stock for services (in shares) Stock Issued During Period, Shares, Issued for Services Options vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Entity Address, Address Line One Entity Address, Address Line One Long-Term Purchase Commitment [Table] Long-Term Purchase Commitment [Table] Silicon Valley Bank Loan Revolver Silicon Valley Bank [Member] Silicon Valley Bank Product and Service [Axis] Product and Service [Axis] Class of Stock [Domain] Class of Stock [Domain] Fair Value Disclosures [Abstract] Issuance of preferred stock and common stock upon net exercise of warrants Temporary Equity, Stock Issued During Period, Value, New Issues Interest expense Interest Expense Options, vested and exercisable, aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Credit Facility [Axis] Credit Facility [Axis] Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Long-Term Purchase Commitment [Line Items] Long-Term Purchase Commitment [Line Items] Subsequent Event [Table] Subsequent Event [Table] Vested (in shares) Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Reverse recapitalization, proceeds received, net of transaction costs Reverse Recapitalization, Proceeds Received, Net of Transaction Costs Reverse Recapitalization, Proceeds Received, Net of Transaction Costs Entity Tax Identification Number Entity Tax Identification Number Share-Based compensation arrangement by share-based payment award, number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Issuance of convertible common stock (in shares) Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock Amendment to the Loan And Security Agreement Amendment to the Loan And Security Agreement [Member] Amendment to the Loan And Security Agreement Shares available for future issuance under equity incentive plan (in shares) Shares Available For Future Issuance Under Equity Incentive Plan Shares Available For Future Issuance Under Equity Incentive Plan Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years) Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term Advertising Advertising Expense Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Vested but unissued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period Atel Loan Facility Draw 3 Atel Loan Facility Tranche Three [Member] Atel Loan Facility Tranche Three Inventory purchases Inventory Purchases, Current Inventory Purchases, Current Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Tranche [Domain] Tranche [Domain] Tranche [Domain] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-based payment arrangement, catch up expense Share-Based Payment Arrangement, Catch Up Expense Share-Based Payment Arrangement, Catch Up Expense Concentration of Risks Concentration Risk, Credit Risk, Policy [Policy Text Block] Other accrued expenses Other Accrued Liabilities, Current Loan revolver borrower capacity as a percentage of inventory balance Loan Revolver Borrower Capacity as a Percentage of Inventory Balance Loan Revolver Borrower Capacity as a Percentage of Inventory Balance City Area Code City Area Code Long-term debt, percentage bearing variable interest, percentage rate Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate Assets Assets [Abstract] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Revision of Prior Period, Adjustment Revision of Prior Period, Adjustment [Member] Purchase obligation Purchase Obligation Statement of Stockholders' Equity [Abstract] Outstanding restricted stock unit, shares reserved for future issuance (in shares) Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance Sale of Stock [Axis] Sale of Stock [Axis] Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Financial Liabilities: Financial Liabilities Fair Value Disclosure Supplemental Disclosure of Non-Cash Investing and Financing Activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Fair value of common stock (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Variable Rate [Axis] Variable Rate [Axis] Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Other long-term liabilities Other Liabilities, Noncurrent Other liabilities Increase (Decrease) in Other Operating Liabilities Loan And Security Agreement Loan And Security Agreement [Member] Loan And Security Agreement Performance-based Restricted Stock Units Performance-based Restricted Stock Units [Member] Performance-based Restricted Stock Units Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Change in fair value of Earn-Out liability Fair Value Adjustment of Earn-Out Liability Fair Value Adjustment of Earn-Out Liability Change in fair value of Additional Shares liability Fair Value Adjustment of Warrants, Additional Shares Liability Fair Value Adjustment of Warrants, Additional Shares Liability Customer [Domain] Customer [Domain] Derivative liabilities Derivative Liability, Noncurrent EX-101.PRE 11 grov-20220630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.2
Cover Page - shares
6 Months Ended
Jun. 30, 2022
Aug. 04, 2022
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2022  
Document Transition Report false  
Entity File Number 001-40263  
Entity Registrant Name Grove Collaborative Holdings, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 88-2840659  
Entity Address, Address Line One 1301 Sansome Street  
Entity Address, City or Town San Francisco  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94111  
City Area Code 800  
Local Phone Number 231-8527  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Central Index Key 0001841761  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Amendment Flag false  
Former Address    
Entity Information [Line Items]    
Entity Registrant Name Virgin Group Acquisition Corp. II  
Entity Address, Address Line One 65 Bleecker Street, 6th Floor  
Entity Address, City or Town New York  
Entity Address, State or Province NY  
Entity Address, Postal Zip Code 10012  
Class A Common Stock    
Entity Information [Line Items]    
Title of 12(b) Security Class A common stock, par value $0.0001  
Trading Symbol GROV  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   43,101,881
Common stock warrants    
Entity Information [Line Items]    
Title of 12(b) Security Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share  
Trading Symbol GROV.WS  
Security Exchange Name NYSE  
Class B Common Stock    
Entity Information [Line Items]    
Entity Common Stock, Shares Outstanding   119,767,876
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 132,393 $ 78,376
Inventory, net 53,494 54,453
Prepaid expenses and other current assets 7,491 8,104
Total current assets 193,378 140,933
Property and equipment, net 15,831 15,932
Operating lease right-of-use assets 19,581 21,214
Other long-term assets 1,249 4,394
Total assets 230,039 182,473
Current liabilities:    
Accounts payable 17,714 21,346
Accrued expenses 40,830 20,651
Deferred revenue 12,575 11,267
Operating lease liabilities, current 3,788 3,550
Other current liabilities 854 1,650
Debt, current 22,708 10,750
Total current liabilities 98,469 69,214
Debt, noncurrent 43,694 56,183
Operating lease liabilities, noncurrent 18,106 20,029
Derivative liabilities 76,686 0
Other long-term liabilities 1,562 5,408
Total liabilities 238,517 150,834
Commitments and contingencies (Note 7)
#REF! 0 487,918
Stockholders’ deficit:    
Common stock - Class A shares, $0.0001 par value – 600,000,000 shares authorized at June 30, 2022 and no shares authorized at December 31, 2021; 38,513,779 and no shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively; Class B shares, $0.0001 par value – 200,000,000 and 194,046,918 shares authorized at June 30, 2022 and December 31, 2021, respectively; 124,355,978 and 9,368,167 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 16 1
Additional paid-in capital 564,343 33,863
Accumulated deficit (572,837) (490,143)
Total stockholders’ deficit (8,478) (456,279)
Total liabilities, convertible preferred stock and stockholders’ deficit $ 230,039 $ 182,473
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues [Abstract]        
Revenue, net $ 79,279 $ 99,023 $ 169,758 $ 201,243
Cost of goods sold 40,322 49,957 88,064 99,985
Gross profit 38,957 49,066 81,694 101,258
Operating Expenses [Abstract]        
Advertising 17,898 22,516 50,691 58,152
Product development 5,922 5,688 12,162 10,850
Selling, general and administrative 57,895 46,971 108,865 94,509
Operating loss (42,758) (26,109) (90,024) (62,253)
Interest expense 2,285 1,096 4,372 2,059
Loss on extinguishment of debt 0 1,027 0 1,027
Change in fair value of Additional Shares liability 2,015 0 2,015 0
Change in fair value of Earn-Out liability (17,345) 0 (17,345) 0
Change in fair value of Public and Private Placement Warrants liability (1,180) 0 (1,180) 0
Other expense, net 6,775 268 4,783 1,044
Interest and other expense (income), net (7,450) 2,391 (7,355) 4,130
Loss before provision for income taxes (35,308) (28,500) (82,669) (66,383)
Provision for income taxes 2 16 25 28
Net loss $ (35,310) $ (28,516) $ (82,694) $ (66,411)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (1.06) $ (3.97) $ (3.86) $ (9.13)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (1.06) $ (3.97) $ (3.86) $ (9.13)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 33,384,292 7,182,025 21,419,222 7,277,677
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 33,384,292 7,182,025 21,419,222 7,277,677
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Previously Reported
Convertible Preferred Stock
Convertible Preferred Stock
Previously Reported
Convertible Preferred Stock
Revision of Prior Period, Adjustment
Contingently redeemable convertible common stock
Contingently redeemable convertible common stock
Previously Reported
Contingently redeemable convertible common stock
Revision of Prior Period, Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Accumulated
Deficit
Accumulated
Deficit
Previously Reported
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2020 [1]     114,795,000 97,611,000 17,184,000                    
Temporary equity, balances at beginning of period at Dec. 31, 2020 [1]     $ 487,918 $ 487,918                      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]     114,795,000                        
Temporary equity, balances at ending of period at Jun. 30, 2021 [1],[2]     $ 487,918                        
Balances at beginning of period (in shares) at Dec. 31, 2020 [1]                 8,468,000 7,200,000 1,268,000        
Balances at beginning of period at Dec. 31, 2020 $ (339,641) $ (339,641)             $ 1 [1] $ 1 [1]   $ 14,605 $ 14,605 $ (354,247) $ (354,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Conversion of preferred stock warrant liability to common stock warrants 1,622                     1,622      
Issuance of common stock for services (in shares) [1]                 4,000            
Issuance of common stock for services 49                     49      
Issuance of common stock upon exercise of stock options (in shares) [1]                 522,000            
Issuance of common stock upon exercise of stock options 517                     517      
Vesting of early exercise of options 1,245                     1,245      
Repurchase of early exercised options (in shares) [1]                 (155,000)            
Issuance of common stock warrants 1,622                     1,622      
Stock-based compensation 7,344                     7,344      
Net loss (66,411)                         (66,411)  
Balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]                 8,839,000            
Balances at ending of period at Jun. 30, 2021 (395,275)               $ 1 [1],[2]     25,382   (420,658)  
Temporary equity, balances at beginning of period (in shares) at Mar. 31, 2021 [2]     114,795,000 97,611,000 17,184,000                    
Temporary equity, balances at beginning of period at Mar. 31, 2021 [2]     $ 487,918 $ 487,918                      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]     114,795,000                        
Temporary equity, balances at ending of period at Jun. 30, 2021 [1],[2]     $ 487,918                        
Balances at beginning of period (in shares) at Mar. 31, 2021 [2]                 8,619,000 7,329,000 1,290,000        
Balances at beginning of period at Mar. 31, 2021 (372,739) (372,739)             $ 1 [2] $ 1 [2]   19,402 19,402 (392,142) (392,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Conversion of preferred stock warrant liability to common stock warrants 1,622                     1,622      
Issuance of common stock for services (in shares) [2]                 4,000            
Issuance of common stock for services 49                     49      
Issuance of common stock upon exercise of stock options (in shares) [2]                 216,000            
Issuance of common stock upon exercise of stock options 227                     227      
Vesting of early exercise of options 221                     221      
Issuance of common stock warrants 1,622                     1,622      
Stock-based compensation 3,861                     3,861      
Net loss (28,516)                         (28,516)  
Balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]                 8,839,000            
Balances at ending of period at Jun. 30, 2021 $ (395,275)               $ 1 [1],[2]     25,382   (420,658)  
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 114,795,034   114,795,000 [3] 97,611,000 [3] 17,184,000 [3] 0 [3] 0 [3]                
Temporary equity, balances at beginning of period at Dec. 31, 2021 $ 487,918   $ 487,918 [3] $ 487,918 [3]   $ 0 [3] $ 0 [3]                
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [3]     168,000                        
Issuance of preferred stock and common stock upon net exercise of warrants [3]     $ 989                        
Conversion of preferred stock warrant liability to common stock warrants $ 516,380               $ 12 [3]     516,368      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [3]     (114,963,000)     (2,750,000)                  
Convertible preferred stock and contingently redeemable common stock conversion [3]     $ (488,907)     $ (27,473)                  
Issuance of convertible common stock (in shares) [3]           2,750,000                  
Issuance of convertible common stock [3]           $ 27,473                  
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2022 0   0 [3],[4]     0 [3],[4]                  
Temporary equity, balances at ending of period at Jun. 30, 2022 $ 0   $ 0 [3],[4]     $ 0 [3],[4]                  
Balances at beginning of period (in shares) at Dec. 31, 2021 [3]                 9,368,000 7,966,000 1,402,000        
Balances at beginning of period at Dec. 31, 2021 (456,279) (456,279)             $ 1 [3] $ 1 [3]   33,863 33,863 (490,143) (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [3]                 156,000            
Conversion of preferred stock warrant liability to common stock warrants 2,182                     2,182      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [3]                 118,205,000            
Convertible preferred stock and contingently redeemable common stock conversion 516,380               $ 12 [3]     516,368      
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $7.1 million transaction costs (in shares) [3]                 20,921,000            
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,981               $ 2 [3]     79,979      
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)                     (93,196)      
Issuance of Earn-Out Shares (in shares) [3]                 14,000,000            
Issuance of Earn-Out Shares 1               $ 1 [3]            
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [3]                 32,000            
Issuance of Class A common stock issued to employees, net of withholding taxes $ (96)                     (96)      
Issuance of common stock upon exercise of stock options (in shares) 205,337               205,000 [3]            
Issuance of common stock upon exercise of stock options $ 333                     333      
Vesting of early exercise of options 125                     125      
Repurchase of early exercised options (in shares) [3]                 (17,000)            
Issuance of common stock warrants 2,182                     2,182      
Stock-based compensation 24,785                     24,785      
Net loss (82,694)                         (82,694)  
Balances at ending of period (in shares) at Jun. 30, 2022 [3],[4]                 162,870,000            
Balances at ending of period at Jun. 30, 2022 (8,478)               $ 16 [3],[4]     564,343   (572,837)  
Temporary equity, balances at beginning of period (in shares) at Mar. 31, 2022 [4]     114,795,000 97,611,000 17,184,000 2,750,000 2,350,000 400,000              
Temporary equity, balances at beginning of period at Mar. 31, 2022 [4]     $ 487,918 $ 487,918   $ 27,473 $ 27,473                
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [4]     168,000                        
Issuance of preferred stock and common stock upon net exercise of warrants [4]     $ 989                        
Conversion of preferred stock warrant liability to common stock warrants $ 516,380               $ 12 [4]     516,368      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [4]     (114,963,000)     (2,750,000)                  
Convertible preferred stock and contingently redeemable common stock conversion [4]     $ (488,907)     $ (27,473)                  
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2022 0   0 [3],[4]     0 [3],[4]                  
Temporary equity, balances at ending of period at Jun. 30, 2022 $ 0   $ 0 [3],[4]     $ 0 [3],[4]                  
Balances at beginning of period (in shares) at Mar. 31, 2022 [4]                 9,455,000 8,040,000 1,415,000        
Balances at beginning of period at Mar. 31, 2022 (498,866) $ (498,866)             $ 1 [4] $ 1 [4]   38,660 $ 38,660 (537,527) $ (537,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [4]                 156,000            
Conversion of preferred stock warrant liability to common stock warrants 2,182                     2,182      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [4]                 118,205,000            
Convertible preferred stock and contingently redeemable common stock conversion 516,380               $ 12 [4]     516,368      
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $7.1 million transaction costs (in shares) [4]                 20,921,000            
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,981               $ 2 [4]     79,979      
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)                     (93,196)      
Issuance of Earn-Out Shares (in shares) [4]                 14,000,000            
Issuance of Earn-Out Shares 1               $ 1 [4]            
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [4]                 32,000            
Issuance of Class A common stock issued to employees, net of withholding taxes (96)                     (96)      
Issuance of common stock upon exercise of stock options (in shares) [4]                 118,000            
Issuance of common stock upon exercise of stock options 162                     162      
Repurchase of early exercised options (in shares) [4]                 (17,000)            
Issuance of common stock warrants 2,182                     2,182      
Stock-based compensation 20,284                     20,284      
Net loss (35,310)                         (35,310)  
Balances at ending of period (in shares) at Jun. 30, 2022 [3],[4]                 162,870,000            
Balances at ending of period at Jun. 30, 2022 $ (8,478)               $ 16 [3],[4]     $ 564,343   $ (572,837)  
[1] (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
[2]
(1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
[3]
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
[4]
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit - Parenthetical (Details)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Reverse recapitalization, transaction costs net $ 17.1 $ 17.1
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities    
Net loss $ (82,694) $ (66,411)
Adjustments to reconcile net loss to net cash used in operating activities:    
Remeasurement of convertible preferred stock warrant liability (1,616) 1,308
Stock-based compensation 24,534 7,269
Depreciation and amortization 2,864 2,337
Changes in fair value of derivative liabilities (16,510) 0
Transaction costs allocated to derivative liabilities upon Business Combination 6,673 0
Non-cash interest expense 312 313
Inventory reserve 1,693 1,719
Loss on extinguishment of debt 0 1,027
Other non-cash expenses 139 387
Changes in operating assets and liabilities:    
Inventory (734) (11,320)
Prepaids and other assets 613 (3,059)
Accounts payable (3,495) (3,426)
Accrued expenses 525 7,327
Deferred revenue 1,308 1,788
Operating lease right-of-use assets and liabilities (52) 45
Other liabilities 302 (1,103)
Net cash used in operating activities (66,138) (61,799)
Cash Flows from Investing Activities    
Purchase of property and equipment (2,610) (2,845)
Net cash used in investing activities (2,610) (2,845)
Cash Flows from Financing Activities    
Proceeds from issuance of common stock upon Closing of Business Combination 97,100 0
Proceeds from issuance of contingently redeemable convertible common stock 27,500 0
Payment of transaction costs related to the Closing of the Business Combination and convertible preferred stock issuance costs (1,267) (340)
Proceeds from the issuance of debt 0 25,000
Repayment of debt (562) (21,165)
Payment of debt extinguishment 0 (2,499)
Payment of debt issuance costs (211) (375)
Proceeds from exercise of stock options, net of withholding taxes paid related to common stock issued to employees 237 525
Repurchase of common stock (32) (297)
Net cash provided by financing activities 122,765 849
Net increase (decrease) in cash and cash equivalents 54,017 (63,795)
Cash and cash equivalents at beginning of period 78,376 176,523
Cash and cash equivalents at end of period 132,393 112,728
Supplemental Disclosure    
Cash paid for taxes 61 52
Cash paid for interest 3,052 1,299
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Transaction costs, convertible preferred stock and contingently redeemable convertible common stock issuance costs included in accounts payable and accrued liabilities 21,435 291
Purchases of property and equipment included in accounts payable and accrued liabilities 122 139
Initial measurement of common stock warrants recorded as debt fees 0 1,622
Net exercise of preferred stock warrants 989 0
Conversion of contingently redeemable convertible common stock and convertible preferred stock to common stock 516,365 0
Assumption of derivative liabilities upon Business Combination 93,196 0
Reclassification of Grove's preferred stock warrant liability to additional paid-in capital 2,182 0
Vesting of early exercised stock options $ 125 $ 1,245
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets - Parenthetical (Details) - $ / shares
Jun. 30, 2022
Dec. 31, 2021
Temporary equity, par value (in dollars per share) $ 0.0001 $ 0.0001
Temporary equity, shares authorized (in shares) 100,000,000 115,527,580
Temporary equity, shares issued (in shares) 0 114,795,034
Temporary equity, shares outstanding (in shares) 0 114,795,034
Class A Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 600,000,000 0
Common stock, shares issued (in shares) 38,513,779 0
Common stock, shares outstanding (in shares) 38,513,779 0
Class B Common Stock    
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 200,000,000 194,046,918
Common stock, shares issued (in shares) 124,355,978 9,368,167
Common stock, shares outstanding (in shares) 124,355,978 9,368,167
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Business
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business Description of Business
Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world, and we plan to become 100% plastic-free by 2025. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016.

On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”).

The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing.
Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 3, Recapitalization for additional details.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Liquidity

The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should
be read in conjunction with Legacy Grove’s financial statements and accompanying notes as of and for the year ended December 31, 2021 (the “audited financial statements”) that were included in the Company’s Proxy Statement/Prospectus filed with the SEC on May 17, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2022 and the results of operations for the three and six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other future interim or annual period.

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business. The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $572.8 million as of June 30, 2022. The Company’s existing sources of liquidity as of June 30, 2022 include cash and cash equivalents of $132.4 million. Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock and contingently redeemable convertible common stock and the incurrence of debt. Upon the Closing of the Business Combination, the Company received $80.0 million in cash proceeds, net of transaction costs. The Company believes the Business Combination eliminated the substantial doubt about the Company’s ability to continue as a going concern from at least one year after the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.

Emerging Growth Company
The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.

Comprehensive Loss
Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.

Significant Accounting Policies

Except for the addition of the Business Combination and related derivative liabilities, there have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, Summary of Significant Accounting Policies, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2021.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement warrants, the fair value of Earn-Out liabilities, and Additional Shares related to the Backstop Subscription Agreement and stock-based compensation expense. Actual
results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.
The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.

Concentration of Risks
Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
The Company depends on a limited number of vendors to supply products sold by the Company. For the three and six months ended June 30, 2022 and 2021, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases.

Revenue Recognition
The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. 
The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.
In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.
A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the
order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.
The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).
At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. The Company records a refund reserve based on historical refund patterns. As of June 30, 2022 and December 31, 2021 the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was $0.1 million.
Disaggregation of Revenue
The following table sets forth revenue by product type (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Revenue, net:
Grove Brands $38,216 $47,469 $85,064 $99,754 
Third-party products41,063 51,554 84,694 101,489 
Total revenue, net$79,279 $99,023 $169,758 $201,243 
Contractual Liabilities
The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. Contractual liabilities included in deferred revenue and other current liabilities were $12.6 million and $0.3 million, respectively, as of June 30, 2022 and $11.3 million and $0.3 million, respectively, as of December 31, 2021. The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the six months ended June 30, 2022 that was previously included in deferred revenue and other current liabilities as of December 31, 2021 was $9.1 million and $0.2 million, respectively.
Customer Referral Credits
The Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase. The liability for customer referral credits was $0.1 million as of June 30, 2022 and December 31, 2021 and is included within other current liabilities in the condensed consolidated balance sheets.

Fulfillment Costs
Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative expenses in the condensed consolidated statements of operations. For the three months ended June 30, 2022 and 2021, the Company recorded fulfillment costs of $20.3 million and $23.6 million, respectively, which included $12.8 million and $13.8 million in shipping and handling expenses, respectively, and $4.5 million and $5.8 million in Fulfillment Labor, respectively. For the six months ended June 30, 2022 and 2021, the Company recorded fulfillment costs of $44.7 million and $48.8 million, respectively, which included $27.1 million and $28.9 million in shipping and handling expenses, respectively, and $11.1 million and $12.1 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors.

Warrant Liabilities

The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.2
Recapitalization
6 Months Ended
Jun. 30, 2022
Business Combination and Asset Acquisition [Abstract]  
Recapitalization Recapitalization
As discussed in Note 1, Description of Business, on the Closing Date, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination, including the Backstop Tranche 2 shares, and proceeds from the PIPE investment (as defined below). The Company recorded $23.8 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were allocated on a relative fair value basis between the issuance of common stock, Public and Private Placement Warrants, Grove Earn-Out Shares, Downside Protection feature and Backstop Warrants (as defined below). Direct and incremental transaction costs allocated to equity-classified instruments have been recorded within equity as an offset against proceeds upon accounting for the consummation of the Business Combination in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net in the condensed consolidated statements of operations. The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows. On the Closing Date, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. See Note 8, Convertible Preferred Stock and Note 9, Common Stock and Warrants for additional details of the Company's stockholders' deficit prior to and subsequent to the Business Combination.

All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of approximately 1.1760, each outstanding restricted stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760.

Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant.

The Merger was accounted for as a reverse recapitalization with Legacy Grove as the accounting acquirer and VGAC II as the acquired company for accounting purposes. Legacy Grove was determined to be the accounting acquirer since Legacy Grove’s shareholders prior to the business combination had the greatest voting interest in the combined entity, Legacy Grove's shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Legacy Grove comprises all of the ongoing operations, and Legacy Grove's senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these condensed consolidated financial statements represents the accounts of Legacy Grove. Net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Legacy Grove.

Earn-Out

At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of New Grove Class B Common Stock (“Earn-Out Shares”), which will vest (i) with respect to 7,000,173 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,999,787 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Mergers (the “Earn-Out Period”).
If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.

If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and it will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of June 30, 2022, the Company did not meet any Earn-Out thresholds.

PIPE Investment

On December 7, 2021, concurrently with the execution of the Merger Agreement, VGAC II entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 8,707,500 shares of the Company’s Class A common stock at $10.00 per share for aggregate gross proceeds of $87,075,000 (the “PIPE Investment”). 8,607,500 shares of the Company’s Class A common stock have been issued for aggregate proceeds of $86,075,000, which consummated concurrently with the closing to the Business Combination.

Backstop Financing

On March 31, 2022, VGAC II entered into the Subscription Agreement (the “Backstop Subscription Agreement”) with Corvina Holdings Limited (the “Backstop Investor”) and Legacy Grove. As part of the Subscription Agreement, the Backstop Investor subscribed for and purchased 2,338,352 shares of Legacy Grove Common Stock (the “Backstop Tranche 1 Shares”) for aggregate proceeds of $27,500,000. The Company initially classified the Backstop Tranche 1 Shares as mezzanine (or temporary) equity on its balance sheet because the Backstop Tranche 1 Shares were contingently redeemable upon the occurrence of certain events not solely within the control of the Company that allow for the effective redemption of such shares in cash at the option of the holder. Upon Closing of the Business Combination, the Backstop Tranche 1 Shares were converted into 2,750,000 shares of Class A Common Stock and the Tranche 1 Share were no longer contingently redeemable. The Company has classified these shares in permanent equity on its balance sheet at June 30, 2022.

In addition, the Backstop Investor agreed to subscribe for and purchase, on the closing date of the Business Combination, certain shares of New Grove class A common stock at a purchase price of $10.00 per share (“Backstop Tranche 2 Shares”) for aggregate gross proceeds in an amount equal to (x) $22.5 million minus (y) the amount of aggregate cash remaining in VGAC II’s trust account, after deducting any amounts paid to VGAC II shareholders who exercise their redemption rights in connection with the Business Combination. The Company issued to the Backstop Investor, as of immediately following the closing of the Mergers, 1,671,524 Backstop Tranche 2 Shares for aggregate proceeds of $16,715,240.

The Backstop Subscription Agreement also provides that the Company will issue additional shares of Class A common stock to the Backstop Investor for Backstop Tranche 1 Shares and Backstop Tranche 2 Shares if the volume weighted average price of Class A common stock is less than $10.00 during the 10 trading days commencing on the first trading date after the Company’s first quarterly earnings call for the fiscal quarter ended June 30, 2022 (“Additional Shares”).

As part of the Backstop Subscription Agreement, the Company issued to the Backstop Investor 3,875,028 warrants to purchase New Grove Class A Common Stock (each warrant exercisable to purchase one share of New Grove Class A Common Stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. The Backstop Warrants were recorded in equity on the Company’s balance sheet at June 30, 2022.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Fair Value of Financial Instruments
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value Measurements and Fair Value of Financial Instruments Fair Value Measurements and Fair Value of Financial Instruments
The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.

The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exception discussed in Note 9, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments.
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 by level within the fair value hierarchy (in thousands):
June 30, 2022
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$129,171 $— $— $129,171 
Total$129,171 $— $— $129,171 
Financial Liabilities:
Additional Shares$— $— $17,355 17,355 
Earn-Out Shares— — 53,136 53,136 
Public Warrants3,381 — — 3,381 
Private Placement Warrants— 2,814 — 2,814 
Total$3,381 $2,814 $70,491 $76,686 
December 31, 2021
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$77,771 $— $— $77,771 
Total$77,771 $— $— $77,771 
Financial Liabilities:
Convertible preferred stock warrant liability$— $— $4,787 $4,787 
Total$— $— $4,787 $4,787 
There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented.

Additional Shares

At closing of the Mergers, the Company recorded a liability of $15.3 million related to the potential issuance of the Additional Shares related to the Backstop Subscription Agreement. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations.

The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):

Balance at December 31, 2021$— 
Assumption of Additional Shares liability15,340 
Change in fair value2,015 
Balance at June 30, 2022$17,355 
Earn-Out Shares

At Closing of the Mergers, certain Earn-Out Shares were accounted for as a liability totaling $70.5 million. Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations.

The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):

Balance at December 31, 2021$— 
Assumption of Earn-Out liability70,481 
Change in fair value(17,345)
Balance at June 30, 2022$53,136 
Private Placement and Public Warrant Liabilities

As of June 30, 2022, the Company has Private Placement and Public Warrants defined and discussed in Note 9, Common Stock and Warrants. Such warrants are measured at fair value on a recurring basis.

The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands):

Private Placement WarrantsPublic Warrants
Balance at December 31, 2021$— $— 
Assumption of Private Placement and Public Warrants3,350 4,025 
Changes in fair value(536)(644)
Balance at June 30, 2022$2,814 $3,381 

Convertible Preferred Stock Warrant Liability
The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands):
Balance at December 31, 2021$4,787 
Change in fair value(1,616)
Net exercise of preferred stock warrants(989)
Balance before reclassification at June 30, 20222,182 
Reclassification to additional paid-in capital(2,182)
Balance at June 30, 2022$— 

The Company recorded a loss on remeasurement of preferred stock warrant liability of $0.3 million and $0.4 million for the three months ended June 30, 2022 and 2021, respectively, and a gain of $1.6 million and a loss of $1.3 million on remeasurement of preferred stock warrant liability for the six months ended June 30, 2022 and 2021, respectively. With the closing of the Business Combination, unexercised preferred stock warrants are converted into warrants of the Company to purchase shares of common stock and the preferred stock warrant liability is reclassified to additional paid-in capital.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.2
Accrued Expenses
6 Months Ended
Jun. 30, 2022
Payables and Accruals [Abstract]  
Accrued Expenses Accrued Expenses
Accrued expenses consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Inventory purchases$3,468 $4,659 
Compensation and benefits1,744 2,072 
Advertising costs3,527 2,363 
Fulfillment costs1,147 1,120 
Sales taxes1,537 1,812 
Transaction costs21,399 1,846 
Other accrued expenses8,008 6,779 
Total accrued expenses$40,830 $20,651 
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.2
Debt
6 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Debt Debt
The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Silicon Valley Bank Loan Revolver$5,947 $5,947 
Silicon Valley Bank and Hercules Mezzanine Term Loan59,263 59,237 
Atel Loan Facility Draw 31,009 1,489 
Atel Loan Facility Draw 4183 260 
Total debt66,402 66,933 
Less: debt, current(22,708)(10,750)
Total debt, noncurrent$43,694 $56,183 
Silicon Valley Bank Loan Facility
In December 2016, the Company entered into a loan and security agreement (the “SVB Loan Facility”) with Silicon Valley Bank (“SVB”). The terms of the SVB Loan Facility, as amended and restated, provided for: (i) a revolving line of credit not to exceed $25.0 million (“Loan Revolver”), (ii) growth capital advance (“Term Loan”) of $3.9 million and (iii) a letter of credit sublimit of $6.0 million. The Term Loan had a maturity date in December 2022 and bore interest at Prime Rate per annum, payable monthly. The Loan Revolver borrowing capacity was limited to 60% of eligible inventory balances.
In April 2021, the Company entered into an amendment to the SVB Loan Facility, which incurs a facility fee of 0.20% per annum assessed on the daily average undrawn portion of revolving line of credit. In addition, the Loan Revolver letter of credit sublimit increased to $10.0 million and the Loan Revolver borrowing capacity increased to 65% of eligible inventory balances. The Loan Revolver borrowing capacity is reduced by outstanding letters of credit and credit available to the Company from certain credit card facilities, which amounted to $3.1 million and $1.5 million, respectively as of June 30, 2022. The amended Loan Revolver bears an interest rate equal to the greater of prime rate or 3.25% per annum and matures on March 31, 2023. Interest on the Loan Revolver is payable monthly in arrears.
In April 2021, all of the Company’s outstanding amounts under the SVB Term Loan were refinanced directly through the SVB and Hercules Loan Facility (see below). The Company determined the refinance represented an extinguishment of the SVB Term Loan and recorded a loss on extinguishment of $1.0 million during the three months ended June 30, 2021.
The SVB Loan Facility is collateralized by substantially all of the Company’s assets on a first priority basis and contains customary events of default. The SVB Loan Facility includes affirmative, negative, and financial covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted
indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends, or repurchase stock, subject to customary exceptions. The SVB Loan Facility contains certain financial covenants which requires the Company to maintain minimum liquidity of $45.0 million. Minimum liquidity is defined as the sum of the aggregate amount of unrestricted and unencumbered cash deposited with SVB plus amounts available to be drawn under the loan revolver, as adjusted for any outstanding standby letters of credit issued by SVB.
As of June 30, 2022, the Company was in compliance with all covenants and had $5.9 million outstanding under the revolving line of credit, with an effective interest rate of 5.00%.
Silicon Valley Bank and Hercules Loan Facility
In April 2021, the Company entered into a Mezzanine Loan and Security Agreement (“SVB and Hercules Loan Facility”) with SVB and Hercules Capital, Inc. (“Hercules”). The availability period runs from the effective date until June 30, 2022, provides for advances of up to $60.0 million. In April 2021, the Company drew $25.0 million, which it used to directly settle the amounts outstanding under the SVB Term Loan. In September and December 2021, the Company drew down the remaining additional borrowings of $25.0 million and $10.0 million, respectively. The SVB and Hercules Loan Facility bears an annual interest at the greater of 8.75% or prime plus 5.5%, payable monthly. The principal repayment period commences on November 1, 2022 and continues for 30 monthly installments with an additional final payment equal to 6.75% of the aggregate term loan advances. SVB and Hercules have committed to fund 51.0% and 49.0%, respectively, of all draws made under the SVB and Hercules Loan Facility.

In May 2022, as part of the Closing of the Business Combination, the Company entered into an amendment with SVB and Hercules Loan Facility which increased the final payment from 6.75% to 8.75% of the aggregate term loan advances.
The SVB and Hercules Loan Facility is collateralized on a second priority basis, subordinate to the SVB Loan Facility, by substantially all of the Company’s assets and contains affirmative and negative covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends or repurchase stock, subject to customary exceptions. The SVB and Hercules Loan Facility does not include any financial covenants, but does contain a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, SVB and Hercules have been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that SVB and Hercules would exercise the subjective acceleration clause is remote.
As of June 30, 2022, the Company had an aggregate of $60.0 million outstanding under the SVB and Hercules Loan Facility, excluding unamortized debt issuance cost, with effective interest rates ranging from 14.26% to 17.31%. As of June 30, 2022, the Company was in compliance with all covenants.
Atel Loan Facility
In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default.
As of June 30, 2022, the Company had $1.0 million outstanding on its third draw and $0.2 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Merchandise Purchase Commitments
As of June 30, 2022 and December 31, 2021, the Company had obligations to purchase $27.0 million and $36.1 million, respectively, of merchandise.
Letters of Credit
The Company had irrevocable standby letters of credit in the amount of $3.1 million as of June 30, 2022 and December 31, 2021 related to the Company’s operating leases. The letters of credit have expiration dates through January 2029.
Contingencies
The Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.2
Convertible Preferred Stock
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Convertible Preferred Stock Convertible Preferred Stock
The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data):
Original
Issue Price
Shares
Authorized
Shares
Outstanding
Net Carrying
Value
Liquidation
Preference 
Series Seed$0.5245 9,693,116 9,693,115 $3,943 $5,084 
Series A0.5245 14,130,360 14,069,657 5,240 7,379 
Series B1.2450 12,689,363 12,563,418 15,545 15,642 
Series C2.4144 15,635,550 15,324,913 36,917 37,000 
Series C-13.1669 8,554,106 8,554,106 27,003 27,090 
Series D7.0135 20,196,682 19,961,423 136,618 140,000 
Series D-19.0731 5,314,209 5,314,209 48,146 48,216 
Series D-26.1850 14,551,371 14,551,370 89,638 90,000 
Series E8.4672 14,762,823 14,762,823 124,868 125,000 
Total115,527,580 114,795,034 $487,918 $495,411 
Conversion

At the closing of the Business Combination, all series of convertible preferred stock of Legacy Grove were converted on an as-converted basis to the Company’s Class B common stock at an exchange ratio of approximately 1.1760. As of June 30, 2022, no shares of convertible preferred stock were outstanding.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock and Warrants
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Common Stock and Warrants Common Stock and Warrants
Prior to the Business Combination, Legacy Grove had one class of authorized common stock (Class B common stock). The outstanding shares of Legacy Grove common stock is presented on the consolidated balance sheet and on the statements of convertible preferred stock, contingently redeemable convertible common stock and stockholders’ deficit for the year ended December 31, 2021.

Merger Transaction

On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each common stock, par value $0.0001 per share (other than Backstop Tranche 1 Shares), preferred stock, outstanding options (whether vested or unvested), restricted stock units (whether vested or unvested) and warrants of Legacy Grove was canceled and converted into a comparable number of awards (i) that consisted of either the rights to receive or acquire shares of the Company’s Class B common stock, par value $0.0001 per share, as determined by the exchange ratio, and (ii) the right to receive a number of the Company’s Earn-Out shares. Each Backstop Tranche 1 Shares issued to the Backstop Investor pursuant to the Backstop Subscription Agreement was canceled and converted into the right to receive a number of shares of the Company’s Class B common stock equal to the exchange ratio, which were immediately exchanged on a one-for-one basis for shares of the Company’s Class A common stock). The exchange ratio is approximately 1.1760.

On June 16, 2022, in connection with the closing of the Business Combination, the Company amended and restated its certificate of incorporation to authorize 900,000,000 shares, consisting of (a) 800,000,000 shares of common stock, including (i) 600,000,000 shares of Class A common stock, and (ii) 200,000,000 shares of Class B common stock, and (b) 100,000,000 shares of preferred stock.

The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to number of voting rights. Holders of Class A common stock are entitled to one vote per share and holders of Class B common stock are entitled to ten votes per share. Each share of Class B common stock is convertible into one share of Class A common stock any time at the option of the holder, and is automatically converted into one share of Class A common stock upon transfer (except for certain permitted transfers). Once converted into Class A common stock, the Class B common stock will not be reissued. The Company’s Board of Directors has the authority to issue shares of the Preferred Stock in one or more series and to determine the voting rights, designations, powers, preferences, other rights and restrictions of each such series of shares. As of June 30, 2022, no shares of preferred stock were issued and outstanding.

Class A Common Stock Warrants

As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assumed 6,700,000 Private Placement Warrants for Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation.

Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets and amounted to $76.7 million as of June 30, 2022.
As of June 30, 2022, the following Warrants were outstanding:

Warrant TypeSharesExercise Price
Public Warrants8,050,000 $11.50 
Private Placement Warrants6,700,000 $11.50 

Public Warrants

The Public Warrants become exercisable into shares of Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments.

The Company may redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any twenty trading days within the thirty trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.

Private Placement Warrants

The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. At Closing, the Company assumed 6,700,000 Private Placement Warrants.
Reserved for Issuance

The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:
June 30, 2022December 31, 2021
Class A Common StockClass B Common StockClass A Common StockClass B Common Stock
Convertible preferred stock— — — 115,287,015 
Convertible preferred stock warrants— — — 735,760 
Private Placement Warrants6,700,000 — — — 
Public Warrants8,050,000 — — — 
Backstop Warrants3,875,028 — — — 
Common Stock Warrants— 923,857 — 688,349 
Outstanding Stock Options9,323,547 15,312,140 — 27,882,520 
Outstanding Restricted Stock Units4,517,208 1,184,158 — 1,777,183 
Remaining Shares available for issuance under 2016 Equity Incentive Plan— — — 1,070,974 
Remaining Shares available for issuance under 2022 Equity Incentive Plan24,544,031 — — — 
Shares available for issuance under 2022 Employee Stock Purchase Plan3,274,070 — — — 
Total shares of common stock reserved60,283,884 17,420,155 — 147,441,801 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Equity Incentive Plan

In 2016, Legacy Grove adopted the 2016 Equity Incentive Plan (the “2016 Plan”). The Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by the Board of Directors. In April 2022, the Company’s Board of Directors authorized an increase in the number of shares available for issuance under the 2016 Plan by 3,500,000. In addition, all equity awards of Legacy Grove that were issued under the 2016 Plan were converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each of Legacy Grove’s equity awards were converted into an option to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760. As of the effective date of the 2022 Plan, no further stock awards have been or will be granted under the 2016 Plan.

In June 2022, the stockholders of the Company approved the Grove Collaborative Holdings, Inc. 2022 Stock Incentive Plan (the “2022 Plan”). The Plan provides for the granting of stock-based awards to eligible participants, specifically officers, other employees, non-employee directors, consultants, independent contractors under terms and provisions established by the Board of Directors.

The 2022 Plan authorizes the issuance of Class A common stock of up to 24,555,528. The number of shares available shall increase annually on the first day of each calendar year, beginning with calendar year ending December 31, 2023 and continuing until (and including) calendar year December 31 2032, with annual increases equal to lesser of (i) 5% of the number of shares of Class A and Class B common stock issued and outstanding on December 31 of the immediately preceding fiscal year, and (ii) an amount determined by the Board.
Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
Options Outstanding
Number of Options Weighted–Average Exercise PriceWeighted-Average Remaining Contractual Life (years)Aggregate Intrinsic Value
Balance – December 31, 202123,708,957 $3.05 7.99$125,429 
Recapitalization4,173,563 (0.46)
Balance – December 31, 202127,882,520 2.59 7.99125,429 
Exercised(205,337)1.60 
Cancelled/forfeited(3,041,496)3.44 
Balance – June 30, 202224,635,687 2.53 7.4254,818 
Options vested and exercisable – June 30, 202215,742,548 $1.81 6.87$44,349 
The weighted-average grant date fair value of options granted during the six months ended June 30, 2021 was $4.41 per share. No options were granted during the six months ended June 30, 2022. The total grant date fair value of options that vested during the six months ended June 30, 2022 and 2021 was $7.8 million and $6.0 million, respectively. The aggregate intrinsic value of options exercised during the six months ended June 30, 2022 and 2021 was $1.1 million and $2.3 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options.
Early Exercise of Employee Options
The Company allows certain employees to exercise options granted under the Plan prior to vesting in exchange for shares of restricted common stock. The unvested shares, upon termination of employment, are subject to repurchase by the Company at the original purchase price. The proceeds are recorded in other current liabilities in the consolidated balance sheets at the time of the early exercise of stock options and reclassified to common stock and additional paid-in capital as the Company’s repurchase right lapses (i.e., as the underlying stock options vest). No and 11,025 shares of common stock were issued due to early exercise of unvested stock options during the six months
ended June 30, 2022 and 2021. As of June 30, 2022 and December 31, 2021, the aggregate price of the restricted common stock subject to repurchase was zero and $0.2 million, respectively. A summary of the restricted common stock is as follows:
Number of Options Weighted–Average Exercise Price
Outstanding and unvested as of December 31, 202169,513 $2.25 
Recapitalization12,237 (0.33)
Outstanding and unvested as of December 31, 202181,750 1.92 
Vested(65,211)1.92 
Repurchase of early exercise(16,539)1.92 
Outstanding and unvested as of June 30, 2022— $— 

Determination of Fair Value
The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
Three Months Ended June 30, 2021Six Months Ended June 30, 2021
Fair value of common stock
$5.86 – $6.45
$5.06 – $6.45
Expected term (in years)
5.03 – 6.28
5.00 – 6.28
Volatility
62.33% – 63.66%
62.33% – 75.19%
Risk-free interest rate
0.81% – 1.16%
0.50% – 1.16%
Dividend yield
Market-Based Stock Options

In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of awards vest upon valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for the six months ended June 30, 2022 which was principally related to service periods completed prior to the Business Combination. As of June 30, 2022, the market-based vesting criteria had not been met.
Performance-Based Restricted Stock Units
Performance-based restricted stock units activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
Number of shares Weighted–Average Grant Date Fair Value Per Share
Unvested – December 31, 20211,511,191 $8.62 
Recapitalization265,992 (1.29)
Unvested – December 31, 20211,777,183 7.33 
Granted4,748,063 6.98 
Vested(593,971)6.93 
Cancelled/forfeited(823,880)6.71 
Balance – June 30, 20225,107,395 6.71 
Vested but unissued – June 30, 2022593,971 $6.93 

RSUs granted under the 2016 Plan contain vesting conditions based on continuous service and the occurrence of a specified liquidity event, which is considered a performance condition. The performance condition is satisfied upon the consummation of (i) an initial underwritten public offering of the Company’s common stock; (ii) a change in control event, or (iii) a merger, consolidation or similar transaction in which the Company’s common stock outstanding immediately preceding such transaction are converted or exchanged into securities that are publicly-traded on an established exchange (the “Liquidity Event”), provided that the Liquidity Event occurs prior to the fifth anniversary of the grant date and the recipient continues to provide service to the Company on such date. The Company satisfied the performance condition on June 16, 2022 with the Closing of the Business Combination. Accordingly, the Company started recognizing stock compensation expense in the three months ended June 30, 2022 using the accelerated attribution method from the grant date. The total cumulative catch up expense related to prior periods recognized for the RSUs was $11.9 million. The vested but unissued RSUs will be issued to the common stockholders in November 2022 upon the termination of the Lock-Up Period, as defined in Section 7.10 of the Company’s Bylaws. There are no other contingencies for the issuance of these RSUs other than passage of time.
Equity Award Modifications

During the six months ended June 30, 2022, the Company modified options held by former and existing employees to extend the post termination exercise period of the awards from 60 days to 1, 2 or 10 years after termination, as well as accelerated the vesting of RSUs. The modifications resulted in modification expenses of $0.6 million and $1.7 million during the three and six months ended June 30, 2022, respectively.

Stock-Based Compensation Expense
For the three months ended June 30, 2022 and 2021, the Company recognized a total of $20.1 million and $3.8 million of stock-based compensation expense, respectively. For the six months ended June 30, 2022 and 2021, the Company recognized a total of $24.5 million and $7.3 million of stock-based compensation expense, respectively. Stock-based compensation expense was predominately recorded in selling, general and administrative expenses in the statements of operations for each period presented. As of June 30, 2022, the total unrecognized compensation expense related to unvested options and RSUs was $47.4 million, which the Company expects to recognize over an estimated weighted average period of 2.6 years.
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss Per Share Attributable to Common Stockholders
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Net Loss Per Share Attributable to Common Stockholders Net Loss Per Share Attributable to Common Stockholders
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Convertible preferred stock— 115,287,015 — 115,287,015 
Contingently redeemable convertible common stock— — — — 
Common stock options24,635,687 27,646,468 24,635,687 27,646,468 
Restricted stock units5,107,395 — 5,107,395 — 
Convertible preferred stock warrants— 735,760 — 735,760 
Common stock warrants923,857 974,350 923,857 974,350 
Private and Public Placement Warrants14,750,000 — 14,750,000 — 
Earn-Out Shares13,999,960 — 13,999,960 — 
Shares subject to repurchase— 320,589 — 320,589 
Total Net loss per share attributable to common stockholders, basic and diluted59,416,899 144,964,182 59,416,899 144,964,182 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events
6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events Subsequent EventsOn July 18, 2022, Grove entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with an affiliate of Yorkville Advisors Global, LP (“Yorkville”), enabling the Company to sell up to $100 million of shares of Class A common stock to Yorkville at the Company’s request during the 36 months following the execution of the Purchase Agreement, subject to certain conditions. As of August 11, 2022, the conditions precedent allowing the Company to sell shares under the Purchase Agreement have not yet been met.
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation and Liquidity
Basis of Presentation and Liquidity

The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should
be read in conjunction with Legacy Grove’s financial statements and accompanying notes as of and for the year ended December 31, 2021 (the “audited financial statements”) that were included in the Company’s Proxy Statement/Prospectus filed with the SEC on May 17, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2022 and the results of operations for the three and six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other future interim or annual period.
Comprehensive Loss Comprehensive LossComprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented.
Use of Estimates
Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement warrants, the fair value of Earn-Out liabilities, and Additional Shares related to the Backstop Subscription Agreement and stock-based compensation expense. Actual
results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.
The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.
Concentration of Risks Concentration of Risks Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts.
Revenue Recognition
Revenue Recognition
The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. 
The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.
In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.
A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the
order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier.
The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled).
At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period.
The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized.
Customer Referral Credits Customer Referral CreditsThe Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase.
Fulfillment Costs Fulfillment Costs Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs.
Warrant Liabilities
Warrant Liabilities

The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.
Fair Value Measurement
The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are:
Level 1 – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;
Level 2 – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and
Level 3 – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.
Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.
The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exception discussed in Note 9, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments.
Contingencies ContingenciesThe Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Disaggregation of Revenue
The following table sets forth revenue by product type (in thousands):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Revenue, net:
Grove Brands $38,216 $47,469 $85,064 $99,754 
Third-party products41,063 51,554 84,694 101,489 
Total revenue, net$79,279 $99,023 $169,758 $201,243 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Fair Value of Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of June 30, 2022 and December 31, 2021 by level within the fair value hierarchy (in thousands):
June 30, 2022
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$129,171 $— $— $129,171 
Total$129,171 $— $— $129,171 
Financial Liabilities:
Additional Shares$— $— $17,355 17,355 
Earn-Out Shares— — 53,136 53,136 
Public Warrants3,381 — — 3,381 
Private Placement Warrants— 2,814 — 2,814 
Total$3,381 $2,814 $70,491 $76,686 
December 31, 2021
Level 1Level 2Level 3Total
Financial Assets:
Cash equivalents:
Money market funds$77,771 $— $— $77,771 
Total$77,771 $— $— $77,771 
Financial Liabilities:
Convertible preferred stock warrant liability$— $— $4,787 $4,787 
Total$— $— $4,787 $4,787 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):

Balance at December 31, 2021$— 
Assumption of Additional Shares liability15,340 
Change in fair value2,015 
Balance at June 30, 2022$17,355 
The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):

Balance at December 31, 2021$— 
Assumption of Earn-Out liability70,481 
Change in fair value(17,345)
Balance at June 30, 2022$53,136 
The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands):
Balance at December 31, 2021$4,787 
Change in fair value(1,616)
Net exercise of preferred stock warrants(989)
Balance before reclassification at June 30, 20222,182 
Reclassification to additional paid-in capital(2,182)
Balance at June 30, 2022$— 
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation
Private Placement WarrantsPublic Warrants
Balance at December 31, 2021$— $— 
Assumption of Private Placement and Public Warrants3,350 4,025 
Changes in fair value(536)(644)
Balance at June 30, 2022$2,814 $3,381 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.22.2
Accrued Expenses (Tables)
6 Months Ended
Jun. 30, 2022
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities
Accrued expenses consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Inventory purchases$3,468 $4,659 
Compensation and benefits1,744 2,072 
Advertising costs3,527 2,363 
Fulfillment costs1,147 1,120 
Sales taxes1,537 1,812 
Transaction costs21,399 1,846 
Other accrued expenses8,008 6,779 
Total accrued expenses$40,830 $20,651 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)
6 Months Ended
Jun. 30, 2022
Debt Disclosure [Abstract]  
Schedule of Debt
The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):
June 30,
2022
December 31,
2021
Silicon Valley Bank Loan Revolver$5,947 $5,947 
Silicon Valley Bank and Hercules Mezzanine Term Loan59,263 59,237 
Atel Loan Facility Draw 31,009 1,489 
Atel Loan Facility Draw 4183 260 
Total debt66,402 66,933 
Less: debt, current(22,708)(10,750)
Total debt, noncurrent$43,694 $56,183 
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.2
Convertible Preferred Stock (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Temporary Equity
The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data):
Original
Issue Price
Shares
Authorized
Shares
Outstanding
Net Carrying
Value
Liquidation
Preference 
Series Seed$0.5245 9,693,116 9,693,115 $3,943 $5,084 
Series A0.5245 14,130,360 14,069,657 5,240 7,379 
Series B1.2450 12,689,363 12,563,418 15,545 15,642 
Series C2.4144 15,635,550 15,324,913 36,917 37,000 
Series C-13.1669 8,554,106 8,554,106 27,003 27,090 
Series D7.0135 20,196,682 19,961,423 136,618 140,000 
Series D-19.0731 5,314,209 5,314,209 48,146 48,216 
Series D-26.1850 14,551,371 14,551,370 89,638 90,000 
Series E8.4672 14,762,823 14,762,823 124,868 125,000 
Total115,527,580 114,795,034 $487,918 $495,411 
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock and Warrants (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Stockholders' Equity Note, Warrants or Rights
As of June 30, 2022, the following Warrants were outstanding:

Warrant TypeSharesExercise Price
Public Warrants8,050,000 $11.50 
Private Placement Warrants6,700,000 $11.50 
Schedule of Reserved for Issuance
The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis:
June 30, 2022December 31, 2021
Class A Common StockClass B Common StockClass A Common StockClass B Common Stock
Convertible preferred stock— — — 115,287,015 
Convertible preferred stock warrants— — — 735,760 
Private Placement Warrants6,700,000 — — — 
Public Warrants8,050,000 — — — 
Backstop Warrants3,875,028 — — — 
Common Stock Warrants— 923,857 — 688,349 
Outstanding Stock Options9,323,547 15,312,140 — 27,882,520 
Outstanding Restricted Stock Units4,517,208 1,184,158 — 1,777,183 
Remaining Shares available for issuance under 2016 Equity Incentive Plan— — — 1,070,974 
Remaining Shares available for issuance under 2022 Equity Incentive Plan24,544,031 — — — 
Shares available for issuance under 2022 Employee Stock Purchase Plan3,274,070 — — — 
Total shares of common stock reserved60,283,884 17,420,155 — 147,441,801 
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Share-Based Payment Arrangement, Option, Activity
Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
Options Outstanding
Number of Options Weighted–Average Exercise PriceWeighted-Average Remaining Contractual Life (years)Aggregate Intrinsic Value
Balance – December 31, 202123,708,957 $3.05 7.99$125,429 
Recapitalization4,173,563 (0.46)
Balance – December 31, 202127,882,520 2.59 7.99125,429 
Exercised(205,337)1.60 
Cancelled/forfeited(3,041,496)3.44 
Balance – June 30, 202224,635,687 2.53 7.4254,818 
Options vested and exercisable – June 30, 202215,742,548 $1.81 6.87$44,349 
Schedule of Restricted Common Stock A summary of the restricted common stock is as follows:
Number of Options Weighted–Average Exercise Price
Outstanding and unvested as of December 31, 202169,513 $2.25 
Recapitalization12,237 (0.33)
Outstanding and unvested as of December 31, 202181,750 1.92 
Vested(65,211)1.92 
Repurchase of early exercise(16,539)1.92 
Outstanding and unvested as of June 30, 2022— $— 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:
Three Months Ended June 30, 2021Six Months Ended June 30, 2021
Fair value of common stock
$5.86 – $6.45
$5.06 – $6.45
Expected term (in years)
5.03 – 6.28
5.00 – 6.28
Volatility
62.33% – 63.66%
62.33% – 75.19%
Risk-free interest rate
0.81% – 1.16%
0.50% – 1.16%
Dividend yield
Schedule of Performance-based Restricted Stock Units Activity
Performance-based restricted stock units activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):
Number of shares Weighted–Average Grant Date Fair Value Per Share
Unvested – December 31, 20211,511,191 $8.62 
Recapitalization265,992 (1.29)
Unvested – December 31, 20211,777,183 7.33 
Granted4,748,063 6.98 
Vested(593,971)6.93 
Cancelled/forfeited(823,880)6.71 
Balance – June 30, 20225,107,395 6.71 
Vested but unissued – June 30, 2022593,971 $6.93 
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss Per Share Attributable to Common Stockholders (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
June 30,
Six Months Ended
June 30,
2022202120222021
Convertible preferred stock— 115,287,015 — 115,287,015 
Contingently redeemable convertible common stock— — — — 
Common stock options24,635,687 27,646,468 24,635,687 27,646,468 
Restricted stock units5,107,395 — 5,107,395 — 
Convertible preferred stock warrants— 735,760 — 735,760 
Common stock warrants923,857 974,350 923,857 974,350 
Private and Public Placement Warrants14,750,000 — 14,750,000 — 
Earn-Out Shares13,999,960 — 13,999,960 — 
Shares subject to repurchase— 320,589 — 320,589 
Total Net loss per share attributable to common stockholders, basic and diluted59,416,899 144,964,182 59,416,899 144,964,182 
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 16, 2022
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Class of Stock [Line Items]            
Accumulated deficit   $ (572,837)   $ (572,837)   $ (490,143)
Cash and cash equivalents   132,393   132,393   78,376
Reverse recapitalization, proceeds received, net of transaction costs $ 23,800     80,000    
Contract with customer, refund liability, current   100   100   100
Contractual liabilities   12,575   12,575   11,267
Contract with customer, referral credit, current   100   100   100
Fulfillment cost   44,700 $ 23,600 20,300 $ 48,800  
Deferred Revenue            
Class of Stock [Line Items]            
Contractual liabilities   12,600   12,600   11,300
Contract with customer, liability, revenue recognized       9,100    
Other Current Liabilities            
Class of Stock [Line Items]            
Contractual liabilities   300   300   $ 300
Contract with customer, liability, revenue recognized       200    
Shipping and Handling            
Class of Stock [Line Items]            
Fulfillment cost   27,100 13,800 12,800 28,900  
Fulfillment Labor            
Class of Stock [Line Items]            
Fulfillment cost   $ 11,100 $ 5,800 $ 4,500 $ 12,100  
Revenue Benchmark | Supplier Concentration Risk | Five Suppliers            
Class of Stock [Line Items]            
Concentration risk, percentage   50.00% 50.00% 50.00% 50.00%  
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Disaggregation of Revenue [Line Items]        
Total revenue, net $ 79,279 $ 99,023 $ 169,758 $ 201,243
Grove Brands        
Disaggregation of Revenue [Line Items]        
Total revenue, net 38,216 47,469 85,064 99,754
Third-party products        
Disaggregation of Revenue [Line Items]        
Total revenue, net $ 41,063 $ 51,554 $ 84,694 $ 101,489
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.22.2
Recapitalization - Narrative (Details)
6 Months Ended
Jun. 16, 2022
USD ($)
$ / shares
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Dec. 07, 2021
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
$ / shares
Schedule of Reverse Recapitalization [Line Items]            
Reverse recapitalization, percentage of voting interests acquired 100.00%          
Proceeds from issuance of common stock upon Closing of Business Combination | $ $ 97,100,000     $ 97,100,000 $ 0  
Reverse recapitalization, proceeds received, net of transaction costs | $ $ 23,800,000     $ 80,000,000    
Common stock, par value (in dollars per share) | $ / shares $ 0.0001          
Reverse recapitalization, contingent consideration, liability, earnout period 10 years          
Tranche One Shares | Corvina Holdings Limited            
Schedule of Reverse Recapitalization [Line Items]            
Sale of stock, number of shares issued in transaction (in shares)   2,338,352        
Sale of stock, consideration received on transaction | $   $ 27,500,000        
Class B Common Stock            
Schedule of Reverse Recapitalization [Line Items]            
Common stock, par value (in dollars per share) | $ / shares $ 0.0001     $ 0.0001   $ 0.0001
Reverse recapitalization, contingent consideration, liability (in shares) 13,999,960          
Class A Common Stock            
Schedule of Reverse Recapitalization [Line Items]            
Common stock, par value (in dollars per share) | $ / shares       0.0001   $ 0.0001
Stock issued during period, shares, conversion of convertible securities (in shares)   2,750,000        
Class A Common Stock | Corvina Holdings Limited            
Schedule of Reverse Recapitalization [Line Items]            
Class of warrants or rights warrants issued during period (in shares)   3,875,028        
Share price (in dollars per share) | $ / shares   $ 0.01        
Class A Common Stock | Tranche Two Shares | Corvina Holdings Limited            
Schedule of Reverse Recapitalization [Line Items]            
Sale of stock (in dollars per share) | $ / shares   $ 10.00   $ 10.00    
Sale of stock, number of shares issued in transaction (in shares)   1,671,524        
Sale of stock, consideration received on transaction | $   $ 16,715,240        
Reverse recapitalization, aggregate gross proceeds amount | $   $ 22,500,000        
Number of trading days after the closing of business combination       10 days    
Class A Common Stock | Private Placement            
Schedule of Reverse Recapitalization [Line Items]            
Sale of stock, number of shares available in transaction (in shares)     8,707,500      
Sale of stock (in dollars per share) | $ / shares     $ 10.00      
Sale of stock, consideration available on transaction | $     $ 87,075,000      
Sale of stock, number of shares issued in transaction (in shares)     8,607,500      
Sale of stock, consideration received on transaction | $     $ 86,075,000      
Class A Common Stock | Reverse Recapitalization Tranche One            
Schedule of Reverse Recapitalization [Line Items]            
Reverse recapitalization, contingent consideration, liability (in shares) 7,000,173          
Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares $ 12.50          
Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days 20 days          
Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period 30 days          
Class A Common Stock | Reverse Recapitalization Tranche Two            
Schedule of Reverse Recapitalization [Line Items]            
Reverse recapitalization, contingent consideration, liability (in shares) 6,999,787          
Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share) | $ / shares $ 15.00          
Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days 20 days          
Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period 30 days          
2022 Equity Incentive Plan | Class B Common Stock            
Schedule of Reverse Recapitalization [Line Items]            
Recapitalization exchange ratio 1.1760          
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: $ 129,171 $ 77,771
Financial Liabilities: 76,686 4,787
Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 17,355  
Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 53,136  
Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 3,381  
Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 2,814  
Convertible preferred stock warrant liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities:   4,787
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 129,171 77,771
Financial Liabilities: 3,381 0
Level 1 | Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 1 | Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 1 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 3,381  
Level 1 | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 1 | Convertible preferred stock warrant liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities:   0
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 0 0
Financial Liabilities: 2,814 0
Level 2 | Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 2 | Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 2 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 2 | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 2,814  
Level 2 | Convertible preferred stock warrant liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities:   0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 0 0
Financial Liabilities: 70,491 4,787
Level 3 | Additional Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 17,355  
Level 3 | Earn-Out Shares    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 53,136  
Level 3 | Public Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 3 | Private Placement Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities: 0  
Level 3 | Convertible preferred stock warrant liability    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Financial Liabilities:   4,787
Money market funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 129,171 77,771
Money market funds | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 129,171 77,771
Money market funds | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: 0 0
Money market funds | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash equivalents: $ 0 $ 0
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Additional Shares | Level 3        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases     $ 15,340  
Changes in fair value     2,015  
Earn-Out Shares | Level 3        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases     70,481  
Changes in fair value     (17,345)  
Convertible preferred stock warrant liability        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Changes in fair value $ 300 $ 400 (1,600) $ 1,300
Convertible preferred stock warrant liability | Level 3        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases     989  
Changes in fair value     $ (1,616)  
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Additional Shares | Level 3        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Balance at December 31, 2021     $ 0  
Assumption     (15,340)  
Changes in fair value     2,015  
Balance at June 30, 2022 $ 17,355   17,355  
Earn-Out Shares | Level 3        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Balance at December 31, 2021     0  
Assumption     (70,481)  
Changes in fair value     (17,345)  
Balance at June 30, 2022 53,136   53,136  
Convertible preferred stock warrant liability        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Changes in fair value 300 $ 400 (1,600) $ 1,300
Convertible preferred stock warrant liability | Level 3        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Balance at December 31, 2021     4,787  
Assumption     (989)  
Changes in fair value     (1,616)  
Balance at June 30, 2022 0   0  
Convertible preferred stock warrant liability | Level 3 | Previously Reported        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Balance at June 30, 2022 2,182   2,182  
Convertible preferred stock warrant liability | Level 3 | Revision of Prior Period, Adjustment        
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]        
Balance at June 30, 2022 $ 2,182   $ 2,182  
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.22.2
Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details)
$ in Thousands
6 Months Ended
Jun. 30, 2022
USD ($)
Private Placement Warrants | Level 2  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]  
Balance at December 31, 2021 $ 0
Assumption of Private Placement and Public Warrants 3,350
Changes in fair value (536)
Balance at June 30, 2022 2,814
Public Warrants | Level 1  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]  
Balance at December 31, 2021 0
Assumption of Private Placement and Public Warrants 4,025
Changes in fair value (644)
Balance at June 30, 2022 $ 3,381
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.22.2
Accrued Expenses - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Inventory purchases $ 3,468 $ 4,659
Compensation and benefits 1,744 2,072
Advertising costs 3,527 2,363
Fulfillment costs 1,147 1,120
Sales taxes 1,537 1,812
Transaction costs 21,399 1,846
Other accrued expenses 8,008 6,779
Accrued expenses $ 40,830 $ 20,651
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.22.2
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Total debt $ 66,402 $ 66,933
Debt, current (22,708) (10,750)
Total debt, noncurrent 43,694 56,183
Silicon Valley Bank Loan Revolver | Revolving Credit Facility    
Debt Instrument [Line Items]    
Long-term line of credit 5,947 5,947
Silicon Valley Bank and Hercules Mezzanine Term Loan | Mezzanine Loan And Equity Security    
Debt Instrument [Line Items]    
Other long-term debt 59,263 59,237
Atel | Tranche Three | Atel Loan Facility    
Debt Instrument [Line Items]    
Other long-term debt 1,000  
Atel | Tranche Four | Atel Loan Facility    
Debt Instrument [Line Items]    
Other long-term debt 200  
Atel | Atel Loan Facility Draw 3    
Debt Instrument [Line Items]    
Other long-term debt 1,009 1,489
Atel | Atel Loan Facility Draw 4    
Debt Instrument [Line Items]    
Other long-term debt $ 183 $ 260
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.22.2
Debt - Narrative (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Mar. 31, 2023
May 31, 2022
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2016
Debt Instrument [Line Items]                    
Loss on extinguishment of debt   $ 0 $ 1,027 $ 0 $ 1,027          
Atel Loan Facility Draw 4                    
Debt Instrument [Line Items]                    
Debt instrument, interest rate, effective percentage   19.23%   19.23%            
Atel Loan Facility Draw 3                    
Debt Instrument [Line Items]                    
Debt instrument, interest rate, effective percentage   19.23%   19.23%            
Silicon Valley Bank Loan Revolver | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Long-term line of credit   $ 5,947   $ 5,947       $ 5,947    
Silicon Valley Bank and Hercules Mezzanine Term Loan | Minimum                    
Debt Instrument [Line Items]                    
Percentage of aggregate term loan advance increase             6.75%      
Silicon Valley Bank and Hercules Mezzanine Term Loan | Maximum                    
Debt Instrument [Line Items]                    
Percentage of aggregate term loan advance increase             8.75%      
Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Growth Capital Advance | Prime Rate                    
Debt Instrument [Line Items]                    
Debt instrument, face amount                   $ 3,900
Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Line of credit facility, maximum borrowing capacity                   $ 25,000
Loan revolver borrower capacity as a percentage of inventory balance                   60.00%
Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Letter of Credit                    
Debt Instrument [Line Items]                    
Line of credit facility, maximum borrowing capacity                   $ 6,000
Amendment to the Loan And Security Agreement                    
Debt Instrument [Line Items]                    
Loss on extinguishment of debt     $ 1,000              
Amendment to the Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Loan revolver borrower capacity as a percentage of inventory balance 65.00%                  
Line of credit facility, unused capacity, commitment fee percentage 0.20%                  
Letters of credit outstanding, amount   3,100   3,100            
Credit card outstanding   1,500   1,500            
Long-term line of credit   $ 5,900   $ 5,900            
Debt instrument, interest rate, effective percentage   5.00%   5.00%            
Amendment to the Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Revolving Credit Facility | Forecast                    
Debt Instrument [Line Items]                    
Long-term debt, percentage bearing variable interest, percentage rate           3.25%        
Amendment to the Loan And Security Agreement | Silicon Valley Bank Loan Revolver | Letter of Credit                    
Debt Instrument [Line Items]                    
Line of credit facility, maximum borrowing capacity $ 10,000                  
Minimum liquidity to be maintained $ 45,000                  
Mezzanine Loan and Security Agreement | Silicon Valley Bank Loan Revolver                    
Debt Instrument [Line Items]                    
Percentage of aggregate term loan advance increase 51.00%                  
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan                    
Debt Instrument [Line Items]                    
Debt instrument, face amount $ 60,000                  
Long-term debt, percentage bearing variable interest, percentage rate 8.75%                  
Other long-term debt   $ 60,000   $ 60,000            
Debt instrument, basis spread on variable rate 5.50%                  
Debt instrument, frequency of periodic payment 30                  
Percentage of aggregate term loan advance increase 6.75%                  
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Minimum                    
Debt Instrument [Line Items]                    
Debt instrument, interest rate, effective percentage   14.26%   14.26%            
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Maximum                    
Debt Instrument [Line Items]                    
Debt instrument, interest rate, effective percentage   17.31%   17.31%            
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Tranche One                    
Debt Instrument [Line Items]                    
Other long-term debt $ 25,000                  
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Tranche Two                    
Debt Instrument [Line Items]                    
Other long-term debt                 $ 25,000  
Mezzanine Loan and Security Agreement | Silicon Valley Bank and Hercules Mezzanine Term Loan | Tranche Three                    
Debt Instrument [Line Items]                    
Long-term line of credit               $ 10,000    
Mezzanine Loan and Security Agreement | Hercules Capital Inc                    
Debt Instrument [Line Items]                    
Percentage of aggregate term loan advance increase 49.00%                  
Atel Loan Facility | Atel | Tranche Three                    
Debt Instrument [Line Items]                    
Other long-term debt   $ 1,000   $ 1,000            
Atel Loan Facility | Atel | Tranche Four                    
Debt Instrument [Line Items]                    
Other long-term debt   $ 200   $ 200            
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.22.2
Commitments and Contingencies (Details) - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
Long-Term Purchase Commitment [Line Items]    
Purchase obligation $ 27.0 $ 36.1
Standby Letters of Credit    
Long-Term Purchase Commitment [Line Items]    
Line of credit facility, maximum borrowing capacity $ 3.1 $ 3.1
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.22.2
Convertible Preferred Stock - Temporary Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
Jun. 30, 2022
Jun. 16, 2022
Dec. 31, 2021
Temporary Equity [Line Items]      
Temporary equity, shares authorized (in shares) 100,000,000 100,000,000 115,527,580
Temporary equity, shares outstanding (in shares) 0   114,795,034
Net Carrying Value $ 0   $ 487,918
Liquidation Preference      $ 495,411
Series Seed      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 0.5245
Temporary equity, shares authorized (in shares)     9,693,116
Temporary equity, shares outstanding (in shares)     9,693,115
Net Carrying Value     $ 3,943
Liquidation Preference      $ 5,084
Series A      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 0.5245
Temporary equity, shares authorized (in shares)     14,130,360
Temporary equity, shares outstanding (in shares)     14,069,657
Net Carrying Value     $ 5,240
Liquidation Preference      $ 7,379
Series B      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 1.2450
Temporary equity, shares authorized (in shares)     12,689,363
Temporary equity, shares outstanding (in shares)     12,563,418
Net Carrying Value     $ 15,545
Liquidation Preference      $ 15,642
Series C      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 2.4144
Temporary equity, shares authorized (in shares)     15,635,550
Temporary equity, shares outstanding (in shares)     15,324,913
Net Carrying Value     $ 36,917
Liquidation Preference      $ 37,000
Series C-1      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 3.1669
Temporary equity, shares authorized (in shares)     8,554,106
Temporary equity, shares outstanding (in shares)     8,554,106
Net Carrying Value     $ 27,003
Liquidation Preference      $ 27,090
Series D      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 7.0135
Temporary equity, shares authorized (in shares)     20,196,682
Temporary equity, shares outstanding (in shares)     19,961,423
Net Carrying Value     $ 136,618
Liquidation Preference      $ 140,000
Series D-1      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 9.0731
Temporary equity, shares authorized (in shares)     5,314,209
Temporary equity, shares outstanding (in shares)     5,314,209
Net Carrying Value     $ 48,146
Liquidation Preference      $ 48,216
Series D-2      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 6.1850
Temporary equity, shares authorized (in shares)     14,551,371
Temporary equity, shares outstanding (in shares)     14,551,370
Net Carrying Value     $ 89,638
Liquidation Preference      $ 90,000
Series E      
Temporary Equity [Line Items]      
Original issue price (in dollars per share)     $ 8.4672
Temporary equity, shares authorized (in shares)     14,762,823
Temporary equity, shares outstanding (in shares)     14,762,823
Net Carrying Value     $ 124,868
Liquidation Preference      $ 125,000
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.2
Convertible Preferred Stock - Narrative (Details)
Jun. 16, 2022
Class B Common Stock | 2022 Equity Incentive Plan  
Temporary Equity [Line Items]  
Recapitalization exchange ratio 1.1760
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock and Warrants - Narrative (Details)
$ / shares in Units, $ in Thousands
Jul. 16, 2022
$ / shares
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 16, 2022
vote
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Class of Warrant or Right [Line Items]        
Common stock, par value (in dollars per share) | $ / shares     $ 0.0001  
Common stock, shares authorized (in shares)     900,000,000  
Temporary equity, shares authorized (in shares)   100,000,000 100,000,000 115,527,580
Number of shares converted     1  
Preferred stock, shares outstanding (in shares)   0    
Preferred stock, shares issued (in shares)   0    
Derivative liabilities | $   $ 76,686   $ 0
Private Placement Warrants        
Class of Warrant or Right [Line Items]        
Class of warrant or right, outstanding (in shares)   6,700,000    
Exercise price (in dollars per share) | $ / shares   $ 11.50    
Number of days after the completion of an initial business combination   30 days    
Public Warrants        
Class of Warrant or Right [Line Items]        
Class of warrant or right, outstanding (in shares)   8,050,000    
Exercise price (in dollars per share) | $ / shares   $ 11.50    
Class B Common Stock        
Class of Warrant or Right [Line Items]        
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001 $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares)   200,000,000 200,000,000 194,046,918
Number of votes | vote     10  
Common Stock        
Class of Warrant or Right [Line Items]        
Common stock, shares authorized (in shares)     800,000,000  
Class A Common Stock        
Class of Warrant or Right [Line Items]        
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001
Common stock, shares authorized (in shares)   600,000,000 600,000,000 0
Number of votes | vote     1  
Number of shares converted     1  
Class A Common Stock | Public Warrants | Subsequent Event        
Class of Warrant or Right [Line Items]        
Number of warrant or right, entitles to purchase (in shares) 1      
Class of warrants redemption notice period 30 days      
Class of warrants or rights redemption price per unit (in dollars per share) | $ / shares $ 0.01      
Share redemption trigger price (in dollars per share) | $ / shares $ 18.00      
Class A Common Stock | Public Warrants | Subsequent Event | Minimum        
Class of Warrant or Right [Line Items]        
Class of warrant or right redemption threshold consecutive trading days 20 days      
Class A Common Stock | Public Warrants | Subsequent Event | Maximum        
Class of Warrant or Right [Line Items]        
Class of warrant or right redemption threshold consecutive trading days 30 days      
2022 Equity Incentive Plan | Class B Common Stock        
Class of Warrant or Right [Line Items]        
Recapitalization exchange ratio     1.1760  
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details)
Jun. 30, 2022
$ / shares
shares
Public Warrants  
Class of Warrant or Right [Line Items]  
Class of warrant or right, outstanding (in shares) | shares 8,050,000
Exercise price (in dollars per share) | $ / shares $ 11.50
Private Placement Warrants  
Class of Warrant or Right [Line Items]  
Class of warrant or right, outstanding (in shares) | shares 6,700,000
Exercise price (in dollars per share) | $ / shares $ 11.50
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.22.2
Common Stock and Warrants - Schedule of Reserved for Issuance (Details) - shares
Jun. 30, 2022
Dec. 31, 2021
Class A Common Stock    
Class of Warrant or Right [Line Items]    
Convertible preferred stock, shares reserved for future issuance (in shares) 0 0
Convertible preferred stock warrant, shares reserved for future issuance (in shares) 0 0
Private placement warrant, shares reserved for future issuance (in shares) 6,700,000 0
Public warrant, shares reserved for future issuance (in shares) 8,050,000 0
Backstop warrant, shares reserved for future issuance (in shares) 3,875,028 0
Common stock warrant, shares reserved for future issuance (in shares) 0 0
Outstanding stock option, shares reserved for future issuance (in shares) 9,323,547 0
Outstanding restricted stock unit, shares reserved for future issuance (in shares) 4,517,208 0
Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares) 3,274,070 0
Total shares of common stock reserved (in shares) 60,283,884 0
Class B Common Stock    
Class of Warrant or Right [Line Items]    
Convertible preferred stock, shares reserved for future issuance (in shares) 0 115,287,015
Convertible preferred stock warrant, shares reserved for future issuance (in shares) 0 735,760
Private placement warrant, shares reserved for future issuance (in shares) 0 0
Public warrant, shares reserved for future issuance (in shares) 0 0
Backstop warrant, shares reserved for future issuance (in shares) 0 0
Common stock warrant, shares reserved for future issuance (in shares) 923,857 688,349
Outstanding stock option, shares reserved for future issuance (in shares) 15,312,140 27,882,520
Outstanding restricted stock unit, shares reserved for future issuance (in shares) 1,184,158 1,777,183
Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares) 0 0
Total shares of common stock reserved (in shares) 17,420,155 147,441,801
2016 Equity Incentive Plan | Class A Common Stock    
Class of Warrant or Right [Line Items]    
Shares available for future issuance under equity incentive plan (in shares) 0 0
2016 Equity Incentive Plan | Class B Common Stock    
Class of Warrant or Right [Line Items]    
Shares available for future issuance under equity incentive plan (in shares) 0 1,070,974
2022 Equity Incentive Plan | Class A Common Stock    
Class of Warrant or Right [Line Items]    
Shares available for future issuance under equity incentive plan (in shares) 24,544,031 0
2022 Equity Incentive Plan | Class B Common Stock    
Class of Warrant or Right [Line Items]    
Shares available for future issuance under equity incentive plan (in shares) 0 0
XML 56 R45.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Narrative (Details)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 28, 2021
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2021
USD ($)
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
Jun. 16, 2022
Apr. 30, 2022
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Fair value of common stock (in dollars per share) | $ / shares       $ 0 $ 4.41      
Share-based compensation arrangement by share-based payment award, options, vested in period, fair value       $ 7.8 $ 6.0      
Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value   $ 1.1 $ 2.3 1.1 2.3      
Share-based compensation arrangement by share-based payment award, fair value of shares subject to repurchase obligation       0.0   $ 0.2    
Stock-based compensation expense   20.1 $ 3.8 24.5 $ 7.3      
Share-based payment arrangement, nonvested award, cost not yet recognized, amount   47.4   $ 47.4        
Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years)       2 years 7 months 6 days        
2022 Equity Incentive Plan | Class B Common Stock                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Recapitalization exchange ratio             1.1760  
Share-Based Payment Arrangement                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based compensation arrangement by Share-based payment award, shares issued in period (in shares) | shares       0 11,025      
Market-based Stock Options                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based compensation arrangement by share-based payment award, options, grants in period, gross | shares 1,017,170              
Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 3.77              
Vesting rights, percentage 100.00%              
Share-based compensation arrangement by share-based payment award, options, grant date, fair value $ 5.5              
Stock-based compensation expense $ 4.6              
Restricted stock units                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based payment arrangement, catch up expense   11.9            
Equity Award Modifications                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based payment arrangement, plan modification, incremental cost   $ 0.6   $ 1.7        
Equity Award Modifications | Sixty Days                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)       60 days        
Equity Award Modifications | One Year                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)       1 year        
Equity Award Modifications | Two Years                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)       2 years        
Equity Award Modifications | Ten Years                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)       10 years        
2016 Equity Incentive Plan                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-Based compensation arrangement by share-based payment award, number of shares authorized (in shares) | shares               3,500,000
2022 Equity Incentive Plan                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-Based compensation arrangement by share-based payment award, number of shares authorized (in shares) | shares   24,555,528   24,555,528        
Share-based compensation arrangement by share-based payment award, annual percent of shares increase   0.05   0.05        
XML 57 R46.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Number of Options    
Options outstanding, beginning of period (in shares) | shares 27,882,520  
Exercised (in shares) | shares (205,337)  
Forfeited and expired (in shares) | shares (3,041,496)  
Options outstanding, ending of period (in shares) | shares 24,635,687 27,882,520
Options vested and exercisable (in shares) | shares 15,742,548  
Weighted–Average Exercise Price    
Options outstanding, beginning of period (in dollars per share) | $ / shares $ 2.59  
Exercised (in dollars per share) | $ / shares 1.60  
Forfeited and expired (in dollars per share) | $ / shares 3.44  
Options outstanding, ending of period (in dollars per share) | $ / shares 2.53 $ 2.59
Options vested and exercisable (in dollars per share) | $ / shares $ 1.81  
Weighted-Average Remaining Contractual Life (years)    
Options, outstanding (in years) 7 years 5 months 1 day 7 years 11 months 26 days
Options vested and exercisable (in years) 6 years 10 months 13 days  
Aggregate Intrinsic Value    
Options, outstanding, aggregate intrinsic value | $ $ 54,818 $ 125,429
Options, vested and exercisable, aggregate intrinsic value | $ $ 44,349  
Previously Reported    
Number of Options    
Options outstanding, beginning of period (in shares) | shares 23,708,957  
Options outstanding, ending of period (in shares) | shares   23,708,957
Weighted–Average Exercise Price    
Options outstanding, beginning of period (in dollars per share) | $ / shares $ 3.05  
Options outstanding, ending of period (in dollars per share) | $ / shares   $ 3.05
Weighted-Average Remaining Contractual Life (years)    
Options, outstanding (in years)   7 years 11 months 26 days
Aggregate Intrinsic Value    
Options, outstanding, aggregate intrinsic value | $   $ 125,429
Revision of Prior Period, Adjustment    
Number of Options    
Options outstanding, beginning of period (in shares) | shares 4,173,563  
Options outstanding, ending of period (in shares) | shares   4,173,563
Weighted–Average Exercise Price    
Options outstanding, beginning of period (in dollars per share) | $ / shares $ (0.46)  
Options outstanding, ending of period (in dollars per share) | $ / shares   $ (0.46)
XML 58 R47.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Schedule of Restricted Common Stock (Details) - Restricted Common Stock
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 81,750
Vested (in shares) | shares (65,211)
Repurchase of early exercise (in shares) | shares (16,539)
Outstanding and unvested, ending of period (in shares) | shares 0
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ 1.92
Vested (in dollars per share) | $ / shares 1.92
Repurchase of early exercise (in dollars per share) | $ / shares 1.92
Outstanding and unvested, ending of period (in dollars per share) | $ / shares $ 0
Previously Reported  
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 69,513
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ 2.25
Revision of Prior Period, Adjustment  
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 12,237
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ (0.33)
XML 59 R48.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) - $ / shares
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Dividend yield 0.00% 0.00%
Minimum    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Fair value of common stock (in dollars per share) $ 5.86 $ 5.06
Expected term (in years) 5 years 10 days 5 years
Volatility 62.33% 62.33%
Risk-free interest rate 0.81% 0.50%
Maximum    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Fair value of common stock (in dollars per share) $ 6.45 $ 6.45
Expected term (in years) 6 years 3 months 10 days 6 years 3 months 10 days
Volatility 63.66% 75.19%
Risk-free interest rate 1.16% 1.16%
XML 60 R49.htm IDEA: XBRL DOCUMENT v3.22.2
Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) - Performance-based Restricted Stock Units
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 1,777,183
Granted (in shares) | shares 4,748,063
Vested (in shares) | shares 593,971
Cancelled/forfeited (in shares) | shares (823,880)
Outstanding and unvested, ending of period (in shares) | shares 5,107,395
Vested but unissued (in shares) | shares 593,971
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ 7.33
Granted (in dollars per share) | $ / shares 6.98
Vested (in dollars per share) | $ / shares 6.93
Cancelled/forfeited (in dollars per share) | $ / shares 6.71
Outstanding and unvested, ending of period (in dollars per share) | $ / shares 6.71
Vested but unissued (in dollars per share) | $ / shares $ 6.93
Previously Reported  
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 1,511,191
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ 8.62
Revision of Prior Period, Adjustment  
Number of Options  
Outstanding and unvested, beginning of period (in shares) | shares 265,992
Weighted–Average Exercise Price  
Outstanding and unvested, beginning of period (in dollars per share) | $ / shares $ (1.29)
XML 61 R50.htm IDEA: XBRL DOCUMENT v3.22.2
Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 59,416,899 144,964,182 59,416,899 144,964,182
Convertible preferred stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 0 115,287,015 0 115,287,015
Contingently redeemable convertible common stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 0 0 0 0
Common stock options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 24,635,687 27,646,468 24,635,687 27,646,468
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 5,107,395 0 5,107,395 0
Convertible preferred stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 0 735,760 0 735,760
Common stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 923,857 974,350 923,857 974,350
Shares subject to repurchase        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 0 320,589 0 320,589
Private and Public Placement Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 14,750,000 0 14,750,000 0
Earn-Out Shares        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total Net loss per share attributable to common stockholders, basic and diluted (in shares) 13,999,960 0 13,999,960 0
XML 62 R51.htm IDEA: XBRL DOCUMENT v3.22.2
Subsequent Events (Details) - Subsequent Event
$ in Millions
Jul. 18, 2022
USD ($)
Subsequent Event [Line Items]  
Purchase agreement, equity interests issuable, not yet issued $ 100
Purchase agreement, equity interests issuable, not yet issued, transaction period 36 months
XML 63 grov-20220630_htm.xml IDEA: XBRL DOCUMENT 0001841761 2022-01-01 2022-06-30 0001841761 dei:FormerAddressMember 2022-01-01 2022-06-30 0001841761 us-gaap:CommonClassAMember 2022-01-01 2022-06-30 0001841761 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001841761 us-gaap:CommonClassAMember 2022-08-04 0001841761 us-gaap:CommonClassBMember 2022-08-04 0001841761 2022-06-30 0001841761 2021-12-31 0001841761 us-gaap:CommonClassAMember 2022-06-30 0001841761 us-gaap:CommonClassAMember 2021-12-31 0001841761 us-gaap:CommonClassBMember 2021-12-31 0001841761 us-gaap:CommonClassBMember 2022-06-30 0001841761 2022-04-01 2022-06-30 0001841761 2021-04-01 2021-06-30 0001841761 2021-01-01 2021-06-30 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:ConvertiblePreferredStockMember 2022-03-31 0001841761 srt:ScenarioPreviouslyReportedMember grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-03-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2022-03-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2022-03-31 0001841761 srt:ScenarioPreviouslyReportedMember 2022-03-31 0001841761 srt:RestatementAdjustmentMember us-gaap:ConvertiblePreferredStockMember 2022-03-31 0001841761 srt:RestatementAdjustmentMember grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-03-31 0001841761 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2022-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-03-31 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-03-31 0001841761 us-gaap:CommonStockMember 2022-03-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001841761 us-gaap:RetainedEarningsMember 2022-03-31 0001841761 2022-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-04-01 2022-06-30 0001841761 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-04-01 2022-06-30 0001841761 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-06-30 0001841761 us-gaap:CommonStockMember 2022-06-30 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001841761 us-gaap:RetainedEarningsMember 2022-06-30 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassBMember 2022-06-16 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:ConvertiblePreferredStockMember 2021-03-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2021-03-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-03-31 0001841761 srt:ScenarioPreviouslyReportedMember 2021-03-31 0001841761 srt:RestatementAdjustmentMember us-gaap:ConvertiblePreferredStockMember 2021-03-31 0001841761 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2021-03-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2021-03-31 0001841761 us-gaap:CommonStockMember 2021-03-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001841761 us-gaap:RetainedEarningsMember 2021-03-31 0001841761 2021-03-31 0001841761 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001841761 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001841761 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001841761 us-gaap:ConvertiblePreferredStockMember 2021-06-30 0001841761 us-gaap:CommonStockMember 2021-06-30 0001841761 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001841761 us-gaap:RetainedEarningsMember 2021-06-30 0001841761 2021-06-30 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:ConvertiblePreferredStockMember 2021-12-31 0001841761 srt:ScenarioPreviouslyReportedMember grov:ContingentlyRedeemableConvertibleCommonStockMember 2021-12-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2021-12-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2021-12-31 0001841761 srt:ScenarioPreviouslyReportedMember 2021-12-31 0001841761 srt:RestatementAdjustmentMember us-gaap:ConvertiblePreferredStockMember 2021-12-31 0001841761 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2021-12-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2021-12-31 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2021-12-31 0001841761 us-gaap:CommonStockMember 2021-12-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001841761 us-gaap:RetainedEarningsMember 2021-12-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-06-30 0001841761 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001841761 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-01-01 2022-06-30 0001841761 us-gaap:RetainedEarningsMember 2022-01-01 2022-06-30 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:ConvertiblePreferredStockMember 2020-12-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:CommonStockMember 2020-12-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001841761 srt:ScenarioPreviouslyReportedMember us-gaap:RetainedEarningsMember 2020-12-31 0001841761 srt:ScenarioPreviouslyReportedMember 2020-12-31 0001841761 srt:RestatementAdjustmentMember us-gaap:ConvertiblePreferredStockMember 2020-12-31 0001841761 srt:RestatementAdjustmentMember us-gaap:CommonStockMember 2020-12-31 0001841761 us-gaap:ConvertiblePreferredStockMember 2020-12-31 0001841761 us-gaap:CommonStockMember 2020-12-31 0001841761 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001841761 us-gaap:RetainedEarningsMember 2020-12-31 0001841761 2020-12-31 0001841761 us-gaap:CommonStockMember 2021-01-01 2021-06-30 0001841761 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-06-30 0001841761 us-gaap:RetainedEarningsMember 2021-01-01 2021-06-30 0001841761 grov:FiveSuppliersMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2021-04-01 2021-06-30 0001841761 grov:FiveSuppliersMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2022-04-01 2022-06-30 0001841761 grov:FiveSuppliersMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-06-30 0001841761 grov:FiveSuppliersMember us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember 2021-01-01 2021-06-30 0001841761 grov:GroveBrandsMember 2022-04-01 2022-06-30 0001841761 grov:GroveBrandsMember 2021-04-01 2021-06-30 0001841761 grov:GroveBrandsMember 2022-01-01 2022-06-30 0001841761 grov:GroveBrandsMember 2021-01-01 2021-06-30 0001841761 grov:ThirdPartyProductsMember 2022-04-01 2022-06-30 0001841761 grov:ThirdPartyProductsMember 2021-04-01 2021-06-30 0001841761 grov:ThirdPartyProductsMember 2022-01-01 2022-06-30 0001841761 grov:ThirdPartyProductsMember 2021-01-01 2021-06-30 0001841761 grov:DeferredRevenueMember 2022-06-30 0001841761 us-gaap:OtherCurrentLiabilitiesMember 2022-06-30 0001841761 grov:DeferredRevenueMember 2021-12-31 0001841761 us-gaap:OtherCurrentLiabilitiesMember 2021-12-31 0001841761 grov:DeferredRevenueMember 2022-01-01 2022-06-30 0001841761 us-gaap:OtherCurrentLiabilitiesMember 2022-01-01 2022-06-30 0001841761 us-gaap:ShippingAndHandlingMember 2022-01-01 2022-06-30 0001841761 us-gaap:ShippingAndHandlingMember 2021-04-01 2021-06-30 0001841761 grov:FulfillmentLaborMember 2022-01-01 2022-06-30 0001841761 grov:FulfillmentLaborMember 2021-04-01 2021-06-30 0001841761 us-gaap:ShippingAndHandlingMember 2022-04-01 2022-06-30 0001841761 us-gaap:ShippingAndHandlingMember 2021-01-01 2021-06-30 0001841761 grov:FulfillmentLaborMember 2022-04-01 2022-06-30 0001841761 grov:FulfillmentLaborMember 2021-01-01 2021-06-30 0001841761 2022-06-16 0001841761 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassBMember 2022-06-16 0001841761 us-gaap:CommonClassBMember 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheOneMember 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheOneMember 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheTwoMember 2022-06-16 2022-06-16 0001841761 us-gaap:CommonClassAMember grov:ReverseRecapitalizationTrancheTwoMember 2022-06-16 0001841761 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-12-07 2021-12-07 0001841761 us-gaap:CommonClassAMember us-gaap:PrivatePlacementMember 2021-12-07 0001841761 grov:CorvinaHoldingsLimitedMember grov:TrancheOneSharesMember 2022-03-31 2022-03-31 0001841761 us-gaap:CommonClassAMember 2022-03-31 2022-03-31 0001841761 grov:CorvinaHoldingsLimitedMember us-gaap:CommonClassAMember grov:TrancheTwoSharesMember 2022-03-31 0001841761 grov:CorvinaHoldingsLimitedMember us-gaap:CommonClassAMember grov:TrancheTwoSharesMember 2022-03-31 2022-03-31 0001841761 grov:CorvinaHoldingsLimitedMember us-gaap:CommonClassAMember grov:TrancheTwoSharesMember 2022-06-30 0001841761 grov:CorvinaHoldingsLimitedMember us-gaap:CommonClassAMember grov:TrancheTwoSharesMember 2022-01-01 2022-06-30 0001841761 grov:CorvinaHoldingsLimitedMember us-gaap:CommonClassAMember 2022-03-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:AdditionalShareMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:EarnOutShareMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueMeasurementsRecurringMember 2022-06-30 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001841761 grov:AdditionalShareMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001841761 grov:EarnOutShareMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member 2022-01-01 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2022-01-01 2022-06-30 0001841761 grov:PrivatePlacementWarrantMember us-gaap:FairValueInputsLevel2Member 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:FairValueInputsLevel1Member 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-06-30 0001841761 srt:ScenarioPreviouslyReportedMember grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001841761 srt:RestatementAdjustmentMember grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember us-gaap:FairValueInputsLevel3Member 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember 2022-04-01 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember 2021-04-01 2021-06-30 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember 2022-01-01 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantLiabilityMember 2021-01-01 2021-06-30 0001841761 us-gaap:RevolvingCreditFacilityMember grov:SiliconValleyBankMember 2022-06-30 0001841761 us-gaap:RevolvingCreditFacilityMember grov:SiliconValleyBankMember 2021-12-31 0001841761 grov:MezzanineLoanAndEquitySecurityMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2022-06-30 0001841761 grov:MezzanineLoanAndEquitySecurityMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2021-12-31 0001841761 grov:AtelLoanFacilityTrancheThreeMember grov:AtelMember 2022-06-30 0001841761 grov:AtelLoanFacilityTrancheThreeMember grov:AtelMember 2021-12-31 0001841761 grov:AtelLoanFacilityTrancheFourMember grov:AtelMember 2022-06-30 0001841761 grov:AtelLoanFacilityTrancheFourMember grov:AtelMember 2021-12-31 0001841761 us-gaap:RevolvingCreditFacilityMember grov:LoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2016-12-31 0001841761 grov:GrowthCapitalAdvanceMember us-gaap:PrimeRateMember grov:LoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2016-12-31 0001841761 us-gaap:LetterOfCreditMember grov:LoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2016-12-31 0001841761 us-gaap:RevolvingCreditFacilityMember grov:AmendmentToTheLoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2021-04-01 2021-04-30 0001841761 us-gaap:LetterOfCreditMember grov:AmendmentToTheLoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2021-04-30 0001841761 us-gaap:RevolvingCreditFacilityMember grov:AmendmentToTheLoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2021-04-30 0001841761 us-gaap:RevolvingCreditFacilityMember grov:AmendmentToTheLoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2022-06-30 0001841761 srt:ScenarioForecastMember us-gaap:RevolvingCreditFacilityMember grov:AmendmentToTheLoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2023-03-31 0001841761 grov:AmendmentToTheLoanAndSecurityAgreementMember 2021-04-01 2021-06-30 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2021-04-30 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember grov:TrancheOneMember 2021-04-30 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember grov:TrancheTwoMember 2021-09-30 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember grov:TrancheThreeMember 2021-12-31 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2021-04-01 2021-04-30 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankMember 2021-04-30 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:HerculesCapitalIncMember 2021-04-30 0001841761 srt:MinimumMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2022-05-31 0001841761 srt:MaximumMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2022-05-31 0001841761 grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2022-06-30 0001841761 srt:MinimumMember grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2022-06-30 0001841761 srt:MaximumMember grov:MezzanineLoanAndSecurityAgreementMember grov:SiliconValleyBankAndHerculesCapitalIncMember 2022-06-30 0001841761 grov:AtelLoanFacilityMember grov:AtelMember grov:TrancheThreeMember 2022-06-30 0001841761 grov:AtelLoanFacilityMember grov:AtelMember grov:TrancheFourMember 2022-06-30 0001841761 grov:AtelLoanFacilityTrancheFourMember 2022-06-30 0001841761 grov:AtelLoanFacilityTrancheThreeMember 2022-06-30 0001841761 us-gaap:StandbyLettersOfCreditMember 2022-06-30 0001841761 us-gaap:StandbyLettersOfCreditMember 2021-12-31 0001841761 grov:SeriesSeedPreferredStockMember 2021-12-31 0001841761 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001841761 us-gaap:SeriesBPreferredStockMember 2021-12-31 0001841761 us-gaap:SeriesCPreferredStockMember 2021-12-31 0001841761 grov:SeriesC1PreferredStockMember 2021-12-31 0001841761 us-gaap:SeriesDPreferredStockMember 2021-12-31 0001841761 grov:SeriesD1PreferredStockMember 2021-12-31 0001841761 grov:SeriesD2PreferredStockMember 2021-12-31 0001841761 us-gaap:SeriesEPreferredStockMember 2021-12-31 0001841761 us-gaap:CommonStockMember 2022-06-16 0001841761 us-gaap:CommonClassAMember 2022-06-16 0001841761 grov:PrivatePlacementWarrantMember 2022-06-30 0001841761 grov:PublicWarrantMember 2022-06-30 0001841761 grov:PublicWarrantMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-07-16 0001841761 srt:MinimumMember grov:PublicWarrantMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-07-16 0001841761 srt:MaximumMember grov:PublicWarrantMember us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2022-07-16 0001841761 grov:TwoThousandAndSixteenEquityIncentivePlanMember us-gaap:CommonClassAMember 2022-06-30 0001841761 grov:TwoThousandAndSixteenEquityIncentivePlanMember us-gaap:CommonClassBMember 2022-06-30 0001841761 grov:TwoThousandAndSixteenEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-12-31 0001841761 grov:TwoThousandAndSixteenEquityIncentivePlanMember us-gaap:CommonClassBMember 2021-12-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassAMember 2022-06-30 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassBMember 2022-06-30 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassAMember 2021-12-31 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember us-gaap:CommonClassBMember 2021-12-31 0001841761 grov:TwoThousandAndSixteenEquityIncentivePlanMember 2022-04-30 0001841761 grov:TwoThousandAndTwentyTwoEquityIncentivePlanMember 2022-06-30 0001841761 srt:ScenarioPreviouslyReportedMember 2021-01-01 2021-12-31 0001841761 srt:RestatementAdjustmentMember 2021-12-31 0001841761 2021-01-01 2021-12-31 0001841761 us-gaap:StockCompensationPlanMember 2022-01-01 2022-06-30 0001841761 us-gaap:StockCompensationPlanMember 2021-01-01 2021-06-30 0001841761 srt:ScenarioPreviouslyReportedMember grov:RestrictedCommonStockMember 2021-12-31 0001841761 srt:RestatementAdjustmentMember grov:RestrictedCommonStockMember 2021-12-31 0001841761 grov:RestrictedCommonStockMember 2021-12-31 0001841761 grov:RestrictedCommonStockMember 2022-01-01 2022-06-30 0001841761 grov:RestrictedCommonStockMember 2022-06-30 0001841761 srt:MinimumMember 2021-04-01 2021-06-30 0001841761 srt:MaximumMember 2021-04-01 2021-06-30 0001841761 srt:MinimumMember 2021-01-01 2021-06-30 0001841761 srt:MaximumMember 2021-01-01 2021-06-30 0001841761 grov:MarketBasedStockOptionsMember 2021-02-01 2021-02-28 0001841761 grov:MarketBasedStockOptionsMember 2021-02-28 0001841761 srt:ScenarioPreviouslyReportedMember grov:PerformanceBasedRestrictedStockUnitsMember 2021-12-31 0001841761 srt:RestatementAdjustmentMember grov:PerformanceBasedRestrictedStockUnitsMember 2021-12-31 0001841761 grov:PerformanceBasedRestrictedStockUnitsMember 2021-12-31 0001841761 grov:PerformanceBasedRestrictedStockUnitsMember 2022-01-01 2022-06-30 0001841761 grov:PerformanceBasedRestrictedStockUnitsMember 2022-06-30 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001841761 grov:EquityAwardModificationsMember grov:SixtyDaysMember 2022-01-01 2022-06-30 0001841761 grov:EquityAwardModificationsMember grov:OneYearMember 2022-01-01 2022-06-30 0001841761 grov:EquityAwardModificationsMember grov:TwoYearsMember 2022-01-01 2022-06-30 0001841761 grov:EquityAwardModificationsMember grov:TenYearsMember 2022-01-01 2022-06-30 0001841761 grov:EquityAwardModificationsMember 2022-04-01 2022-06-30 0001841761 grov:EquityAwardModificationsMember 2022-01-01 2022-06-30 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-04-01 2022-06-30 0001841761 us-gaap:ConvertiblePreferredStockMember 2021-04-01 2021-06-30 0001841761 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-06-30 0001841761 us-gaap:ConvertiblePreferredStockMember 2021-01-01 2021-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-04-01 2022-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2021-04-01 2021-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2022-01-01 2022-06-30 0001841761 grov:ContingentlyRedeemableConvertibleCommonStockMember 2021-01-01 2021-06-30 0001841761 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0001841761 us-gaap:EmployeeStockOptionMember 2021-04-01 2021-06-30 0001841761 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0001841761 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-06-30 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2022-04-01 2022-06-30 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2021-04-01 2021-06-30 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-06-30 0001841761 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-06-30 0001841761 grov:ConvertiblePreferredStockWarrantsMember 2022-04-01 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantsMember 2021-04-01 2021-06-30 0001841761 grov:ConvertiblePreferredStockWarrantsMember 2022-01-01 2022-06-30 0001841761 grov:ConvertiblePreferredStockWarrantsMember 2021-01-01 2021-06-30 0001841761 us-gaap:WarrantMember 2022-04-01 2022-06-30 0001841761 us-gaap:WarrantMember 2021-04-01 2021-06-30 0001841761 us-gaap:WarrantMember 2022-01-01 2022-06-30 0001841761 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001841761 grov:PrivateAndPublicPlacementWarrantsMember 2022-04-01 2022-06-30 0001841761 grov:PrivateAndPublicPlacementWarrantsMember 2021-04-01 2021-06-30 0001841761 grov:PrivateAndPublicPlacementWarrantsMember 2022-01-01 2022-06-30 0001841761 grov:PrivateAndPublicPlacementWarrantsMember 2021-01-01 2021-06-30 0001841761 grov:EarnOutShareMember 2022-04-01 2022-06-30 0001841761 grov:EarnOutShareMember 2021-04-01 2021-06-30 0001841761 grov:EarnOutShareMember 2022-01-01 2022-06-30 0001841761 grov:EarnOutShareMember 2021-01-01 2021-06-30 0001841761 grov:SharesSubjectToRepurchaseMember 2022-04-01 2022-06-30 0001841761 grov:SharesSubjectToRepurchaseMember 2021-04-01 2021-06-30 0001841761 grov:SharesSubjectToRepurchaseMember 2022-01-01 2022-06-30 0001841761 grov:SharesSubjectToRepurchaseMember 2021-01-01 2021-06-30 0001841761 us-gaap:SubsequentEventMember 2022-07-18 2022-07-18 shares iso4217:USD iso4217:USD shares pure grov:vote 0001841761 --06-30 2022 Q2 false P20D P30D 10-Q true 2022-06-30 false 001-40263 Grove Collaborative Holdings, Inc. DE 88-2840659 1301 Sansome Street San Francisco CA 94111 800 231-8527 Virgin Group Acquisition Corp. II 65 Bleecker Street, 6th Floor New York NY 10012 Class A common stock, par value $0.0001 GROV NYSE Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share GROV.WS NYSE Yes Yes Non-accelerated Filer true true false false 43101881 119767876 132393000 78376000 53494000 54453000 7491000 8104000 193378000 140933000 15831000 15932000 19581000 21214000 1249000 4394000 230039000 182473000 17714000 21346000 40830000 20651000 12575000 11267000 3788000 3550000 854000 1650000 22708000 10750000 98469000 69214000 43694000 56183000 18106000 20029000 76686000 0 1562000 5408000 238517000 150834000 0.0001 0.0001 100000000 115527580 0 0 114795034 114795034 0 487918000 0.0001 0.0001 600000000 0 38513779 38513779 0 0 0.0001 0.0001 200000000 194046918 124355978 124355978 9368167 9368167 16000 1000 564343000 33863000 -572837000 -490143000 -8478000 -456279000 230039000 182473000 79279000 99023000 169758000 201243000 40322000 49957000 88064000 99985000 38957000 49066000 81694000 101258000 17898000 22516000 50691000 58152000 5922000 5688000 12162000 10850000 57895000 46971000 108865000 94509000 -42758000 -26109000 -90024000 -62253000 2285000 1096000 4372000 2059000 0 -1027000 0 -1027000 2015000 0 2015000 0 -17345000 0 -17345000 0 -1180000 0 -1180000 0 -6775000 -268000 -4783000 -1044000 7450000 -2391000 7355000 -4130000 -35308000 -28500000 -82669000 -66383000 2000 16000 25000 28000 -35310000 -28516000 -82694000 -66411000 -1.06 -1.06 -3.97 -3.97 -3.86 -3.86 -9.13 -9.13 33384292 33384292 7182025 7182025 21419222 21419222 7277677 7277677 97611000 487918000 2350000 27473000 8040000 1000 38660000 -537527000 -498866000 17184000 400000 1415000 114795000 487918000 2750000 27473000 9455000 1000 38660000 -537527000 -498866000 168000 989000 156000 2182000 2182000 114963000 488907000 2750000 27473000 118205000 12000 516368000 516380000 17100000 20921000 2000 79979000 79981000 -93196000 -93196000 14000000 1000 1000 32000 96000 96000 118000 162000 162000 17000 20284000 20284000 -35310000 -35310000 0 0 0 0 162870000 16000 564343000 -572837000 -8478000 1.1760 97611000 487918000 7329000 1000 19402000 -392142000 -372739000 17184000 1290000 114795000 487918000 8619000 1000 19402000 -392142000 -372739000 4000 49000 49000 216000 227000 227000 221000 221000 1622000 1622000 3861000 3861000 -28516000 -28516000 114795000 487918000 8839000 1000 25382000 -420658000 -395275000 1.1760 97611000 487918000 0 0 7966000 1000 33863000 -490143000 -456279000 17184000 1402000 114795000 487918000 0 0 9368000 1000 33863000 -490143000 -456279000 168000 989000 156000 2182000 2182000 114963000 488907000 2750000 27473000 118205000 12000 516368000 516380000 17100000 20921000 2000 79979000 79981000 -93196000 -93196000 14000000 1000 1000 32000 96000 96000 2750000 27473000 205000 333000 333000 125000 125000 17000 24785000 24785000 -82694000 -82694000 0 0 0 0 162870000 16000 564343000 -572837000 -8478000 1.1760 97611000 487918000 7200000 1000 14605000 -354247000 -339641000 17184000 1268000 114795000 487918000 8468000 1000 14605000 -354247000 -339641000 4000 49000 49000 522000 517000 517000 1245000 1245000 155000 1622000 1622000 7344000 7344000 -66411000 -66411000 114795000 487918000 8839000 1000 25382000 -420658000 -395275000 1.1760 -82694000 -66411000 -1616000 1308000 24534000 7269000 2864000 2337000 -16510000 0 6673000 0 312000 313000 1693000 1719000 0 -1027000 139000 387000 734000 11320000 -613000 3059000 -3495000 -3426000 525000 7327000 1308000 1788000 52000 -45000 302000 -1103000 -66138000 -61799000 2610000 2845000 -2610000 -2845000 97100000 0 27500000 0 1267000 340000 0 25000000 562000 21165000 0 2499000 211000 375000 237000 525000 32000 297000 122765000 849000 54017000 -63795000 78376000 176523000 132393000 112728000 61000 52000 3052000 1299000 21435000 291000 122000 139000 0 1622000 989000 0 516365000 0 93196000 0 2182000 0 125000 1245000 Description of Business<div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grove Collaborative Holdings, Inc., a public benefit corporation, (formerly known as Virgin Group Acquisition Corp. II) and its wholly owned subsidiaries (collectively, the “Company” or “Grove”) is a digital-first, sustainability-oriented consumer products innovator specializing in the development and sale of household, personal care, beauty and other consumer products with an environmental focus and headquartered in San Francisco, California. In the United States, the Company sells its products through two channels: a direct-to-consumer (“DTC”) platform at www.grove.co and the Company’s mobile applications, where the Company sells products from Grove-owned brands (“Grove Brands”) and third-parties, and the retail channel into which the Company sell products from Grove-owned brands at wholesale. The Company develops and sells natural products that are free from the harmful chemicals identified in the Company’s “anti-ingredient” list and designs form factors and product packaging that reduces plastic waste and improves the environmental impact of the categories in which the Company operates. The Company also purchases environmental offsets that have made it the first plastic neutral retailer in the world, and we plan to become 100% plastic-free by 2025. Grove Collaborative, Inc. (herein referred to as “Legacy Grove”), the Company’s accounting predecessor, was incorporated in Delaware in 2016. </span></div><div style="padding-left:18pt;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 16, 2022 (the “Closing Date”), the Company consummated the previously-announced transactions contemplated by the Agreement and Plan of Merger, dated December 7, 2021, amended and restated on March 31, 2022 (the “Merger Agreement”), among Virgin Group Acquisition Corp. II, a blank check company incorporated as a Cayman Islands exempt company in 2020 (“VGAC II”), Treehouse Merger Sub, Inc. (“VGAC II Merger Sub I”), Treehouse Merger Sub II, LLC (“VGAC II Merger Sub II”), and Legacy Grove (“the Merger”). In connection with the Merger, VGAC II changed its jurisdiction of incorporation from the Cayman Islands to the State of Delaware and changed its name to Grove Collaborative Holdings, Inc (the “Domestication”), a public benefit corporation. On the Closing Date, VGAC Merger Sub II merged with and into Legacy Grove with Legacy Grove being the surviving corporation and a wholly-owned subsidiary of the Company (the “Initial Merger”), and, immediately following the Initial Merger, and as part of the same overall transaction as the Initial Merger, Legacy Grove merged with and into VGAC Merger Sub II, the separate corporate existence of Legacy Grove ceased, and Merger Sub II continued as the surviving company and a wholly-owned subsidiary of the Company and changed its name to Grove Collaborative, Inc.(together with the Merger and the Domestication, the “Business Combination”).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination is accounted for as a reverse recapitalization with Legacy Grove being the accounting acquirer and VGAC II as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Legacy Grove. The shares and net loss per common share prior to the Closing have been retroactively restated as shares reflecting the exchange ratio established in the Closing. </span></div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, VGAC II’s public shares, and public warrants were listed on the New York Stock Exchange (“NYSE”) under the symbols “VGII” and “VGII.WS,” respectively. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 17, 2022, the Company's Class A common stock and public warrants began trading on (“NYSE”), under the symbols “GROV” and “GROV.WS,” respectively. See Note 3, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recapitalization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span>for additional details. Summary of Significant Accounting Policies <div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should </span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be read in conjunction with Legacy Grove’s financial statements and accompanying notes as of and for the year ended December 31, 2021 (the “audited financial statements”) that were included in the Company’s Proxy Statement/Prospectus filed with the SEC on May 17, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2022 and the results of operations for the three and six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other future interim or annual period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the realization of assets and liabilities and commitments in the normal course of business. The Company has historically incurred losses and negative cash flows from operations and had an accumulated deficit of $572.8 million as of June 30, 2022. The Company’s existing sources of liquidity as of June 30, 2022 include cash and cash equivalents of $132.4 million. Prior to the Business Combination, the Company historically funded operations primarily with issuances of convertible preferred stock and contingently redeemable convertible common stock and the incurrence of debt. Upon the Closing of the Business Combination, the Company received $80.0 million in cash proceeds, net of transaction costs. The Company believes the Business Combination eliminated the substantial doubt about the Company’s ability to continue as a going concern from at least one year after the date of issuance of this quarterly report on Form 10-Q (the “Quarterly Report”). Over the longer-term, the Company will need to raise additional capital through debt or equity financing to fund future operations until it generates positive cash flows from profitable operations. There can be no assurance that such additional debt or equity financing will be available on terms acceptable to the Company, or at all.</span></div><div style="text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Emerging Growth Company</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. The JOBS Act permits companies with emerging growth company status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. Following the closing of the Business Combination, the Company uses this extended transition period to enable it to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date the Company (1) is no longer an emerging growth company or (2) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the Company’s condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.</span></div><div style="text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Except for the addition of the Business Combination and related derivative liabilities, there have been no significant changes in the Company's significant accounting policies from those that were disclosed in Note 2, Summary of Significant Accounting Policies, included in the Company’s audited financial statements and the notes thereto for the year ended December 31, 2021.</span></div><div><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement warrants, the fair value of Earn-Out liabilities, and Additional Shares related to the Backstop Subscription Agreement and stock-based compensation expense. Actual </span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company depends on a limited number of vendors to supply products sold by the Company. For the three and six months ended June 30, 2022 and 2021, the Company’s top five suppliers combined represented approximately 50% of the Company’s total inventory purchases. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled). </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when r</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evenue is recognized. The C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ompany records a refund reserve based on historical refund patterns. As of June 30, 2022 an</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d December 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the refund reserve, which is included in accrued liabilities in the condensed consolidated balance sheets, was $0.1 million.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenue by product type (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grove Brands </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,754 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,694 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,279 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,023 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,758 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,243 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contractual Liabilities</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has three types of contractual liabilities from transactions with customers: (i) cash collections for products which have not yet shipped, which are included in deferred revenue and are recognized as revenue upon the Company’s delivery to a third-party carrier, (ii) cash collections of VIP membership fees, which are included in deferred revenue and (iii) customer service credits, which are included in other current liabilities and are recognized as a reduction in revenue when provided to the customer. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual liabilities included in deferred revenue and other current liabilities were $12.6 million and $0.3 million, respectively, as of June 30, 2022 and $11.3 million and $0.3 million, respectively, as of December 31, 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The contractual liabilities included in deferred revenue are generally recognized as revenue within twelve months from the end of each reporting period. Revenue recognized during the six months ended June 30, 2022 that was previously included in deferred revenue and other current liabilities as of December 31, 2021 was $9.1 million and $0.2 million, respectively.</span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customer Referral Credits</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase. The liability for customer referral credits was $0.1 million as of June 30, 2022 and December 31, 2021 and is included within other current liabilities in the condensed consolidated balance sheets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fulfillment Costs </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. These costs are included within selling, general and administrative expenses in the condensed consolidated statements of operations. For the three months ended June 30, 2022 and 2021, the Company recorded fulfillment costs of $20.3 million and $23.6 million, respectively, which included $12.8 million and $13.8 million in shipping and handling expenses, respectively, and $4.5 million and $5.8 million in Fulfillment Labor, respectively. For the six months ended June 30, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded fulfillment costs of $44.7 million and $48.8 million, respectively, which included $27.1 million and $28.9 million in shipping and handling expenses, respectively, and $11.1 million and $12.1 million in Fulfillment Labor, respectively. The Company's gross profit may not be comparable to other retailers or distributors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrant Liabilities</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.</span></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Liquidity</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s unaudited condensed consolidated financial statements (the “condensed consolidated financial statements”) have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and include the accounts of the Company and its wholly owned subsidiary in which it holds controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements have been prepared in accordance with GAAP applicable to interim financial statements. These financial statements are presented in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) and do not include all disclosures normally required in annual consolidated financial statements prepared in accordance with GAAP. As such, the information included herein should </span></div>be read in conjunction with Legacy Grove’s financial statements and accompanying notes as of and for the year ended December 31, 2021 (the “audited financial statements”) that were included in the Company’s Proxy Statement/Prospectus filed with the SEC on May 17, 2021. In management’s opinion, these unaudited condensed consolidated financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments, which include normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2022 and the results of operations for the three and six months ended June 30, 2022 and 2021. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or any other future interim or annual period. -572800000 132400000 80000000 Comprehensive LossComprehensive loss represents all changes in stockholders’ deficit. The Company’s net loss was equal to its comprehensive loss for all periods presented. <div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported amounts of revenue and expenses during the reporting period. These estimates made by management include the determination of reserves amounts for the Company’s inventories on hand, useful life of intangible assets, sales returns and allowances and certain assumptions used in the valuation of equity awards, the estimated fair value of common stock liability classified Public and Private Placement warrants, the fair value of Earn-Out liabilities, and Additional Shares related to the Backstop Subscription Agreement and stock-based compensation expense. Actual </span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">results could differ from those estimates, and such estimates could be material to the Company’s financial position and the results of operations.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The novel coronavirus (“COVID-19”) pandemic has created significant global economic uncertainty and resulted in the slowdown of economic activity. As of the date of issuance of these condensed consolidated financial statements, the extent to which COVID-19 may impact the future financial condition or results of operations is still uncertain. The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known. Actual results could differ from those estimates and any such differences may be material to the condensed consolidated financial statements.</span></div> Concentration of Risks Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains the majority of its cash and cash equivalents in accounts with one financial institution within the United States, generally in the form of demand accounts. Deposits in this institution may exceed federally insured limits. Management believes minimal credit risk exists with respect to this financial institution and the Company has not experienced any losses on such amounts. 0.50 0.50 0.50 0.50 <div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company primarily generates revenue from the sale of both third-party and Grove Brands products through its DTC platform. Customers purchase products through the website or mobile application through a combination of directly selecting items from the catalog, items that are suggested by the Company’s recurring shipment recommendation engine, and features that appear in marketing on-site, in emails and on the Company’s mobile application. Most customers purchase a combination of products recommended by the Company based on previous purchases and new products discovered through marketing or catalog browsing. Customers can have orders auto-shipped to them on a specified date or shipped immediately through an option available on the website and mobile application. In order to reduce the environmental impact of each shipment, the Company has a minimum total sales order value threshold policy which is required to be met before the order qualifies for shipment. Payment is collected upon finalizing the order. The products are subsequently packaged and shipped to fill the order. Customers can customize future purchases by selecting products they want to receive on a specified cadence or by selecting products for immediate shipment. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also offers a VIP membership to its customers for an annual fee which includes the rights to free shipping, free gifts and early access to exclusive sales, all of which are available at the customers’ option, should they elect to make future purchases of the Company’s products within their annual VIP membership benefit period. Many customers receive a free 60-day VIP membership for trial purposes, typically upon their first qualifying order. After the expiration of this free trial VIP membership period, customers will be charged their annual VIP membership fee, which automatically renews annually, until cancelled. The customer is alerted before any VIP membership renews.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue when the customer obtains control of promised goods, in an amount that reflects the consideration that it expects to receive in exchange for those goods. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps: (i) identify the contract with a customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration, if any, (iv) allocate the transaction price to the performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies a performance obligation. The Company only applies the five-step model to contracts when it is probable that it will collect the consideration to which it is entitled in exchange for the goods it transfers to a customer.</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A contract with a customer exists when the customer submits an order online for the Company’s products. Under this arrangement, there is one performance obligation which is the obligation for the Company to fulfill the </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">order. Product revenue is recognized when control of the goods is transferred to the customer, which occurs upon the Company’s delivery to a third-party carrier. </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The VIP membership provides customers with a suite of benefits that are only accessible to them at their option, upon making a future qualifying order of the Company’s products. The VIP membership includes free shipping, a select number of free products and early access to exclusive sales. Under ASC 606, sales arrangements that include rights to additional goods or services that are exercisable at a customer’s discretion are generally considered options; therefore, the Company must assess whether these options provide a material right to the customer and if so, they are considered a performance obligation. The Company concluded that its VIP membership benefits include two material rights, one related to the future discount (i.e., free shipping) on the price of the customer’s qualifying order(s) over the membership period and the second one relating to a certain number of free products provided at pre-set intervals within the VIP membership benefit period, that will only ship with a customer’s next qualifying order (i.e., bundled). </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception of the VIP membership benefit period, the Company allocates the VIP membership fee to each of the two material rights using a relative standalone selling price basis. Generally, standalone selling prices are determined based on the observable price of the good or service when sold separately to non-VIP customers and the estimated number of shipments and free products per benefit period. The Company also considers the likelihood of redemption when determining the standalone selling price for free products and then recognize these allocated amounts upon the shipment of a qualifying customer order. To date, customers buying patterns closely approximate a ratable revenue attribution method over the customers VIP Membership period. </span></div>The Company deducts discounts, sales tax, customer service credits and estimated refunds to arrive at net revenue. Sales tax collected from customers is not considered revenue and is included in accrued liabilities until remitted to the taxing authorities. The Company has made the policy election to account for shipping and handling as activities to fulfill the promise to transfer the good. Shipping, handling and packaging expenses are recognized upon shipment and classified within selling, general and administrative expenses. Discounts are recorded as a reduction to revenue when revenue is recognized. 100000 100000 <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth revenue by product type (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.596%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.021%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.023%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue, net:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Grove Brands </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,469 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,064 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,754 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third-party products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,554 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,694 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,489 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,279 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,023 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,758 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,243 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 38216000 47469000 85064000 99754000 41063000 51554000 84694000 101489000 79279000 99023000 169758000 201243000 12600000 300000 11300000 300000 9100000 200000 Customer Referral CreditsThe Company has a customer referral program under which credits are issued for future purchases to customers when the referral results in the generation of a new customer order. The Company records a liability at the time of issuing the credit and reduce the liability upon application of the credit to a customer’s purchase. 100000 100000 Fulfillment Costs Fulfillment costs represent those costs incurred in operating and staffing the Company’s fulfillment centers, including costs attributable to receiving, inspecting and warehousing inventories, picking, packaging, and preparing customer orders for shipment (“Fulfillment Labor”), shipping and handling expenses, packaging materials costs and payment processing and related transaction costs. 20300000 23600000 12800000 13800000 4500000 5800000 44700000 48800000 27100000 28900000 11100000 12100000 <div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrant Liabilities</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 9, Common Stock and Warrants) as liabilities. At the end of each reporting period, changes in fair value during the period are recognized within the condensed consolidated statements of operations. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.</span></div> Recapitalization<div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As discussed in Note 1, Description of Business, on the Closing Date, VGAC II completed the acquisition of Legacy Grove and acquired 100% of Legacy Grove’s shares and Legacy Grove received gross proceeds of $97.1 million, which includes proceeds from issuance of common stock upon the consummation of the Business Combination, including the Backstop Tranche 2 shares, and proceeds from the PIPE investment (as defined below). The Company recorded $23.8 million of transaction costs, which consisted of legal, accounting, and other professional services directly related to the Business Combination. Transaction costs were </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">allocated on a relative fair value basis between the issuance of common stock, Public and Private Placement Warrants, Grove Earn-Out Shares, Downside Protection feature and Backstop Warrants (as defined below). Direct and incremental transaction costs allocated to equity-classified instruments have been recorded within equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> as an offset against proceeds upon accounting for the consummation of the Business Combination </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in the condensed consolidated financial statements. Direct and incremental transaction costs allocated to liability-classified equity instruments were expensed in the condensed consolidated financial statements and included in other expense, net </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">in the condensed consolidated statements of operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The cash outflows related to these costs were presented as financing activities on the Company’s condensed consolidated statement of cash flows. On the Closing Date, each holder of Legacy Grove common stock received approximately 1.1760 shares of the Company’s Class B common stock, par value $0.0001 per share. See Note 8, Convertible Preferred Stock and Note 9, Common Stock and Warrants for additional details of the Company's stockholders' deficit prior to and subsequent to the Business Combination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity awards of Legacy Grove were assumed by the Company and converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each outstanding stock option was converted into an option exercisable for the Company’s Class B common stock based on an exchange ratio of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximately 1.1760, each outstanding restricted stock unit was converted into restricted stock units of the Company that, upon vesting and issued, will be settled for shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760 and each outstanding warrant to purchase Legacy Grove common stock or preferred stock was converted into a warrant to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each public and private warrant of VGAC II that was unexercised at the time of the business combination was assumed by the Company and represents the right to purchase one share of the Company’s Class A common stock upon exercise of such warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization with Legacy Grove as the accounting acquirer and VGAC II as the acquired company for accounting purposes. Legacy Grove was determined to be the accounting acquirer since Legacy Grove’s shareholders prior to the business combination had the greatest voting interest in the combined entity, Legacy Grove's shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Legacy Grove comprises all of the ongoing operations, and Legacy Grove's senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these condensed consolidated financial statements represents the accounts of Legacy Grove. Net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Legacy Grove.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earn-Out</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the closing of the Business Combination, Class B common stock shareholders (including Grove stock option, restricted stock unit, and warrant holders) were issued 13,999,960 shares of New Grove Class B Common Stock (“Earn-Out Shares”), which will vest </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) with respect to 7,000,173 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $12.50 per share for any 20 trading days within any 30-trading-day period and (ii) with respect to 6,999,787 of the Earn-Out Shares, upon the closing price of the Company’s Class A common stock equaling or exceeding $15.00 per share for any 20 trading days within any 30-trading-day period. Such events can occur during a period of ten years following the Mergers (the “Earn-Out Period”).</span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If, during the Earn-Out Period, there is a Change of Control Transaction (as defined in the Merger Agreement), then all remaining triggering events that have not previously occurred and the related vesting conditions shall be deemed to have occurred.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If, upon the expiration of the Earn-Out Period, any Earn-Out Shares shall have not vested, then such Earn-Out Shares shall be automatically forfeited by the holders thereof and canceled by the Company. The settlement amount to be paid to the selling shareholders of the Earn-Out Shares can change and is not indexed to the Company’s stock. Due to the change in control event contingency and variable number of Earn-Out shares to be settled to the holders, the Earn-Out Shares fail the equity scope exception and are accounted for as a derivative in accordance with ASC 815 and it will be remeasured on a recurring basis at fair value, with changes in fair value recorded in the condensed consolidated statements of operations. As of June 30, 2022, the Company did not meet any Earn-Out thresholds. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PIPE Investmen</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">t</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On December 7, 2021, concurrently with the execution of the Merger </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, VGAC II entered into subscription agreements with certain investors (the “PIPE Investors”) to which such investors collectively subscribed for an aggregate of 8,707,500 shares of the Company’s Class A common stock at $10.00 per share for aggregate gross proceeds of $87,075,000 (the “PIPE Investment”). 8,607,500 shares of the Company’s Class A common stock have been issued for aggregate proceeds of $86,075,000, which consummated concurrently with the closing to the Business Combination. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Backstop Financing</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 31, 2022, VGAC II entered into the Subscription Agreement (the “Backstop Subscription Agreement”) with Corvina Holdings Limited (the “Backstop Investor”) and Legacy Grove. As part of the Subscription Agreement, the Backstop Investor subscribed for and purchased 2,338,352 shares of Legacy Grove Common Stock (the “Backstop Tranche 1 Shares”) for aggregate proceeds of $27,500,000. The Company initially classified the Backstop Tranche 1 Shares as mezzanine (or temporary) equity on its balance sheet because the Backstop Tranche 1 Shares were contingently redeemable upon the occurrence of certain events not solely within the control of the Company that allow for the effective redemption of such shares in cash at the option of the holder. Upon Closing of the Business Combination, the Backstop Tranche 1 Shares were converted into 2,750,000 shares of Class A Common Stock and the Tranche 1 Share were no longer contingently redeemable. The Company has classified these shares in permanent equity on its balance sheet at June 30, 2022. </span></div><div style="padding-left:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> In addition, the Backstop Investor agreed to subscribe for and purchase, on the closing date of the Business Combination, certain shares of New Grove class A common stock at a purchase price of $10.00 per share (“Backstop Tranche 2 Shares”) for aggregate gross proceeds in an amount equal to (x) $22.5 million minus (y) the amount of aggregate cash remaining in VGAC II’s trust account, after deducting any amounts paid to VGAC II shareholders who exercise their redemption rights in connection with the Business Combination. The Company issued to the Backstop Investor, as of immediately following the closing of the Mergers, 1,671,524 Backstop Tranche 2 Shares for aggregate proceeds of $16,715,240.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Backstop Subscription Agreement also provides that the Company will issue additional shares of Class A common stock to the Backstop Investor for Backstop Tranche 1 Shares and Backstop Tranche 2 Shares if the volume weighted average price of Class A common stock is less than $10.00 during the 10 trading days commencing on the first trading date after the Company’s first quarterly earnings call for the fiscal quarter ended June 30, 2022 (“Additional Shares”). </span></div><div style="padding-left:18pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As part of the Backstop Subscription Agreement, the Company issued to the Backstop Investor 3,875,028 warrants to purchase New Grove Class A Common Stock (each warrant exercisable to purchase one share of New Grove Class A Common Stock for $0.01) (such warrants, the “Backstop Warrants”). The Backstop Warrants are exercisable by the Backstop Investor at any time on or before June 16, 2027, and are on terms customary for warrants of such nature. The Backstop Warrants were recorded in equity on the Company’s balance sheet at June 30, 2022.</span></div> 1 97100000 23800000 1.1760 0.0001 1.1760 1.1760 1.1760 13999960 7000173 12.50 P20D P30D 6999787 15.00 P20D P30D P30D P10Y 8707500 10.00 87075000 8607500 86075000 2338352 27500000 2750000 10.00 22500000 1671524 16715240 10.00 P10D 3875028 0.01 0.01 Fair Value Measurements and Fair Value of Financial Instruments<div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exception discussed in Note 9, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2022 and December 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by level within the fair value hierarchy (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,491 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,686 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of financial assets or liabilities into or out of Level 1, Level 2, or Level 3 during the periods presented. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Additional Shares</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At closing of the Mergers, the Company recorded a liability of $15.3 million related to the potential issuance of the Additional Shares related to the Backstop Subscription Agreement. Subsequent changes in fair value of the Additional Shares liability until settlement is recognized in the statements of operations. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):</span></div><div style="padding-left:18pt;text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumption of Additional Shares liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earn-Out Shares</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Closing of the Mergers, certain Earn-Out Shares were accounted for as a liability totaling $70.5 million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent changes in fair value, until settlement or until equity classification is met, is recognized in the statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumption of Earn-Out liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,481 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,136 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement and Public Warrant Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company has Private Placement and Public Warrants defined and discussed in Note 9, Common Stock and Warrants. Such warrants are measured at fair value on a recurring basis.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Private Placement Warrants and Public Warrants (in thousands):</span></div><div style="padding-left:18pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Public Warrants</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumption of Private Placement and Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Preferred Stock Warrant Liability</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,616)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net exercise of preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance before reclassification at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:18pt;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded a loss on remeasurement of preferred stock warrant liability of $0.3 million and $0.4 million for the three months ended June 30, 2022 and 2021, respectively, and a gain of $1.6 million and a loss of $1.3 million on remeasurement of preferred stock warrant liability for the six months ended June 30, 2022 and 2021, respectively. With the closing of the Business Combination, unexercised preferred stock warrants are converted into warrants of the Company to purchase shares of common stock and the preferred stock warrant liability is reclassified to additional paid-in capital.</span></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis. The Company determines fair value based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants, as determined by either the principal market or the most advantageous market. Inputs used in the valuation techniques to derive fair values are classified based on a three-level hierarchy. These levels are: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</span></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></div><div style="margin-top:12pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Level 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> – Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash equivalents, accounts payable, accrued liabilities, debt and convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrants. Cash equivalents, convertible preferred stock warrant liability, Additional Shares, Earn-Out Shares and Public and Private Placement Warrant are stated at fair value on a recurring basis. Accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short period time to the expected receipt or payment.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears interest at a rate that approximates prevailing market rate.</span></div>The Public Warrants are classified as Level 1 due to the use of an observable market quote in an active market. Private Placement Warrants are classified as Level 2 as the fair value approximates the fair value of the Public Warrants. The Private Placement Warrants are identical to the Public Warrants, with certain exception discussed in Note 9, Common Stock and Warrants. The Additional Shares and Earn-Out Shares are classified as Level 3 and their fair values were estimated using a Monte Carlo options pricing model utilizing assumptions related to expected stock-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimated the expected volatility assumption based on the implied common stock volatilities of a set of publicly traded peer companies. Changes in this assumption, including the selection of or quantities of companies with the peer company set, could materially affect the estimate of the fair value of these instruments and the related change in fair value of these instruments. <div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2022 and December 31, 2021 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by level within the fair value hierarchy (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,171 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional Shares</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,136 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,491 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,686 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,771 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrant liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 129171000 0 0 129171000 129171000 0 0 129171000 0 0 17355000 17355000 0 0 53136000 53136000 3381000 0 0 3381000 0 2814000 0 2814000 3381000 2814000 70491000 76686000 77771000 0 0 77771000 77771000 0 0 77771000 0 0 4787000 4787000 0 0 4787000 4787000 15300000 <div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Additional Shares liability (in thousands):</span></div><div style="padding-left:18pt;text-align:justify;text-indent:45pt"><span><br/></span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumption of Additional Shares liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,340 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,015 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,355 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of changes in the estimated fair value of the Earn-Out liability (in thousands):</span></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumption of Earn-Out liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,481 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,345)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,136 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the preferred stock warrant liability is determined using the Black-Scholes option pricing model, which involve inherent uncertainties and the application of management’s judgment. The following table provides a summary of changes in the estimated fair value of the preferred stock warrant liability (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,787 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,616)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net exercise of preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance before reclassification at June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,182 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification to additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,182)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> 0 15340000 -2015000 17355000 70500000 0 70481000 17345000 53136000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.297%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Public Warrants</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assumption of Private Placement and Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,350 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,025 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in fair value</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2022</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,814 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 0 0 3350000 4025000 536000 644000 2814000 3381000 4787000 1616000 989000 2182000 2182000 0 -300000 -400000 1600000 -1300000 Accrued Expenses<div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:18pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,830 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following (in thousands):</span></div><div style="margin-top:18pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,468 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,659 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,072 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advertising costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,527 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,537 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,812 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,399 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,008 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,779 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,830 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,651 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 3468000 4659000 1744000 2072000 3527000 2363000 1147000 1120000 1537000 1812000 21399000 1846000 8008000 6779000 40830000 20651000 Debt <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silicon Valley Bank Loan Revolver</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silicon Valley Bank and Hercules Mezzanine Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,263 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,933 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, noncurrent</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,694 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,183 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Silicon Valley Bank Loan Facility </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2016, the Company entered into a loan and security agreement (the “SVB Loan Facility”) with Silicon Valley Bank (“SVB”). The terms of the SVB Loan Facility, as amended and restated, provided for: (i) a revolving line of credit not to exceed $25.0 million (“Loan Revolver”), (ii) growth capital advance (“Term Loan”) of $3.9 million and (iii) a letter of credit sublimit of $6.0 million. The Term Loan had a maturity date in December 2022 and bore interest at Prime Rate per annum, payable monthly. The Loan Revolver borrowing capacity was limited to 60% of eligible inventory balances.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into an amendment to the SVB Loan Facility, which incurs a facility fee of 0.20% per annum assessed on the daily average undrawn portion of revolving line of credit. In addition,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the Loan Revolver letter of credit sublimit increased to $10.0 million and t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he Loan Revolver borrowing capacity increased to 65% of eligible inventory balances. The Loan Revolver borrowing capacity is reduced by outstanding letters of credit and credit available to the Company from certain credit card facilities, which amounted to $3.1 million and $1.5 million, respectively as of June 30, 2022. The amended Loan Revolver bears an interest rate equal to the greater of prime rate or 3.25% per annum and matures on March 31, 2023. Interest on the Loan Revolver is payable monthly in arrears.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2021, all of the Company’s outstanding amounts under the SVB Term Loan were refinanced directly through the SVB and Hercules Loan Facility (see below). The Company determined the refinance represented an extinguishment of the SVB Term Loan and recorded a loss on extinguishment of $1.0 million during the three months ended June 30, 2021. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SVB Loan Facility is collateralized by substantially all of the Company’s assets on a first priority basis and contains customary events of default. The SVB Loan Facility includes affirmative, negative, and financial covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends, or repurchase stock, subject to customary exceptions. The SVB Loan Facility contains certain financial covenants which requires the Company to maintain minimum liquidity of $45.0 million. Minimum liquidity is defined as the sum of the aggregate amount of unrestricted and unencumbered cash deposited with SVB plus amounts available to be drawn under the loan revolver, as adjusted for any outstanding standby letters of credit issued by SVB. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company was in compliance with all covenants and had $5.9 million outstanding under the revolving line of credit, with an effective interest rate of 5.00%. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Silicon Valley Bank and Hercules Loan Facility </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2021, the Company entered into a Mezzanine Loan and Security Agreement (“SVB and Hercules Loan Facility”) with SVB and Hercules Capital, Inc. (“Hercules”). The availability period runs from the effective date until June 30, 2022, provides for advances of up to $60.0 million. In April 2021, the Company drew $25.0 million, which it used to directly settle the amounts outstanding under the SVB Term Loan. In September and December 2021, the Company drew </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">down the remaining additional borrowings of $25.0 million and $10.0 million, respectively</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The SVB and Hercules Loan Facility bears an annual interest at the greater of 8.75% or prime plus 5.5%, payable monthly. The principal repayment period commences on November 1, 2022 and continues for 30 monthly installments with an additional final payment equal to 6.75% of the aggregate term loan advances. SVB and Hercules have committed to fund 51.0% and 49.0%, respectively, of all draws made under the SVB and Hercules Loan Facility.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, as part of the Closing of the Business Combination, the Company entered into an amendment with SVB and Hercules Loan Facility which increased the final payment from 6.75% to 8.75% of the aggregate term loan advances. </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The SVB and Hercules Loan Facility is collateralized on a second priority basis, subordinate to the SVB Loan Facility, by substantially all of the Company’s assets and contains affirmative and negative covenants that restrict the Company’s ability to, among other things, incur additional indebtedness, other than permitted indebtedness, enter into mergers or acquisitions, sell or otherwise dispose of assets, pay dividends or repurchase stock, subject to customary exceptions. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The SVB and Hercules Loan Facility does not include any financial covenants, but does contain a subjective acceleration clause in the event that lenders determine that a material adverse change has or will occur within the business, operations, or financial condition of the Company or a material impairment of the prospect of repaying any portion of this financial obligation. In accordance with the loan agreement, SVB and Hercules have been provided with the Company’s periodic financial statements and updated projections to facilitate their ongoing assessment of the Company. The Company believes the likelihood that SVB and Hercules would exercise the subjective acceleration clause is remote.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company had an aggregate of $60.0 million outstanding under the SVB and Hercules Loan Facility, excluding unamortized debt issuance cost, with effective interest rates ranging from 14.26% to 17.31%. As of June 30, 2022, the Company was in compliance with all covenants.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atel Loan Facility </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2018, the Company entered into an equipment financing arrangement (the “Atel Loan Facility”) with Atel Ventures, Inc. (“Atel”) for funding of machinery and warehouse equipment that will become collateral. The loan agreement contains customary events of default.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2022, the Company had $1.0 million outstanding on its third draw and $0.2 million outstanding on its fourth draw, which mature in April 2023 and May 2023, respectively. The effective interest rates on the loans are 19.23%. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By the end of the equal monthly installments of principal and interest, the principal under each loan will be fully repaid.</span></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding debt, net of debt discounts, consisted of the following (in thousands):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">June 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silicon Valley Bank Loan Revolver</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silicon Valley Bank and Hercules Mezzanine Term Loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,263 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 3</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atel Loan Facility Draw 4</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,402 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,933 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,750)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt, noncurrent</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,694 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,183 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 5947000 5947000 59263000 59237000 1009000 1489000 183000 260000 66402000 66933000 22708000 10750000 43694000 56183000 25000000 3900000 6000000 0.60 0.0020 10000000 0.65 3100000 1500000 0.0325 -1000000 45000000 5900000 0.0500 60000000 25000000 25000000 10000000 0.0875 0.055 30 0.0675 0.510 0.490 0.0675 0.0875 60000000 0.1426 0.1731 1000000 200000 0.1923 0.1923 Commitments and Contingencies<div style="margin-top:6pt;padding-left:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merchandise Purchase Commitments</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2022 and December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had obligations to purchase $27.0 million and $36.1 million, respectively, of merchandise. </span></div><div style="margin-top:12pt;padding-left:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had irrevocable standby letters of credit in the amount of $3.1 million as of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2022 and December 31, 2021 related to the Company’s operating leases. The letters of credit have expiration dates through January 2029.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows.</span></div> 27000000 36100000 3100000 3100000 ContingenciesThe Company records loss contingencies when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company also discloses material contingencies when a loss is not probable but reasonably possible. Accounting for contingencies requires the Company to use judgment related to both the likelihood of a loss and the estimate of the amount or range of loss. Although the Company cannot predict with assurance the outcome of any litigation or non-income-based tax matters, the Company does not believe there are currently any such actions that, if resolved unfavorably, would have a material impact on the Company’s financial position, operating results or cash flows Convertible Preferred Stock <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data): </span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Original</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issue Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liquidation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preference </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series Seed</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,693,116 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,693,115 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,130,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,069,657 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,689,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,563,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,545 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,635,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,324,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,554,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,554,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,003 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,196,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,961,423 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0731 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D-2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,551,371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,551,370 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,762,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,762,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,868 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,527,580 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,795,034 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,918 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,411 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Conversion</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">At the closing of the Business Combination, all series of convertible preferred stock of Legacy Grove were converted on an as-converted basis to the Company’s Class B common stock at an exchange ratio of approximately 1.1760. As of June 30, 2022, no shares of convertible preferred stock were outstanding.</span></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s outstanding convertible preferred stock consisted of the following as of December 31, 2021 (in thousands, except share and per share data): </span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Original</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Issue Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Authorized</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liquidation</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Preference </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series Seed</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5245 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,693,116 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,693,115 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,943 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,084 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,130,360 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,069,657 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,240 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,379 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,689,363 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,563,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,545 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4144 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,635,550 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,324,913 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,917 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,554,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,554,106 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,003 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,090 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0135 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,196,682 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,961,423 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,618 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D-1</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0731 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,314,209 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,216 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D-2</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1850 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,551,371 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,551,370 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,638 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,000 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series E</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,762,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,762,823 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,868 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,527,580 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114,795,034 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,918 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,411 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.5245 9693116 9693115 3943000 5084000 0.5245 14130360 14069657 5240000 7379000 1.2450 12689363 12563418 15545000 15642000 2.4144 15635550 15324913 36917000 37000000 3.1669 8554106 8554106 27003000 27090000 7.0135 20196682 19961423 136618000 140000000 9.0731 5314209 5314209 48146000 48216000 6.1850 14551371 14551370 89638000 90000000 8.4672 14762823 14762823 124868000 125000000 115527580 114795034 487918000 495411000 1.1760 Common Stock and Warrants<div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Prior to the Business Combination, Legacy Grove had one class of authorized common stock (Class B common stock). The outstanding shares of Legacy Grove common stock is presented on the consolidated balance sheet and on the statements of convertible preferred stock, contingently redeemable convertible common stock and stockholders’ deficit for the year ended December 31, 2021.</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Merger Transaction</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Closing Date and in accordance with the terms and subject to the conditions of the Business Combination, each common stock, par value $0.0001 per share (other than Backstop Tranche 1 Shares), preferred stock, outstanding options (whether vested or unvested), restricted stock units (whether vested or unvested) and warrants of Legacy Grove was canceled and converted into a comparable number of awards (i) that consisted of either the rights to receive or acquire shares of the Company’s Class B common stock, par value $0.0001 per share, as determined by the exchange ratio, and (ii) the right to receive a number of the Company’s Earn-Out shares. Each Backstop Tranche 1 Shares issued to the Backstop Investor pursuant to the Backstop Subscription Agreement was canceled and converted into the right to receive a number of shares of the Company’s Class B common stock equal to the exchange ratio, which were immediately exchanged on a one-for-one basis for shares of the Company’s Class A common stock). The exchange ratio is approximately 1.1760.</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 16, 2022, in connection with the closing of the Business Combination, the Company amended and restated its certificate of incorporation to authorize 900,000,000 shares, consisting of (a) 800,000,000 shares of common stock, including (i) 600,000,000 shares of Class A common stock, and (ii) 200,000,000 shares of Class B common stock, and (b) 100,000,000 shares of preferred stock. </span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The rights of the holders of Class A common stock and Class B common stock are identical, except with respect to number of voting rights. Holders of Class A common stock are entitled to one vote per share and holders of Class B common stock are entitled to ten votes per share. Each share of Class B common stock is convertible into one share of Class A common stock any time at the option of the holder, and is automatically converted into one share of Class A common stock upon transfer (except for certain permitted transfers). Once converted into Class A common stock, the Class B common stock will not be reissued. The Company’s Board of Directors has the authority to issue shares of the Preferred Stock in one or more series and to determine the voting rights, designations, powers, preferences, other rights and restrictions of each such series of shares. As of June 30, 2022, no shares of preferred stock were issued and outstanding. </span></div><div style="text-align:justify;text-indent:22.3pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Class A Common Stock Warrants</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As the accounting acquirer, Grove Collaborative, Inc. is deemed to have assume</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d 6,700,000 P</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">rivate Placement Warrants for Class A common stock that were held by Virgin Group Acquisition Sponsor II LLC (the “Sponsor”) at an exercise price of $11.50 and 8,050,000 Class A common stock Public Warrants that were held by VGAC II’s shareholders at an exercise price of $11.50. The warrants will expire on July 16, 2027, or earlier upon redemption or liquidation.</span></div><div style="text-indent:22.3pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequent to the Closing of the Business Combination, the Private Placement and Public Warrants for shares of Class A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the private placement warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets and amounted to $76.7 million as of June 30, 2022.</span></div><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June 30, 2022, the following Warrants were outstanding:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public Warrants</span></div><div style="text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants become exercisable into shares of Class A common stock commencing on July 16, 2022 and expire on July 16, 2027, or earlier upon redemption or liquidation. At closing, the Company assumed 8,050,000 public warrants. Each warrant entitles the holder to purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to certain adjustments.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">redeem, with 30 days written notice, each whole outstanding Public Warrant for cash at a price of $0.01 per warrant if the Reference Value equals or exceeds $18.00 per share, subject to certain adjustments. The warrant holders have the right to exercise their outstanding warrants prior to the scheduled redemption date during the Redemption Period at $11.50 per share, subject to certain adjustments. If the Company calls the Public Warrants for redemption, the Company will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis”, as described in the warrant agreement. For purposes of the redemption, “Reference Value” shall mean the last reported sales price of the Company’s Class A common stock for any <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVhY2Q0NmZjZTYzNzQzZmViMWQxODg5MjgyOWNjMDE1L3NlYzplYWNkNDZmY2U2Mzc0M2ZlYjFkMTg4OTI4MjljYzAxNV80OS9mcmFnOjQwMzI3ZDkwZWNjZDRjOTQ5ZGEzZjJmYTA1ZmVjOWNkL3RleHRyZWdpb246NDAzMjdkOTBlY2NkNGM5NDlkYTNmMmZhMDVmZWM5Y2RfMTA5OTUxMTY4Mzk1Mw_c7ddbb52-03af-4545-9237-0573b80ddef9">twenty</span> trading days within the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmVhY2Q0NmZjZTYzNzQzZmViMWQxODg5MjgyOWNjMDE1L3NlYzplYWNkNDZmY2U2Mzc0M2ZlYjFkMTg4OTI4MjljYzAxNV80OS9mcmFnOjQwMzI3ZDkwZWNjZDRjOTQ5ZGEzZjJmYTA1ZmVjOWNkL3RleHRyZWdpb246NDAzMjdkOTBlY2NkNGM5NDlkYTNmMmZhMDVmZWM5Y2RfMTA5OTUxMTY4Mzk1NA_1ee58f86-73d5-4ce2-89fd-f682292f949b">thirty</span> trading-day period ending on the third trading day prior to the date on which notice of the redemption is given.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private Placement Warrants</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Private Placement Warrants are identical to the Public Warrants, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants are exercisable on a cashless basis and are non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, then such warrants will be redeemable by the Company and exercisable by the warrant holders on the same basis as the Public Warrants. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Closing, the Company assumed 6,700,000 Private Placement Warrants.</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserved for Issuance</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis: </span></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.371%"><tr><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,760 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backstop Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,857 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,349 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,323,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,312,140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,882,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Restricted Stock Units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,517,208 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184,158 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777,183 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining Shares available for issuance under 2016 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070,974 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining Shares available for issuance under 2022 Equity Incentive Plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,544,031 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for issuance under 2022 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,283,884 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,420,155 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,441,801 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.0001 0.0001 1.1760 900000000 800000000 600000000 200000000 100000000 1 10 1 1 0 0 6700000 11.50 8050000 11.50 76700000 <div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June 30, 2022, the following Warrants were outstanding:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.425%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.150%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 8050000 11.50 6700000 11.50 8050000 1 11.50 P30D 0.01 18.00 11.50 P30D 6700000 <div style="padding-left:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has the following shares of common stock reserved for future issuance, on an as-if converted basis: </span></div><div style="padding-left:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.371%"><tr><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">June 30, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class A Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class B Common Stock</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,760 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,700,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public Warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,050,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Backstop Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,875,028 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,857 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688,349 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Stock Options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,323,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,312,140 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,882,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding Restricted Stock Units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,517,208 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,184,158 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777,183 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining Shares available for issuance under 2016 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070,974 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining Shares available for issuance under 2022 Equity Incentive Plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,544,031 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares available for issuance under 2022 Employee Stock Purchase Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274,070 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shares of common stock reserved</span></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,283,884 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,420,155 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147,441,801 </span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 0 0 115287015 0 0 0 735760 6700000 0 0 0 8050000 0 0 0 3875028 0 0 0 0 923857 0 688349 9323547 15312140 0 27882520 4517208 1184158 0 1777183 0 0 0 1070974 24544031 0 0 0 3274070 0 0 0 60283884 17420155 0 147441801 Stock-Based Compensation<div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plan</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, Legacy Grove adopted the 2016 Equity Incentive Plan (the “2016 Plan”). The Plan provides for the granting of stock-based awards to employees, directors and consultants under terms and provisions established by the Board of Directors. In April 2022, the Company’s Board of Directors authorized an increase in the number of shares available for issuance under the 2016 Plan by 3,500,000. In addition, all equity awards of Legacy Grove that were issued under the 2016 Plan were converted into comparable equity awards that are settled or exercisable for shares of the Company’s Class B common stock. As a result, each of Legacy Grove’s equity awards were converted into an option to purchase shares of the Company’s Class B common stock based on an exchange ratio of approximately 1.1760. As of the effective date of the 2022 Plan, no further stock awards have been or will be granted under the 2016 Plan.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In June 2022, the stockholders of the Company approved the Grove Collaborative Holdings, Inc. 2022 Stock Incentive Plan (the “2022 Plan”). The Plan provides for the granting of stock-based awards to eligible participants, specifically officers, other employees, non-employee directors, consultants, independent contractors under terms and provisions established by the Board of Directors. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The 2022 Plan authorizes the issuance of Class A common stock of up to 24,555,528.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The number of shares available shall increase annually on the first day of each calendar year, beginning with calendar year ending December 31, 2023 and continuing until (and including) calendar year December 31 2032, with annual increases equal to lesser of (i) 5% of the number of shares of Class A and Class B common stock issued and outstanding on December 31 of the immediately preceding fiscal year, and (ii) an amount determined by the Board.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,708,957 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.99</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,173,563 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,882,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.99</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,041,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,635,687 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable – June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,742,548 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant date fair value of options granted during the six months ended June 30, 2021 was $4.41 per share. No options were granted during the six months ended June 30, 2022. The total grant date fair value of options that vested during the six months ended June 30, 2022 and 2021 was $7.8 million and $6.0 million, respectively. The aggregate intrinsic value of options exercised during the six months ended June 30, 2022 and 2021 was $1.1 million and $2.3 million, respectively. The aggregate intrinsic value is the difference between the current fair value of the underlying common stock and the exercise price for in-the-money stock options.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Early Exercise of Employee Options </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company allows certain employees to exercise options granted under the Plan prior to vesting in exchange for shares of restricted common stock. The unvested shares, upon termination of employment, are subject to repurchase by the Company at the original purchase price. The proceeds are recorded in other current liabilities in the consolidated balance sheets at the time of the early exercise of stock options and reclassified to common stock and additional paid-in capital as the Company’s repurchase right lapses (i.e., as the underlying stock options vest). No and 11,025 shares of common stock were issued due to early exercise of unvested stock options during the six months </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ended June 30, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 30, 2022 and December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the aggregate price of the restricted common stock subject to repurchase was zero and $0.2 million, respectively. A summary of the restricted common stock is as follows: </span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of early exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested as of June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Determination of Fair Value</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.86 – $6.45</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.06 – $6.45</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.03 – 6.28</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00 – 6.28</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.33% – 63.66%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.33% – 75.19%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81% – 1.16%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50% – 1.16% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market-Based Stock Options </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In February 2021, the Company granted 1,017,170 stock options with market and liquidity event-related performance-based vesting criteria with an exercise price of $3.77 per share. 100% of awards vest upon valuation of the Company’s stock at a stated price upon occurrence of specified transactions. Fair value was determined using the probability weighted expected term method (“PWERM”), which involves the estimation of future potential outcomes as well as values and probabilities associated with each potential outcome. Two potential scenarios were used in the PWERM that utilized 1) the value of the Company’s common equity, and 2) a Monte Carlo simulation to specifically value the award. The total grant date fair value of the award was determined to be $5.5 million. Since a liquidity event is not deemed probable until such event occurs, no compensation cost related to the performance condition was recognized prior to the Business Combination on June 16, 2022. Subsequently, the Company recorded stock-based compensation expense of $4.6 million for the six months ended June 30, 2022 which was principally related to service periods completed prior to the Business Combination. As of June 30, 2022, the market-based vesting criteria had not been met.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> </span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units </span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance-based restricted stock units activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511,191 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.62 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,748,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(593,971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,107,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but unissued – June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs granted under the 2016 Plan contain vesting conditions based on continuous service and the occurrence of a specified liquidity event, which is considered a performance condition. The performance condition is satisfied upon the consummation of (i) an initial underwritten public offering of the Company’s common stock; (ii) a change in control event, or (iii) a merger, consolidation or similar transaction in which the Company’s common stock outstanding immediately preceding such transaction are converted or exchanged into securities that are publicly-traded on an established exchange (the “Liquidity Event”), provided that the Liquidity Event occurs prior to the fifth anniversary of the grant date and the recipient continues to provide service to the Company on such date. The Company satisfied the performance condition on June 16, 2022 with the Closing of the Business Combination. Accordingly, the Company started recognizing stock compensation expense in the three months ended June 30, 2022 using the accelerated attribution method from the grant date. The total cumulative catch up expense related to prior periods recognized for the RSUs was $11.9 million. The vested but unissued RSUs will be issued to the common stockholders in November 2022 upon the termination of the Lock-Up Period, as defined in </span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="https://www.sec.gov/Archives/edgar/data/1841761/000119312522180310/d332953dex32.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.10 of the Company’s Bylaw</a><a href="https://www.sec.gov/Archives/edgar/data/1841761/000119312522180310/d332953dex32.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">s</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. There are no other contingencies for the issuance of these RSUs other than passage of time.</span></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Modifications</span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2022, the Company modified options held by former and existing employees to extend the post termination exercise period of the awards from 60 days to 1, 2 or 10 years after termination, as well as accelerated the vesting of RSUs. The modifications resulted in modification expenses of $0.6 million and $1.7 million during the three and six months ended June 30, 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and 2021</span>, the Company recognized a total of $20.1 million and $3.8 million of stock-based compensation expense, respectively. For the six months ended June 30, 2022 and 2021, the Company recognized a total of $24.5 million and $7.3 million of stock-based compensation expense, respectively. Stock-based compensation expense was predominately recorded in selling, general and administrative expenses in the statements of operations for each period presented. As of June 30, 2022, the total unrecognized compensation expense related to unvested options and RSUs was $47.4 million, which the Company expects to recognize over an estimated weighted average period of 2.6 years. 3500000 1.1760 24555528 0.05 <div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.854%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.411%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options </span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,708,957 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.05 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.99</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,429 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,173,563 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,882,520 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.59 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.99</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,429 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205,337)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.60 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,041,496)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.44 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,635,687 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.42</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,818 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options vested and exercisable – June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,742,548 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.81 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.87</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,349 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 23708957 3.05 P7Y11M26D 125429000 4173563 -0.46 27882520 2.59 P7Y11M26D 125429000 205337 1.60 3041496 3.44 24635687 2.53 P7Y5M1D 54818000 15742548 1.81 P6Y10M13D 44349000 4.41 0 7800000 6000000 1100000 2300000 0 11025 0 200000 A summary of the restricted common stock is as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Options </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Exercise Price</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,513 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;text-indent:9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,237 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,750 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;text-indent:13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of early exercise</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,539)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.92 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding and unvested as of June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 69513 2.25 12237 -0.33 81750 1.92 65211 1.92 16539 1.92 0 0 <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock option awards granted to employees was estimated at the date of grant using the Black-Scholes option-pricing model, with the following assumptions:</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.869%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended June 30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.86 – $6.45</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$5.06 – $6.45</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.03 – 6.28</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00 – 6.28</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.33% – 63.66%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.33% – 75.19%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.81% – 1.16%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50% – 1.16% </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">—</span></td></tr></table></div> 5.86 6.45 5.06 6.45 P5Y10D P6Y3M10D P5Y P6Y3M10D 0.6233 0.6366 0.6233 0.7519 0.0081 0.0116 0.0050 0.0116 0 0 1017170 3.77 1 5500000 4600000 <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance-based restricted stock units activity under the 2016 Plan is as follows (in thousands, except share and per share amounts):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of shares </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted–Average Grant Date Fair Value Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,511,191 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.62 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,992 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested – December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,777,183 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.33 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,748,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.98 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(593,971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.93 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancelled/forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(823,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.71 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance – June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,107,395 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.71 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested but unissued – June 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593,971 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.93 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1511191 8.62 265992 -1.29 1777183 7.33 4748063 6.98 593971 6.93 823880 6.71 5107395 6.71 593971 6.93 11900000 P60D P1Y P2Y P10Y 600000 1700000 20100000 3800000 24500000 7300000 47400000 P2Y7M6D Net Loss Per Share Attributable to Common Stockholders <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently redeemable convertible common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,635,687 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,646,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,635,687 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,646,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,107,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,107,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Private and Public Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14,750,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,999,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,999,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,416,899 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,964,182 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,416,899 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,964,182 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):</span></div><div style="margin-top:12pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended<br/>June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Six Months Ended<br/>June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,287,015 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingently redeemable convertible common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,635,687 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,646,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,635,687 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,646,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,107,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,107,395 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">735,760 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">923,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">974,350 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Private and Public Placement Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">14,750,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,750,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Earn-Out Shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,999,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,999,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares subject to repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,589 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Net loss per share attributable to common stockholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,416,899 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,964,182 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,416,899 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,964,182 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 115287015 0 115287015 0 0 0 0 24635687 27646468 24635687 27646468 5107395 0 5107395 0 0 735760 0 735760 923857 974350 923857 974350 14750000 0 14750000 0 13999960 0 13999960 0 0 320589 0 320589 59416899 144964182 59416899 144964182 Subsequent EventsOn July 18, 2022, Grove entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with an affiliate of Yorkville Advisors Global, LP (“Yorkville”), enabling the Company to sell up to $100 million of shares of Class A common stock to Yorkville at the Company’s request during the 36 months following the execution of the Purchase Agreement, subject to certain conditions. As of August 11, 2022, the conditions precedent allowing the Company to sell shares under the Purchase Agreement have not yet been met. 100000000 P36M (1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.The accompanying notes are an integral part of these condensed consolidated financial statements. (1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.The accompanying notes are an integral part of these condensed consolidated financial statements. (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.The accompanying notes are an integral part of these condensed consolidated financial statements. (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3. EXCEL 64 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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�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end XML 65 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 66 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2 html 320 313 1 true 94 0 false 5 false false R1.htm 0001001 - Document - Cover Page Sheet http://www.grove.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.grove.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1003003 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofOperations Condensed Consolidated Statements of Operations Statements 3 false false R4.htm 1004004 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Deficit Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Deficit Statements 4 false false R5.htm 1005005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Deficit - Parenthetical (Details) Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Deficit - Parenthetical (Details) Statements 5 false false R6.htm 1006006 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1402401 - Statement - Condensed Consolidated Balance Sheets - Parenthetical (Details) Sheet http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails Condensed Consolidated Balance Sheets - Parenthetical (Details) Statements 7 false false R8.htm 2101101 - Disclosure - Description of Business Sheet http://www.grove.com/role/DescriptionofBusiness Description of Business Notes 8 false false R9.htm 2102102 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.grove.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2107103 - Disclosure - Recapitalization Sheet http://www.grove.com/role/Recapitalization Recapitalization Notes 10 false false R11.htm 2109104 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments Fair Value Measurements and Fair Value of Financial Instruments Notes 11 false false R12.htm 2115105 - Disclosure - Accrued Expenses Sheet http://www.grove.com/role/AccruedExpenses Accrued Expenses Notes 12 false false R13.htm 2118106 - Disclosure - Debt Sheet http://www.grove.com/role/Debt Debt Notes 13 false false R14.htm 2122107 - Disclosure - Commitments and Contingencies Sheet http://www.grove.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 14 false false R15.htm 2124108 - Disclosure - Convertible Preferred Stock Sheet http://www.grove.com/role/ConvertiblePreferredStock Convertible Preferred Stock Notes 15 false false R16.htm 2128109 - Disclosure - Common Stock and Warrants Sheet http://www.grove.com/role/CommonStockandWarrants Common Stock and Warrants Notes 16 false false R17.htm 2133110 - Disclosure - Stock-Based Compensation Sheet http://www.grove.com/role/StockBasedCompensation Stock-Based Compensation Notes 17 false false R18.htm 2140111 - Disclosure - Net Loss Per Share Attributable to Common Stockholders Sheet http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholders Net Loss Per Share Attributable to Common Stockholders Notes 18 false false R19.htm 2143112 - Disclosure - Subsequent Events Sheet http://www.grove.com/role/SubsequentEvents Subsequent Events Notes 19 false false R20.htm 2203201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.grove.com/role/SummaryofSignificantAccountingPolicies 20 false false R21.htm 2304301 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.grove.com/role/SummaryofSignificantAccountingPolicies 21 false false R22.htm 2310302 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables Fair Value Measurements and Fair Value of Financial Instruments (Tables) Tables http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments 22 false false R23.htm 2316303 - Disclosure - Accrued Expenses (Tables) Sheet http://www.grove.com/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://www.grove.com/role/AccruedExpenses 23 false false R24.htm 2319304 - Disclosure - Debt and Convertible Preferred Stock and Common Stock Warrants (Tables) Sheet http://www.grove.com/role/DebtandConvertiblePreferredStockandCommonStockWarrantsTables Debt and Convertible Preferred Stock and Common Stock Warrants (Tables) Tables 24 false false R25.htm 2325305 - Disclosure - Convertible Preferred Stock (Tables) Sheet http://www.grove.com/role/ConvertiblePreferredStockTables Convertible Preferred Stock (Tables) Tables http://www.grove.com/role/ConvertiblePreferredStock 25 false false R26.htm 2329306 - Disclosure - Common Stock and Warrants (Tables) Sheet http://www.grove.com/role/CommonStockandWarrantsTables Common Stock and Warrants (Tables) Tables http://www.grove.com/role/CommonStockandWarrants 26 false false R27.htm 2334307 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.grove.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.grove.com/role/StockBasedCompensation 27 false false R28.htm 2341308 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables) Sheet http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersTables Net Loss Per Share Attributable to Common Stockholders (Tables) Tables http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholders 28 false false R29.htm 2405402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails Summary of Significant Accounting Policies - Narrative (Details) Details 29 false false R30.htm 2406403 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Sheet http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) Details 30 false false R31.htm 2408404 - Disclosure - Recapitalization - Narrative (Details) Sheet http://www.grove.com/role/RecapitalizationNarrativeDetails Recapitalization - Narrative (Details) Details 31 false false R32.htm 2411405 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) Details 32 false false R33.htm 2412406 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details) Details http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables 33 false false R34.htm 2413407 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) Details 34 false false R35.htm 2414408 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) Sheet http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details) Details 35 false false R36.htm 2417409 - Disclosure - Accrued Expenses - Schedule of Accrued Liabilities (Details) Sheet http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails Accrued Expenses - Schedule of Accrued Liabilities (Details) Details 36 false false R37.htm 2420410 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://www.grove.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 37 false false R38.htm 2421411 - Disclosure - Debt - Narrative (Details) Sheet http://www.grove.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 38 false false R39.htm 2423412 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.grove.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.grove.com/role/CommitmentsandContingencies 39 false false R40.htm 2426413 - Disclosure - Convertible Preferred Stock - Temporary Equity (Details) Sheet http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails Convertible Preferred Stock - Temporary Equity (Details) Details 40 false false R41.htm 2427414 - Disclosure - Convertible Preferred Stock - Narrative (Details) Sheet http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails Convertible Preferred Stock - Narrative (Details) Details 41 false false R42.htm 2430415 - Disclosure - Common Stock and Warrants - Narrative (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails Common Stock and Warrants - Narrative (Details) Details 42 false false R43.htm 2431416 - Disclosure - Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details) Details 43 false false R44.htm 2432417 - Disclosure - Common Stock and Warrants - Schedule of Reserved for Issuance (Details) Sheet http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails Common Stock and Warrants - Schedule of Reserved for Issuance (Details) Details 44 false false R45.htm 2435418 - Disclosure - Stock-Based Compensation - Narrative (Details) Sheet http://www.grove.com/role/StockBasedCompensationNarrativeDetails Stock-Based Compensation - Narrative (Details) Details 45 false false R46.htm 2436419 - Disclosure - Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) Sheet http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details) Details 46 false false R47.htm 2437420 - Disclosure - Stock-Based Compensation - Schedule of Restricted Common Stock (Details) Sheet http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails Stock-Based Compensation - Schedule of Restricted Common Stock (Details) Details 47 false false R48.htm 2438421 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) Sheet http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details) Details 48 false false R49.htm 2439422 - Disclosure - Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) Sheet http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details) Details 49 false false R50.htm 2442423 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 50 false false R51.htm 2444424 - Disclosure - Subsequent Events (Details) Sheet http://www.grove.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.grove.com/role/SubsequentEvents 51 false false All Reports Book All Reports grov-20220630.htm ex10232022eipexecrsuagt.htm ex10242022eipexecoptionagt.htm exhibit311.htm exhibit312.htm exhibit321.htm grov-20220630.xsd grov-20220630_cal.xml grov-20220630_def.xml grov-20220630_lab.xml grov-20220630_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 70 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "grov-20220630.htm": { "axisCustom": 6, "axisStandard": 25, "contextCount": 320, "dts": { "calculationLink": { "local": [ "grov-20220630_cal.xml" ] }, "definitionLink": { "local": [ "grov-20220630_def.xml" ] }, "inline": { "local": [ "grov-20220630.htm" ] }, "labelLink": { "local": [ "grov-20220630_lab.xml" ] }, "presentationLink": { "local": [ "grov-20220630_pre.xml" ] }, "schema": { "local": [ "grov-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 524, "entityCount": 1, "hidden": { "http://www.grove.com/20220630": 2, "http://xbrl.sec.gov/dei/2022": 5, "total": 7 }, "keyCustom": 87, "keyStandard": 226, "memberCustom": 49, "memberStandard": 36, "nsprefix": "grov", "nsuri": "http://www.grove.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://www.grove.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107103 - Disclosure - Recapitalization", "role": "http://www.grove.com/role/Recapitalization", "shortName": "Recapitalization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109104 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115105 - Disclosure - Accrued Expenses", "role": "http://www.grove.com/role/AccruedExpenses", "shortName": "Accrued Expenses", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118106 - Disclosure - Debt", "role": "http://www.grove.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122107 - Disclosure - Commitments and Contingencies", "role": "http://www.grove.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "grov:ConvertiblePreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124108 - Disclosure - Convertible Preferred Stock", "role": "http://www.grove.com/role/ConvertiblePreferredStock", "shortName": "Convertible Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "grov:ConvertiblePreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128109 - Disclosure - Common Stock and Warrants", "role": "http://www.grove.com/role/CommonStockandWarrants", "shortName": "Common Stock and Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2133110 - Disclosure - Stock-Based Compensation", "role": "http://www.grove.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2140111 - Disclosure - Net Loss Per Share Attributable to Common Stockholders", "role": "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholders", "shortName": "Net Loss Per Share Attributable to Common Stockholders", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2143112 - Disclosure - Subsequent Events", "role": "http://www.grove.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:InventoryNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2203201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2310302 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments (Tables)", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316303 - Disclosure - Accrued Expenses (Tables)", "role": "http://www.grove.com/role/AccruedExpensesTables", "shortName": "Accrued Expenses (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2319304 - Disclosure - Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)", "role": "http://www.grove.com/role/DebtandConvertiblePreferredStockandCommonStockWarrantsTables", "shortName": "Debt and Convertible Preferred Stock and Common Stock Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2325305 - Disclosure - Convertible Preferred Stock (Tables)", "role": "http://www.grove.com/role/ConvertiblePreferredStockTables", "shortName": "Convertible Preferred Stock (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329306 - Disclosure - Common Stock and Warrants (Tables)", "role": "http://www.grove.com/role/CommonStockandWarrantsTables", "shortName": "Common Stock and Warrants (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2334307 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.grove.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2341308 - Disclosure - Net Loss Per Share Attributable to Common Stockholders (Tables)", "role": "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersTables", "shortName": "Net Loss Per Share Attributable to Common Stockholders (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails", "shortName": "Summary of Significant Accounting Policies - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i9cae39c9020d4ef393e6ba5037629fec_I20211231", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ContractWithCustomerRefundLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003003 - Statement - Condensed Consolidated Statements of Operations", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations", "shortName": "Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406403 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails", "shortName": "Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i0c5ed04e6f8e44819d09adc6987b56dd_D20220401-20220630", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i8a6a4bc807384df7a1c207ebe2f88719_I20220616", "decimals": "2", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Recapitalization - Narrative (Details)", "role": "http://www.grove.com/role/RecapitalizationNarrativeDetails", "shortName": "Recapitalization - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i8a6a4bc807384df7a1c207ebe2f88719_I20220616", "decimals": "2", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationPercentageOfVotingInterestsAcquired", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i7d32c39941a84eaf9139663f8a0ae3bc_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i7d32c39941a84eaf9139663f8a0ae3bc_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "iea35f1bb790148c482242a9e3a104281_D20220101-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412406 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details)", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "ifa6b7e0621cb4834932cfd3122389fe4_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413407 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "ifa6b7e0621cb4834932cfd3122389fe4_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "grov:FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "ifc943a76d47743f2b4142d2b98ec9bf4_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414408 - Disclosure - Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details)", "role": "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "shortName": "Fair Value Measurements and Fair Value of Financial Instruments - Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "grov:FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "ifc943a76d47743f2b4142d2b98ec9bf4_I20211231", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:InventoryPurchasesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417409 - Disclosure - Accrued Expenses - Schedule of Accrued Liabilities (Details)", "role": "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails", "shortName": "Accrued Expenses - Schedule of Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "grov:InventoryPurchasesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2420410 - Disclosure - Debt - Schedule of Debt (Details)", "role": "http://www.grove.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421411 - Disclosure - Debt - Narrative (Details)", "role": "http://www.grove.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i3d2279c42b11484f86221f00ff799960_I20220531", "decimals": "4", "lang": "en-US", "name": "grov:LongTermDebtCommitmentByLender", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423412 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.grove.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:PurchaseObligation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i35bc23a0c9f34206a6bcd13ef8a1b4ef_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004004 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Deficit", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i35bc23a0c9f34206a6bcd13ef8a1b4ef_I20201231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquitySharesAuthorized", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426413 - Disclosure - Convertible Preferred Stock - Temporary Equity (Details)", "role": "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails", "shortName": "Convertible Preferred Stock - Temporary Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:TemporaryEquityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i9cae39c9020d4ef393e6ba5037629fec_I20211231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:TemporaryEquityLiquidationPreference", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i7b7eb549b69045f5879882e09b93e9d5_I20220616", "decimals": "4", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationExchangeRatio", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427414 - Disclosure - Convertible Preferred Stock - Narrative (Details)", "role": "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "shortName": "Convertible Preferred Stock - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i8a6a4bc807384df7a1c207ebe2f88719_I20220616", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430415 - Disclosure - Common Stock and Warrants - Narrative (Details)", "role": "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "shortName": "Common Stock and Warrants - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i8a6a4bc807384df7a1c207ebe2f88719_I20220616", "decimals": "INF", "lang": "en-US", "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i5d7aebfddba040deb795cbf1cb99102f_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431416 - Disclosure - Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details)", "role": "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails", "shortName": "Common Stock and Warrants - Schedule of Stockholders' Equity Note, Warrants or Rights (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "grov:ScheduleOfReservedForIssuanceTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i91bf60f9cd6f46e5bd6ac125727279fb_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ConvertiblePreferredStockSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432417 - Disclosure - Common Stock and Warrants - Schedule of Reserved for Issuance (Details)", "role": "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "shortName": "Common Stock and Warrants - Schedule of Reserved for Issuance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "grov:ScheduleOfReservedForIssuanceTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i91bf60f9cd6f46e5bd6ac125727279fb_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ConvertiblePreferredStockSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2435418 - Disclosure - Stock-Based Compensation - Narrative (Details)", "role": "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "shortName": "Stock-Based Compensation - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i9cae39c9020d4ef393e6ba5037629fec_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436419 - Disclosure - Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details)", "role": "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails", "shortName": "Stock-Based Compensation - Share-Based Payment Arrangement, Option, Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": "INF", "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i1a9ab88d8482405f975ac7309bd0f994_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2437420 - Disclosure - Stock-Based Compensation - Schedule of Restricted Common Stock (Details)", "role": "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "shortName": "Stock-Based Compensation - Schedule of Restricted Common Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i1a9ab88d8482405f975ac7309bd0f994_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i663e2c3fd8484ad68236d1796fb7f51a_D20210401-20210630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2438421 - Disclosure - Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details)", "role": "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "shortName": "Stock-Based Compensation - Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i663e2c3fd8484ad68236d1796fb7f51a_D20210401-20210630", "decimals": "2", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i5a394a85c6ae49b49cdc6495f7899663_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439422 - Disclosure - Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details)", "role": "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "shortName": "Stock-Based Compensation - Schedule of Performance-based Restricted Stock Units Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i5a394a85c6ae49b49cdc6495f7899663_I20211231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationTransactionCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005005 - Statement - Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Deficit - Parenthetical (Details)", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "shortName": "Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders\u2019 Deficit - Parenthetical (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "-5", "first": true, "lang": "en-US", "name": "grov:ReverseRecapitalizationTransactionCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442423 - Disclosure - Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "role": "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "shortName": "Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "ix:continuation", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i034835beee034d23a07b3fbf978775a2_D20220401-20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i239faa02828340b893bea7ebb6416c45_D20220718-20220718", "decimals": "-6", "first": true, "lang": "en-US", "name": "grov:PurchaseAgreementEquityInterestsIssuableNotYetIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2444424 - Disclosure - Subsequent Events (Details)", "role": "http://www.grove.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i239faa02828340b893bea7ebb6416c45_D20220718-20220718", "decimals": "-6", "first": true, "lang": "en-US", "name": "grov:PurchaseAgreementEquityInterestsIssuableNotYetIssued", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006006 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": "-3", "lang": "en-US", "name": "grov:AdjustmentOfConvertiblePreferredStockWarrantLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1402401 - Statement - Condensed Consolidated Balance Sheets - Parenthetical (Details)", "role": "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "shortName": "Condensed Consolidated Balance Sheets - Parenthetical (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "if55bf4437ac04ddfa0319a10aa242a48_I20220630", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Description of Business", "role": "http://www.grove.com/role/DescriptionofBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.grove.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "grov-20220630.htm", "contextRef": "i54ed2d6b058e4a9e9502341f9eb1ea0c_D20220101-20220630", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 94, "tag": { "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]", "terseLabel": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]", "terseLabel": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r469" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_FormerAddressMember": { "auth_ref": [ "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "Former address for entity", "label": "Former Address [Member]", "terseLabel": "Former Address" } } }, "localname": "FormerAddressMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.grove.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "grov_AccruedFulfillmentCostsCurrent": { "auth_ref": [], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued Fulfillment Costs, Current", "label": "Accrued Fulfillment Costs, Current", "terseLabel": "Fulfillment costs" } } }, "localname": "AccruedFulfillmentCostsCurrent", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "grov_AdditionalShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional Share", "label": "Additional Share [Member]", "terseLabel": "Additional Shares" } } }, "localname": "AdditionalShareMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_AdjustmentOfConvertiblePreferredStockWarrantLiability": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustment of Convertible Preferred Stock Warrant Liability", "label": "Adjustment of Convertible Preferred Stock Warrant Liability", "terseLabel": "Remeasurement of convertible preferred stock warrant liability" } } }, "localname": "AdjustmentOfConvertiblePreferredStockWarrantLiability", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_AdjustmentToAdditionalPaidInCapitalEarnOutLiabilityUponReverseRecapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to Additional Paid in Capital, Earn-out Liability Upon Reverse Recapitalization", "label": "Adjustment to Additional Paid in Capital, Earn-out Liability Upon Reverse Recapitalization", "terseLabel": "Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination" } } }, "localname": "AdjustmentToAdditionalPaidInCapitalEarnOutLiabilityUponReverseRecapitalization", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grov_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement", "label": "Agreement [Axis]", "terseLabel": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "grov_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Domain]", "label": "Agreement [Domain]", "terseLabel": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_AmendmentToTheLoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amendment to the Loan And Security Agreement", "label": "Amendment to the Loan And Security Agreement [Member]", "terseLabel": "Amendment to the Loan And Security Agreement" } } }, "localname": "AmendmentToTheLoanAndSecurityAgreementMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_AtelLoanFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel Loan Facility", "label": "Atel Loan Facility [Member]", "terseLabel": "Atel Loan Facility" } } }, "localname": "AtelLoanFacilityMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_AtelLoanFacilityTrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel Loan Facility Tranche Four", "label": "Atel Loan Facility Tranche Four [Member]", "terseLabel": "Atel Loan Facility Draw 4" } } }, "localname": "AtelLoanFacilityTrancheFourMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_AtelLoanFacilityTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel Loan Facility Tranche Three", "label": "Atel Loan Facility Tranche Three [Member]", "terseLabel": "Atel Loan Facility Draw 3" } } }, "localname": "AtelLoanFacilityTrancheThreeMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_AtelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atel", "label": "Atel [Member]", "terseLabel": "Atel" } } }, "localname": "AtelMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_BackstopWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 8.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Backstop Warrant, Shares Reserved for Future Issuance", "label": "Backstop Warrant, Shares Reserved for Future Issuance", "terseLabel": "Backstop warrant, shares reserved for future issuance (in shares)" } } }, "localname": "BackstopWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrant or Right Redemption Threshold Consecutive Trading Days", "label": "Class of Warrant or Right Redemption Threshold Consecutive Trading Days", "terseLabel": "Class of warrant or right redemption threshold consecutive trading days" } } }, "localname": "ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ClassOfWarrantsOrRightsRedemptionPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrants or Rights Redemption Price Per Unit", "label": "Class of Warrants or Rights Redemption Price Per Unit", "terseLabel": "Class of warrants or rights redemption price per unit (in dollars per share)" } } }, "localname": "ClassOfWarrantsOrRightsRedemptionPricePerUnit", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_ClassOfWarrantsOrRightsWarrantsIssuedDuringPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrants or Rights Warrants Issued During Period", "label": "Class of Warrants or Rights Warrants Issued During Period", "terseLabel": "Class of warrants or rights warrants issued during period (in shares)" } } }, "localname": "ClassOfWarrantsOrRightsWarrantsIssuedDuringPeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ClassOfWarrantsRedemptionNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of Warrants Redemption Notice Period", "label": "Class of Warrants Redemption Notice Period", "terseLabel": "Class of warrants redemption notice period" } } }, "localname": "ClassOfWarrantsRedemptionNoticePeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_CommonStockWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 5.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Common Stock Warrant, Shares Reserved for Future Issuance", "label": "Common Stock Warrant, Shares Reserved for Future Issuance", "terseLabel": "Common stock warrant, shares reserved for future issuance (in shares)" } } }, "localname": "CommonStockWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ContingentlyRedeemableConvertibleCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingently Redeemable Convertible Common Stock", "label": "Contingently Redeemable Convertible Common Stock [Member]", "terseLabel": "Contingently redeemable convertible common stock" } } }, "localname": "ContingentlyRedeemableConvertibleCommonStockMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "grov_ContractWithCustomerReferralCreditCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract with Customer, Referral Credit, Current", "label": "Contract with Customer, Referral Credit, Current", "terseLabel": "Contract with customer, referral credit, current" } } }, "localname": "ContractWithCustomerReferralCreditCurrent", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ConversionOfRedeemableConvertiblePreferredStockToCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Conversion Of Redeemable Convertible Preferred Stock To Common Stock", "label": "Conversion Of Redeemable Convertible Preferred Stock To Common Stock", "terseLabel": "Conversion of contingently redeemable convertible common stock and convertible preferred stock to common stock" } } }, "localname": "ConversionOfRedeemableConvertiblePreferredStockToCommonStock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_ConvertiblePreferredStockTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock", "label": "Convertible Preferred Stock [Text Block]", "terseLabel": "Convertible Preferred Stock" } } }, "localname": "ConvertiblePreferredStockTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStock" ], "xbrltype": "textBlockItemType" }, "grov_ConvertiblePreferredStockWarrantLiabilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Warrant Liability", "label": "Convertible Preferred Stock Warrant Liability [Member]", "terseLabel": "Convertible preferred stock warrant liability" } } }, "localname": "ConvertiblePreferredStockWarrantLiabilityMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_ConvertiblePreferredStockWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 4.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Warrant, Shares Reserved for Future Issuance", "label": "Convertible Preferred Stock Warrant, Shares Reserved for Future Issuance", "terseLabel": "Convertible preferred stock warrant, shares reserved for future issuance (in shares)" } } }, "localname": "ConvertiblePreferredStockWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ConvertiblePreferredStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Preferred Stock Warrants", "label": "Convertible Preferred Stock Warrants [Member]", "terseLabel": "Convertible preferred stock warrants" } } }, "localname": "ConvertiblePreferredStockWarrantsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "grov_CorvinaHoldingsLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corvina Holdings Limited", "label": "Corvina Holdings Limited [Member]", "terseLabel": "Corvina Holdings Limited" } } }, "localname": "CorvinaHoldingsLimitedMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_CreditCardOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Credit Card Outstanding", "label": "Credit Card Outstanding", "terseLabel": "Credit card outstanding" } } }, "localname": "CreditCardOutstanding", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_CustomerReferralCreditsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Referral Credits", "label": "Customer Referral Credits [Policy Text Block]", "terseLabel": "Customer Referral Credits" } } }, "localname": "CustomerReferralCreditsPolicyTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grov_DeferredRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Revenue", "label": "Deferred Revenue [Member]", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenueMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_EarnOutShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earn-Out Share", "label": "Earn-Out Share [Member]", "terseLabel": "Earn-Out Shares" } } }, "localname": "EarnOutShareMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "grov_EquityAwardModificationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity Award Modifications", "label": "Equity Award Modifications [Member]", "terseLabel": "Equity Award Modifications" } } }, "localname": "EquityAwardModificationsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_FairValueAdjustmentOfEarnOutLiability": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment of Earn-Out Liability", "label": "Fair Value Adjustment of Earn-Out Liability", "terseLabel": "Change in fair value of Earn-Out liability" } } }, "localname": "FairValueAdjustmentOfEarnOutLiability", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "grov_FairValueAdjustmentOfWarrantsAdditionalSharesLiability": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment of Warrants, Additional Shares Liability", "label": "Fair Value Adjustment of Warrants, Additional Shares Liability", "terseLabel": "Change in fair value of Additional Shares liability" } } }, "localname": "FairValueAdjustmentOfWarrantsAdditionalSharesLiability", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "grov_FairValueAdjustmentOfWarrantsPublicAndPrivate": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair Value Adjustment of Warrants, Public and Private", "label": "Fair Value Adjustment of Warrants, Public and Private", "terseLabel": "Change in fair value of Public and Private Placement Warrants liability" } } }, "localname": "FairValueAdjustmentOfWarrantsPublicAndPrivate", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "grov_FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation", "label": "Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Observable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObservableInputReconciliationTableTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "grov_FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "label": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedTerseLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "label": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "terseLabel": "Assumption of Private Placement and Public Warrants" } } }, "localname": "FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value", "label": "Fair Value, Measurement with Observable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance at June 30, 2022", "periodStartLabel": "Balance at December 31, 2021" } } }, "localname": "FairValueMeasurementWithObservableInputsReconciliationRecurringBasisLiabilityValue", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "grov_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisObservableInputReconciliationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Observable Input Reconciliation [Roll Forward]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisObservableInputReconciliationRollForward", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "grov_FiveSuppliersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Five Suppliers", "label": "Five Suppliers [Member]", "terseLabel": "Five Suppliers" } } }, "localname": "FiveSuppliersMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_FulfillmentCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fulfillment Costs", "label": "Fulfillment Costs", "terseLabel": "Fulfillment cost" } } }, "localname": "FulfillmentCosts", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_FulfillmentCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fulfillment Costs", "label": "Fulfillment Costs [Policy Text Block]", "terseLabel": "Fulfillment Costs" } } }, "localname": "FulfillmentCostsPolicyTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grov_FulfillmentLaborMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fulfillment Labor", "label": "Fulfillment Labor [Member]", "terseLabel": "Fulfillment Labor" } } }, "localname": "FulfillmentLaborMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_GroveBrandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Grove Brands", "label": "Grove Brands [Member]", "terseLabel": "Grove Brands" } } }, "localname": "GroveBrandsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "grov_GrowthCapitalAdvanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Growth Capital Advance", "label": "Growth Capital Advance [Member]", "terseLabel": "Growth Capital Advance" } } }, "localname": "GrowthCapitalAdvanceMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_HerculesCapitalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hercules Capital Inc", "label": "Hercules Capital Inc [Member]", "terseLabel": "Hercules Capital Inc" } } }, "localname": "HerculesCapitalIncMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_IncreaseDecreaseInOperatingRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Operating Right of Use Asset", "label": "Increase (Decrease) in Operating Right of Use Asset", "negatedTerseLabel": "Operating lease right-of-use assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingRightOfUseAsset", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_InitialMeasurementOfCommonStockWarrantsRecordedAsDebtFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial Measurement of Common Stock Warrants Recorded as Debt Fees", "label": "Initial Measurement of Common Stock Warrants Recorded as Debt Fees", "terseLabel": "Initial measurement of common stock warrants recorded as debt fees" } } }, "localname": "InitialMeasurementOfCommonStockWarrantsRecordedAsDebtFees", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_InventoryPurchasesCurrent": { "auth_ref": [], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Inventory Purchases, Current", "label": "Inventory Purchases, Current", "terseLabel": "Inventory purchases" } } }, "localname": "InventoryPurchasesCurrent", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "grov_LenderAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lender", "label": "Lender [Axis]", "terseLabel": "Lender [Axis]" } } }, "localname": "LenderAxis", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "grov_LenderDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lender [Domain]", "label": "Lender [Domain]", "terseLabel": "Lender [Domain]" } } }, "localname": "LenderDomain", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_LoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan And Security Agreement", "label": "Loan And Security Agreement [Member]", "terseLabel": "Loan And Security Agreement" } } }, "localname": "LoanAndSecurityAgreementMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_LoanRevolverBorrowerCapacityAsAPercentageOfInventoryBalance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan Revolver Borrower Capacity as a Percentage of Inventory Balance", "label": "Loan Revolver Borrower Capacity as a Percentage of Inventory Balance", "terseLabel": "Loan revolver borrower capacity as a percentage of inventory balance" } } }, "localname": "LoanRevolverBorrowerCapacityAsAPercentageOfInventoryBalance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_LongTermDebtCommitmentByLender": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long Term Debt Commitment By Lender", "label": "Long Term Debt Commitment By Lender", "terseLabel": "Percentage of aggregate term loan advance increase" } } }, "localname": "LongTermDebtCommitmentByLender", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_MarketBasedStockOptionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Market-based Stock Options", "label": "Market-based Stock Options [Member]", "terseLabel": "Market-based Stock Options" } } }, "localname": "MarketBasedStockOptionsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_MezzanineLoanAndEquitySecurityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mezzanine Loan And Equity Security", "label": "Mezzanine Loan And Equity Security [Member]", "terseLabel": "Mezzanine Loan And Equity Security" } } }, "localname": "MezzanineLoanAndEquitySecurityMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_MezzanineLoanAndSecurityAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mezzanine Loan and Security Agreement", "label": "Mezzanine Loan and Security Agreement [Member]", "terseLabel": "Mezzanine Loan and Security Agreement" } } }, "localname": "MezzanineLoanAndSecurityAgreementMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_MinimumLiquidityToBeMaintained": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Minimum Liquidity To Be Maintained", "label": "Minimum Liquidity To Be Maintained", "terseLabel": "Minimum liquidity to be maintained" } } }, "localname": "MinimumLiquidityToBeMaintained", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_NumberOfDaysAfterTheCompletionOfAnInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Days After the Completion of an Initial Business Combination", "label": "Number of Days After the Completion of an Initial Business Combination", "terseLabel": "Number of days after the completion of an initial business combination" } } }, "localname": "NumberOfDaysAfterTheCompletionOfAnInitialBusinessCombination", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_NumberOfSharesConverted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Shares Converted", "label": "Number of Shares Converted", "terseLabel": "Number of shares converted" } } }, "localname": "NumberOfSharesConverted", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_NumberOfVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Votes", "label": "Number of Votes", "terseLabel": "Number of votes" } } }, "localname": "NumberOfVotes", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "integerItemType" }, "grov_NumberOfWarrantOrRightEntitlesToPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Warrant or Right, Entitles to Purchase", "label": "Number of Warrant or Right, Entitles to Purchase", "terseLabel": "Number of warrant or right, entitles to purchase (in shares)" } } }, "localname": "NumberOfWarrantOrRightEntitlesToPurchase", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_OneYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Year", "label": "One Year [Member]", "terseLabel": "One Year" } } }, "localname": "OneYearMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_OutstandingRestrictedStockUnitSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 9.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance", "label": "Outstanding Restricted Stock Unit, Shares Reserved for Future Issuance", "terseLabel": "Outstanding restricted stock unit, shares reserved for future issuance (in shares)" } } }, "localname": "OutstandingRestrictedStockUnitSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_OutstandingStockOptionSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 3.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Outstanding Stock Option, Shares Reserved for Future Issuance", "label": "Outstanding Stock Option, Shares Reserved for Future Issuance", "terseLabel": "Outstanding stock option, shares reserved for future issuance (in shares)" } } }, "localname": "OutstandingStockOptionSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance-based Restricted Stock Units", "label": "Performance-based Restricted Stock Units [Member]", "terseLabel": "Performance-based Restricted Stock Units" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "domainItemType" }, "grov_PostTerminationExercisePeriodAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Termination Exercise Period", "label": "Post Termination Exercise Period [Axis]", "terseLabel": "Post Termination Exercise Period [Axis]" } } }, "localname": "PostTerminationExercisePeriodAxis", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_PostTerminationExercisePeriodDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post Termination Exercise Period [Domain]", "label": "Post Termination Exercise Period [Domain]", "terseLabel": "Post Termination Exercise Period [Domain]" } } }, "localname": "PostTerminationExercisePeriodDomain", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_PrivateAndPublicPlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private and Public Placement Warrants", "label": "Private and Public Placement Warrants [Member]", "terseLabel": "Private and Public Placement Warrants" } } }, "localname": "PrivateAndPublicPlacementWarrantsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "grov_PrivatePlacementWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant", "label": "Private Placement Warrant [Member]", "terseLabel": "Private Placement Warrants" } } }, "localname": "PrivatePlacementWarrantMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_PrivatePlacementWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 6.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Private Placement Warrant, Shares Reserved for Future Issuance", "label": "Private Placement Warrant, Shares Reserved for Future Issuance", "terseLabel": "Private placement warrant, shares reserved for future issuance (in shares)" } } }, "localname": "PrivatePlacementWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_ProceedFromIssuanceOfCommonStockReverseRecapitalization": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceed from Issuance of Common Stock, Reverse Recapitalization", "label": "Proceed from Issuance of Common Stock, Reverse Recapitalization", "terseLabel": "Proceeds from issuance of common stock upon Closing of Business Combination" } } }, "localname": "ProceedFromIssuanceOfCommonStockReverseRecapitalization", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ProceedsFromIssuanceOfRedeemableConvertibleCommonStock": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from Issuance of Redeemable Convertible Common Stock", "label": "Proceeds from Issuance of Redeemable Convertible Common Stock", "terseLabel": "Proceeds from issuance of contingently redeemable convertible common stock" } } }, "localname": "ProceedsFromIssuanceOfRedeemableConvertibleCommonStock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_PublicWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public Warrant", "label": "Public Warrant [Member]", "terseLabel": "Public Warrants" } } }, "localname": "PublicWarrantMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "grov_PublicWarrantSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 7.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Public Warrant, Shares Reserved for Future Issuance", "label": "Public Warrant, Shares Reserved for Future Issuance", "terseLabel": "Public warrant, shares reserved for future issuance (in shares)" } } }, "localname": "PublicWarrantSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_PurchaseAgreementEquityInterestsIssuableNotYetIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued", "label": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued", "terseLabel": "Purchase agreement, equity interests issuable, not yet issued" } } }, "localname": "PurchaseAgreementEquityInterestsIssuableNotYetIssued", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "grov_PurchaseAgreementEquityInterestsIssuableNotYetIssuedTransactionPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period", "label": "Purchase Agreement, Equity Interests Issuable, Not Yet Issued, Transaction Period", "terseLabel": "Purchase agreement, equity interests issuable, not yet issued, transaction period" } } }, "localname": "PurchaseAgreementEquityInterestsIssuableNotYetIssuedTransactionPeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "durationItemType" }, "grov_ReclassificationOfPreferredStockWarrantLiabilityToEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reclassification of Preferred Stock Warrant Liability to Equity", "label": "Reclassification of Preferred Stock Warrant Liability to Equity", "terseLabel": "Reclassification of Grove's preferred stock warrant liability to additional paid-in capital" } } }, "localname": "ReclassificationOfPreferredStockWarrantLiabilityToEquity", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_RestrictedCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Common Stock", "label": "Restricted Common Stock [Member]", "terseLabel": "Restricted Common Stock" } } }, "localname": "RestrictedCommonStockMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Abstract]" } } }, "localname": "ReverseRecapitalizationAbstract", "nsuri": "http://www.grove.com/20220630", "xbrltype": "stringItemType" }, "grov_ReverseRecapitalizationAggregateGrossProceedsAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Aggregate Gross Proceeds Amount", "label": "Reverse Recapitalization, Aggregate Gross Proceeds Amount", "terseLabel": "Reverse recapitalization, aggregate gross proceeds amount" } } }, "localname": "ReverseRecapitalizationAggregateGrossProceedsAmount", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Earnout Period", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period", "terseLabel": "Reverse recapitalization, contingent consideration, liability, earnout period" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriodStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Stock Price Trigger", "terseLabel": "Reverse recapitalization, contingent consideration, liability, earnout period, stock price trigger (in dollars per share)" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriodStockPriceTrigger", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDayPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Liability, Earnout Period, Threshold Trading Day Period", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Day Period", "terseLabel": "Reverse recapitalization, contingent consideration, liability, earnout period, threshold trading day period" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDayPeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days", "label": "Reverse Recapitalization, Contingent Consideration, Earnout Period, Threshold Trading Days", "terseLabel": "Reverse recapitalization contingent consideration, liability, earnout period, threshold trading days" } } }, "localname": "ReverseRecapitalizationContingentConsiderationEarnoutPeriodThresholdTradingDays", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_ReverseRecapitalizationContingentConsiderationShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Contingent Consideration, Shares", "label": "Reverse Recapitalization, Contingent Consideration, Shares", "terseLabel": "Reverse recapitalization, contingent consideration, liability (in shares)" } } }, "localname": "ReverseRecapitalizationContingentConsiderationShares", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ReverseRecapitalizationExchangeRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Exchange Ratio", "label": "Reverse Recapitalization, Exchange Ratio", "terseLabel": "Recapitalization exchange ratio" } } }, "localname": "ReverseRecapitalizationExchangeRatio", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "pureItemType" }, "grov_ReverseRecapitalizationPercentageOfVotingInterestsAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Percentage of Voting Interests Acquired", "label": "Reverse Recapitalization, Percentage of Voting Interests Acquired", "terseLabel": "Reverse recapitalization, percentage of voting interests acquired" } } }, "localname": "ReverseRecapitalizationPercentageOfVotingInterestsAcquired", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "percentItemType" }, "grov_ReverseRecapitalizationProceedsReceivedNetOfTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Proceeds Received, Net of Transaction Costs", "label": "Reverse Recapitalization, Proceeds Received, Net of Transaction Costs", "terseLabel": "Reverse recapitalization, proceeds received, net of transaction costs" } } }, "localname": "ReverseRecapitalizationProceedsReceivedNetOfTransactionCosts", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ReverseRecapitalizationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization", "label": "Reverse Recapitalization [Text Block]", "terseLabel": "Recapitalization" } } }, "localname": "ReverseRecapitalizationTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/Recapitalization" ], "xbrltype": "textBlockItemType" }, "grov_ReverseRecapitalizationTrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche", "label": "Reverse Recapitalization Tranche [Axis]", "terseLabel": "Reverse Recapitalization Tranche" } } }, "localname": "ReverseRecapitalizationTrancheAxis", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_ReverseRecapitalizationTrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche [Domain]", "label": "Reverse Recapitalization Tranche [Domain]", "terseLabel": "Reverse Recapitalization Tranche [Domain]" } } }, "localname": "ReverseRecapitalizationTrancheDomain", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche One", "label": "Reverse Recapitalization Tranche One [Member]", "terseLabel": "Reverse Recapitalization Tranche One" } } }, "localname": "ReverseRecapitalizationTrancheOneMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization Tranche Two", "label": "Reverse Recapitalization Tranche Two [Member]", "terseLabel": "Reverse Recapitalization Tranche Two" } } }, "localname": "ReverseRecapitalizationTrancheTwoMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ReverseRecapitalizationTransactionCostsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reverse Recapitalization, Transaction Costs Net", "label": "Reverse Recapitalization, Transaction Costs Net", "terseLabel": "Reverse recapitalization, transaction costs net" } } }, "localname": "ReverseRecapitalizationTransactionCostsNet", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "grov_ReversedRecapitalizationNumberOfTradingDaysCommencing": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reversed Recapitalization, Number of Trading Days Commencing", "label": "Reversed Recapitalization, Number of Trading Days Commencing", "terseLabel": "Number of trading days after the closing of business combination" } } }, "localname": "ReversedRecapitalizationNumberOfTradingDaysCommencing", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "durationItemType" }, "grov_SaleOfStockConsiderationAvailableOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale of Stock, Consideration Available on Transaction", "label": "Sale of Stock, Consideration Available on Transaction", "terseLabel": "Sale of stock, consideration available on transaction" } } }, "localname": "SaleOfStockConsiderationAvailableOnTransaction", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_SaleOfStockNumberOfSharesAvailableInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of Stock, Number of Shares Available in Transaction", "label": "Sale of Stock, Number of Shares Available in Transaction", "terseLabel": "Sale of stock, number of shares available in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesAvailableInTransaction", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "grov_ScheduleOfReservedForIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Reserved for Issuance", "label": "Schedule of Reserved for Issuance [Table Text Block]", "terseLabel": "Schedule of Reserved for Issuance" } } }, "localname": "ScheduleOfReservedForIssuanceTableTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "grov_ScheduleOfReverseRecapitalizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Reverse Recapitalization [Line Items]", "label": "Schedule of Reverse Recapitalization [Line Items]", "terseLabel": "Schedule of Reverse Recapitalization [Line Items]" } } }, "localname": "ScheduleOfReverseRecapitalizationLineItems", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_ScheduleOfReverseRecapitalizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Reverse Recapitalization", "label": "Schedule of Reverse Recapitalization [Table]", "terseLabel": "Schedule of Reverse Recapitalization [Table]" } } }, "localname": "ScheduleOfReverseRecapitalizationTable", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_SeriesC1PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series C-1 Preferred Stock", "label": "Series C-1 Preferred Stock [Member]", "terseLabel": "Series C-1" } } }, "localname": "SeriesC1PreferredStockMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "grov_SeriesD1PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D-1 Preferred Stock", "label": "Series D-1 Preferred Stock [Member]", "terseLabel": "Series D-1" } } }, "localname": "SeriesD1PreferredStockMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "grov_SeriesD2PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D-2 Preferred Stock", "label": "Series D-2 Preferred Stock [Member]", "terseLabel": "Series D-2" } } }, "localname": "SeriesD2PreferredStockMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "grov_SeriesSeedPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series Seed Preferred Stock", "label": "Series Seed Preferred Stock [Member]", "terseLabel": "Series Seed" } } }, "localname": "SeriesSeedPreferredStockMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentOfSharesIncrease": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Percent of Shares Increase", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Annual Percent of Shares Increase", "terseLabel": "Share-based compensation arrangement by share-based payment award, annual percent of shares increase" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualPercentOfSharesIncrease", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "pureItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRepurchaseOfEarlyExercise": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Repurchase of Early Exercise", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value, Repurchase of Early Exercise", "terseLabel": "Repurchase of early exercise (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRepurchaseOfEarlyExercise", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "perShareItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchaseOfEarlyExerciseInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Repurchase of Early Exercise in Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Repurchase of Early Exercise in Period", "negatedTerseLabel": "Repurchase of early exercise (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRepurchaseOfEarlyExerciseInPeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "sharesItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButUnissuedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period", "terseLabel": "Vested but unissued (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButUnissuedInPeriod", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButUnissuedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period, Weighted Average Grant Date Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested but Unissued in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested but unissued (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedButUnissuedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value of Common Stock", "label": "Share based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Fair Value of Common Stock", "terseLabel": "Fair value of common stock (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsFairValueOfCommonStock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfSharesSubjectToRepurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value of Shares Subject to Repurchase Obligation", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value of Shares Subject to Repurchase Obligation", "terseLabel": "Share-based compensation arrangement by share-based payment award, fair value of shares subject to repurchase obligation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueOfSharesSubjectToRepurchaseObligation", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Aggregate Intrinsic Value [Abstract]", "terseLabel": "Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueAbstract", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, exercisable, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableAggregateIntrinsicValue", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Fair Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, grant date, fair value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodFairValue", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term [Abstract]", "terseLabel": "Weighted-Average Remaining Contractual Life (years)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermAbstract", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "grov_ShareBasedPaymentArrangementCatchUpExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share-Based Payment Arrangement, Catch Up Expense", "label": "Share-Based Payment Arrangement, Catch Up Expense", "terseLabel": "Share-based payment arrangement, catch up expense" } } }, "localname": "ShareBasedPaymentArrangementCatchUpExpense", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "grov_ShareRedemptionTriggerPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Redemption Trigger Price", "label": "Share Redemption Trigger Price", "terseLabel": "Share redemption trigger price (in dollars per share)" } } }, "localname": "ShareRedemptionTriggerPrice", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "grov_SharesAvailableForFutureIssuanceUnderEquityIncentivePlan": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 1.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Shares Available For Future Issuance Under Equity Incentive Plan", "label": "Shares Available For Future Issuance Under Equity Incentive Plan", "terseLabel": "Shares available for future issuance under equity incentive plan (in shares)" } } }, "localname": "SharesAvailableForFutureIssuanceUnderEquityIncentivePlan", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_SharesAvailableForIssuanceUnderESPPSharesReservedForFutureIssuance": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 2.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance", "label": "Shares Available for Issuance Under ESPP, Shares Reserved for Future Issuance", "terseLabel": "Shares available for issuance under 2022 Employee Stock Purchase Plan (in shares)" } } }, "localname": "SharesAvailableForIssuanceUnderESPPSharesReservedForFutureIssuance", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "grov_SharesSubjectToRepurchaseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares Subject to Repurchase", "label": "Shares Subject to Repurchase [Member]", "terseLabel": "Shares subject to repurchase" } } }, "localname": "SharesSubjectToRepurchaseMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "grov_SiliconValleyBankAndHerculesCapitalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Silicon Valley Bank and Hercules Capital Inc", "label": "Silicon Valley Bank and Hercules Capital Inc [Member]", "terseLabel": "Silicon Valley Bank and Hercules Mezzanine Term Loan" } } }, "localname": "SiliconValleyBankAndHerculesCapitalIncMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_SiliconValleyBankMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Silicon Valley Bank", "label": "Silicon Valley Bank [Member]", "terseLabel": "Silicon Valley Bank Loan Revolver" } } }, "localname": "SiliconValleyBankMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_SixtyDaysMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sixty Days", "label": "Sixty Days [Member]", "terseLabel": "Sixty Days" } } }, "localname": "SixtyDaysMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_StockIssuedDuringPeriodEarnOutShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Earn-Out Shares", "label": "Stock Issued During Period, Earn-Out Shares", "terseLabel": "Issuance of Earn-Out Shares (in shares)" } } }, "localname": "StockIssuedDuringPeriodEarnOutShares", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "grov_StockIssuedDuringPeriodSharesReverseRecapitalization": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Reverse Recapitalization", "label": "Stock Issued During Period, Shares, Reverse Recapitalization", "terseLabel": "Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $7.1 million transaction costs (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "grov_StockIssuedDuringPeriodValueEarnOutShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Earn-Out Shares", "label": "Stock Issued During Period, Value, Earn-Out Shares", "terseLabel": "Issuance of Earn-Out Shares" } } }, "localname": "StockIssuedDuringPeriodValueEarnOutShares", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grov_StockIssuedDuringPeriodValueReverseRecapitalization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Reverse Recapitalization", "label": "Stock Issued During Period, Value, Reverse Recapitalization", "terseLabel": "Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs" } } }, "localname": "StockIssuedDuringPeriodValueReverseRecapitalization", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grov_StockVestingOfEarlyExerciseDuringPeriodShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Vesting of Early Exercise During Period, Shares", "label": "Stock Vesting of Early Exercise During Period, Shares", "terseLabel": "Vesting of early exercise of options" } } }, "localname": "StockVestingOfEarlyExerciseDuringPeriodShares", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grov_TemporaryEquityConversionOfStockAmountConverted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Conversion of Stock, Amount Converted", "label": "Temporary Equity, Conversion of Stock, Amount Converted", "negatedTerseLabel": "Convertible preferred stock and contingently redeemable common stock conversion" } } }, "localname": "TemporaryEquityConversionOfStockAmountConverted", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grov_TemporaryEquityConversionOfStockSharesConverted": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Conversion of Stock, Shares Converted", "label": "Temporary Equity, Conversion of Stock, Shares Converted", "negatedTerseLabel": "Convertible preferred stock and contingently redeemable common stock conversion (in shares)" } } }, "localname": "TemporaryEquityConversionOfStockSharesConverted", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "grov_TemporaryEquityStockIssuedDuringPeriodSharesConvertibleCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock", "label": "Temporary Equity, Stock Issued During Period, Shares, Convertible Common Stock", "terseLabel": "Issuance of convertible common stock (in shares)" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConvertibleCommonStock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "grov_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues", "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of preferred stock and common stock upon net exercise of warrants (in shares)" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "grov_TemporaryEquityStockIssuedDuringPeriodValueConvertibleCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock", "label": "Temporary Equity, Stock Issued During Period, Value, Convertible Common Stock", "terseLabel": "Issuance of convertible common stock" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueConvertibleCommonStock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "grov_TenYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten Years", "label": "Ten Years [Member]", "terseLabel": "Ten Years" } } }, "localname": "TenYearsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_ThirdPartyProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third-party Products", "label": "Third-party Products [Member]", "terseLabel": "Third-party products" } } }, "localname": "ThirdPartyProductsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche", "label": "Tranche [Axis]", "terseLabel": "Tranche [Axis]" } } }, "localname": "TrancheAxis", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "grov_TrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche [Domain]", "label": "Tranche [Domain]", "terseLabel": "Tranche [Domain]" } } }, "localname": "TrancheDomain", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Four", "label": "Tranche Four [Member]", "terseLabel": "Tranche Four" } } }, "localname": "TrancheFourMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche One", "label": "Tranche One [Member]", "terseLabel": "Tranche One" } } }, "localname": "TrancheOneMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheOneSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche One Shares", "label": "Tranche One Shares [Member]", "terseLabel": "Tranche One Shares" } } }, "localname": "TrancheOneSharesMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Three", "label": "Tranche Three [Member]", "terseLabel": "Tranche Three" } } }, "localname": "TrancheThreeMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Two", "label": "Tranche Two [Member]", "terseLabel": "Tranche Two" } } }, "localname": "TrancheTwoMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheTwoSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Two Shares", "label": "Tranche Two Shares [Member]", "terseLabel": "Tranche Two Shares" } } }, "localname": "TrancheTwoSharesMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TrancheTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Type", "label": "Tranche Type [Axis]", "terseLabel": "Tranche Type [Axis]" } } }, "localname": "TrancheTypeAxis", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "stringItemType" }, "grov_TrancheTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Type [Domain]", "label": "Tranche Type [Domain]", "terseLabel": "Tranche Type [Domain]" } } }, "localname": "TrancheTypeDomain", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TransactionCostsAllocatedToDerivativeLiabilitiesUponBusinessCombination": { "auth_ref": [], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs Allocated to Derivative Liabilities Upon Business Combination", "label": "Transaction Costs Allocated to Derivative Liabilities Upon Business Combination", "terseLabel": "Transaction costs allocated to derivative liabilities upon Business Combination" } } }, "localname": "TransactionCostsAllocatedToDerivativeLiabilitiesUponBusinessCombination", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_TransactionCostsCurrent": { "auth_ref": [], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs, Current", "label": "Transaction Costs, Current", "terseLabel": "Transaction costs" } } }, "localname": "TransactionCostsCurrent", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "grov_TransactionCostsIncurredButNotYetPaid": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transaction Costs Incurred but Not yet Paid", "label": "Transaction Costs Incurred but Not yet Paid", "terseLabel": "Transaction costs, convertible preferred stock and contingently redeemable convertible common stock issuance costs included in accounts payable and accrued liabilities" } } }, "localname": "TransactionCostsIncurredButNotYetPaid", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_TwoThousandAndSixteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand and Sixteen Equity Incentive Plan", "label": "Two Thousand and Sixteen Equity Incentive Plan [Member]", "terseLabel": "2016 Equity Incentive Plan" } } }, "localname": "TwoThousandAndSixteenEquityIncentivePlanMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TwoThousandAndTwentyTwoEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Thousand and Twenty Two Equity Incentive Plan", "label": "Two Thousand and Twenty Two Equity Incentive Plan [Member]", "terseLabel": "2022 Equity Incentive Plan" } } }, "localname": "TwoThousandAndTwentyTwoEquityIncentivePlanMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_TwoYearsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Years", "label": "Two Years [Member]", "terseLabel": "Two Years" } } }, "localname": "TwoYearsMember", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "grov_VestingOfEarlyExercisedStockOptions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Vesting of Early Exercised Stock Options", "label": "Vesting of Early Exercised Stock Options", "terseLabel": "Vesting of early exercised stock options" } } }, "localname": "VestingOfEarlyExercisedStockOptions", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "grov_WarrantLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liabilities", "label": "Warrant Liabilities [Policy Text Block]", "terseLabel": "Warrant Liabilities" } } }, "localname": "WarrantLiabilitiesPolicyTextBlock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "grov_WarrantsExercisedPreferredStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants Exercised, Preferred Stock", "label": "Warrants Exercised, Preferred Stock", "terseLabel": "Net exercise of preferred stock warrants" } } }, "localname": "WarrantsExercisedPreferredStock", "nsuri": "http://www.grove.com/20220630", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r40", "r42", "r85", "r86", "r193", "r234" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r155", "r268", "r274", "r441" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]", "terseLabel": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r168", "r169", "r170", "r171", "r192", "r233", "r291", "r293", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r439", "r442", "r458", "r459" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r168", "r169", "r170", "r171", "r192", "r233", "r291", "r293", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r439", "r442", "r458", "r459" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r155", "r268", "r274", "r441" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]", "terseLabel": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r153", "r169", "r170", "r268", "r272", "r411", "r438", "r440" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r153", "r169", "r170", "r268", "r272", "r411", "r438", "r440" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r163", "r168", "r169", "r170", "r171", "r192", "r233", "r282", "r291", "r293", "r326", "r327", "r328", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r439", "r442", "r458", "r459" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r163", "r168", "r169", "r170", "r171", "r192", "r233", "r282", "r291", "r293", "r326", "r327", "r328", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r439", "r442", "r458", "r459" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r41", "r42", "r85", "r86", "r193", "r234" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r97", "r99", "r100", "r102", "r103", "r117", "r357", "r358" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]", "terseLabel": "Revision of Prior Period, Adjustment" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r1", "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r96", "r97", "r99", "r100", "r101", "r102", "r103", "r104", "r117", "r159", "r160", "r345", "r356", "r357", "r358", "r359", "r387", "r390", "r391", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]", "terseLabel": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r1", "r89", "r90", "r91", "r92", "r93", "r94", "r95", "r96", "r97", "r99", "r100", "r101", "r102", "r103", "r104", "r117", "r159", "r160", "r345", "r356", "r357", "r358", "r359", "r387", "r390", "r391", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Domain]", "terseLabel": "Revision of Prior Period [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r98", "r292" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r1", "r89", "r91", "r92", "r93", "r94", "r95", "r96", "r97", "r99", "r100", "r102", "r103", "r117", "r159", "r160", "r345", "r356", "r357", "r358", "r359", "r387", "r390", "r391", "r443", "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]", "terseLabel": "Previously Reported" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r98", "r104", "r167", "r292" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r98", "r104", "r167", "r292", "r397" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r24", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedAdvertisingCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for advertising of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Advertising, Current", "terseLabel": "Advertising costs" } } }, "localname": "AccruedAdvertisingCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued expenses", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r17", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r89", "r90", "r91", "r335", "r336", "r337", "r357" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r296", "r338", "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r188", "r247", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments to Additional Paid in Capital, Warrant Issued", "terseLabel": "Conversion of preferred stock warrant liability to common stock warrants", "verboseLabel": "Issuance of common stock warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r341" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "terseLabel": "Advertising" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Total Net loss per share attributable to common stockholders, basic and diluted (in shares)" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r10", "r83", "r142", "r145", "r151", "r157", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r349", "r351", "r372", "r392", "r394", "r413", "r428" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r23", "r83", "r157", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r349", "r351", "r372", "r392", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r320", "r322", "r323", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r353", "r354" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation and Liquidity" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r88" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r74", "r75", "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred but Not yet Paid", "terseLabel": "Purchases of property and equipment included in accounts payable and accrued liabilities" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r8", "r72" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsFairValueDisclosure": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents, Fair Value Disclosure", "terseLabel": "Cash equivalents:" } } }, "localname": "CashAndCashEquivalentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r66", "r72", "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r66", "r373" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental Disclosure of Non-Cash Investing and Financing Activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r14", "r15", "r16", "r80", "r83", "r107", "r108", "r109", "r111", "r113", "r121", "r122", "r123", "r157", "r177", "r181", "r182", "r183", "r186", "r187", "r231", "r232", "r236", "r240", "r247", "r372", "r468" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r255", "r298" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]", "terseLabel": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]", "terseLabel": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r248" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise price (in dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]", "terseLabel": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Class of warrant or right, outstanding (in shares)" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r255", "r298" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]", "terseLabel": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofStockholdersEquityNoteWarrantsorRightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r34", "r417", "r433" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies (Note 7)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r164", "r165", "r166", "r172", "r456" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r174", "r457" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "terseLabel": "Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "terseLabel": "Class B Common Stock" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r36" ], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "totalLabel": "Total shares of common stock reserved (in shares)" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r89", "r90", "r357" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r16", "r247" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balances at ending of period (in shares)", "periodStartLabel": "Balances at beginning of period (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r16", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock - Class A shares, $0.0001 par value \u2013 600,000,000 shares authorized at June 30, 2022 and no shares authorized at December\u00a031, 2021; 38,513,779 and no shares issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021, respectively; Class B shares, $0.0001 par value \u2013 200,000,000 and 194,046,918 shares authorized at June\u00a030, 2022 and December\u00a031, 2021, respectively; 124,355,978 and 9,368,167 shares issued and outstanding at June\u00a030, 2022 and December\u00a031, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r280", "r281", "r294", "r340" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r131", "r132", "r155", "r370", "r371", "r455" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark [Domain]" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r131", "r132", "r155", "r370", "r371", "r453", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r131", "r132", "r155", "r370", "r371", "r453", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]", "terseLabel": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r127", "r426" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Risks" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r131", "r132", "r155", "r370", "r371" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage", "terseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r131", "r132", "r155", "r370", "r371", "r455" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type [Domain]" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r257", "r258", "r269" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Contract with Customer, Liability, Current", "terseLabel": "Deferred revenue", "verboseLabel": "Contractual liabilities" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r270" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Contract with customer, liability, revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerRefundLiabilityCurrent": { "auth_ref": [ "r271" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.", "label": "Contract with Customer, Refund Liability, Current", "terseLabel": "Contract with customer, refund liability, current" } } }, "localname": "ContractWithCustomerRefundLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r231", "r232", "r236" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]", "terseLabel": "Convertible Preferred Stock", "verboseLabel": "Convertible preferred stock" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesReservedForFutureIssuance": { "auth_ref": [ "r35" ], "calculation": { "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails": { "order": 10.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Aggregate number of nonredeemable convertible preferred shares reserved for future issuance.", "label": "Convertible Preferred Stock, Shares Reserved for Future Issuance", "terseLabel": "Convertible preferred stock, shares reserved for future issuance (in shares)" } } }, "localname": "ConvertiblePreferredStockSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r53", "r411" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails", "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails", "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r79", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r206", "r213", "r214", "r216", "r225" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r11", "r12", "r13", "r82", "r87", "r189", "r190", "r191", "r192", "r193", "r194", "r196", "r202", "r203", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r212", "r219", "r220", "r221", "r222", "r385", "r414", "r415", "r427" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument, basis spread on variable rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r189", "r219", "r220", "r383", "r385", "r386" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "auth_ref": [ "r32", "r424" ], "lang": { "en-us": { "role": { "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).", "label": "Debt Instrument, Frequency of Periodic Payment", "terseLabel": "Debt instrument, frequency of periodic payment" } } }, "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r31", "r218", "r383", "r385" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument, Interest Rate, Effective Percentage", "terseLabel": "Debt instrument, interest rate, effective percentage" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r32", "r82", "r87", "r189", "r190", "r191", "r192", "r193", "r194", "r196", "r202", "r203", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r212", "r219", "r220", "r221", "r222", "r385" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r32", "r82", "r87", "r189", "r190", "r191", "r192", "r193", "r194", "r196", "r202", "r203", "r204", "r205", "r207", "r208", "r209", "r210", "r211", "r212", "r215", "r219", "r220", "r221", "r222", "r248", "r251", "r252", "r253", "r382", "r383", "r385", "r386", "r425" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r70", "r140" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability, Noncurrent", "terseLabel": "Derivative liabilities" } } }, "localname": "DerivativeLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r268", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r51", "r94", "r95", "r97", "r98", "r99", "r105", "r107", "r111", "r112", "r113", "r117", "r118", "r358", "r359", "r420", "r435" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Net loss per share attributable to common stockholders, basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r51", "r94", "r95", "r97", "r98", "r99", "r107", "r111", "r112", "r113", "r117", "r118", "r358", "r359", "r420", "r435" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Net loss per share attributable to common stockholders, diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r114", "r115", "r116", "r119" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share Attributable to Common Stockholders" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholders" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Compensation and benefits" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount", "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Share-Based Payment Arrangement, Option [Member]", "verboseLabel": "Common stock options" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r45", "r46", "r47", "r89", "r90", "r91", "r93", "r100", "r103", "r120", "r158", "r247", "r254", "r335", "r336", "r337", "r344", "r345", "r357", "r374", "r375", "r376", "r377", "r378", "r379", "r391", "r443", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r70", "r226" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "terseLabel": "Changes in fair value of derivative liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r360", "r361", "r368" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r204", "r219", "r220", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r361", "r399", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r360", "r361", "r362", "r363", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements and Fair Value of Financial Instruments" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r204", "r283", "r284", "r289", "r290", "r361", "r399" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r204", "r219", "r220", "r283", "r284", "r289", "r290", "r361", "r400" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r204", "r219", "r220", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r361", "r401" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r364", "r368" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r365" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "negatedTerseLabel": "Changes in fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r366" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases", "negatedTerseLabel": "Assumption", "terseLabel": "Fair Value, measurement with unobservable inputs reconciliation, recurring basis, liability, purchases" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r364" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Balance at June 30, 2022", "periodStartLabel": "Balance at December 31, 2021" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r204", "r219", "r220", "r283", "r284", "r285", "r286", "r287", "r288", "r289", "r290", "r399", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsNarrativeDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisObservableInputReconciliationDetails", "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r367", "r369" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueLiabilitiesMeasuredonRecurringBasisUnobservableInputReconciliationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.", "label": "Financial Liabilities Fair Value Disclosure", "terseLabel": "Financial Liabilities:" } } }, "localname": "FinancialLiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r70", "r223", "r224" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r52", "r83", "r142", "r144", "r147", "r150", "r152", "r157", "r177", "r178", "r179", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r372" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r49", "r142", "r144", "r147", "r150", "r152", "r412", "r418", "r422", "r436" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r84", "r102", "r103", "r141", "r343", "r346", "r347", "r437" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Provision for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r69" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r69", "r409" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "terseLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r69" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r69" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r69" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedTerseLabel": "Prepaids and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Temporary Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInTemporaryEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r48", "r139", "r381", "r384", "r421" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r65", "r67", "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r22", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r161" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write-down", "terseLabel": "Inventory reserve" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit outstanding, amount" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r28", "r83", "r146", "r157", "r177", "r178", "r179", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r350", "r351", "r352", "r372", "r392", "r393" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r21", "r83", "r157", "r372", "r394", "r416", "r431" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities, convertible preferred stock and stockholders\u2019 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities, Convertible Preferred Stock and Stockholders\u2019 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAssumed1": { "auth_ref": [ "r74", "r75", "r76" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.", "label": "Liabilities Assumed", "terseLabel": "Assumption of derivative liabilities upon Business Combination" } } }, "localname": "LiabilitiesAssumed1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r6", "r30", "r83", "r157", "r177", "r178", "r179", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r350", "r351", "r352", "r372", "r392", "r393", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r13", "r415", "r427" ], "calculation": { "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-Term Line of Credit", "terseLabel": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r26" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails", "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage", "terseLabel": "Line of credit facility, unused capacity, commitment fee percentage" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r13", "r203", "r217", "r219", "r220", "r415", "r429" ], "calculation": { "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "totalLabel": "Total debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebtNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-Term Debt, Current Maturities", "negatedTerseLabel": "Debt, current", "terseLabel": "Debt, current" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r13" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long-Term Debt, Excluding Current Maturities", "terseLabel": "Debt, noncurrent", "totalLabel": "Total debt, noncurrent" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtPercentageBearingVariableInterestRate": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.", "label": "Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate", "terseLabel": "Long-term debt, percentage bearing variable interest, percentage rate" } } }, "localname": "LongTermDebtPercentageBearingVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongTermPurchaseCommitmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Long-Term Purchase Commitment [Line Items]", "terseLabel": "Long-Term Purchase Commitment [Line Items]" } } }, "localname": "LongTermPurchaseCommitmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermPurchaseCommitmentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule setting forth key provisions of an arrangement under which the entity has agreed to purchase goods or services over a period of time greater than one year or the normal operating cycle, if longer, including the item for which expenditures will be made, minimum quantities, milestones, time period and committed amount.", "label": "Long-Term Purchase Commitment [Table]", "terseLabel": "Long-Term Purchase Commitment [Table]" } } }, "localname": "LongTermPurchaseCommitmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r32" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r32", "r176" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-Term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r124", "r136" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r66" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r66", "r68", "r71" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r2", "r43", "r44", "r47", "r50", "r71", "r83", "r92", "r94", "r95", "r97", "r98", "r102", "r103", "r110", "r142", "r144", "r147", "r150", "r152", "r157", "r177", "r178", "r179", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r359", "r372", "r419", "r434" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r55" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Interest and other expense (income), net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses [Abstract]" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r142", "r144", "r147", "r150", "r152" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r389" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r389" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease liabilities, noncurrent" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r388" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r9" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other long-term assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other Current Liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r29", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r33" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r13", "r415", "r429" ], "calculation": { "http://www.grove.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-Term Debt", "terseLabel": "Other long-term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r71" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Other Noncash Expense", "terseLabel": "Other non-cash expenses" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r56" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "negatedTerseLabel": "Other expense, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaidInKindInterest": { "auth_ref": [ "r70" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Paid-in-Kind Interest", "terseLabel": "Non-cash interest expense" } } }, "localname": "PaidInKindInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r60" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Repurchase of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtExtinguishmentCosts": { "auth_ref": [ "r63" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.", "label": "Payment for Debt Extinguishment or Debt Prepayment Cost", "negatedTerseLabel": "Payment of debt extinguishment" } } }, "localname": "PaymentsOfDebtExtinguishmentCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r62" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedTerseLabel": "Payment of debt issuance costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r64" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedTerseLabel": "Payment of transaction costs related to the Closing of the Business Combination and convertible preferred stock issuance costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r57" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedTerseLabel": "Purchase of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r320", "r322", "r323", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r320", "r322", "r323", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name [Domain]" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r15", "r231" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrimeRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.", "label": "Prime Rate [Member]", "terseLabel": "Prime Rate" } } }, "localname": "PrimeRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r59" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-Term Debt", "terseLabel": "Proceeds from the issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r58", "r334" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options, net of withholding taxes paid related to common stock issued to employees" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r162", "r394", "r423", "r432" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "terseLabel": "Purchase obligation" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r61" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-Term Debt", "negatedTerseLabel": "Repayment of debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r342", "r410", "r460" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Product development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]", "terseLabel": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]", "terseLabel": "Restricted stock units" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r18", "r254", "r394", "r430", "r447", "r452" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r89", "r90", "r91", "r93", "r100", "r103", "r158", "r335", "r336", "r337", "r344", "r345", "r357", "r443", "r445" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated\u2028Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r137", "r138", "r143", "r148", "r149", "r153", "r154", "r155", "r267", "r268", "r411" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue, net", "verboseLabel": "Total revenue, net" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations", "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r78", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r279" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue from Contract with Customer [Policy Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenues [Abstract]" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails", "http://www.grove.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Sale of stock, consideration received on transaction" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]", "terseLabel": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of stock (in dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales and Excise Tax Payable, Current", "terseLabel": "Sales taxes" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesScheduleofAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r131", "r155" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]", "terseLabel": "Revenue Benchmark" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of Accrued Liabilities [Table Text Block]", "terseLabel": "Schedule of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtandConvertiblePreferredStockandCommonStockWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r360", "r361" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/FairValueMeasurementsandFairValueofFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule of Nonvested Performance-Based Units Activity [Table Text Block]", "terseLabel": "Schedule of Performance-based Restricted Stock Units Activity" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r295", "r297", "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r320", "r322", "r323", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r302", "r318", "r321" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Share-Based Payment Arrangement, Option, Activity" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "terseLabel": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "terseLabel": "Schedule of Restricted Common Stock" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r14", "r15", "r16", "r80", "r121", "r122", "r227", "r229", "r230", "r231", "r232", "r233", "r234", "r236", "r240", "r245", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]", "terseLabel": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r255", "r298" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of Stockholders' Equity Note, Warrants or Rights" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r54" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r14", "r15", "r247" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r14", "r15", "r247" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesCPreferredStockMember": { "auth_ref": [ "r14", "r15", "r247" ], "lang": { "en-us": { "role": { "documentation": "Series C preferred stock.", "label": "Series C Preferred Stock [Member]", "terseLabel": "Series C" } } }, "localname": "SeriesCPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [ "r14", "r15", "r247" ], "lang": { "en-us": { "role": { "documentation": "Series D preferred stock.", "label": "Series D Preferred Stock [Member]", "terseLabel": "Series D" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesEPreferredStockMember": { "auth_ref": [ "r14", "r15", "r247" ], "lang": { "en-us": { "role": { "documentation": "Series E preferred stock.", "label": "Series E Preferred Stock [Member]", "terseLabel": "Series E" } } }, "localname": "SeriesEPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r69" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period", "negatedTerseLabel": "Cancelled/forfeited (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r317" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value", "terseLabel": "Cancelled/forfeited (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Granted (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Granted (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r312", "r313" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Outstanding and unvested, ending of period (in shares)", "periodStartLabel": "Outstanding and unvested, beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r312", "r313" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodEndLabel": "Outstanding and unvested, ending of period (in dollars per share)", "periodStartLabel": "Outstanding and unvested, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period", "negatedTerseLabel": "Vested (in shares)", "terseLabel": "Vested (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Vested (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r327" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r326" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Share-Based compensation arrangement by share-based payment award, number of shares authorized (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r305" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, exercisable, weighted average exercise price (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedTerseLabel": "Forfeited and expired (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Forfeited and expired (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, grants in period, gross" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r319" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Fair value of common stock (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r333" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "terseLabel": "Options, outstanding, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Options outstanding, ending of period (in shares)", "periodStartLabel": "Options outstanding, beginning of period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]", "terseLabel": "Number of Options" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r303", "r304" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Options outstanding, ending of period (in dollars per share)", "periodStartLabel": "Options outstanding, beginning of period (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]", "terseLabel": "Weighted\u2013Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r323" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value", "terseLabel": "Options, vested and exercisable, aggregate intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number", "terseLabel": "Options vested and exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price", "terseLabel": "Options vested and exercisable (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost": { "auth_ref": [ "r331" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "An excess of the fair value of the modified award over the fair value of the award immediately before the modification.", "label": "Share-Based Payment Arrangement, Plan Modification, Incremental Cost", "terseLabel": "Share-based payment arrangement, plan modification, incremental cost" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Share-based compensation arrangement by Share-based payment award, shares issued in period (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r299", "r300", "r301", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r312", "r313", "r314", "r315", "r316", "r317", "r319", "r320", "r322", "r323", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofPerformancebasedRestrictedStockUnitsActivityDetails", "http://www.grove.com/role/StockBasedCompensationScheduleofRestrictedCommonStockDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "terseLabel": "Exercised (in dollars per share)" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Vesting rights, percentage" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r325" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationScheduleofShareBasedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r322" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Options, outstanding (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Options vested and exercisable (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r320" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value", "terseLabel": "Share-based compensation arrangement by share-based payment award, options, vested in period, fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r323" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Share-based payment arrangement, option, exercise price range, exercisable, weighted average remaining contractual term (in years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Original issue price (in dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]", "terseLabel": "Shipping and Handling" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r173", "r175", "r348", "r454" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters of Credit [Member]", "terseLabel": "Standby Letters of Credit" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r14", "r15", "r16", "r80", "r83", "r107", "r108", "r109", "r111", "r113", "r121", "r122", "r123", "r157", "r177", "r181", "r182", "r183", "r186", "r187", "r231", "r232", "r236", "r240", "r247", "r372", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CommonStockandWarrantsScheduleofReservedforIssuanceDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails", "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/RecapitalizationNarrativeDetails", "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r38", "r45", "r46", "r47", "r89", "r90", "r91", "r93", "r100", "r103", "r120", "r158", "r247", "r254", "r335", "r336", "r337", "r344", "r345", "r357", "r374", "r375", "r376", "r377", "r378", "r379", "r391", "r443", "r444", "r445" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r89", "r90", "r91", "r120", "r411" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficitParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockCompensationPlanMember": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.", "label": "Share-Based Payment Arrangement [Member]", "terseLabel": "Share-Based Payment Arrangement" } } }, "localname": "StockCompensationPlanMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/StockBasedCompensationNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r37", "r207", "r247", "r248", "r254" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Stock issued during period, shares, conversion of convertible securities (in shares)", "verboseLabel": "Convertible preferred stock and contingently redeemable common stock conversion (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Issuance of common stock for services (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r15", "r16", "r247", "r254" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of preferred stock and common stock upon net exercise of warrants (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r15", "r16", "r247", "r254" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Issuance of Class A common stock issued to employees, net of withholding taxes (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r15", "r16", "r247", "r254", "r308" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Exercised (in shares)", "terseLabel": "Issuance of common stock upon exercise of stock options (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/StockBasedCompensationShareBasedPaymentArrangementOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r38", "r247", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Conversion of preferred stock warrant liability to common stock warrants", "verboseLabel": "Convertible preferred stock and contingently redeemable common stock conversion" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Issuance of common stock for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r15", "r16", "r254", "r319" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "negatedTerseLabel": "Issuance of Class A common stock issued to employees, net of withholding taxes" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r38", "r247", "r254" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Issuance of common stock upon exercise of stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r15", "r16", "r247", "r254" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Repurchase of early exercised options (in shares)" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r16", "r19", "r20", "r83", "r156", "r157", "r372", "r394" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balances at ending of period", "periodStartLabel": "Balances at beginning of period", "totalLabel": "Total stockholders\u2019 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders\u2019 deficit:" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r81", "r232", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r246", "r254", "r256", "r355" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Common Stock and Warrants" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r380", "r396" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r380", "r396" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r380", "r396" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r380", "r396" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r395", "r398" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]", "terseLabel": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/RecapitalizationNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Disclosure" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]", "terseLabel": "Supplier Concentration Risk" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r7", "r228" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]", "terseLabel": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r177", "r181", "r182", "r183", "r186", "r187" ], "calculation": { "http://www.grove.com/role/CondensedConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "periodEndLabel": "Temporary equity, balances at ending of period", "periodStartLabel": "Temporary equity, balances at beginning of period", "terseLabel": "#REF!", "verboseLabel": "Net Carrying Value" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheets", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]", "terseLabel": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockNarrativeDetails", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityLiquidationPreference": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Liquidation Preference", "terseLabel": "Liquidation Preference" } } }, "localname": "TemporaryEquityLiquidationPreference", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r7", "r228" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Temporary equity, par value (in dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Authorized", "terseLabel": "Temporary equity, shares authorized (in shares)" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CommonStockandWarrantsNarrativeDetails", "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Issued", "terseLabel": "Temporary equity, shares issued (in shares)" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "periodEndLabel": "Temporary equity, balances at ending of period (in shares)", "periodStartLabel": "Temporary equity, balances at beginning of period (in shares)", "terseLabel": "Temporary equity, shares outstanding (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedBalanceSheetsParentheticalDetails", "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit", "http://www.grove.com/role/ConvertiblePreferredStockTemporaryEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of new stock classified as temporary equity issued during the period.", "label": "Temporary Equity, Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of preferred stock and common stock upon net exercise of warrants" } } }, "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofConvertiblePreferredStockContingentlyRedeemableConvertibleCommonStockandStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r7", "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity [Table Text Block]", "terseLabel": "Temporary Equity" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/ConvertiblePreferredStockTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r125", "r126", "r128", "r129", "r133", "r134", "r135" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Common stock warrants" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CoverPage", "http://www.grove.com/role/NetLossPerShareAttributabletoCommonStockholdersScheduleofAntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r106", "r113" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r105", "r113" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.grove.com/role/CondensedConsolidatedStatementsofOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r119": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r166": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907907&loc=d3e12803-110250" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r225": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "27", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130611-203046-203046" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225" }, "r281": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r294": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r398": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r461": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r462": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r463": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r464": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r465": { "Name": "Form 10-Q", "Number": "249", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r466": { "Name": "Form 8-K", "Number": "249", "Publisher": "SEC", "Section": "308" }, "r467": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r468": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r469": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r470": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r88": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" } }, "version": "2.1" } ZIP 71 0001841761-22-000015-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001841761-22-000015-xbrl.zip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

SV!O-J#;.A7OHK/W$N-U*5X^C W77"=SXN7"T@BQ;].! M_N4MX^QI-[-V=]1U?:V=('<2!EG-^T4XAVXY^6?C%TK><&:5#%QE\PQUG' : MJ#.@D!J7KBW[,RM4S3F%=G[$N?\B@B;)7LY5O&B2O:-6I_49QKG;^;JW^_ZL M=7'XM?FY>;9WM'>6G4-[?\\[@_Z!^82CY@7,A7XB7[8_DIW/?QTV=[?8SF\? MO^]=O&VWCMX>-C__>C@=--G,V3=G^XIR'F!C49!:(]AY@XQ5$;$H18S"QL3Y M73=&7H_:^K=L2%J#X@L"18T)"30F#'#(0V+.<1&,MR0(;))V-2@^95 $,&R/ MXIJ:=&=K7SBMHG<"62II;D9BD66Y6SP++D4FX35Y6J#X$F(Z9X//;V0B?6$A MGRL@'O4F2BFT\-9Q)ZDF&F8MX37%"GMSXXC/NX>^EQ6C_G 8.(H2.OI*6Q_W M%0]"!QX0UE8AKCU%SBB%DC%"$494)/[5&[;!Q(I5U>XUOO.NS2(O'@>""AKX M6RM&"4_*:*$3Q3@9DD+0A-"$+(4_AAE6*(,1(]$XSX#%]B2:3SS?-3EF/'8QJO:JY_ M"@),S?5WQ/7->:%%$)-H] %1[Q*";6?(.1E0\L$JAA/PNWGU1G*^'ES_$JPS MJZ:KU3UMZYZVMZNSK:+@WM'@J>78:6=\5)IR:AR#?]?687T0FWVMK-X2]^>\ MF=)I0YE"43.-N(P1628U,E[D$D"6:Q5R[6PX]Y]![]NZBWB-N.N$N"I01H(( M2CG#">/&&*P#MJ!Z:9]2J!'WR2/NQWE7*55)46$%,CH5W<8)) M:Q,*-\&JE6S6$G$7NHU/5\%^F1VQW_6ZQ9+E'?BS'U/LYQR1,J5D/K?G_"9Y M4"O5:9U*')-/KYO[DB2.D_$2#HHEK%)PILJPMG-BSS#VCXOZ0@_ Y^ZW6^Y>I'N:$\W/RT6U7P M+GK%9S]YOJ$].>F,Z@'#Z&#"]J" XR+P0?TR:!R=AH.R#?*])+1\(%]3H12J5G++AH'8EK5#[V>8JS)T>MB\YABW[B((+"&#_@G=U6 M.S<-V-G^0)LP+GB-FQ>'G05Q]KC)=CZ_9U]@3"#*TKVCCZ))/XC6Q2<8W][W M/=H4>:X[O_TS%PX-S_BX;TAB+":-O XN-Q,,R#D;D-0Y'CY1QB7-WFZEU:-Z MNTLV>DA7]^,Q[IW5:KR5P^OQYK^*MXL9:2P0J>6,<"R[\ :\$G*BE'7A&"N+(8&8(Y"C80HE0.9U>OWI -21[-#WX;1'MJXF4K M#AOQ>^S[]J!0=BY1=!XA/+E&N3NNHEWCU@JX]6$*MSQI7KS?#]CH0(U#S&B. M>,C-4 FC2*D XKCA7"7SZHW1YK'*R[XD06RD%;L(1W7,15]FFT9=Y]I?14B[ MA5MIS8!ME=Q;XTR*GE)'/ ?%4UN@^"1T8#P(3D5=D_79 5WKZ$,.4PR2,865 M0]0YT#MM\$A'.+Y<\D)G%TNP1=-GHNF:YIN])/GMKWGD&_8:>>SYM>TT3FP[ M(%!7O3W);I1:BKLD'CMY;8(UPFK!&>7:&D:=5)QQ(_GU 3HUVCU%M/O>VMJW MD5ANM$"4!0U271)("Y>06O6"/.?73F%Q]#B"^NC-7":"^F0 M-X$@GG!$UFF&DK28>^H-L?:>RBD\4)30_&EQ71^"ZX-]GGWYTU$YV]Q>&C8C MY+;PO<$@UY/-[#SFZBOLHU.!('#1*AWDO2-*>V6]8+%P\ 9F%7=$,QVI(*$R M(/(K.L@/8%WAU9K[2UY>;_F/YS#:?2)TLB!=(BX!=WB@$CD:"8K1,.DX5C%W MIL*;[-)^\D48U"HTQ5F0CI%\F%'.F+;>:FJQU])Y&5-)4V1$4Z2FJ:=#4Y]P M/B5;.XCT#G?*-ZWC0/8S%71SRH5 ML0\BV"@XT*K6WOB4HJ"264?5=>X341/HFA$H@-[%UCZE4IB@#=+$@YSEL$,& M-A=);IR11&JLS:LW9'/1QSL#>J.#>#6BXM3R8!+SUC+0[9DCE!G%!#;<>A#Y M*_@C-?P].>J:@3_1VMHWQ"2,0T 6I"C$?2+()!612L1K125@H'& ML> 3+QQ<=Z4=>JXKPVI:2=V0:GE#*K*P%C=K2)7G4L#(M>V0F'IU!UVL%*V[ M6-5=K.HN5G47JRNZ6$VGR>C+TZDJ Q*:.A<>>DYBLSSM%W_>4Z^8D3"ZY7WO M% CB3WN>N7NK&^"=/I#%5/N8[?8@BQ8@V:Q).YB+UKDY]L>_=K/MW0]B[_BO]I?CWV$$'R^:NY\N_F!_=>+__77^Y7,X M<93+G5T84[[_T=99\ZC5;OWV\?N7W''VJ-/^\MOOQWO'7XY;V\WOK=U6:NYN MB9W=3]^;NWN@F1S0UL$^8U3SD!+BE$E03J)#5M. J 0$58(X+FVI4A1@J3W00SY0F ?.X8&MC_M)$1$<*!Z4.]!# M5)3()6L15L1C0:ECS"UT&'H>V:,C4H\5J6-%%=%Y,F9PDA /Y MDBGK,0\A6=YO97VCKZR%I'H=W:]>?-SW^UF]N=-EPOFO0]'WT'GG7ZA7Z2 MS8OW=&]WZZ+YVZ>SG=T]VMKVM$4_D-;%A^]??OMPMO/Y PB;7R_V=@_3.(H% M?K=V/^Y'S+4T'B/,378L:X^<]A(T&!$)U1ZG)'*I&_CD;DO=/(OR836VO01L M,]Y&9KS!% <>$S,L2F<%9DK2G-IRHT9)-;8]!+9=3&,;BSQ)+1,R.K>!RR4/ MC.8X%\PES$O,8["Y[H$4BYEVZXAM+Z+^?^\XZ_Y5[ETW-%SLQM3^P;3AIUL- M_ %%KY&1[OWQ2:=W'N-?V;4Y8Z*KD>JND:H]*X5I*YGP"J,8A$2H!2,5"XY*['+66!8W57.:UVK_X:=%$,QFB(XRO<&=9_$^Y?< _X()A$<(!%D"H([/YQ">)%:#)WX@ZJP&=JV=_E5:\1Z(X1J/5N5H80@AH;,0;)(2>" M,=!AK L<::Z##U$'ZUBV1A!^:QFBMD:L+P_?B=NCYN$'X^%9*8(!ON9F@4X; MD/YE"BBWAD4ZL20M,R)04? PO76G\]H.L1('_FUS*XNA_;X845/K+W=M@2@6 M>ZL;WG_/R6Z[]GL5XE[CSUWCSUQ%1)0$SI7T)B6; M\4>PV@[QC/GXKNP0-1\_'!_/QE (*YSE$C$J N(!$Z25=$BDY),BF O#,Q]K M%A[#?L7,9E M;9&X;XM$L>Z+6= U&-VC-)$5&>PE8R(ZA!6/B%O!D<$.Y(D(6RH3I8+&5V_T M!L9WE>A2&R36D(WORB!1L_'#RQ29C:54BFG"@8.31QP[@[3#'#%,5"3!&I_8 MJS=R [2#-6+C.[)'E-S(UERRV.T-;>=:R6*MZNX_D?R[!RV]_U00_8Z#56LP MOT:D?MH3^O9B% M:N2LD7.M9.$:.1\".6?$8*>,XTQ3E%R0B'L=D8,]0S0*FJQ64GOZZ@W%&U*0 M9X"XM;5/F&/6"H<(-A1Q1@5R#C1U:E2PVN#("9TOALE9;H4LX,,H M>$K4)N>M"H!G#+;$+Q3#S(O?^($*F-<_9W9IJTKJ=9U]-\P:4BZWJ:=3W-FT;]@V8,Z-OXQW8Z\;SQUG:_-O[HP3C^BM]Z M'1AI75VSKD!W>6M'*W,3(HZ%49P[K25VRLN$G>=.QAMWF/T#!K&3WO5C:#\- MX\R/"IN5<<;GHNKP_+\ZS>V]BV8VSM"FV-G^]+WU6_[]]KAY$8Z;]#V>-\[ M/+ZW+CZ(+[]].H/1G[>V/=N[^,I;N^]Q_MW,S:1H;DKUUT)-3>><=SH9E +6 M()UJAYQ1&$FE#6@?!FLI7[T1&^;V^9-U3#>8<6$NZGMN4:T>T*T&7-S8B'P*##RW&/$/37(>)R[Y'E)$^R3$/0I M(=I+R ]9)G'F@IK_%_O^-*>@-N/%A>W"]QJ[L7]<2*-U"LFE$AAWW!*L,1:$ M,\FT3(PE$BPE7DC+5PK__*/7/2S9MU[8MT9>8,:K0UF$H&F*Q$'W3='>8)"96#GC#?<$%^R[NW3Q^N\D=7* M: YCI[1<_6I]V;!WNV_/&JQ.';FTBW@0!,> (Z>*!\L-YLI2[[@"54<17,L. MCP] )I?SUC!>IS#S.EODCCD7$R_%$@ZFI)C+&*<4R-M<9CYA)WDH,PL5K2 MZ2S^U!!S8XB9KX^IE'*)F82$5CGZR#MDC)<@(1BIH_%6)M!.B*ZM"L^8-;5A M$O[#(0?/!\:M,\;QR%C GAB9;B$:U*RY"FO.MM^PH&DIYU"D#N1VS!,RW$I$ M$Y9)8JM](J_>4/D,BUX^I>30')=X&WO!+5S%3QIT[BK7L59%[@6,YN) 2$HV MA1B18A0C3H5"1E"&*.:@C$1/E):OWDBY :+=DW";/H)]X:5R^EWEYM65+ M^#)A]859(GYZ9-'C*:4)/PU Z,>Q^21,VX=\^XLP&723OB%462Y,*W42JDG0J(&:.5$DX; MD4V,>$.)15/&HS#N"[5B;#1@Y2^1'FXHPM6%6NYI:=8;PQ]9]FJ-R;9&\3M# M\;DHD@#4*'6@R$NO$,^Q\R:%A$C0PA'JO>+NU1O.-J2Y=5_W.V2KOI" M\2]___-V=NF*]\DO/S?.VL/#QK*5_FGRU='%FXU<3P8&<#P8E819N/%&PPX: M (BPCJ$863\.AG88PT;CI-_[ULYO Q2^;OS4_ADFT"\*&N22,GDE\EU]D9T) MBM*P 5.,WX'E0N._5@F#PIPZ!YND1.1<>N,(R%$\L!08)4ID("=R GQVUZ_7Q3">6=/X)/A^/_A6DSP&=\W/)%(K$/>.IR[ M\A $_SPPCZ58,$L$"Z_>4+&Y:)IH 'MU\FZ/:'&F!L:(*C> E("6 *G/@)2] M/6D7%:7#-]OUL,W%&-TQ!64D C(I,*<3AX!A4U@S@,.[?=P>KDH201C0V"PF/&FN M?+0R12F%@O\2@R'72/-P9/))[.>]$,Y*A'FTB(O<.4@%B1BS(,X'KKFVN13D MY4!3'G!CJ&@<6CC#&K#:Y=D:X!R#DW?Z?*:T("V0^?(G^6P>#!MVV/BS#S)! MXZ_\A9/<.:<+.P4G8-F'LG$,5'38.2\?-P-J^4[EAF82C 98$&?LC>MP:;/T9^[F0E#T (O[0_08O>_WS MM[:3\7=,D8B^-)*\ .1RRA.97.YCY27B<'(@2Z)&7@EE5=1*D1S4LTB1_YVQ M*()\VL[TTAZM:L.5RSK8_/&2>^LM^VZ=]-N=S%CD*L&W6XJ8A9P+?U\BB9X= MMOTA? -$8Y!)&VFD-J182)JK,5*446(N)>R8Y=C!Z4\%\S92YD"FC:$HTTDP M+\MTPHM9^RJ_">A_ZIX.8ABQ%DP=F+Z0$F*<,-G+9:F=[4_G^X%@0YQ32.-< MTC-8C8S/2K_A%"!>)*[(JS=X8#%H*8,(_X5&KUN03[! S@T+" =+ M#*00^O:LVSCI]0O2 &JY3%/9; #59A[+%VZ,V'*:>R[UI#T46Q43G#UF+I>! M@%WZT0[*LV85:2A:P[T0BFNB>:"^\#O07-P*#AV7JLSY>;ZHI:%[J8'[O;FU M[R@1UFF#/.4".(4Y9+ U2! BDA IQ[=GM_!5FE<6;H;+B/JA:/EFLG5[ , >3CW0CCN?*8U<(N1@"B(S+XQ>?H/C MHA#E*^EC)*:D?N^XX6-_:$%/J"[VMA]&PD<[#D9RB2W4_M5QED=/J5-)!>TX MI]8I[:1E&I02H2F)E_AW%W&VG. (:G5>OP.*G-KO>J_+A/ M U-&8XF893;;+QER3N?\34P#YS':" A%-A&-PI!0(M;(=#Z'7-%F%:8[L3'TLVDA_N?4=D80= !G8"73G136A^*2 M7G_%$Y%X#((;%Y$EP7V@V;(EA>>"1&<-)069,0#! M_0,_,WI^J&:3[20O^2ALBM;'?:M=3"E:T&2T0UQCC+1G#"6?&+$XB&@*2*'+ M#L,IQ09@I;!8@0P&F]VT?7]8$1HI"(UEC:6BHDKYF24V.!/G#%79Z&7[_4R$ MEQL>'M*3>+6Z<^D0GX@MA-!%6XCM=$8^MZL:.I1"Q2 KL+"3([O(Q*()HBD M0TSM;I:20B.T^P!,L,/#0]!0#P['7YDI_CCK=?UI$",@4J=W5GD$1\)/B-DW M"#,)Q6W&CX%7)T!NL9!VX$ZPP##6T_;@L##@3+D2)P,M78<^^])#X>@<%.2\ M^-55CE#&O8N12V.,Y7!XVHQK*KMPB(I,RWD;SI*S= "D J_FX>XWD/<&?_2R M46&G^WYFD&53EOJ,O:9;"VX>[7'06D$'4U)IBRBG/-=+B"!C,8FDHLI(CD&7 MS<',2Y36$N5&XE4XS2=-05E V['"LD&C/%Y'S1@*[MJ\42#!D[.F[BZSBF9T M+YJJ *O"J"]*Q6=PZC*$#-L ,^=784TVFPT+3K2-U.[#$0(8U2N\(\X.VH-2 M28*A97YH>%@0F >H93'K9X.RRTRRIYUAB1Q+AM?UG=, BV 3W!\8!H2FW*'F MH'J5[U_""HP5G@3WM?G.PT,[+&(-^FT_7#YT5SYAV-O(, FTT:D]Z@>,CK M?NP4\YHTI_GOV=Y#58P1GGS%ND&O*?9NJL')B*O*@;PI&GO, M+=W4S\/^Y+P^B,B!W/$5%"N8R6O;.;/G@U?_FN518-#JR2KSZ&4+,\7+_"JF M3.G>F+*$AI#/M8)"7A?G=+X*AF/79BP- $PX+__?]8T!%2FZB&_*J(1G-M^?/G7M:Q!S)S@X= K.+D_](GX!WLY!?-V0C\1^ENQ/0<&T@]S!K>>_;F11 MXBCZPBT[=?Q_]_&D>-)EY_Y$9JB,I\L.^=)PVH\P\*S>3AM>\]S@:\57X4#( MWJ)&IPT7AGSW%?6$V[JR"E-;LQS%'Z-![/;>QF8UQ!AJ?6"I/G#4Q#L?]XV1 M"6,3$6AJ!''B K(Q5 MI&L/#OI9RHR5#IW?/^V.),HJF!6T!I 2L]4,WO!V< @W+"0S^+.,I 7"/NF< M#L:*^(RGP %7%7[EB7I>1/#V*]-+&3P;,G:48;*-3-K3^GWQ @3V1>]$>S X M+85Y&,-FXWFJ-%N7V$YG8T5RP%1VO\"?G79A@"CV)JLU$RS)VYGCNQ[%];)R M'YJ7!P1[K'6PKX)*T@F.8H(?7"B'C#()28]EXHH!'N?DCJLB/Z>Y9\)VET5S M;%2DTFUD6VQALI^SN:\<./1C1+-@4)^-&YZVG+\?C;2.$1\Z,RST!-O&2*"$ S[M%S[7.J+G"T/M,TVMN%F(X MU?%H;)#^>Y1ELS7)LIG*L+E\*>?2;>:O?5X8P';C[C#_$+6";(&XDC#&G_Z754<2VMC$)N!, M3[LMG:.S5.63^6169A9F](I*JU'.=+]Q,LBG&ZT0]L#ER&[,01PY-_.YU<1" M7A&LO\#YKRHFLMH;+Y^8)VE+F4,;.J=' ^:8XPQEK?5\J6"46=:[::C!)BXL M,39)3;C4TDC@ARI8SC7UG@PZ0V-30^6.H +_?-QC"H96^H!T(* QDP._0D:/ M&$Q&)N-4!'954>)-\[><4F#../&2)$YIM"+!M :A&.>61G%!@X':>5QHDL$' MH$83(C!'RE*%.!,::>HBLDHQ$Y4E3K(K\I\G4[<>,P_Z/&YZ"6$?I8GE5*"R M@GE>D3:5(G;#-.F%Z%V=%'8;&?[X$VPZ W7!D[7(:="$D:QL@*F%6L6 #>>64KAQAA?4>XTTQ9E MDMB_SKD"?QV#.(;MH^'$YPDG+WK&"9@F[VAN]@1DWN:20=!12$MND&0PV-HE M)V*)7,R9\ L*3$$&CGSK&/1!-\()Q6T=.(Z^[@HSELH)E+W=KM9[A\'.,2J;U]W: MC:&#,IJQEJ(CDHA7Y_]-V=P=5^PGIC(F?.GF^M[W/N0HE H*0%T M%@N&#"<2"1 53@Q7%HM<^3[?2DRO?^4DSD%GF4%,:'66>!S8[[&HCRH1"B0D M@7-V4S&AU@:!"4DFC0-S,B^?\G_+C-]L1IV.0F#,DG(N;UWJ5$C>Y7J([RF-_ MT^[T:O%DSZ?*,F!\,26+CRI TO"P,W M@W'>@@(4!@?50;CF24M*2;$(L+BH!J&%_:J^:CV/KY&>[Q'F]M M?#O;DS)8YVA"4;&(> @!*!UUR I/(M/:2V4OM-XWIV9:)ID,#D#3.8])*^>Q M82(OJ>>-[NNIO:.IW5D_W8-1=(%R8.LIUW113I"AW".M9(C8.1$\O=A]OPXQ M>WZ)/J7ZZ1K!KME"AE*5T(L@[F&J+*&D)7:Z(>O?>$G'F 5*(28*'L:*%LJ! M8=W"HQQ':L<_(9OVY->:3)65O*_EP9'66+:1;7VSFOLJJ]+=S)XQ:KC(9P MH@8SOQ_!02L3'0QU66/%RKS!.,3_%Q MJ\DO2@3D!=!QM-\I[U?:"8T/P^">DQ62+K9;,*E5\FF[]0T^'G0ZH9K+F5S5=9P-\RPG @Y%XFZCF)VBEB5* :*\RT$+C.$;U;B7O_8VM]SS&BD\<8 M1>M XG"@R#GLD"0!@^\K-!;ZPASK!(BBG'OE6?8@0-&U"J;[=3SOZN- MNZLWN%N#O#09Q>O]V'X96<-_GK1SP(_HRX-WN3;MN J[5=PRD\-N-@VS7?EG M!V\R3[@<_QM^E9NY3"4'YV.CL_.J;%Y^&80=#ZT'HA_!S\IF[]1VXT$GL\/S M9RM\L[@&#MSEPSCF25>$=9)N7Z^B_X53SAL5&&+F8UX2-2IRK9)A+(K@A#4X M6>Q#33'OV!A\R9K?6F0NP\Q5Q"6@ MT^J&LH1RXY3 H$-DPDLCHN*8*\.\)5H&[ZC3UE^[GJP6@^N*04ZAP(9P%ZQ% M#(8:<4\]LL0##0PP%SE=14A9.@C?2 Q2YZ0+.CO+P3"+NFK#E:G!*+.>%1D9 MK!VQR>6X2O->Z%X,>G5ES=P#DQ)O2#^I-4%F9]8DQZ5+#G@G!8'35&'!DJ_I MY]V*FB?;N:<;P5B!/^N# /JI/4,V:H:)M*Q! Y$\$A30A#GX$)8'@.RWA ?HA(F*C =9I7. M;C(VS[%8MJ!WX3JOSZJH,VBH01"S2O^:FSI6M9D<)!9FI3945\U!%'AXK K$ M1."D%:L(6V'U.HV4BMQ=V9&&LY4K**B^F((.^";*WSQ2'Q.U M6A'-V3\OR[L4((PT2(>%CMR:: 28%TZ2@0&*P"A+WB5X+U7>Y4 [3"J$\X7< MWOI1>%.&?S_"),;>1JOGVYT>&+,=N./K=L=_>VPU<#94 Z^_;K_[_.,+W&=K M8YWF)-JM?SYS^/?G]D[X^N7K)M_\N2]V__GT;5H-;+[;Y+L[?[1V#S=QWK%P M:^,SV=W9AW\WQ1;=:L'O?FYOM-N[[SZEG&P'ST#A/?#FUV^YO( ')1CS*@<4 M!,J%(\A24 G>68F58PKD??-[(* O>2"^DXU89FW22 M6 =,F,5"X@L;Y,QU\%<>7M]=&,Z8#[[-F!!M_QAN) Y-@G/,;91>;A+ M:9!FW>Z) L*)MK;D,:MS9J,!YTN:9>%PM"I^HX6HQ7;RGG$/AY*\/7JF)^(? M/K22__I6;.^LGVW^?$^VOG[A6^M[2FLE.<&(4NF!]R6/7.04.>P$MTDJQ\W* M&E5W62BXX$[$];0O;-O?\[WHB?18!<2=,XB#:4?:!XDH@Y$/Q&*3MQ%F\I*. M_G.2:P_/[A$LU!6-PNMFX4^D5:3=;/0E]@L=&%?:/Z:U_([0_\] M[S%8=1MXCM[/SA1O;W5S:SA?U-0ES1:/QOJ@W#2_C$01E$^<<4FXT^"#@P/N M9" AY+UF%NHB^$PVRGM@YG>>K_^6;.Y\H7O@6@'9$QQ1DC3*KA)VN@9CH([ODC3CWJN[V2NC=8X6G#H$L$A M[\TK<\D]11I3)RA+.(4+MO"ZQ-5[)K&41O$UJKK>N5O.5%GC99L\\# '79UG M]61)RHX_CEN#-.505C*'>\W\:<' =LM2J'GR^5'S;>CCQ>P_ 'GS9W6\?A"O M_[@G!'%.8):W0P4/G_$ NAUCY(WPT1NEC+ S\7HJ([-4B* 5EXP9Z3R<3%4@ M,6E&9^/UUX[//P_Z=,$RPY7#-C7,#(=D>(C)$VZEMC0ZX$=2<)4\,WR2ILT) MG5P<^@7+FN@CC,"5;U1M;M6K=K;RXW+3.#V(.:>D;,36[;BJ>WA5[=-N#:O# M%+CDHI!R/3+;GZY>M\/CQ; MNW\PVOYL>'L8M.K-P)3Y03&V[?5.NB7%-Y_9.>F7[,E\9_A!WM^U"K3F6P#R M :#Y.')59;;]D05 ^V(TEQZ=,[5%NOYA/[)WD?6.'Y4@@ M$]^:@>*@8X*ER+3_:]V_:K)^70PTCB,TQ4P_W M.6GW2U59:7V?VIW3WBP8[W(M7S[MM7S]T&OYU1ZOG:/OL=O/J/O0C2EFY?!7 M+L9<%C*PU1J0@<-/<,[[L]V-]VSSZZ?V]L['T^V-/UM;/_?Q]KNW=&OC$SS! MMQ^[[S[^F"8#N^_@>;[^^6WSJS_;>O=9 )G@FX?OV?;&1_X%C/_6N]W#[9T_ MONUN_#%)!G;VV>;IGO82.\P=6/^4$[.L!I ZAZR,04N01:+2M)7R =QVRI,V M&.>^7%9*I<"Z10)Z6 D_APP,YZ$QFHA&F8G& FOW5][^OLGF3CP\!NW2/7L+ MNKI_5D*Y+U>D1DV8SK8WUD\W/^XEKIRFP2'-$_B3.#)DO% H< ]N9:*>9GXY M*2+/A 7NS',1QU)D_1@2CD=(* 7B^5BO5?8[&1CIU&FWJUW:*V_Z @_UEQ*# MZYS <^>]B*J*\D;O(%O-;/_SCKC5)W Z[:^O;M,H 8:U/X@(#A;:NB%V42F: M..[%5\.__)Y+Y-OV[%7KJ Q2^='O@\L/5N?RDEX9#&_;@]DLLU@=/E^/6L75 MFE2_"_^&X9T'AU?+H=_Z8?88PZM"R@L/XU5RX;'++DOH*M87__2RRUY^C./Z M8>N'O;^'O=YE?RLPJZ &:,Z*HK0EF^Q-]0HW2-$&P^M=UVSV9&:OF>]6_; M/JEU[:5#5&W[6=SW99_-*C:1VX /8E.S$WL%/9I=W/0^QI1^7W0^'R,%\2_X M&5SMKSAF>"9IXX6O.? 'BP.9G="<-]7(3SPQ +CQ%(;A7_?T\N,OWU#D"Q(([]+/\^V-3^VM=[EL\\^#S0WX[[L_ MOFW]\ZF]^?,+VKD90D(*X<1\Z3B"+U6"K" M#8XVUW@+RF=;;TZIP3O%03YT0SQ<8B^O5+P7VEQZ]35NH=6>$,!+C+!W)]A^ MO_7'%3'S"NSG'L[U4K5J!7 M!?!S7 $0Q;6T*2 7L$)<>HMLD@8I3464FA'L MX\J::4K#FH3,-OBJ=4"M ^Y3!XSYQ;42N$,E0,:5@#>4.JUSN9XRB&/+00D$ MB8RSFE*:'/7\7 F\*")0NS0OV:6Y$U6'9C9YF])TPW!6M87S>K_?;;F3LB:Z MT_E@N_&ZVSJS6O5=1_6Q<=6'.>8N48R"S^UT&4_("J50,D*"^O.!FKQ/6-/P MV88UM=JKU5ZM]A96>V.AW_/0:JWI[E#3B7%-QRA/DBL.JLUSE'NW(\.#0EC% MR)TEA@BRLB::6/,GH>EN'&L?%!(]P5C[^O3(7\LUG?.^3]T!O3C*'.!*%@?, M)"&<,JZ](\Q3F81WPM91YH=5/:W)*+,S@FDP%BA&#"0K18DTF!/$DN)11DFT M8W<599Z/\GOE4E.W7"B.] S!.C=:M!A.ZXCQHX)Y(F(LJ>.81HP,-03Q& T" MZD"1(T9I[EPT5.?M()J$X2:3LPV?:D#7@*[#OX^+Z(GP+P^,^)$&?B@E(+\,[& M.3O^#KE()7)*4\J$=X] M-%"/;9*$>\\HQ76L[B$5S-EDK,[ W# 3&0K:@#/ L$!&2@ZJQE-LF2![Y4L,YU[1?#:1VK>U0P3\3J%!8N6:<0-2%[]D(ADZA'PG'! M#!BM4IK!S88T"VR_S?(N, V\Y; M':U1E)(*T4*R)B>Z1O1S0?2L1[\8G.M8W7+!>R)69XA,S@N!!%$1\>C O0\Q M(2V)(=1$'S4!>(NFN+-ZK!K:+P?:=;#NOM$\$:R+7 GNI %?FN>\%T.0#H$@ MD502@&T?@BYHEGQV$]W'0_,+RJQ[4V?6716M\X%2KQU)3DLN4W!4$4MYT(C +7)NZ!S9 2WB.3]#:47GDI> MT04&#L#MP^\UH%\PH.MHW?T@>B):Q[2Q,%D"1>/ /%,GD=&8HJ"X(> 9X(1Q M032CO&G(K>/O-:*7!=&S+OUB<*ZC=7-\,%:-=)LS6TZVC=LJ%Y(EK')>54>(^\UX!FRG/8G2:4A(K6.<64 MREM;JR;(W1*A^07EUKU!I,ZNNRI>ETCD*GB#E6&<1&6U9R:Z:+AC 7-=Q^L> M4L=,]5O$$2;&I(B<]B2O"% $5@*CR%U(00?-N2F;:4IYZ_S=>GUO6< ZU[U? M#*=UO.Y1P3P1K[,<*YJL0XH' #-3%NE@+(J4<^LEII[3E37=%((W";ZKWHDU MGE\BGNMPW?T >B)X T$08Y 38:1("!K 'JYBI ?T, 3WKTB^& MYCI:MUSHGHC6R9@ TDXBS1E%/'J&+#1Y#M0;*]G*&LW^?9T(7T.[CM8M M&YHGHG7&D4BC22A)'A%7*B&#G4IXL;$!!]Y':M[2 TSU;7.",G '"2D%%59PSADO/;(8<=L M4IK#5RMK:A435G>M>S9@O<"W7P2G=:SN4<$\$:M+#$MA.<]L'^B"R#VN6$K( MJ6"]DHQ2+H$NX"8QLBGUK=/Q:T"_8$#7P;K[0329+*X!U'H<$'>1(\X-0IY+OPB#*SU[:O<:VR_.&S7X;K[AO-4,ZN^[1XG5U=MW5$3OIA6/*@$I@DA.N-5.YK2KFPDBC M2%T-^Z!*9JIW';71$^4\BLZ 7Z!9+K=1'&F,$Y867/T$+H%9Q8J1)5H3J%?X M[M[!7PRG=<3N4<$\V;O.*Q>BI(A0+Q#''"/+B4/8&$\ZX#=L@%Z(F"7C)&>2@_B1/)6FY0B'71"6-!DJ7:,6E\#^AD">M:G7PS- M=;QNN= ]$:]S*F)JC3,HXAWXTLDAYW(GZ4"$ MUPE[I=G*FJFSZQXM7O>VSJV[*EIGG#"44DF,)EQI9PFH'LJBYSP&:5T=K7M( M#3/5N +J^ H+-->-O7ZWMT[]XOA MM([6/2J8)Z)U')QW93!!0N9MYH00R('THH"I=?!_;S-= -]>2=K4MZ^=JP'] M@@%=1^ON!]&3^\(*)K'4 24:+.*&4.02 8 'I3BG,3>DKQ']'!$]Z](O!N@WL8FB4H30FR,LS2OK5%Q%_&ZYP^'1?N?X59Z:7J?="M61 MYZ1)Y_L]WD9FO,$T[["8F&%1.BLP Y)L4JR+!)=.D6[NK/UD_8S MT"&/IC>6CBW^ZS%F_P:SOE2J=(Y?NY >K6-6RZ97Q[D9%33HZ"+R*A=\!X^1 M"YXC%G$2WFM-K,U%9*II[JR%6ZU3:YU:Z]1[U:EUK/#>U>CV.#U--$7F)$?" M' M !J_]F_XT7TI(;[>M+KM]+9_4&W7/%5JP^W M\Q-@5M-@)A3 _*9S!$/1@WD:35!YW['W*T_?.@I 5E5 )Y_DR?/U6%LSCHHJZ,$/ MX"30G/"FMH?.OW*VU^HU^IUR>[@K#,79__<_&E#V.SQ%V\*SO(8K'!YVC@;W ML/U\D?C#']BC_=CHYH?,-[;'Q]W.#]!\_=@^:URHL4%+NMB=4MHJ9V,+;IPT MF(LDM#):TXB- _5M@BA*FV))Y-PD2$#S]U>?8I:J^"EZ>UQD\6<9OK>#!_V4 M/SWUD$$[_N?3V>X_X=A1+G??P?-\_?/;YE=_MO7NL]C:6.>;A^_9]L9'_F7G M"P9]>[B]\\>WW:Q??[X7VQN??VYM[//-G]].-_?W=%Y\4128J6 2<:KRSM\Z M(8Z#Y-' ')"IV3CJ-*JHT5726J2S MQ(^)V,N[, ]^=- ]5ZK[$;ENM-^03?#ZKVS[U)[U5GZ;-$A@ MC0:/J[)!NF@TQPP7OTSWIG0_0TGQ_U86 +1(IZBNHU= !&(WGP6/8Y?F61H' MW:P:_^?J:5,K:SN9-V2XO0#R#ZRF\D&S.&VT>IDSGG3C#MSL=1O.>60JL_W7@,I\_7@*-(/M M;GP[W87K@7OX%>B,V'WW]N?NUS\/P64D<-^O<*]OTU0&J,O/S:_AV_;.Z_87 M"O=^MPETIOWMR\[6X>;A+KB,?Q_N_K,IOM!/X"I^P? ,%-X#GF/]Y_;ZGK.6 M$6,LN%K/#KL5/)@D!+/&<*N2C31$@X,E MG LJTTHC E<\S@R@>Q*SUU(X\%\5!SX*C7]LMVN+JIWRTZYOIJ<(3C6/5S_8 MY(LP&[4&"R%U! F36!L9<;168A:<+C;]B?I('[JM3G?HF\QWC2:\G0.;79SL M5&6W);LDHV2$21?FEWF.S:^KC9V#"3XZ1F,G[C-Q+?">@-?VLMHM#E;QZL:5 MO+-M4/(1+A9COTC.X*S>N":P7?QWA8+/[XCR:=M*/!;P<* M9.#2@?.46K[5SW&K\@QGT78;$68Z-#:BC]DU&]!Y4N@\N=CF7B D-_71ER8L ML1F[^[';V %0]RHOYP9(?GH(*\9MNY+$-X,HQ 8(9!&=UE'#>B"EH4CN::M_ M4,X#9G'8JV3KQ'V-OC\$)\AA*/Y4[_)(!G#9@PE!;3:.00"_V_9);/QK@>I) M;67>&45CQ30/25GB*5;119HT.+!F?N!@3B9"I=Z+=O]@N]O=0LC"W_G!EJZ2 M\N$M[KK8WOG\ RPOW]KX+#;7]S"-/$:2D,0Q@,5E 9F4##)2!2$\%BG)E36\ M"N([&YUM' /.BFYM_-(!8*$GNX< M5[+WR^E!+-?['GM%'7=!AJJ_PS7@2GTPT/U1_"'+U^4_*K)^.C#TL]$UVVOX MC) V_"R?>1Y6:QT!,FP6=9#OHJJKN%>Q2G#! /=M_9K?NU^L1:NZ=6K$UF! M8J-$C8O[T 75G+TA>#3K@0IVXYAINF[@KH;:$X3:]L<]8X'"FJB0Y\8 U +0 M7,TU8EA@KC6,?D[4N1)JS09(:XA9A8-B!EIR5B1G,H[;+&+\2ZN(YD "QP70 MCHGQ/+E[:[M':/ND/Q#/U09\ QK_0F0#>\H%ZR..-SSO?0$@B/OQ2;=W N"; M.>.O$]?SW58!?F-]OQL+D[H2DE>^U_.#BT^-Y>M"" 2B1SM;A M80RM*CP^/*V*R6?6BH"2HJXA\)FC7>9;U>1QV*C@/EZN#\TL,^BVXYM;/ MSV1[XS/>_+G_\Y:A^6=-6PM5!]J:%QX:1 [7'("P@LP>Q4J>1X3U6LMK8^!J M@,069RBKCLP7B@>768+/;A;X3IDAP]5:1\".CP=1VXS]D:MY,;CFIM+>AU5] MFIGXCVQJ\?;Z'A'!)"83HLYI0)O6R&(L$ %U%W'P<(O24*AT%)I;I330V>!4TH]ARIHFV)FGN(T[.2)%"+1Q=K+W D^ M&D\0U]XA ^* 5+11!-#)PIB5-7VU7%2!GG%.#HJD?5*MQOCYC?<]CW(A)62U@DP-? 8GNF$'76,"Y#E"_A;+29WKDI^ M;.8M83T8F!20D!X(G0)'SAK,$.&<18NYPQI4";V)F$R[^45,W$VEY,Z(R+,H M"WQDA9*-CDM":N\#\D%GA2+ Z&C!D=>4.AXE-@84"KF>I$S%SU8;S]])V#D/ MH0WH_V MY"(%6X S/^4M>^_Y?7+Z9C.[U_&X7WD9,+['@T#X>1#A>Z<0O^KN MJR6)X=+[PN7SQ?OM*A1R(7#ANM-1N5MS@.*>;Y5'WTY_YX2%"83"Z/N,TM-. M-_3B40U0 .CFS\VSS?4]323#-MOY7#?'DZ?(*1=1,$181JQ-%*^L=8[B+##S M1(Y%P;/@S0CG'!E<5$ANS0!J(5E 2+[]V-S?8TEZ#J.+P*PZQ".HQ)IPB7D^, ^8D)7*^K\9!F%K MJ;E::K)J\4Y@+PE&B5$#JB4I9'60R!',A(\X+P!CUSZ;CJ0_L*M:2]4MI6I[?8]I8AQS 6%B^72@^AM_RQ;UG*1J<67#R/^7"6 P2OEM1IXP\-.7HVM MJC,R;N "HU6V\M,),MB$@ST@RR5N#)^..Z,&@CA$CBERGK,0T@6,V(LP=923BW70\3F MQ,5+_<'1T(T%#BYL\9!:/V) /V/WY:X&33-- "XGVHG@'7()@SD(CB$K(D;8 MZY"\D0Y3=M,>'O$A#':FX:LZ& .:4O?MK?T-Y,Y/>>Y_8^ M]RC)^L >I][161#-<@P AHXIR"CJL/(Y##GH%:>Z('-.10@78=Q."3C;W)A MN>U#O6*X\=(;X,X$(#6756*;!^UB,7N ./FD2B@;-R'%?69%-=% ;],$\L M'TKZNJWO.6?@0]OZ*D5IJ%L*/YY+ITM68-'9![%=,K7^;N5RF0S(D^/&>@9H M5;[8^.LXIYIW&^_?-_[[WS>-7S*6,^&E^/?!H?*)_/[KJ&XW=GVKEW/,6[XP M^D5R 450-KH4 L"$XQ"=,L*[1+PSAF":YD.$7@L@;P=/6'8Q&1WL#8[VR(L% MQN;7M\ >UL^ .?S8A'MNK>]%0J.5P 1CDD ,HW)()\R0USAZ; D5,F]I0%;G M;"9))[#3&.A(N,N$25J9*21TE MT9> 3?QQG)/8.SF/KWTVS.-3S1Q0B;;;;L5N%53*M4Z'@QAEM]$^;\)SS;JD MV[@H2\S:<_9S_+^3>)X8_>:ZF8X?9@A)M@/3F)],/YZK)@YS.5N[95VKG0-G MI>BNRI!LE8DK7D15W@;/XJM@V$@,#NU9%;(KIQ4_PN4X6K^L;^5T3ML[:)1R M^(9M]&/Y2R>!6[L*+D@CSU7U3K/O,[I'#ED>=W(]?*M$L,>*EFPCM%*)N/4' M-ZV&HG3,RYGR-@?=3MK]_/HNYI$=*K_\&D/:565W@[N=D[ABY4H=#Q[H>/:! M4K=S.+A:R0^$=RHO&T!;CI+@RR+?V?\/ W]Z-%RM!P2!2]_)6?QP2B].ON-P MZ+-WWQM-28D+CNH1!^7G%UFL+=^?A%;7S_SS9V/9'-G'6]]W%/$8L-\0)+GM6E@!$$ZN>[5H6NN>N]B=:6\"G=8YS6Q[Y-=,MYQ[=5TW4MQFI:NT M]3SG-:6/J,\*][@77PW_\GMH];>AHC5Z58U&-VDS$;!GL;)=H[ M,7:+PNW:_:"7NMO\5.#O7J7J^ELNO<1-E>K%M;O@S8.N]5L'6S\]W?V:[_&1 M[W[]^'.3 A_>^/-PZ_"/@\W#SV3KG[^_;6ZTOTYWK?]"W[(M>)/R/AL'AUL; MFW"?_=-->.HO_[P]V]WY3';_^7@*]TN;K4''^K\PW]SYS&^]('>KOO7/8H./ M%[V%Q_/=I*->WWWRFN[GN:;[#^1TA^M8H M7CJ->'VB-N\5GZB"NIB.+::E:CKV&+IIBHX%:E*B BG"+.*:!N013J&Z?:%+449=BO'TQ&:B% /.V[]=R==8-_BQ M9/AADPX;LLDOZ7!7E%?<"^=:/=Q!Z, M&8!)Z/8^C;C/5@HW3;FZ?66KH@R?ALV&&F77E6H'BU[Q;GZ =Q]Z MCR8AY;KG\K#3;>WOQVX1BUH>!O*P_7%/8YN;T7-$HY0@#Q*XHZ<8"*36RK-( MM,B]8?7J7-?CVB1@O')SU*"RM/N8V$=E5.L+W[:Z$_IH5*=V/+Z77V^0RQW& M'>B4CA10ZCK:X/(MZ' M7Q]W2C^^GLTAB!%KN+:SF<T#X M@G."(LP UQP@0QE"F&AF-,8QB>!Y]\_A?D]&W@:N6UB4:@5&02&/Y"(>HSG MC/'6^AZ)4>BD)5(LYZ?X2)$V*: D0? -388;!V-\T.K.C#&",<[Z)IN<.-A@ ML!KL?'H8GXI)LU8L6-Y^J%2%5TQ]%I*Y>=9^ZWL\;V'P&![M3;J^/?DUE*OS M7NYM$)8\J''QT$PVO1^*^)1!&_7"+R9P?GN)B0OF3JW##K!YN2:;N=(/M132 M=K/)*7_-O>C:EP8Q;L+JYD2Q-T"/KN?":AB%;-3:,6-S.ZT?O0=&V;+M80>- ML08:=6QC6MNRS8TO8O/C'E,X1LL,^*>2(\X"049RC*QPD5HO.;"%BV,;I!A;7[N1^B858\+HYO,3YXF]'R95D>/1^PP>%I M)W&XQ3D ;SB*8EN4:[0Y>1(N[Z<(E_H.DYIC<;D;?V[T=@/M>S^] M7*HEGE$CE^%#_M'I#A^QJ(ZZ=[)D;(/$*[%F-6F2*+=&LA>E70Q1J@W--EK^BKPFC]L$_K8?E==*RY MLD+0S)SZ-+J*Y,93C6'/J6O44#[;@=B(X ?GS4\9*8-!;M)AY2;=:!;IN;*$ MXS5OTYGKU.!>^?HO;@Q?WW0,7^Q(U=)VK])V1PT$JK)9/*=N=IRX(S/++!^U MV/3-V*:S4[N/72AIU^@+\(+;01GBDL3)^" 3EU&X(*TG5"@*_YAT@T6#\ZF9 MMU7?F!/^1_&HAJ[X<]V];U"HNTFWW_T)]_ZCM?OU_8_=G8\_M@X_M;9^[O.M M?SZS[(9O;_SY=>OP(YDIU/WYA7\YW#S=_.?/P\VO?[2W-M[2W7?O&;P3V=WQ M8FOG+=^$Z^]N_)TV_SIO(K#U<_ULCQDMO8X:A2AU=N@U,D)+Q%3"6C$A&!8K M:R6_BOY^1Z6ZR]$?Z@[;A;Q@M4"IXR8Z1C'GG#BC'65&\)@+QJ1+I%8+3T(M MC+53VM[XR/\$QBD1[Q(TUR%C&41)$Z/IMR C3Q[;-XZ$%%C385C%!!; Y&1$P(AH3343,!,"F$1(98C1R M.IDD,(N)U'9SF;%Y:Y?\[K%9N^6W NBD6\XH4X#-")PV6OB#Y;9^,2'@NTP& M2UVD:F5-,=%4\H:]>)=HGX,GZG@OL -"O7O!7?GA@\$?C7VMJAY<54WZX!03 MX[22*'"-$5?6(!LQ..(ILT=+/9#^9[VA00WR.W?H[P+DM:^P$+ZWWDSY\;)* M':!(6Z( WP)<>.\5\AHXBM4*8.[O>O6P1O=RHOMN0@(UNA\3W9.1 $YI#-%Q ME)PR@&[LD;'P-^-P\)X;41I!U^A^">B^FZ!"C>['1/=D&($2H;F7%"42$^+1 M1^0<%42"@#&SM_C^XBIET_\&U M2\H1C+31%'%A$W(89SUC&-@0+9+P"V]672\F/"&??6$\UM9^,2C^->6I"QH$ MC12C:'"&(L/(1G#7A?$6_I4$J$"]JK?$0+PC][H&XH,#<=*I=L9J+K%"B=D( M3K4B2&LED A*FR!T=&G1D%D-Q"?D"== ?' @3OF_SBD!,X@PM@3Q@!,"' K$ M--&*4ZCGGM'#^X_IETCH,B2@6N M$1&1(9Z[&3IL++*Y3C]B&D)FY*P)2JF)J5ZB"%P=7U]6/_LVX*YYQ6*XGBZT M]UC[E+Q!.!+PM#%WR$G*$!4V'R%&6;R,H?@Q43]7)1RZT\!19 MH&'96^#(>"91%#2!'0>5K1:-G]6H?F*HOIL(0(WJQT#U9 P ,PYLFX"M9L(C M#DP+.:\%2CXFIK#D_CFL@3_15/KQ1HCU&OD]%*WGX:W+[1Y#1 ZLBI&$!!?K:P-Y!*C\:[JT6L#^7B0G'2;=:"*,,J1I;:T;Q'( M\MQDR0JNG;6!R+R]I=9-QLV373I_HF[SV&ZM ]]YN]JON%Y?>FSLR]!7 M(U\KJH=35)/.M6*.A%-1FB3 M\+K)Q/,&^=WX_G< \MK_7Q3?D_Y_(@XSSSUBFH*+X9A&QGJ#2!3:1\ [\W4^ MS0L!]]V$$FH+_M@(GPPG<,6\EKG9)*<<<<,!X28D1*C$$B@:"YBOK%'5!.[> M%'29+/B+6(@?CR@ /OK=EL_[7E?!A<\ V'I5_CXB".=#748Z#W2MHQY.1TU& M$B23T3EA4-"<(1X= 2_#1Z2P,!Y\2.:#6EGC34%4D^(;9NO7ZQ!/TOVO ?J( M )TN<'JG>&A;1V4Y MOT"D8;_;5MOFK=T $HW6 " X1"[#8J);+S]OY-6_ZSQ'KX^ZK>^EW;T1_7Z M_R4:SB:+;30YPY-Q'J/#'M-(HE;<1GU=YZ":H/7A_,PHL<]YBJK)&YT0);JA*3!@EOO$PZF7CEX&?@V!E"L0V):&BXP MUHH:K"2SP5IGB:CQO?3XWMQ9[P]WF(#C>'M]+Z@0&3C^R!(>$!=E'[D@CU(C_)$1/NR3DX]O M9H1CXK6FB,2RPP3V2-LH$.$Z2.HUTX37"'\9"$]>B)"LE]I)'E0" TXD$0![ MZ[A*ZB$17@<@;@GSO1;3%/Z7?0X;)3?:.**TP^"9",(2$?XA/9%: MB]W2'1F1%7^ZN;^'!0BO" %%EP.I/BJDG9?(6!.(P%0Z&U?6*&\*SIN8D7JI M8_G@25/"TFLB$\ S<:Q3HE@Q\""\MMCR.E#P!)#Y=CI0P#4),A"/O&$><6(" MTB3FC2F(E29P;F)=1+S,L.3)21:T$EA2KCFWED4I'3?">2/]-5<@:U@^,BRG MO'M&.:$86^2$(XA+G&2.!(X]MCA9 M(D,2G"8B6:IA^31@.>F-"V M +V^!WYXW.ZKP M#C^W-];WP&*1*!5P#VLD KFAR &E1()RQBU/W@F2^^]3Q7/8<8E"CO7:PK(6 M!]PUYFM*LSCE039P@G0R1E$NF2?U9M8O!.QW4VA0 M@WUIP+XU9=N991J [9%R3"%NC4*:"X*(D%9IXX7!BS;5K<'^Q,!^-[4+-=B7 M!^Q3EMUH&DCP"5G.-.(4,V03Q@C4>^ZM'3%V:1G!_B(R!W8Z?=MN5,!L=!*\ M:&GJWRLAB>X *]>)1G2Z #-4OJEZGW0K5 MD6>OWFX=K#CIH7UKC\<;K+ZQQRV8MCH\\6!:[?U8*@&\[_I>"C1I&R5B@3K$ M7<+(D*20QX1AEBCSTJVL2=RDFC6UOFE&U!V@Z=$656I5<%\QC%H5+(9:<857UHAJ O5I$B%J55"K@EM'..Y(%=1N MSL):8"I5 N-HO5<4&2%SJ1-7R))@D="<1ZX8ME8MZN74*N 9JH!;QSUJ-K < M>F R-X/B()AV 4FJ(^@!'Y#F5"+,(W"!1+#(ZQB$ QW@I*GQ#9.,'U,7E(#( M;_T<7X/_AM;WM>&S;YT< F1\]3E+>>OHQ):7^3><-GSV 5BX #0==WJM?,*K M;FS;G"_T^VDK] ^&2!K[U>!5\?E/K(,7.^E?_).QU\K92+'[2 J!JM$LEM$J M?U1?N.YO:Y,'Q__,[U+ !S8E*PX*N#']TT#U7 MS_L1N6ZTWY!-\/JO;/O4GO56?IL8ID6L7I5TFCR6? X=FF>I7'0S:K]?ZZ>-J ".R4YJ),: M;[)5*%MGVK49>9D_";\_O(2K.4.QLO:NV_D>X0W:;>O*>,"G_W3:6=7TFKFX M:/6IO=%6IP\7ZW?RM(1XU(LA_ZUH4IN[JO[1.@(;VK+MQE]]^.(PSUSCEX'. MB^'7I_:^OWP^LB>AU9]Y],M>@.BLPBN3@G*0N_IF(M*=OWFD=R)XM3*BLW_^ M>\)@327+\AAH +],Z,BMB49@RCA)!O ;+?9[&R4^0W#.M!P&:F:XV#$(35$, MZT=AF.+W.A[%U.KGS+[>#MSO=1O(VN/R*[+9&O"KP]W#S<-/!YO__'VX^\]N M>^OKI\/-C:V#3?I%;'U]?;"] >=3N,_7;Z? E=KQ/Y_.=O\)QXYR"75JRY8&L],U:FK66&!ZZ,Y$Q+342D M$I1KHDSYQ%<:$0CL<68!W1,P#X47H]>V O+Y[,Q2EW'AGZ(QU4Q=?>O)1\6! M.2XP\\Y;[H2&'ZM@J;2!6B69O-#,RHO156F,KR>]?BN=W1^\RA5?95^BY:\! MN,N+2:_F/F/#<)WWGE T5#V GIE'!%;6WA^5=E[-QG_COO5GC<3Y-_MY<[U< MZPODVY[:;BBF*P[4#IC@T.I&W^]T>PU[E/WSH]Y)NY\WZAYD(H/A M.:R.E?OT\D9D@*!,\EN] [BJ.RLW?=V!B^<[;@PON HOU%@_[K;:)9VY64[+ M"+-'9R7,H7[OS?E9PY[T#SI=&&5X8@#6D0>>VHOPEW(!\$8=/%9^M6OD48^& MN(P4/.H- _*8!*ZYUU83[D72S+J@#!$6W&X=V" @SZ\,R!>'N^B8"0.0MT'< M+Q3A]=GY*1_L6?YJ/4_75GG=[31(7Q@-S9-PT1_!A*R+[+IG4[*U\X5M[>_) MO+Q*24)*@I/-"=/(8NJ0H!I+Y4F*).0L88%Q$Y3!C+-=I#BKG/RIV;#M=B-6 M N5(24V!63D4GN''28"Z2T,IH32,VSK (A&*XND;D.)CY1!;1 MIP@OW8N?HJ\"::V?!C[^A;0MWZ6@W%;&Y\Q$#AM;)**\KST M!>BC*N5MO1+B.$@._%DK A2,K!(EYT%O?20[,24P#]DV9B]K^&TID\F :C:. M.HUTTH4ONP-!&@CK@87?N!B/,FI.6P!?-["0\Z%YL3]Z(;UZ'H2%T(JP_'ER M%,<,=AG, _#80>ZG@%RA\?N R5SMZ5?3514S7(T!A! HE$PX_G;*DY3I6:C3QS M8-;S]!6EDT4X#[D^,L M)#?CA4Q9&2D5@EG-I4I.NP1\,!%EA4DA7CM1H^:%#\X+-W]^%KDOG1?$<^%0 M=-PCSJA %B8-6:Z"3"PQ*5C5ZD6()I#%6>LTA,_=2CV]EM0W&O=S]^MC[A(_ M#+X ,SMRW.S1T4FE9"L/+K6ZO3Z8\:QU*]J9A?(HV&[C+-IN$PST?NNH-*LZ M;?6GCC9BM8W51O2Q/ CS8Q_-G1?NE?6K_>D'XNIC/H;!+[(NIBO;S2!_ 9 MX)NAUG@_>,&16D#T)>N%#3CWXUZT0A$/KJ)2N5^E" IIS7-K?8^34,G3O$_4 M;([6_P[)T0PPQFQ/EL:Y7L_ 5!A#JW*!CH$HQ')N M:N59'$ H7^B7%LAHMHF''0 #R%2F(8#E2;JQ.A/7O,?H]U\>V,Y).PXD<$:2 MQW9S[*UGN@]>9UD&>[DQ\4D!W5[?PTK('&%&$1,P7#FTX9QF" ?E7?+$:6RF M8]P7K=+0:\:1EX#LE7AJY3L, @UV("!S RPM,$C926BW.Z<]@$(V/9T3N'< MMAY_^)BS'[(,5K0\=H>?"EAZO[ZZSC+=_/&#L>E7=G B(\-GS^BX%U\-__)[ M:/6.V_;L5>NHO&GYT>^#RP^2&L1L-4B9BNKP^8K\*JY6Y0?5*(,[#PZOED-3 M>2+5, 7'L:KY,)CEUV6T%50 0M=]O)CG"SVR_IA'^UAU;4N>\U:JHOS M"S"^D/DQ-HKEJ)KK9FK8Q=8VQKI8G$KMN."YO.L[PZ]6NY!VQK1*^& M0W=A\=E-WOWE#. _Y4,,)0Q/?E^'1[/[L?&V6E"(C0] _&(]I@N-*1J.YGF_ MY3>#:&#V(/_;2K'Q2V;HO5_K$;[1"*_O[W?C?@[]OX?Q;!WUP#OYV[9/XDVT MY76K@60Y@"_,Y$06& M)^.4)-=.MU\X2#,P:&-48&L02'K&,=TJ'?_KP;?-?\ -_OGWP=8_?[2^?/V4 M4_,/-M]]X;OO_C[8W8#KO-MJ;?^SVYI.Q]]^]_''[M?UGUO_O"5?_OFSM?4N MI^:_/=V%:^[^\\>WK$M=$AYK% W"<' MOK2CB+)$.:=2\+QQ(F5-A773"'5'S0<>HR+GQCU([E%5+)U._=?]S. -9FZI M].-)+WR(W:*D[D1)TGM4D4/J-6!>0QI;6&RM&V^F&W^.ZT8:I+*6!:1P(BC7 M*"*;4S=R#V_F \QQWM&%K>*;UBL_::UXDVLL1+V75DW,71/ +!%,4L#4!@X_ MUQ%3IXG52C$M@RAK F2X)C!0#'-T@;M:%[@;ZX*1$S;F@^W$[B&=(%0P+/Y5 M..EFMZQ6$]=1$V1<3>"D5124(L]X1!PSAG3@0*98-,;: '\"A5*KQER84%^3 MEIJTW EIN1.R@M@]LI51\*+$+J[GV+%:*UU'*[$)QXY)[EQ*B#J1$!<,(ZTI M05@GC&5*0CFSLD:H:')JG@1_N7%H*Y7_S>^9SY9NGH%^.QL%KCB\#]^3GA%G24# L2SB@21D M*! P DR<.^RM(&YEC3>)8DTAV6U5W"7*Y+X8XL!C8H9%Z:S 3$EJ4O0U MOWOZ:GWKS3B_^W:VQZ.6VC&!HM 4YO= MC9Z-#KB8WRVF".K%MZ>!_S%:]^UT3T0=@,QQE(S2B%L.M"Y*BXQ@(CEKC2WE M::OBKJ)7RXC\V]&@I<7\W)4TS8)P-&APXBDW06L2N!"!1">5=,;6*VG/$/-D MS)6C>^"[:^&B0R)AP#PVV>8GCR3+VQTI+'&4#[>4]H+M[YW8W7H=Z6EBDHUA MDN\)EM<+N48"*X%XT#9WH MY72D&GH,OC-WU0E*]7'1#+ ]YY[7V(7H10>+Y M>[TO4L![>40AUV.^+[7+&R>@D/;!/E[,.YJA.F1P#TM"9\* MZC+$?^_]4:4BZLC!W2\(%37 :&)):8J)E0XHX):YTT-F\VM#JG MW]KS61-^ZM>XHT6AI\'>WN2UH78[AM^ &J28.XV_L/6@Q^=QM_1,_Z@F[B2W M(CL*;W\*GZ=:> K$[[:*H>:!=[^"5/2")I8'21P*+@(/#,(@T 46 M"2\\5F%IWZ-.XKB+37]FTX.*OV'&2Z)0?0V ;T7W,L@ M">$2YTQ9CWD(R6)&C"786LJIY?K^^]/6*4/WKO#_FB2"@5OP\QE%TA!<*7P; ME49@ZYEFSIN8&U=2WI1,-*6^=2^#&Z%L60(#=83P5AJBSB5Z&HIA@@EB:JR0 M3B')8ED=$,@R(E#DW,GH@PHY0YRNBN=<)7([TK2TD+^W1KUU*M$3@_Q$43ZE M2MLH/$K..<0EMGD1 #2 ]U1&)4TB*F<2<7HGF42U];UF)M%B5K?.)'J:D)RH M2->1.JPY!2 &C[@!Y>N(5H!0(9)VS@1+5M8$;VHRN]?$X]GAEU">-&PD^SWV M^H,F_./;J]U=8&*R4<#56[1/'WI.RG&YXQ9_%U&H0M;1PU]W.OFKM^=B48W:MC.G<3T[DQW"\*]9 ZU',K33 1Z@&D4VJ31<0SBKCV"5GI+,). M:J!*G&&15M;DZOF"SV/V7ZRIQS*]VQ.,7%VMA$8[1=21K7O30!.1+2Z2%DIR M1)("#21\0"9JA2R8J[SWM[8$-!#G3<:7KD+NM[+IVG"7MVD%^4QVS\9)'E;IS%(-E7_?N_. MS;O\^A>E*9:#&S!V?\#0#=3+T_9F%MZA3\'ICL1FW2JGU Q#Z,W8[+UB<]D_W MJ(6)BL&#"4D.\=S"UQ#G4*!6>^T<=DJLK&UU9H5IJ+Q.8ST/UPUN=INRS' ]C7FW(H_$_3B&0YD?R3:Y'N62+TS"MSPYM;[' M]EFEZ^QH;[W6:&^]&4T7AQ7\#Z;G%G0Y1W(*GL/W6]OSNW(L7YRX[GP^W2/: M<"TI1Y:YB+AF EEI!&+$2IR<,E*3'*6>PPH7U7*4:6>\2Y12S[WE%CQ&291D M"OQ&[%W5JZ<6FF45&K:GB#5<2)%M(48\ OES2FO$64HL8=!T3N1TU=ELU<5T M7*M75%EHI02D,5>BN-@_C?&H?.U/NO!E?XK^Y2-EU_GV65:%OG,(6A#<^KP[ M?9;8?'RH,!O'>;4KSWPT? MNWW;.FK$P?N#T'7.160ZYE)DJTC1AS8\/D@02 _\('L:6>#RA7[X@ZR.BF!5 MR31Y?.$_(-XY,#HAE14(3HX&KDIU?K-Q<@PG]&/WL'545%R^0O6$6:4U&W!6 MHW?BO@*6\NV[\?BD"[>%)W9GY?%&;]DO'SO=%LP9.$ZC\XKP5W<_[G9\C*%7 MKMJ-/N=2A/PJ'?AI=X2T=LNZ5KO5;\$+M08@A+')=24V/[L;U(OU#F+L]X9W M[L/\#9$9B]3%,:F;P%I!*-R_;7N]5FK!)>'59B"- M-](S$53B@F -@NTE.'_*8 X\Z0%; 51-GZIF4//+_NOP1MK<\6?;'_>TP8P+ MHU&2/%LV"NZ?5@[F2%!O?0"^HN<'.+)HWDQ$O!01'$Q)")=)AL)V/8NOG9[*]\9[ LX@]9<%MISBAE Q0:2X) F8= MD/;&&NN\(3:GPY$FIK/[<8[9APD]5Z)DK3(=X-7%8I)F=.>YT9A05_.]P$EK MGI\CRV+KZ*2(R(1]'UA,+K)Q[_2*LGW5C6V;:=OOIZW0/Q@N4X[]:I"8A\]_ M8AW8AI/^Q3^9V=?^D59;J9[A.M6#K/W;=7];FQJZL3\/NL-'/;;[$;ENM-^0 M3? FKVS[U)[U5GZ;9$Y FP9W5IDR7C0P8PR+7\:54KHWKE0QMI#)0)&05Y5Y MA+/@<>S2/$OCH)MUZ?^T(BAG+A/XE$R!0Q(="41K0S4UWF,". 7V5[+& 3DY M[27W1OOW;W;M.C273Y+:!Q+6^*TV]:5\8!/_^FT,P4'WOC^R%_+ M8UFF-]KJ]"O6#=,"#D*.9+T9YY5_ '$]\BW@=W_UX8O2U:[QRT!]Q?#K4WO? M7SX?V9.0NVG].D^U3*GFRKSBP!P7F'GG+7="6V94L%3:0"UP$EE1BS(>Z]EB M8Z^C\-X$.,8IUM9&3#06RN<=-O/^T+?TZ![)@;LPF#D=AAA MG?=P#_4,JXWUPB^6K0-MIT$2X>KF=SJ?1JVV[_\?>ES?%C63[?A6%[\Q[[8@2 MK52FEG3?ZPB\M,?S!MRV<3OP/T1N N%:N*4J8_CT[YS,E$JU 6:Q"U#$C!LH M52J7R RWFD8#^ZH6_? +RKK9QNN7DS*KS>S"_%WWXZ-&1P'X$B+ M8$ .D.P$C?7Q%$R_;1!J U 7SRZ3?66%?M5B9)WLSX*U*>X_'%5Y MLD9#OG0ES__;II3._!7VQJ!"0^JD,L_J'_[09772%V?/RJ%5 ^R7_O#3\DX. M](PLI+!:#=E]/#/KMR)GVOMKVO[-_N,M^]%"8JW[+"-;G*[_.-HB:S^[:%@2 M;T7Y^J]>-.S%G[$HO9O)TBL->\E5^!^XKG3!K21G,OZ<6P+\,CO2DI6[Z(R, MN!2RNWR%#VTSZH1.7Q/ YW7.(ISV9N/<_CR* @JS,HC['\'Y2G:/_]0[L=O3_&_7XZ/CG8&[^/=P=\PW[?QE^/7 M!&;"%B_=[!Z_/M_?^W"\^^;?Q_O'+_"_@W=O7I]]>;4??_F\V]\YAOGLP5R. MCXJ=A6J/)A'49)$*%<<(HBEX*)(8_F%9EH%))W6>/7F>\EY";ES6[8@G7 L[;NQMR==A\\/>,?C9H+E3")"2)F DS M)L!T%;D$T"QHF,2*"4X5%2F6R-U:$4+?1,B\J^K@[2PZOFR#_E+N_V!\%E9Y M;KGOD77\^S&%48A$WLP7Q. M#[C,*,MS&HHB 9U1Y3R43(@P9H2(-):)8#'V,NW%*QH$/IQ2P \3&=;WD%JO M%UT/'W#_8+G_\R3L%*3[#Q+G,Y!0I[O;!RR+4QIQ%H+*G(2,:YSEL)4)E0/)2 M1P7GK%.*'C#>G2TI12EE+#,I=DS&WLF%UB$75(6@*ZFBR&1N(O'D>4YZ67+C MCJD;7$OOD2'#>IWH>O#0^8H> #0LJD))1*BD11$JS63(-TL2AC56NHLD1'# M:_&*YG'T$Z\(7HIM\R5!.KWG+IQ!Z @G8.3'$48/"2M"%N4LS O*0I*; GXI MTC3'.B))#R3=9IAYG1/HCO2=&\+#3U1\YL&ATW[NRA'DFDFJ5-*<>N(+:\3!"MU:D9?[BD%ASZ0/+-\Q=X'UDGJ!? MIAK=[++"I=#7NK-0V)HJ=<)AIRK=K8OH;;SS_H K./S6XOVL1_W)*5>1L\^8L]6#?V6FT<(%\]C7W5 M$N\I,EZ0E'4M>-S0 &2'F[>J6]J;/[I02JW(;8%EM_D%_M0:"\NE'O%Z M?NVXA\DY]*FJZ<#]K:NJT*ZJ\/X@H454Y(R&:91@VJ7F82X)_"IY443,D#A9 MJI+P@*HESY?7;E>:# 22TZPT,M:H;&HH8Y$C+(D\L!7")5MYRF^]U$*<;!$2WY.Z$':R75V("THA[!V-C0EV1K;NZ^NF8%[M.UF? MA/SPM^9C^?VJ&_,8TM?_G /W=OV>F[2@O;*U?N6]V<":P=?II"AXGN8L+R*> M$L9,)F-"8T8I)RH5>9'["FSLLDZ*MU2 K:7TM8JRO;148+7$!V(-JNC+*Y7L M##XE._%.M/OJ_?GNYQWVY158A&_^??3ES8?^SOD^V?W\EBQ9@^?SW[ MLO?U?/\Z!B?OX;WG74WWFU$^WL?2+O]CXQG/N[SZ]/=][ VM[L).]@ MO;NOOM)=_&QO)]DY?W^0216E$=78;"\+&0$;4R0)#Q,%YB;0%&5%\N0Y*@?+ ME=Y\09QKM?X$@I49D&:"=BW3BM-49C11F2Z,X#'M"+8CV"6"W7UU>) 3ICDW M)HRQ623#:VI<%#SDF=:<4**C.,%V:&SY/O]"2>2[")IW,NSZ,BS+.%_P%X ]H=LPEDKVCW6Y M?_[E:'?P;UC'BZ_[>W]^W?US08;MO3V0M$A(JM-0%R#(F$Q4*(IL4(9%MRW#5**4!LHD-&<%%S*2.1>$,D)3T+TZ@NT(UA+LV<[>UV3GU=OS M'1A[%YX]4"G52IHTC!0C(,1(@4(L"FF>"Z$T,8"#5Q=BCR&#X_5WK"6,OD S M'@2_EI&:?]'?W/GR%/2+X/GA_M'_^[\'^WFN (YC?FT_)[N<_,>)XM$,6 M[4)UD*199C*EL62BH9F 7)DQIDQ1QQJU,I8OUEQN1>@E-_KCYU]'D MXZ7)W5=O#PJ=9"D'@2DBFJ.O N_F&O@U!SH1+(U49DV_.+^X)OB=7"[KY,V- M[+B.M^\%;U^D$I.=P?OONV_VO^]__G3ZY?,^\//[;>GC_://]$O@[<1C,G>O=EAN_T%]7?O[8%)8QUE.@WS*%8A M,Y$)@9*R,,[SG$8YDX7$\N_QJC)]_UP4FE_SZ(,YCK"H* MI*%B5.PH#WF:%&%NXA3T,!*;" F6;J7+COE_;D:P[M%*JAL&XSK&OP>,?Y$> MG>R^VH7U['S?/_^[OQN_C7;V5(+K_#+X=+8_>'T*>Q#OOMD]^O(W&'.1U)3F M.@IE7&!!14I#'O,<1),N4A;'!=AXMRZ:;A9]ZRCT$5%HFN6'!_TGG/-;?\P=5OTH5NV^O##L\?7=7O_KSO&'8YC_\;O/@%7G[Y-W M;]Z>[^QI6,>+KS#K:#?>CY="<<>?#K26C"<9#V,NL1>OX:'@61I&N60ID

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

21'\B# M[8'L4;>!ZE(G)7]39LT.JQ >2O@1'.$]]-\6=+7UE]Y!BERV)^>EG3@;@_-N M6@7!XV#=1M0E63!H_%F8GE]B_!I\<6+G#]\VJ=@H&M@?(=W%:3?K"-RBDFS M8".#P%T[I,9Z\1A08!-^I>@+QS1OB7#=B&,N5P^TXRK5!XYP I^9&P29<4)2 M47M7U\6-)F7!F>O66.%JN*DDU4Y0;4']X%.1Y5[;_ M\J0U,M.UPTU=9U5S M36^'L,D3UQ9,$AFY563: NTZ4CK SXX\O#J[!;TZ?0M)27;:MBWB8K,*&"$. MOB"/0U A:=EP;-]:7CS7A5*"W+%M88L;+. !=#Q(^L*R%65=S\%!_&2UMC5; MVX::6WV[Q /]>U]+*YAW(C+MCK5\&P.GN20D8>#4%M_WVY_&#WYYVWCSDV^: M5L!!N(A9D20-E5BW90$J\W%O L<:DY)SM!0JJ8C%X^G?6)O\RX_PVZIVZ(-@ MHH]MN80;:&ECASWJPH7;#KRAJ(FY&A_&2&WFO']D MB)3A / VC 3K%B5P^&ZTDTO*Y+6D@3(OX@S[IAZ/FFR+@/P3(B#]LAE"1+:? M!>[]+9=N0 \=IL1(S?^AQN_$NI5JN6'",G:.2^;1#G%4J0SYZ^!J$)VC$/'R M#:-WTVE1UEB%=,ZY+H1&BUW+#/Y)S:^]3#7IL:4K>5/5&YN\*);3##'KC79V?VGYPNVVC;SYP M.K]1-W*F>4943R2;[TT=[\$9S>AU[FY[NP 2W$FL<3- A)&K=\+YX-@B5Z(O MK/05BJO32*%DRI7 E[#::%SU>*FV/?*E:JI[E%526*VJWMBZR%Q.TL:VTR& MUO(C&8<;I#<@506EE;%T=-'[XK9AMGT^MHS/BHK9%56CQA1[4(8E%VN$Q6@3 MF5Q @P7U%<,D*-=7B*9E_^+-+LB#!)RHS/73OAHG/3)$Y+1:68, 3C$Y\)=YCV4'V/+6\34J#FG#&,TF */!7 M*?G;5A@8:?B-\\-I#\)EP\6WD_"F27&QX$);2HF':9=AY\1^L+C\\N*87TOK MFQ4)C*3=%V]7!,3\@,TA%>P'>?\GWP^_67MGTG@6/ GICHZM?AN!0)40!P&" M&N-=U)Z=V$4\1 #;YXN5IE5FB:(#G6CEN*$.%>XM(^JSA0TSA36'H4S^VB[' MJMD'I(<.(J$-CB_[A+%3[;9J?)M4O*@)VXVC?6MZGA04;1+# ;VG=7?-O*'Y M.@PQYGF["X+2MQ[5X%7M$K>MP=J-=@68ELXZMI%DOU@2#Y:*[7L;U\WY"BO) MQ[844M#[NBWEL9"OWI_IB;6O/#719K$O*HRV\CT&_XH,.RT2>U\>K%_((%_: MHZ!E#F %IKJW()*7+=]IC$5(O?-3-T::?9\6 9*YJ=N&%8YR:>26V?GEGNS) M8TQ@&93M#\ZW""5_X SW(SM 97@Q,#(T,C R,F5I<&5X96-O<'1I;VYA9W0N:'1M M[7UK<]M&LO;W]U?@>,^[*U5!E$3?Y6RJ%$F;=55B^[64Y-U/IX; D)PUB$%P MD_/3T[/#R_.@_^>?7S3\&ST=%Q<)6+M%"ETJE(#@\OWCT) MGLS+,CLY/+RYN1G=/!WI?'9X]?$0'_7L,-&ZD*.XC)]\_QU^ _^5(O[^_WSW M7P<'P;F.JH5,RR#*I2AE'%2%2F?!;[$L/@4'!^:J,YTM2[B8Z7WW\7J^M Q7]_HHY>3L3KZ.4X$L?1 M,SF>3B(IA)#'KXZ.7X^/7KW\GV-HY"%:BA_S/6UA 66)&*B)M&H^WM&RF+B]\K52Z#TS3& MWD [L88:AP(,XW/\9C\, MLBHO*I'2O.#(@099%($ ?13I-"8WBF8*?[M]5@)?J8D5I;8%D^/KWDW.#(T> MCA:O"58RP>DLEY(\TKU2SR3\GO/J*N<*UA&MMG>Z5)$,@\$/M>O,$,9[A&Z\ MDD[625QOF0-4/:(L130'S0=3(4L-CQ&9*D%!_P>^X\64ZC*(Y11>S5>I%#5@ MDK#ZQ.J)0>33>],1[!1)>E7IP\AW9CT?$?^NUX].KEBS]X M9W]C7XU'+U_K0J>S)QTK2_L]8)\W)(?]FX%W.OV]@D:226M847 WP?6,YJ*0P337"[)P MQC,.:'\U3*?%G^(O^>]F5R;L5(-+VH7!#D#DP;5(*AG\-YG+XR #KY+V:&%0 M5)-_FUV;B''#R8Y/$62P%U!QTU&YX^67< 6*P+/1V'I;?:[-.ILU_E-LUHN= MO?D">Q.,---^%K#O#&S>W.KFVG7;OX+/-(@9/Z M(5?1SK3M3-N#=/R_OR';MG'5>]_]S*:;O6[PO;W39L<5AVBW>?M&C-ROLB@1 MV'2)F8PJV9FYG9E[D(Y??(YD1NI78RKS!OVL[L!20\]@0@S#A'13(-S7$UG> M8/S1#R7:2Z>!*HO@LIH4*E8BQTP?9O /?)J=3- V:'^ %-$+_"T[=7<.* MX3#E_WC_D+D) S4-Z>$Z39;T8:FK@,P/?NOBI"&FV&'=5;HJX,(]R:,Q-4T6 MDT*FD:3/UR*B11L&B83;PT"6T0C;+")8S[' ZTP>V'4=,YO'+]\4. 3MOIO? M@DPG*H+/^[3J@CVU'\A%EN@EC/]D><>!A'M?X[UP,\C!-2H2F%$*_AY<\--D M<*YR&%R=\\7P,+@>;N#9QEOHU@BFQ0 1[C*!.(=@QZ]5 5?!OS">1964(BU# MFE 1S8-(%#!>+L0S7&-D.5\C);B#*X#FIM*.C(!LM1F'PR^AR%'P0 MB&F*@A*:%UKW"L3_8 ES!!8W5;!8"Y$O;3;0<[W(71CR;%EW=1>I[QF@N;Z1 M,+\;'1]PPH.B F>0O;\H DT0Q%5.KBHXEQD\5\?!S5SZOC_N"B@P1+4GH$#8 MBUR^F](A$W1; G MAHWI_"$!@ZVK,OA '1\"LI-4%H^^F0TS.S=S%9MQS5M\ & M5B=5N7K++55._-^YVT9E8B8/)KD4GPYHD$]$<@,C_N1>57!WKZPRGN4!NI$G MX^=F\_:@P-5G1Z/Q^-D?P:V^&H^>OWC^U1&F+T?C%U\?M_IB].K%Z_O 5IN[ MA-=_TIYU$\KJQX_O?[T(SM[_]-/I#^\_GE+UX#_?_W3^]MV/EV'P]MW9J+%9 MV@4:AC!I/RR;&_@-XY^W9_O?)!7$Y0MG>2M@_1O8MRND!Q@4"IE M=?R_MK-YS]L&5>BTMK@M^I3JFT3&,PZ;G$88_J-$#>88UM:^#:!^:R4NW5V; M_6ST?)/5V7UF.2A@(>,6;R(3?4,#GLNRRE-.ZK1*)7$S=I>"X[=4O0<[-.'F M5L)S(ZFR<@7([FH'.7\I(H[^UIO-62[2DO>4"Y8)2F3B9]AR3G#\; JNOR:W ML^BSNPV[HL$[[[V.7ORAO=?K5Z/71_T_/V@9WC=O*[^B(VE$"O79T>@ES$%0 MZ$3%@>W$UHR)#5L^[%9Q)VJ/4-3\S/E@G,,'"V#:6X9 OD.O.B'*@>@.$W<) MC17@"H%3(&;D;723&_0'9N].5_;,T95]Y6!NQ_AO'Z79>I:P>_-9/4"[QZ_N M%:E\8+U$K3.ZVIO_38P1L^#\OU_>7OTK.'UWCJ-R\8Y&ZL-/I^\&,CX;'J.[ MJ)T[B/]]V;(:K%LOQRN[UP<+^.\8KAXH^VLV[;3?=NA2$ !UK>)*),'>H(>R M[=-O[ !8-_I]5B(G-"TSCJR*Y*ARXZR;4$)P-7 M_GX_AC%IZ[62*,W*P@_U(&^[*AM2#;@Q%L,?M"$0D%FIK3+-9(Y>^6]O8J66 M5LH>A=V2GC8*U/X,VL<[45O?LJO9UMW1\::""+<(M=VO7M9RY"5VP2H-@M-T M%%RU0?H3-*+P?Y3;:ZWBH$H3";;2(9WY,I>F;!3'P>Y)?I915=J:N,92,"); M9"+RJC>Q-%-R*:.??"4V4S53*6R\S#.AC9'.'/B_G9GU?8$]K.M(8.!SG6(8 M/%F:%M=Y7==H+(=433BW\Q.8HSHCBM_+H=#W7=XGM(%'\6:'8^&1Q6R3GA^%I_5HEH$5V#6!R(LL.\$_R*0UZCI%F+I TLF=95)3,[+ MS5PGDJK 4]P+E6%WK<(W$7485'&O819_Q'[<>#3>LL5NJ5#05@S,0G1Y=9%> M,"\!TNU"D_WZI1YZ",MB4!BREZU?\\-BK[''"5S5]6;HV:+_D<&GW'J+T\K0 MBF]6 SF4'#UKF.8,$S192%,,_V,%.R.9K $=F/CHW1#W+9JH3V/9S^::M M;3:U?"L;"29+8:QE>SM0/Z8OOM6X8]L;]=AN'*$X6XHJWIN12@-&%) MGZ/HJ$25&TUY@E>X7D3;>]RZ=+]HZB:9QE8E-=Y1#; 6FNG!:3 MD!T]-VAAO5]61.E$-;-,W-.E%K&[;O4VLV;X=_WFT"&@S2.,JPQ=( _8=Y6Q ME2X: EU8'4@*5^@\;,8!D))I)A(8E@QV_C#,E#<*@UD%1E3QZ2V%@ND6.=H# M'+HJ+572037DV$ TUZAC;Y"2R?6.*Y85=#F5 ;,G.$^^H_OXT==0\$)B:<++ M6X[R8W92]R9;K(J8 ZV<@Z!AM.U,5+AJ!J>9ZH#ID ?6HU[9B_L=?:)G6(9KXJEH8)SSW,JN/E WQ"$3*S7I% PYL"PRW#<%=/R M5BV22>G5C>&=+<.7Z^X4)AOZO??Z:+_-''&WQNX4>9\BC[98D;MELK4N9$.? M=*52[J%A/*51-EEY0B33(>T"EV".E5=^N,)&I18+"0Y8*4%74 )X_:KJ7SB/ ME ]EB]).8*RW:^&?@6&<483N#)Z2ZV27>GH(,5&]8O+6^ V44"%W:&6*[NI6 M^3C#+HHIU%G./\$,=E%4"*ME_EKD Z[)=XLJOU;$J$L)Y]\K1,[Q+3!X*'O\4EQ MYPMS@EB3:I>(L6@OG!NF*P]=EA795'"3]AS M,XS0LYJPV5?TC3E:'1(#VVF'Q?LHM_9OCS]TOKQ[0AZU:Z8&L?9VZVX[UIV+ MVW6XF;>YITBS1ZZC'\7#X^=A613D6/ZH050^LJMJ8$+C9\$"VCHOO+!]]_3> MKA+NX&S^X<#D+G0X++4FM\SQO.K:@@7G3(@Y(/).VHBN+#1"J^ B@/X,>90' M1>&\AN?VB]EHT?Q@G>*@T]$#$NMOG)/VVP6V[DVW3-&?8^4!^W.[V,)F8PO# M%) !Q)J#?X S#ENV3!>R)C2S85YT7P=M5S8^@A;JBA'_)]*KW5" M485I+BJPN+$JYO"<@M.@"Y QV)'#>E!E%1LWE]Y'SI8QN[^D=!;!94F;8?/\ MHF3S#QM(/37GH\5, MJ+0HF\D>>OE9S\M5BLX%?">2L(Y"L*OIC1X&9')Z7Y\L.GEI1PIT;A^"@X* M'40 2YT;DLB_HHM(N>!LQR710T,6ZH8IFHB]," NPA)$KY(;VF/BC\ M(DSK5QZ_L&V[^!QQQ.4T,H?-N'C9/CT754Z!!0TX$S",IN9]L-YO&X;GAM1^("WUGIJ@_;2AC&"JQZ%B= [ M&%13-:-RE.E,<.B9K!FX67BR)1H!-+O3"LMU2W6-=S>A7' U1N:Y0-:I$PP? M9/-E@=^324&L*E@HT!TJ-X=@@@:,A"DART KL<7,)9ZJB0UQ "ZZ="XP#L2X MJ[SK1OR1M9!WU*E7%8&.'I4A$U ,C'L"*G'O>+QO@_'-@[FMN2B"\7A/[N\] MY3P!!B7VQ/[>>'\OVL==@Q>@X$"[M5>K69D=Z.-6MD&CPS>DLN_B5GR14V'W M#!-1J,(%Q\SZ@5>A*X>$#\6=O9PO:TX,SFX!?D9N^,'K74"D\JA:%,0U4#QR M,[YM=MQ+.0[8D \^Y#*08=P%7OYHX,6;P,[PB_=[A\MDV_JW(K@&JPK^2[YL M;'!=\KZ.UXAZ[YQ+W"L;\$;G3F^"%&2%@%XNZRC*O9Y@(@98U!17?#1DC@X4 M[.X*1;Z>0NB&]6K"P)R/&=K]>N0 !__6D\#Z$3!=+M_O7U/BD3'[9HQP^LC+ MD8AK<5FYU=;;H34D,)T=26&IW*DS 5%\U=YILN07N0,SY[;R]4Z/JZ,B9SCT MX'+I:'WT AZ>8LPJ0986IN'Q!)>&E3W8@M<@0B?06Y:]DP@?#L"["N*<04"Q M8JN+7N-"Y]+XJR"V>\='X*PJ&,:ZLRN/(P&/JCRGO)IK+4)2R+D@.@=BAC?> M-FB/-E E;*[N!5AD*T1.I1@N3C-.[);,N ,]>)G"9HY]EF1AE(NR/D/\#Q*$_-LL57XG%_-(K&N^C"N\^I%U^T)JD/# M&#N89*^6WRY1](DL9B9MT)]AF)_0EU&N)G5\P=[(#']+"]>K"4V9G*>F-?4I M/\U94)8;E:D*Z/RIB!_K4(JF+:12,F$-GV%@@Q82V02RI^'=N+.<419*FU)K M=XONU" %#'TQ%:36]VUZ /<*\.1(%//08 /[\2.-/6[HC?&R/<)[YO'PMLJD M.^@RTW:XOV!)\.G6\+M)HHKYRL#O-TEC&Z,+?KNAI!,S$*$9.JW_$"H/?A;Y M)Y"R7Q$T&_I!H]5BUZ[S?(-GUEQ7#J7 @.SS7(YF?B+X0WF'7NG=Z.XU%#V1+!S)XHO_13,,GU M)YF#@A0)R1_1.N*E+0DE:#D8>:VB>KP7:P>*[W M^:6PD"=>J@<6E5E,!G&K]MEMV9OL-VD8^3A['54,%F^%I[#W+$C0"/SS]PK6 MR"AXIPTE;WNB,7Z+9PN!PX=SXL@,>+_1?8_#HJFBJ#@&7(L% Y5),Z+N:2V# MTF>'I%VQ$4>25/&9*11S25X;HNFM6E7ID,VH@\F-CC=;/$XAB0F&#S*AXL<< M*QR/GFV9+]8)T=X*MD&S'U&E7ZXA.ERV(0]_C=U^-C"V-S>H;=^6*@IM 4@- M3O!\C.T8\ & Y9%@V(GSU@W@T\U:'1,$;M<'!;]DYI=>+%*CJ(I\ I!W@WE! M/X"38+P,_+(S0X#8H+9^-)CTIZ-@F )Y!1O,8@H3]A&<3O#W>./.QZ7@/ISV MFA\]OJP=2/VA)&;;N)??Z?3 BI,'E1F"4^399_2)3/*E-(W-VXQRI2-$FBP9 MD**;X%[ B5%%^O!$-&&(DG M?O_U080=*&;@H!APIN5,4Q@ ST),(\FY>U-$MI*@2-14$@-M?V$946K=1H%X M;Z;#1MWPZF(!*<"<2KUD0I<[#X,LD?&,,J3+#%^P5IKW+5/<47IIZ_CAF%ZC>!:08]M MF:QO6$V]C']4C(7PF#=>U@7/IUS]0C+!I%Z@;',_&EKYH4&!'' M 1")=/5"V!@CF2ZV324N)B?E>V$B]?+TW%YC9J@5)(=?W/:P[?MQ_G&1U5"# MQJO7OI"[US]$9*LM@Z*:VJ3!BA<9M@^-XMP'+#2+0W$C0!D6P;E1ET34*TF_ M.I[%8#+2%]3>W-IB8C5G> M^[$]=E!3"?%U^S//IH@T+.A!H%.8Y9UV#!<.9*I,T>#-NKAK3JD@S=ZCT9MZL^7D>N>"S/LH>-J*WQQA:DSRBD'.Q J.!@VO68'N M?,)F#KZAPT.V8@9QT4(3..Q&@5$#8V/BT+@;=&YD[05;3 \+WPCV;84*R##PRX MVJATN[.$R9M &+:)@#1P1TVY;/!#&^.,$%IR8^)KDG>\NK.S)CW<)\0M_(HK M]JX-/J*($,%.3D3W*QA^BZXU2S+!;=FKL-QZ%H+50NA!#VS''G-T9,UAX M'-0-'2_8YD-@-CU=MS;2]B4":&?K/B-U;1;O/6&<+<6P$30GL];< M!N8^- GZ&/$"FK'*S@"CFXYPRB59D]4(?GII5-AW[:72DYU[= MNFCOO& ][M&5E7=?M82-U17E0:K,,9;#K.PP!$/'$*029[ST?8GV]&^F7J![ MCU CVGE%*&:$P>*"Q[Q=>[9UR>Q3=\3!QC'MY=P_=0*S,"!Y)69,BC*O8-M' M:)J][O3P/\#32R,LJS^M?8A+/"]!Y'%A\AF=/YWIF-<-VH,KG:DH>'G\*B27 M5*:%L!7ZQ^,WO'#\'QSC8Q6AUZ-S#J91Y;L[A]B\LC"O--QV$9+3<60O8Z0( M+%(^&6*M!>#B;1LAQ+!G03^1$9*8^^'/!7CE)7S(5*JGT]!QUDVG7$M)#8U$ MIDI82O^Q)(5@/V9S3FR6N: CE#&90QY]_0;/6E%R+A'L[7J9S*)9,^H!91B4 M;/SU#Q3\K'FT<B6.8YHUHP.]HP1&32' M*@Q\!HB%S&<(+D*G52MQV9]M*W%' $U6OTM,ZB/"3N!D,E%BM*+(ZQV2W$X0:5G3P4=@$ M@,#RP&!+;5Z:B?IN%>F81SUE*BUE!SS1I'G@ HJV:,?,41AD),.-16)5V@SS M-JGA%YSH>.EN*L4G8SYKU6PN8LA78P0V\H M\^;P>%13Y 4S5,: 8">E4(29G>;2P5*\ YVP?;TA,!8_QW" 9 K$B(),MJZ& MF+ Y.N=CJ2SGDWUSK4._4F\?MV;=MH+5MQY"Z-Q#"'&H<[.:U96>]>79.]>X M'R V""1S5TC6K7HN7Y-9@B\?S87C5N72^Q>>!["ATE)<9]=J5-5R5 MSH/U?2UX LZ*X;K4^E,7>S0%I^(JJ9DCT&^SU5QB9ERN7N7!34$T@J#Z%C5# M_ZD>//0=#ZP TAN8$=QLH'O4AH185RHE>L+8@EPSI--+ MY(QU'R; \V*NLE4 2K=^[/%>V=E"]<$Q1-\YPPA'DS[)Q!ZK/V07\ &NJUQ7 MX\(A/ VT(\5YC+MA->;UW+R^<4/_"-193B2.K8?[&KO]AC:('1]7Z,X!>-PZ MX,6WH@-@TO%84CZ[]L*17FX\LNK80@QS!0CM#/FLO=(:TR=<7JC,>'=B.#;M ML@AMM),,?!W)\9TKN[7\D A8MC,LQ^":/D.#"D-$7WH'QBPY:$2Q33=Z'F5H M&YF&=SBR7&L&8I@9-SR]NQ]SN^0)4@);F@Y68 MQ],[M2<]4OTE8^6P]G-UQ6_[*GZY9:OXW$0CR;*M'@>]^1#4VAH,QW+MU@Z8 M&(T'-N"O!.FDOC'\"*,B!"SKB--T+']KA?DD'SPD*L]R60J+^FP0A[0B(Q1J MQD:+3]*=^]/3E3KL:U4&7]-0*$.)_NXRY8-5/:^V3/5W76[98WA'(<\,KY92W@]B0T)9,%+7MPZ,;J]1$ MU+U#D@S?;Y]%0UM)Y^!U%.#^B)0Q\$V2B F-"GSZ)\/%H0EOTV@4!J=E:8[" M9*[XGX@0Q/#$A\'QTZ/CX!+ZC=4ZER6\'C;-\#GX1XY8B2+287"&J0"=ITH$ MKY\='Q_7M.S:6WN6^!D/D/J4ZALT\^ ,HQ6.X]Q 79U+CUX\94!L8IJWX&V5 M\&>.*@4,,'D&3;0,R3EUEE4)G2;KS M(RFT(%4&@[H7X1,VR>>^Z17\Y'LK$6;.^6!4;I8Y'75![/Z(T(X-LIPX=#,2 MH$A7.3(F%ECSC(4L?=T%Y!VV!UP07-DV/IF41WV#D<.P3T#@']51'0 M=UU9JZ5=]F0BM[P,S167D.;!!/9C*8KP'$08]+HJ;UN?QN@ M6"S;IN-1>W#'1UOFPOU("!2_J.J'#YST9\HS#8.?S-,&=R9,/QP!BE M;I"-^'<7(3"#<'PXHPF3S-><)Q[6*Z=]OW\/78P?SB5\+7++F)(B;I:],&]S M5%HN$'=,LCF4R-*]:'LH4L)9'[20B8H8U8?O?>2K;]M('&H7N76."^Z%A[0: M.]!V+M/@A)VBA(3Z\MT MJO-(>H3;%$BG^HK*<.#VYN-K*(NP='Z6_MJS?MZ:[@NK-?U)8KNC54G0)V7. MQS)-;[4[:5C:&XG5B%QZ_LA7R[9ABT^19=79F-^$VG!$@]?+6B_.5$!9?E@L MF18FZL 4V[@>+%7FBEGLT_*A8;6E.!W#U1!R7#$.'SF8,&'& &5!]%^\&&RN M>VV3>3.#:T U^(PD"*:\T&:BI&/C< ? 3P,#)U.S]2E=W6I9\P3[W96 MUG.%)>>68 %+.5!DBW;R??QBN\3[0ZY++I1BR.1F11PE>^YR5FVX0%W0H'B+ M0 8$PWNHU[4Y-YZ(D)I[%F*]V[/49U.3*,6BXIQ+^*CR5\ C3:$<)T_(-N15 M.9]6R+&+-,V6M2WDN\SA"7 =4PZGAF;=5BD:%4)L4:8+[1X[C_S?*;(?>7C'C(A5(L1A MTYO"^@WOA.&?_0D3VL%':9F2"1SF77@N49=8*TQ7NXI%NL!CTT:EX,XSKYO9 MH$^[O#BS/&'[;5XZF<[$S$B 8<3$''JR/,BGHMPM3NJD%'[V'_C.6WC&/$FQJ,RU346=BV)/F0S[,*1<&_D[% MG_7WE"YIDW;5TFO:X1JY0[@-G O&DQA1$[SB:C8'IG1(!D\_LY^Q "!19P)3 M0KJGS#&+44BD[C08T"F7I['T-92$GM*!1DD8Q I)UY,ERYW]Q*N1Z.\%S'V> MRF5H"Z'-6]'[529W@CSA\(BI6<)9E=O35'*).L:047BJC%EK*MI>0L>OE4[\ M,V.,2T=T'@0?399A4P,WZC>('BG*%:9T$NY+A)4O\&>B:'-:EU0;NER"LE%6 MI3%P./RV&UY'*4K4N)"/V% UCST-Q-ZI_6)U MH\O? 6INJM9\:;%P-INBU;'4(:W M5B-IM (M#_$1-0)?3!XY4!6.OP4/"=C@9IM9;Q>>13JPC"6^N M=6.BFDWG1#*A@FRY(=QD*#M;D!);=F3'J_#8##BMP'<[AH()EEYC-J-VWURY M71,V.*3]X?KG+&![ ,Z,\:>.MZLNX1")1>!_\W*1?/^_4$L#!!0 ( +.0 M"U7\LT\ME @ "LM . 97AH:6)I=#,Q,2YH=&WM6FUS&CD2_GZ_0DOJ M$J>*M^$E-MAQ%0&RHK=V>C/BE5:K5/S7ZM-I@,R(?) MO\Y(JUKWR$311'/#94)%K38\+Y'2S)BT6ZLM%HOJHEF5:EJ;C&NX5*LFI-2L M&IJP='J"=^"3T?#T'R>_5"ID((,L9HDA@6+4L)!DFB=3\BED^II4*KE47Z9+ MQ:\-#,NEZ]_L^2E3L]B61B8#,%D]U7MT9A)<-N3(4*/DVZUIZ2F[H:#J20 MJONB;O^.<:02T9B+9??5A,=,DW.V(&,9T^1564,,*IHI'CE!S?_+0"=0SUXN M!Y?'G5.Y^0R<5WK_GXZFQX2;PFK7BM _J:],X'Q&N'^=75^6 X)I,/ M0W(Y[%^-1Y,1" ]_[W_HG?\Z)+W^A%R\)UZGV2I_]X;V+DEO5BY^/QO^L;*R4:\W"D8^$J/_R;3AT?+)/="ZUP.C M,KDT&56&G-$$*,]G:EHF 5.H$S$S:EZ^:!\=/]Z0A^U/:1@"RU8$BTRW^094 M+2[D;G'0*C'="@K]GWSD5$ Q\=+-*$\(398D M2XS*&!@"I8"M"B!AEG B1LF=@^8$X+6R;BE;OD6-PE#H6X/D$.V@"G POJ MLO=&T=9&$6R$=MZ%+$A@9G[ZXL6V8]\QQ*!BWP6Q =.@,?C;II?/@Z&,F2^@ MF=Y_"J8@GT%@\YU<4I.9@@6 0N9<6V("*9;8=;#B7%/:)BTJ)JA%2I[5UM$N MYY2)@QSH#7314O#0=O,Z\S4/.54<#> N]UJB3G"E3&,^M&=+V^1I:4QJ!@I! M'V\GI5#.\2 3%-D7S+)*K/,JS'!9>K.X@&\^0T$@2)C/PH<),:9J"BV^+XV1 M<;=>]2"VCV- M#BS!W2+9$-PI&FPINL,$FHEB608EP1[\ZR[OK]$L1F$B<*=VE: O,[-[[WTR M!+V59ECF1I]O0(B_*J#ML6/.!Z"/A1AN\,R:7PMZX6[6=+$M8@2;XKP4LR-W M(/@(EL3,+H,@4XB!C32ZM5XLM8$[^%005M$!+/&G>YQ"#@K"$0 8..N.7*XF MM#3,=N_8V"?9K2ZOG28SJF_K#&0["W@6VC1@K<\I>@D]^C43>2M_1[[\!0ZI M_M3/U-I?M?.Q#^'"%83+:TI!AMN$U)I=$!J/* X*12?H1:'D-%+IVTQL;\!B M<Q>SO8E9'D<"3GH9*5[6G(DL V[*^? MFYH'FIJ>@,('=.8 $>P$L:<,.(. YMGPMKE8,'J-ZK[W M$=)SYOR&_48/$F2DX.B7(?S,4A4 R#Z6S9%6=AF')W,IY@S33D*G^=-EE;,; MBU,AEPQ&%S/I^(QNX1AP]X49N)AP'@K=PV/&-B]Y$'S *5.5 '_/2#7KKKX< M R.G@BZ[/+$>M9..M['0!O?/D=DA@^>QMS%WP_GOW)VCZJ%WB#]U&]#&A*N- MW2C "8=J)KQO[(WWT.CN,:]:WSG6Z%1;7N,."S+XR=>$> Q7=7;.=QNX^%%'G-?;L73=?NTVE>^FXZWZ,G+/"B[AK?#O" M64^A/B \,\4IGWEW-_]TKQ';%YI/_P=02P,$% @ LY +54B*NF1^" MGRP X !E>&AI8FET,S$R+FAT;>U:[W/:.!/^_OX5.CIOF\[PRT!20M+, M4*!79GI)CY#IW:=W9%L&O9$MGR1#N+_^=B432 P):9N[])I\(-C:E7:UCY_= M%3[^J7_6&__^:4"F)A;DT\6[C\,>*55JM<_-7JW6'_?)A_$O'TFK6O?(6-%$ M<\-E0D6M-C@MD=+4F+13J\WG\^J\695J4AN/:CA5JR:DU*P:FK!TY1&43OT_8-61 _\ M>D!;?G38:D?L(&CO_\\#(VL@[G2T60CVMA3SI#)EN'[G32,U1W,>FFG'J]?_ M6[)R)\>13 PLID#9?75S%&8R[,I4J."3I&/]*3G5Y7 @A52=%W7[=X0CE8C& M7"PZK\8\9IJG0*<1^<7W=,Q M&9\]>T3[S],+^Z..T/1F3\84#.![V+T7 \!.'! M;[T/W=.?!Z3;&Y.S]\0[;+;*3][1[CGI]L\^C0?]]?B@7S9FS7H#?;&N=D?O MNJ>#\\K9;Q\'OR^];-3K1? ^$*/_S[3AT>+1=Z"U<0>&97+.U(1+TF-J1B$6 MNDP"IM D8J;4O'RQWSYZN!]WNY_2, 2.K0@6F4[S "PM3N1N\20$@'0J*/0/ M;9%7)2]?> ?UH^+GD$SIC!'%9IS-(7.8*=?DUXPJ@+18D!%+I3)$)N2]5#'Q MZI5?B8S(STJ"4D\*07VIJ.%P]4$*W!'8_&$25&'3#[=O^E?MWK\H,(WM@7E' M-80#-CY>D,M$S@4+)ZSLXJ-<5$()EB02TCXL1'E":+(@66)4QL 1* 1L30#A MHB2&*\6I(!$-X)8B,H;,9:23*P@D+&!:4[5 D9A>,EAW;4X-]T(P!I84MJ" M-5 @X H*"!!+0!TL"9DB\RD/ID1G^+'2GS/%\DG0@9AK 94&%BUS;J;@H$Y9 M8 W$>5,P38;@Y@S40N(OUK?A&6F[(*WY!4AC).()Q!)AL8I=&6 &XC"LUL9Y M$@%!4"QGX7L@LA#F!'RL!:H,V.)(*BF$%Y&)B!5B!;T\ZOK6TH#NT-;)993( M! @ WB2 PBZGK3T!U5,2"3G72S J-N':0)%M",6;SFZPLKR&*;TTIF#M,ZQV M@55K.ZS&-V+P2N>0R3,S/NHRBCA<[NG7-C1#0A6S(("@F0[? ZY#H04F>@AQRHI'!H2)4,6 BW-=F#X(<,T.0B/+@*IC29,-(% M>AEE B1LE;B_QYP5MDK$*W?)L;9+' IQ?H(>%HAL+1; 0^GD; MLB"!F?GQBQ?;C#UAB$'!O@UB?:;!8MAOFU[N!T,9,U] ,[V["J8@GT%@\Y5< M4I.9@@F 0F9<6V("*9;8>;#B7%':.BTJ)JA%2I[55M$NYY2)@QSH#6S14O#0 M]O(Z\S4/.54<'> N]UJB3G"F3&,^M,^6MLG3TIC4# R"+MXJI5#.\2 3%-D7 MW+)&K/(J:+@LO5Y?H2 0).BS\%L3HM?^$D)\\FCU=T3KSL12 .WNE+0S M=@'O,QXB)*F6"47NI1K@C(4V,$L.H I_G!''62O M(!P!,(%W;LGE9D*[P6QGC4UWDEW;\MI9,J7ZN@9 QK) 9J&E$""+Q2$8!>% MO"?\[H):8M5\S8 MQ&7+,'OVMCRZ>!!,\AK=]<@;^(.&H*C9-7UL@%1>MH$PH .JJ[++FAI2IL[B M&%J,/YEU(Z?GC<<[SQGQ&_0"74A\D8)'N@QA99:" !CV*#1'4-EE$I[,I)@Q M3"<)G>0GNBIG+1:G0BX8C,ZGTO$4O8%/P--79M9B(KDK3%\^9FS3D0?(!VPR M50GP]X54L\[RRQ&P<"KHHL,3N]M6Z0AP.^%)Q9?&R+BS#Z&9(9M#ULYQ8?'@ MAO-?G0_;U?:;-O[P;, :$RX7=J/UJH=#-1-N&COPZG>,;M?TJMOU&H?5_6;C MBZ:]>ZS5:C_"K(^Q!=Z;:L-K_=!;T*K6VP<_] XTV]7#QWD.]G>;M6;Y0"T% MEG1N4XC!YE'HE"9O2\W2K8S4J1,GM5SB6?3?*)KCXZ;.84&GD5ZAUGIQ@A5+ M(3')].\O31K[@/8^5!FVTB?=; )E$_&\LGTM[#HUW]Z8HI-;]_ [W(]WBYM] MSW:7\MHDKS;JU084',2>UI.EF7=X[=X5>CI^OWS1>G.D[6?A+9H;F[$C\!^ MB6\KFH<%=O*[C\EW'8?O:)][4\XB\OZZYSES!S_%[:[9/N.![\>MO^J:2O>B M;\?]!#ACA9=?5S!VM+)2H3X .3-%E7O>E\T_W:N[]B7BD[\ 4$L#!!0 ( M +.0"U6 ''U:I 4 # K . 97AH:6)I=#,R,2YH=&WM6NMSVC@0_WY_ MQ1Z92]L9_(0DO)H92L@U-[G0!CJ]?KJ1;1ET,99/$B'<7W\KVVPLI M#'BP]Z'=WZY6THX[/Q\->J,/;_HP4=,$WKQ[=7K2@XKE..]K/<=B%T"BUY66%R/B!_%)*K% M;CV@<1 '84 ]+]C'7S/P__302 ?9\XB-6EY MKOM+Q? ==F*>*AQ,H'#^-]>QI$G1*V61A(W3EO&GDHN6Y("$%V/!9VEDA3SA MHK43FT^[N'/-IZU%K)A,6;)H/1NQ*95P1N=PSJ]?KGHY/CDUYW=#(XP]P^'[[KGHU@-%CIXJ-WR6O .WMH]VP8]GO& M+:^VYU:A.X3NT>#-J'_T-/PLO6NZ^S XAM'K/@R[YZ^Z9_VA-?CCM/\!NKV1 MIOBNZZ^5L?[=C/UK)A6+%_DCED:(0LMOV/M[V?W)^?5=KG_4Y9,40IZF--0% M%N9,34!-*+R=$8$!2A9P3C,N%/ 8?A7\DF)U3!(2<$$4P[O7/(FPA,HJG*2A M#<^U[.Y.P_?==H]/,Y(NS)W7?@&H_IB+*7BN]19B+LPX&5K-(Z"IU@*_S5(* M-4PL4WB)A)@E6*6OK1K2<"9P*4#W21I!_RJ,J]":,QJ@>AS->#N*8A51H$+2NPK,J MX#,=SBID,R%G!*.G.-Q,EMT=;_^@7 MIU/4JM=L_W]+42]'TFTO7T>(5Y&@\2S!; TQ-(G.C^N<$?3O&1-4+]=2 RF+ M5/=JSPDFI0!O[WGTXAK\FPR[SJXB EZS5D>HFVV=>ROA7A/>RLI5_/-U/:)0 M^0^'BJ4X[Z?$X(]51Q%4$.%3 WT91\)TV03-)6^:<=,9DE9-%BJ0';"+6+*1UPI?BTI9/B M4A>BD"1%8AASK#U!7TSS; M74G3N'G-+U+[,*U>_Q9:OP4$WH'MU^L_- 1XOFO^V C4&G:S>? M(-C;6TO2 M,?5 E QE-3?E"^6P$$DLE2\KM+9]]^9^'HF'.'VP6R4H3L;X[X)/"\_9EPOS?>!679R)88;B,>K MQ=UCPVJ7BKU)L=MP;1\W'"!YPB(HS7S Z_R@_WC\WMVI'[2EN2Z?_.Z@L6;F M?T92?%W6(B[Z8+?I0=GL0&P0T"L:&\MP.^:DL6YS:]O)>AR=+)PYC$./BDN" M>2?+1M;Q]1GYQVAD/8I6R,9WK?YCB^I1!&';C]KVH[;]J&T_:MN/VO:CMJQ/ M@77;C]KVHYYL/^K>^6VCNB!/J1VUR7'8()Q7="?6Z$8]?)3Y,MJ]+8=Y]S+C M^9NG+4$3TR9:>AOS)OWS/ FSC7_]6 M"W" .('L"&DMO)+8 6E)6JHYNVI6=W7U/__OQX/]!^]Y=C0YG/[KH?Z'>OC@ M_W[[S_^OZ_[]W?.?'ZP=YI,#GAX_^'[&=,SEP8?)\>Z#5X6/WCZHL\.#!Z\. M9V\G[ZGKYJ_Y_O#=Z6SR9O?X@5'&7'MR]HT&\A1J[!PFUP$@=+%:[+0O[$(. M[#S^GS??6.\<1&^ZZCQTH&SM$BGL4C&>69NLC?D_Y1NF7,#7S-X&L)63+CI& M--%@SDJ[]K&[Q_+MY!M.C[YY,SM\_Z^'N\?'[[YY].C#AP__: _P/_+AP:-V ML\I;^>IGEQ[-CC]?6>DH_>-P]N:1/#B_\.*BR=$A&!VNO.7'--N?7VR4LH_. MK[AXP<>CR96+/]B+2_6C?Z___"+O\@%UD^G1,4TSG[_J2Z_0B/CH8_MJ%V]] MN?L./QYT\=^46+JZ=3/70\H^E1/9P=T+%P2-Y!3*]B9_7G+RX?,ODS.UW]RO*Y?W2QMI<^^//; MRP-O_]A.[=F+2W]WY=4;:4\G.KIT(\=?OOK/OKU1G3*=-I>_?;EF\?-/](_. MGIQ?^LT^3=_\ZR%/NY/YHQX].W__,___/-XCLP?_^>CLK=-A M.?WVGV7R_L'1\>D^_^MAF1R]VZ?3;Z:'4Y8;F'S\IEW(L[,?)Z7P=/ZC/+\A M3F$VR6>?__'X.==_/9PXX&**3\I%!D)&IXP%75%&)I/*K]?FMZ*5[GX;<%,Z M:!_-DV^>3.7^3K^7KS.C_:?3PA__'Y\^?# I\M;%_GJ:U@[?_VR>O]^VZR=E M[\G[G1]Q;_/@U]UM\TQM'.SL[6QM?]KX].S3SL&OD_57SSYNKKUQZWMO3C=? M;>RMKSW1/]N-_>U/[_:W7VV\W5C;.=@V+\WZIZS6S<[^]MX/;]>WWL#FUE-8 MW]O?V_[T^./&KU'];'9.MU]EO_[JZ8>=O2=VVVSL[LA[;JR],3L'/TUVUO+' M=?/#[L;64[W]Z9G9-D_>EQ]_F*0?7_K-'Y_ QH\O/\CG3W9>;:N-M;?JO$Z430P>M_/KH"Z5TB_/W);";P_C YRK2_ MS31[,BUK$E4>/C@;/_()'X^_*?)(=R ?N]M>V14Z[7@Z\N F'IS^QH.G>OW3 MX]= (7J?4X>8J .G?8>NF,YBQ:@=1P5"A)].IOR@.8>EL>!"4OQ&@Q_DD:,1 MX9L0_G0=X5"R$QRI*PI$3B4*730RU N@J*#*@HYZ^&W#8&7P_B+O?UA&@&\% ML+H.L " .AC?A2SC&,1_=VA,[H)/)N:80JKAX;?/E@GO8\&VS/'=IS]_=D^W^?_?7ZZ\ZJ\ M2P;\QMKC3^M[Y>WFUG?[0I^W&S^NNXVU_;?;6QL'ZP<[N^MKOQ[LO%H7J)_7 M=8%\<^OEQ_6M;5C_]%:O?WB=0RDI.=,I2U5BK+AA-#9TR@6;HA+)7/'AM[\8 MM?97P/1)1F8)N;B8H;:D.52C4LV&N!:M1C 7#Z8H9\WL8HWB;6V1<)HEDD:L MI:L^&H.F(J (IE_L%\!\=#5#FG%E4;J9C[Z0V+4D\YNC>;(O<#^8YZ??'$LZ M]Z^'1Y.#=_LM^YP_)GC5,V@_>^)_?#PJ\A:/KK['V>?_]J'G]W!T>#*;_S;/ MO[\YI]@9S/]-%+AX(YXG:A>_34K[O4YX]F!^0_S%Z8+OG_Z_JTG']1=_>_'0 MU7=_-]1>?>;B]XL/>73% M4%^T6P&E@PIB.>- D8O%@).03!P\>N85V.W\Z_.;%I7/?BWR81_?[4_RY'B= M#Y)\1)G(LV=3?+_EVH]+$98<\='Y#VU.X?''R='#;]LU/TA.QK/SI\[>YI^/ MOOCNGRWW^28&@:4N,JQSJ%X%A"1)48!BJ12/X+5XW@%@>3Z]]\V+8[%!>\UY M#'AQ?)C?GD%Y<25,^??WP?T40O'LQ:XI0=H,>DDA%);3)8QT1XO] \ M#_+W$WH_%L0OWX')?8*?C\ M](N+YRY^;^_Q19RC9I^" MB)"2/(C\D+S%9E\T))$A"LU]P_F[_N)\=?PYERJ #905E%))68VD%9$! 2F> MX](/17C5 I<]T'_)]).YP+Y*Y?-UO&]>OEC[RRQ'D886,RJC"G"U:(7UY)0- MWJ!XN+DUM396]\N:NM.FL_KO6_,7GKUH#N+SURN3]W);ER^=IU%T?#C[+PW_ MN]>W!]=X>G@PF7[I;6_KMJZ\Q:.K=W\C[CJ)L*R8BZ_@V:7B*6OC@I%_L:;E MC:)[$L7^^[%]U;OE(%DO .3J("5-T4M&QR'6(($HQ>6-Q_N R]_R$E=P\=FA M*( J,J\5=90D>1CY0%%&C8R7=3 MU??-C]VY2EN0'U,6HG6)F>6G8BRID&Q-%4,,P9$Y3W>AWQ-XL/3LTGO+)MM: M(D2@XJ.QDG,$]#6%ZC3-[:8O[*;[:#=]>[OIA=E-5; N6NLL>6!;L9+/B,!B M2R.9V[G==+_M=MO9C,79K>@243QGL<%!5 J3X21&@Y8/),)S_VG[%]>.9L?? M/.>C"^]YYC';@R\R3TD,\,N,WT\.3X[V3Y_SN\/9,9<;?.=B7?;T/<^.)VF? M?YFO?,RXS"^[:_]M%Q-7@ZHY)]0RDC288J/67-&'8LEFPM1?7MP"I+/E2/FZ MD^D;N: 1I# ?D(!U";>SJ'L;T%; U;[PA"AEB>Q"%V+05=A26]RREEU)D'O, MDS[XCR?_.6DUI8<'[PZG\NO1EV3?D+R&9@T!*02M-10L$DQ0HK!!F[ F&MGP M-]CPN)1)JY.@_5]H4IY.OZ=WDV/:'PHS2E35H]$Q@LBQ@!C$1600+I@L?$, M4$T5_8^(#FV,.DGRV%]*#"H3^&]HVA>*Z*RIFE@5Y@S1^59C2L&8E+DZXZ&_ M%%FQU[AO^A]LL@*Y*P@64K%MDX=$]IRM5Z65'_:6"%^10P=7?'*DG-45,,?( M)EI;&%#R=>V'#=*B'7I?0$.7"+)UC&P@Y(K1$Y20M=$AAV@'!-J]P;"1^0<%12K"*+QZ&UTR4:O"9#Z/%-YMS,0 M?<%'.6U !<5D')0:D@N4HB93$Q.6)8:EE3&4# 7-MLEG\,&B-L)74=)$/B=, M*U@SOQ\R:O7+^LX3.Q=*]"*,M2":?8SHK,_.:%W*$*%=81Q?/:"Q%FU<]J2R M @:F:$-MFV2K$J>E5E'?0@\ZY! NLG62R56FL4)S "VJ(X/8R M55H]U#8U3\RL2HD ,IXU4+85JE*QL-5#A'K5\G#UJ&:?8VG[L;(,VH!(E-B2 M"['8**(_W).JT!7-0RVH1-0I3P@&8\UMN[=&&[3H(F5*LC9'(/7"N=P): MKBJ(MT3G)1 F(*S>%PPA)HOLV T(M-[,0RT(&G*^.IV5R9K!6A,]8Z8L/Y)" M5894"M\3)7HG,)6DDPIHBU$6#+L8G*G*E<#5B0BY/R-HV?-0"\(GI,#) 2:/ M"EP5?#!&(RXOH64LG_'1OO?X+&1'R:T_]O$'FI7?>G3,(^#6A\.MW<.3(YJ6 MQ].R]4%NZE0>.R/.TVEN7_8]_[)/T[MGA_;_'3L^[Q:=GK1[^8-=YN_DQXLW MN/7NVY!=#K44[5L1/@%ZH5NFFHHVP8L, M.1)(;""OK:=4BO6U>N5&7O1?V"V.#9D)B%24K$@4@U/16RM)$VFO@_6FC&P8 MEI9<'#,"&-+%QU2M@>(L)BZV[2#/QMGD>QP_QJKJNPH=G#BF0D06VY;H6"AK MA]J[4-EA["\E[B\FP29QUYX5>P!$%XW833*+@K$FX_0 ,?DZJZH71XFV^2%0 MR<$I!%%ZQ$@N6RI1(6D<*?&UB#O.FE*HI!L1LG-)8*J"V+R1A7:YOT3XBD9K M$"!(9#?F5H7I6U MDJ0C1=9['SZHL )(WVUA-]K&"-9%:=]=D4!F6F/RY@\PR.^\,V=D?K;PE M$&LLVIHJ2!G 8DC;B!F]]IHE5MQ#0%=3HK<2<#6W\RN2B3H3<'(DL25:KUC% M7-QY0>V] G?)=5LK0=6D;$O44$*RH%6.F*++ROF"24,UYU%H"&#V,!E:T *Y MCI2038VQM?RQ!HWG5,$;DQ4;:P<$4F^2H475+F15J[*J;2\ \(P^A+8=3>=: ME RL>P/-BI*A!<&$)A8H1IND"7)R27L?=)#4-82VV^G>P+3L9&A!^!@;$^94 MC;@T$'U!.;,7$]K ,KS.MPKVI8?DG5@@65U+3LEI!D@8)%'WF:M\?^,-73"T MC^V.^[#DW+_8OZAVRR'*V[&,"G .BG:D%+>#'F,M2(FQO[P85#.8E:UX+HHG M!$KX((X3<@2)%%,4.75*+!UEA,XDEHI\.BP1(". [(MK_,& N8[H@2T6/K M26Z$&@HL09MF,,H#0L6V.-Y?2MQ?3*IFC=H;-"F ]1E9:P23)9R+%\)1=KAY?ZXGL\6@>WUWJ1 MH%D;?43E2?)I9:*KXFBU#+4H:CGV6 G=>Z='*E0?DS6@'"1#D4PUA7Q6RM<, MZMY ,^STTI,KOE0J,2?@"N1L<#IF'PDD[^RQ;NWW0LO"AI%)UBMCJD0C<$Y% MYZV/[+6F(BK"W:]#T5?8\6X%QZ1#2-ZX'"U5L @D*;U/)L>:O2HE#1':OI33 MK0102DG%:%7E("'/>73*,48L(&*K:G7_ %U9Q[OE@ZM4.^:CZ!(4 6%.0?+X M*@F#\4Z7$H<(;B\3A=5#3=4G3Q%<,2*"JB$M0C:RE;Q"5_9UB%"O6ARM'M4L M^8B-)A3-\\HO@L2N!$N%(&(\2TA4'Y5N'Y;8>J'9+BELM3"%W;J7@LO), 10 MV40N6 0Y7T1@N_.C649>]$_PW0D;DLZNG:\6=1%][D7/1@UA-4AN;M73EG<4AL2W>8:(06#"BJ;Z M8@H6TN3R>3W84O!9E06('1;K55"0H5B-(+'8&1(?'UTRYKPW@;X_O0F6VDGD MMI/K"VPVH1BT0D,:'00+,9;$*M2V;4$[LO!&>X#*CJ M9.1Q;WB\_#H;:SB3 _*6N9W%D= :YQU73@J+B@-2BR./^\'CE>ACE1T7!>QK M9("HA;M()7N,(3D_B /)&X"_S [+23[>G+W@V?M)OGSTV(_R%W\WHVFYEP'5 M!XY*W(^W'D"!BZ3(N4HN0BHUZ0$D.+T!<"7*WCJEG;6)C18$74QHB@^JK=I& M)2 .0!'U!L"52 %?O"&=P3LPD'-)1HG(Y9(J0C$N#T *] ; E<3 7(+@IJV6 MF >^.E0E):VS52EF9EQ\?2V*H49')KBUAYV1$KKKHE2TYA*SZ M?U+Y=[1/T\PO=IF/?S[,\[F#2S"NG1>0G4]MW&F!Q>(.*,>H=#%:*V4KN'90 MB?->B0JMR,H$/V18+J[8/-[EV?C3N5H^K.$OE)< %G=IIQH3!^U@(0#+OQ)X&@.L?R_O/RTZ[ MDW?O)M,WCZ?E?VE:]N7'^XAE+2%Q05,*:3 H(Y5C9@XZ8W95#Z%,JH]8KF3Z MI%BKD"5.%DM@*U-,@&#!.--ZL^9!C\NS5=F3_3K9WV]O]C.EP]E]')%M]JO- M2J-W$:*N*7L10CIH70EUJ(,>D:M <25C4=(_="GY7+4&3A2C )5B+L%:$]$- M>FEAI3%R!DA%HS:Z& M/")7%".7/Q8C>6JG JE@(Y0:2&>C J?YT:)!X\4\MO;]VB@XY['V"YCN"A@1 M(#4F&Y D+!K=#EW/2F,A8RZ*^\4"78],<7W\7S;&C>/_MTO_5M;JJPK!4SOW M.6D;LQ4GGHPH9PNS7J8VU8*!%.0!^*"[ 6BI M--WZ<'@??5#2'*T%(_\DT(#8E$H&JQB24='TUP>-G%JB#S*E%.(*M1B1MY8D M7X-4G&>EB%,Y;^>B)7?M+G[H+5].TM&D3&AVVK;T?9$OO\PF[X54O^Q3GC/K MWL2G:Q,>6@@2;C?A<>72O^%OC.'6HT^II VDD*.J%A6$1*7$ )_+PD;^])$_ MUPN>?J/$WVG>V2:[ A>BDB!60Z&U<"R$@442YXM-8-:>ST?;_M6FM9G,[P]/ MY$O-WK6*Z TZN!P%OC^ZGX[0;EC13K8(;*HS.0E ^&HTQIVIKKA4%S:=]!7$E8W^5XO=/78Y(VKMR.5>%K5U0 M+UH;BZ33P16=(2=$9X+PT$9O2*5D!^!%1@(NB8"K]Y*H).'R&BE6*VF83IDU MJ=R:*#-:#/W=]C*2="5>:(UWCN7-9H$\O]$T6/)&90SB#24/@TC 5?@ M)5=1G \A0$TVN 1)Q91)L;?:%PN0SK>>C:&\=UG(G0B\$H(.7 UXFZ%J1[?CCETW6:O>7C'TYN;E5R MZ\_^@2:S7VG_A+\[76O4F/E]\Z=*CYYQ/9K.;2RG_ MFUOZ_./_BH%IEG=/?^;WO/\'=_5T^N[D^&A^A1Y(W/46DBDYIB"$34:T7D'( MP?LDR4J(>B3O5TA>,Q#RS11Y"+XUMM+_N,2L!U6P:K'R4K/R/M?,\4. M;R3UA;RY*"=Y-:G4=H\I2GE^VKN*QC*R+2-Y1[Y!B MJRXV46S[G=&Q3K8$ETFA,0.06Z/D62F!0K$F6XE?6@C$5%%;]-[6UE69;8NMC2V0\\P!YAO,532A0$@F%Z,' ML HV4F59T_: 2GL&0]9)'NFQ1'F@UI@#FH*V_U2Y"9=VYN?FR?%M0!DR/;^F MV;.4M6(#M23*$"DE#-'4$+/0U'L:0.XZDO:KF['+AHS.:"HZ;NWN4M0Z(G(L MQ=DRA!F[%9/V:Q*P?2%MB$F%Z%TJ@( Z) 4!=*P5N'IM!J D[[>G[0M/G(H9 M%6BM1$L2$(:@';:S&A@X&1H^3WXY2?(.YT\/CRBCCOP2:WU6E+1)H4WGA(($ M6EQ=T;DFQ6H \Y(C:[\^(5G1UE(#B,\E$/E(IGJ.(BUUSKG0R-I12?:0M:"T MRRZSRM4!JYI28@K.5TCDJW,C:T>BG$U>BV"T*EIN._T1=,&2PE!E%Y1?XFP)&B@$R%TF:K4$E,9FM;Z6BS@^A-G3D[]$OV="R>F-*JL NILBLC"?R[20V M>P^F+$?*+)@RAFQ4GJH2DD"UD$HVG()&-L36E?X?D_EU;/^Y1WIS<2>(@BEM MBV5@Y0$D<&-2UHBS"RIS",&,Y/T*R7NW8G-QY'70&EU[W[;20:::''EKC4TZ M1TKH1O(.1N@.138LCKSM<,)875#(XGIMB#[[R-6C3F1S&<#IVCTA[U?"E^C MVL@EA$*B,2M"TH%M,BX54ZWJ/U_N:;0\/I^]Y M=CQ)^_S+C"O/9ESF_0S/7_'SA-)D7[[1\ ;^J(.^P&AKK-- (J?%ZX"RL<1L M3A=D5'ZT*5%*Y>JL@8DZ>*@?K;(I!6>]'1H^38\-2';:@ M!H4V1S#@)5NMSF80T2&BT8AT'!D]DNA&$C%95W5* 96&F"$: X:0K:2Q8*(> M0"?Z7KJCE>]E7WW;^$H^M353HW."V$[F-;D6JXVQ$2L/P#^-C+K[((91Z1H2 M. ; $&,%<4GR6TX!-''_:XE&DMS]'EEB9RNS;5UAHU.QA%I+==E[G2W2@(+4 M?=WA/<@(I9R)2.B]L]B:4I-&8Z*KH3)*C K]CU CG>YXUB"I7,&5&@-(?,JI M."&-;QNQ:XZ^]C\\C0RYX[VB&<%2\*6=D63K_-1W4TS"R!E3'8#*[4\Q]+V? MA!2MJXOAJH0F4*I-HGL+9M+B5K#&>[!0U-N-Q4-9>3$9601)=)D2)&^BCLRU MG7Y@5% 9[Y'6_3H=R^IE;PDEROO%8(V&&C"Z6(U2%74M)6JX3Q3[BMS1ZHG% M@1WD=L*:(5 I)LP0\RU M#N%$J-'YW/%QC3%JU-PJ*C4XDV/5QOAL;4E,%P?/#EHNW\LU^[Y(:8L>R8(G ML!J42VA4R8F+LJK(<_=IVGCD45\T4,6$E;,Q26=H[1D)2J@N%@NE]?\>?EB[ MEUR[\6;:4>+/^>CB3.^S3VP/OL@\):&'V.+]Y/#D:/_T.;\[G-U\D'A?HJRI M.6(A=-2V3QF(A-8D'T TF8<^J_8_Q.3R@V7OY.BX_;2L-=9[.3[Z0E9,GA4A MFQ(0K#"W!%4M$I,)(=, >N>,]%DA?7+2H6W&RL[R/*,HE@(D'6UDXW0YEX0P M2L)%JC!8N@H#6WRRNCD&T[8$4Z9H2.7H4_9>_C[.^/03>Z@QBF7:PQNEXZ_0=7[J1 M=?[TB::3*?]\2%.YB=:2Z/CT1=NS-!P'44C7(NE;#0??X1.$OL^/Q,>\O ?OV,0WVBTBQ M)5)3OOW6[HR'LDM$@8LQL+.>(U3,*"F"N 7G=%8FE!XW__HZD5_"\O,E=\DY[1?7&[(@.6T\*;9@C(N2H%+!J)VJI(/J+^O_VQ2QI5]Y7: MQ6'QD92&&B%D)E_;)I0@_]56;=E_:O^9G_N9CX6*F_7LFI%J*Z4:>_8*O _: MMST"XD.-LYG8V%18_KV^,@L]%>U?@N:Q_%[:8UN'6[O\7P+5%P+V:IKY;ZPT MPX+VMA!"=BY %"85DTE9C2;E%$5\IGH^Z]A'NJ[(10Y]@/S=5.<*\?[.8HB$ M8=(YH_9MM["F=E8G!ULYV1!RZB_Q[@4-AN4G[X2!,"]G#S64F ,I1"3)QLY MLXM&][A >&3@_:@)T%E)N 7'MCK(Q;0DQ;L,3G,B-&??!T,G.^# MN*BXO]@0\?LM$C\(J\7M&>-LINZ"M:Y 3,WA$)!!G2XWLH4TUM?-L MHA] _>K=,G^Y.<2BJMO85/(E6,\:V =L1P#'(-EOK1 5]ES*K:ARX0^)=+U> M8:E3(@O45Y&CUY"-4FW+58V)9/"W$S\\!X:+,V-&6GSAL\]7KBY]^/DCF]/% MS"G?9]Y1!4<:J?JHP4>/7I1].SD-HLE9GZ^>*AQY=WO>;7TXO+^\P\7P+H5 MF4%GKRL8P^2JD*RX8 '(<(\/6;L!^UN4S/2?VGUDWL+Z[VGKO;9&A7:TC5+1 M%@HA6S+&VJ344!8?1G[T8$4@&Z(B"9FN6,"PCTPZ5X=8(H!SKN>R[2YP7-)\ M1%\$5(KLG%*VAI1:H7$*I>8,EE--/I2^YW,]8L!?]E5]H8 MQ@3,8)+6$*%& M;XRN2M4:$-%?E)N[GFJ9%062>8\.FK[AW^8(UR?3R<')P5U/2+L%[5"*OOJ* MJHB: . :0\JB89W/RK>]*"/LMX6=/@X(]G;Z1-$FL\((+D?27@)_ULH120B@ MGJ^$C;+QCIK2. 3Q!-E7DT%S3$%C*":JH&P4A3#2HE\:9'7A9T&$L]8Y'PP: MZQ1 4FA 1_FW..N$9ST^EF(DW'(#WX((Q\IF;HM5&!ABJ&@MNY(^RINR^N-)Y;9_-W>1.M]@TU!<:E5C8NNS1<0 % 6TF'7W)R:1(>9"51'W! M^&^.A 'M^C.$Q3?QC36!3S5)V#/M'%P3)..JN;\LNBA.:;MBGHH!9B8 >=_#Y;\$9TAYY+5$[Y H6O(84$_E0*?FB M2RDV8(\=\&UJOEZ(64HZ/2MF/[IE-7MOH'&5 B6TV+J5BYJG[*HASE:Q@S2$ M@\3Z!=Y];MY0[G(")L;@ MHQ?,Y6K/N8$ 5$ I4D59KS48"S$G;;/QU67)408.T.=+YA@]'B1 5F29,36 M888V>UI,5E1;V5NV$G#N$4#?#1*@7(S),>DJ>@U\+KOU^%D;)$ ^NR093A$][4%#C#9 2JS H<>@A^W@+HV?M6&.G];/ M)W JP50%5A<$\7#:6;&C@4QT;^ Q@X0'DT-CC-<8-8282+?S)(@'3,+H<2K5$$MLT>8(V06=6$WOUVFJ+V P;H^\.#@\/IW<,RG]31 M?@&PD%'54$C.6 LFIV1K(EM,,2 &=/H>P3)__G%_<3F93LY >7]XS)^M?U$G=QSFQ?4 $,65)9;N=QBO1#8AL% MA) !,QE_44 9^NL85W+Z[XN3=,3_.9$[??)>_OJML]X?7+"PS^U7% @+BL[1 M!-&UXM82@0]&[3=(,.KA2!?3C3G/[IN^;_I\.1%TB"@%B MJ39Z!*=4# 95\)8*42(]@$.X_QHUOANIC" MT?V^M_8O,WX_$=#V3Y_SN\/9,9?%@W.]YYJ^=<^U*S[Q[YS"4E@A,Q>B #+@ MT.E6?J99Y9"KZ7&9X!\">/G!LG=R='QP\YI"7T)4M,4E4Z(!-H E1HE8SA7- MR0>?D%8PL 9!X^2QB7_K2JC@YB?=J^PEX =40 ;F=C,7=NMU_'C\@6;E"VMD M38*)Z'HGU].QO.)NPL45*,WMH32+Z^GN'4-*;>.9A^ J1HS6J51]B%BCOC8$ M1B@7/RH7!64EBUEY&9R^[9!.)%9.UHA><*H=,-O?X/('",[57(LOLTD607#[ M\MEAR)$["6E$KF AFT*U0-4D4RT'7YVG$HKGD03W6])H0DHQE@BB:I3X\^ H M!RL.H*B*.(#UP47AWQ=$"K=B>0L.E0-;2BK!)069O*1$P M%DC5(!BHD*-C;6M*%E!R<;;]GROIQ\A:W+P(8?3BYZIJNQ6 0S+:&K 6=?84 M:QS *5/++-*\KE"7?X"4 ):"0..R\P EH_4IV+;QJS*AL0,%[*[*#EK-/L M+1]_1T?GVY$WW[49F*.[1]+<'DG3F;B(F3273*ODMNV4]50C0AMXSMM$3L?/ MQY&- -XB][J"R=\II+;>H,_: Q.@S1B\2)"256"C178,,QO^A6?U<'9 T\QS M8'[3\'.(7DXGQS&!)Z#1:)J78])<3"YVP M6C4#^T('1Q:AI22>&# !YI(]H*LA(GIO^TN'KP0@4;"Z2JHH&;V686IB<9R] M3FW(!J?TP.?/5H/4ZJ?36L-+&U(Q5E++*BHI6:I:1P24=R%G<:+-) M.]:L(-8(!=JL %)PH%-M)_^$ 3C1L_%U>'2\Q;.#R72^E/_D(\_RY(A_F5OB MRHDL'X]/U^CT;^O@/QOL9Q6%\V?6#XM\K4S+R&Y7XJY]+CHD\=!&,BD370I> MF$2<(F%K1#, MT!E(LE[>:4MYGNX*2$U=,G.FLQ:\4) 8)JR5:N!2PA9Y? M#H ^?PG*K0^'#@AA))^0KG\4=D Y%#)B8B$TFHV)+V^:Z[_*Y^G"?R009^^C2 (I%O@IRK*0P1;5=Z2:0 M]@&A):*65,1BVLE@0&%0D\+WF1PK"2NZ*)/(L2L@RH C6>^5RPA>O$1*90!% M,%\%.592<,,!H@=7(E0 5JU7DC!!8DIC2F$_:HY+8E28<2POD=MJR_R%^8"$ M))?XLM2:[^5KD.JH1)]T8FV$'XER, DDE4S6,^@\:I!^DF4EFD3KP+YZ;3&H M5ON%Q+XT_5HE"A4_J"GRKXDLJ]EW"^A\K=%H(TGPV8$G$)E+U)7RYU+XKUZC M](TL*]$LN5"MKEK+20''$(MW6E=@+1R2O&?4+%<%[9.#=_N'I\R7*E;OI3KQ MI502@$)M;6$"6380)/IDE[S)-*J35=-B)3HDN\*D?0Z*"F@=$Y4D 88EUL20 MAK7A]'[28C6S(BY%;Q,$4QUHHZ)S4;5)L^0"9Q]'Q;%J6JQ$6WA/.>:DM \ M"7VTI1;'Q7L4]U''-9BCK[9H$% 1^< Z6 0C[L-B;?,A.GL#&L85F%Y08R4: M QPZ16C05 :, 1.SA^C0*O I^%%C]($:JUG41ZY!Z019M7V0&M<6W2Z\NKV=GE!=S>\/%58B(8RDI\3%@FTM/[-' %T3 M>0V(A2N,$F)%7F'Y6D$[59M20,L>"D:LNFK"[%64_X4T:H7+[2]FD_=BY\?3 M[SG 5XB^00'0& 4S:%8"O5R(S*(@ZA#>W7PY#5M%%U*EUNP*!42B!(9 M!4>/&+(2'8+L8ZY<*Z,'SS81Q0S!I\3M*%8>= M(BZ\AVK;Z4W$T/8S82FH:RU^E!RK(<-JZCW1*>4\.5TJR!]B(PY"*U5CLB6. M\Q:K\PS+%Q(.#86034F_:[E^6O+(C!7YC!7HC+8Q@)2))MIY;V&;F )+ M8@K:9[CHSAAT["Y^Z"LS!+$C_L^)O.C)>_GK"\<)7[W@[@=ZZ'2\Y4"_?.EM MX9Q\_&;&^V<]YG8G[Q[0+,\.]Z_:O;WD'X>S-X^,4O;1^16/*N7CKAX>'D\/ MC_GA@RJCYCG7H[:2;G\]36N'[W\VS]]OV_63LO?D_?@U\GZJVN/6]-Z>;KS;VUM>>Z)_MQO[VIW?[VZ\V MWFZL[1QLFY=F_5-6ZV9G?WOOA[?K6V]@<^LIK._M[VU_>OQQX]=H-M;R^YWI M3[L[G]Z]W?GQJ=YXM;&_L_?LX\Z!?.;:3WO;>T\_[@(;6_ORN=L?=[9>JG7YL[WWQJROO=6;:R]A9^W7_?6] M]=.=B]?\^Z?==%#V-_?RQ^VM-WKSU:][&WL_[&]L/?NXL?5\LKFV_6%SZZ6\ MY^[;C5':]O/3U>?Z$^_KSU1.[KZ>EK<9;.NVP[:PMVD"!V MR8+OF#(DS3J6&!^,9OU3LSYIYOP@?^:F75][K#<>OT8.[2Q8E%6U>N7S:-@;#*LN&W9C[9G>^/":*&HBR)TM*7:MSU9'[+A3ME9D-@FM M'@W[YX85)W Z=P+B$!Y_D&M?%U6"K=IUWH;4@1;.)F.X,VUC9JT)T)G1JC?0 M]?0+?L!JL%EIVV5,W($WL8N^L==H!,EL@G$P&O86?N#TFF%K$5)JSYW+1G40 M'71"5-L%L,842(AIC%PW&#:W\7])$+RTKTLFA>!J%Y1H 0"5NY2BZ[@=F4M6 MIZQQ-.N?FW7]PJ1BWF?R&>NODY7,)*72854BLZSF3@26[DJMA3D"I3 &K9N# MUF_J]?7 MHEJS$X?:!2VFA92Q:\TJN[83GW7AJGFTZLU6O>Y9HPW><):1KYT3L]8D9K6Q M$Z):MI6S&<4L9G5:=*N5B)71*)-:YR\:\]>;S7K-M>K*+F0O$8I3;7_I#K'J MSM6H/3F+V931JC?I@(T75Y-756MP$6/GBR@ *-9V*"*VJV1ST='9[$<7<"-7 M-TZO<-Y*V&MNU![H@6C9XPES-Z )N,7F5KZ:M58&*KF"G M DJ"160E$\BUXXQ$R68.I8YFO3'!NA:OBK.M_#!VE+60E3)U6'+NQ-22;+$\ M&4>KWL*S7D];%6A-P75H"3H(X#MLRR^. ME(BK;&LG''6=TZ6@,F 4VD]>/KZJ =OB@A"OL MR)%D AIT1P'$S_JV?:*=.Z?&3. O50BCZ\JH7L-JT MY6I)7(/&#J(MHE^=_*1J2M5BL6I<%;C)K!^^5'B1HE,43)<9@N2NW+2 %U=@ MN?A@2LHX\O5FW7IM1L!7D?O@45(K*R0UXE;)8.P*<&W9@%7C/,LME@6NI:[. M*+*FU@Y9<:ME\1TED5FZ!A6MCCZ7,%KU%D[@>I&09%<6,CH)6N()H$;=);*A MJSXG% $&,"8$MY"NU]9;G$\Q^5PE(2A"5R9QK9!25Q56K&V:4(W3@K=1KM>D M@/(&?5:H75(N=JXUC*PN9AYUZRU*KZX7"&C+%E#25TV-K1*IA*V! M.QTI>QU4T7XL;;T%6]>OU5X9ZQB3Z;QO!0(V-2?KJ!//2L&C8K+NX8/]R?3M M\S_?U3'?TM&N>_C@^'"@^SAV_KVK\L&O4WJ%)YL'S]]N[[W4V^;7@XVU'PYV MUD0Z'6Q,UO?D=>;7WWGDBB19PU M8E?*?+J%L4N8A+X*06/,:!4]?' X*SS[UT/]\-M_/KJVDV;<6G-I@)B=@Z=Z M\\>GL"'ON+.6U<:/3\74;S_M[&W(^_VTN['67OO2_7Z R/WMO80VF#;D6OE> M,K#6W>;6QL&Z$8@/GLA]_[HK@^_:\OG+T[.B!(^N%!D0SK4"&@$T^8B=R6# M@P\\X%*/)5E5OMNE?'E3!M+KE,6<&F)GH,V:N40R.F(4O^XB^VR2\L/-EY=& MUDM!4J_O/=.O-8(SHHB[K)M9P>0NV>(ZC5HD=""*,-P,9%ELO3(-L;'U5&V( M5@;#NJ+NS'P)/7CJJ)5]^>*-Q,Q6FN1&P][L!O)5-Z !5&3"SG,KIK4:Q V( ME4D[#39:C />5K,DL_Y^_4PI\:=&G&M$:DOH+G51%3%RC*#(!:OK<-/E99'U M]%+,$N3]7<+:,8EG2KG3E55 MQ0?8V%%LI1\ZI5!$'C@8[C3$,F/6Z;68921_2R5S9TV3KD;2D!24ZTK5&77. MDO4--V->EF$_?4$,1&L0$JDN %+;JR!1JU3L N90F<;YP5N%@*_F\LVSD1B MZ J6VKI$V2ZB^ &V(K JY!+R&*YNHP.N3F(Y \DD5SH50C.KBT+6$#L+H)PR M;&)-HUEOG,M^<96L.N:LVS8%T"7*7QXZ,HH[$[5D7;6=S#G)P5N8=9K*99*V6*K_60*6%A^0 MVY1 TMY%DZK'T:RW<*WK5UVK*JT/?;82L2*(O)($*SD?6M,X3<;[Z+T?S7JC M:[VF W+('%FT?[2MYQ9KVZ76;X=2C"JQ1@S#W0FR/'5U+6#58I.1D-7I-O#! MFM9[3PC+%OKEE5$BF3':?.ZOF^Q10Z@J(Z+3H@QF;;,LZU MWF+1Y5K++VRXM7'+TP)&H^B^FWL MHK9M-2OE+I*Q[5>-F0NQ'2/6S558UWVK*/ZJO%BUM(G68F!>(M Y+:+5665J M'A<&_M(,]OF*BRLUYK9=$:QK5;7SC6'>=L14/?F<+(^YZRWJL*YE6BK$V=R)>J8,4V\*KYTZAR;4P M.%"C<[UY9>!Z\EJ@4,C*=X4P2I;5:EQCB%U);1Z+:S T:JR;-=:U92SV'%T& M259=ZV7$U/;;2RKK#%A6-F:EQWS@9A]P?0Y;O&>N7G582;5&W-2A+[DK02=J MYR2C'X7K#59=_UV6EMVQ@D2D M&DN3 K:V2%8GUA#"*IL%DUM+JV0)VIK26$ M,-A8/VY9^LM;EIZ^UBG[I"U)"F#:_N7@F[S"3HNQG3P5HM?CEJ5;CH]W>SMK MOQZL;SW?V_BT+F.CW><3(Z\YW?CTW63=K,/ZI[9';^?M]HMKX^- [O'5]L>- M']?MNHP-@=%L;^T(C$_MNHRQ[4]O/FWL/78;!\]WKSIS>=>M_#JHU,[;TQ(= M17, E="E&K%CC\F6 (;L8)./95GUV?'F]Y>LNO?RM2?#;7VLXQ@DD4/)0E)M M_H![C.50A4;&OT6P-*0N=JVPDJJ4=QT27( MA7"X'>J7IP%^L^JZW//V:XNH*%;Q +ZM[Y2L.BI:A(!3#%# >!CLO.ZRK/KV M=UPMDA23;W,XV;=F"29UI-K>-(#( M*X3@.H]:FU*J0QZM>K.RNE:9'-&UA0;?E=KJYW(6OPHH&HMKL$PZFC38^KE5 M**NS+$!)U _M4(JDH$WJMKX%X"5X54YM05WE/.96-WJ WW*K,ZXFX.BU"YVK MILWHF'F3#7$(%"5!T+%M9AZM>J-?O>8!$F4-K=R;33OVBUWM8J3MT292B MIM&OWIP%O+B:!2C [*IW79FW_+8*.PE?67XM3C?#YC#8!8CE1:OK'L I;8M6 MKF/5.OR1K1U145VF&BI976H:LX"_D 6<[TXJ8DG5]GP5,2WD-F?5%B& K<\N ME1H#C3/E-\Z4/Q%PWNKUK2=R;ZT;W9/7DD9YA9Z[HDG$E6];%-G;KE@B7\0) MB&@=9\IONY+T:;,]M_?VT\:KY_N;:T^$Y[_N;?ZX[K;W&N_;9S[[L+V7S?;I M]94DN<;\.MG<6M<[/[X$&6,R7M9A^]/^1.[Y4_M^&VO?338^[>Q=4W,RYM9? M%ZV+LJ2[P-A&A:1RR:K2L67?@!2_,]@9G659]ON:04$@IDZUG>;@ M)>E I7/'FB%3J%F'T:HW6O4*5_>V7U5;]W3P9N&"<;M4. M[>@&;#,Z+5JF&!(KC&SK8/.Y57B ,ZMFB-5BR%UTMJWKBE63UJX+U9= @*70 M8.=TEV75EU?\ZN;:X]=M\0':D;BLD^Y@7JTCKK8KR5 "JXVBP<[H+,NJ;WXW M]^"*TH2$7:FV'>0.JDO8V@HC*M"F5#7@;3M+TZN75B#GRBHF!@G_MK.Z=9L( MOG881!*XK'2+8][ET0/<&*VNSSUDFHL TSE0HJPL"5>!52L'WA'Z)6 M$!82H\4&/OV;=21 8K'!2$*"TS.V$3I++9E/KI7IHG;(^'PB6D>P JP@"-2J MX+&((BUPW^'9X>K56)GAW#HP 3-QTDD!:4*K"I$$X[& ++B!:Z"/SMH"URY!2Y(/S,$&,GN M+#V!RGMGA>.($\T0#PFP(&&!DHE46X45,14"_-J[L4AR\8ZD? Z760!9L :D=2X&T+IT MP+^(/PQ^TVWW.SYV!Q\/HH4;X.?0^+[R)_P%% \+':T/7.9NG$QQEJ(C@6AM MJ*;&@^$A]LH77-S3[9WFO3QJM-!!;.P?]%YQ<=Q[_:,1>@>O",;_O51>M_)G M]]BVSJ_V[6:[\^I?&/Y+Z75JMWHHV:-&\_35_]MN',5N48\_BH_M(]OZ?[6N M;751-W8:PPN[C;,(#X9WE!]_#%^*\6N@F'@^"%BM_W[=BR<]%*)O=\J5>-5O MP83S53 F.S=C*0XZ,?WOTK]^O?)J:67;NF8LVJGX\P^[L)-X ^^)K5ZWG,,? MF3#.*>J"KFZE%QC6V/16.PW;O&U2] Z36EHIBO-!],K5';[4E0R%X-U->]R- MK\Y_>!T:W>.F/7W5:)7/*F]Z?60[^\ #KMWKM8]>91;X'CN]AK=-9)N-_=:K M<$@/^+ 7SM\\_'JY_.J/7KC^G='+!M_^-5XF%]_]43Z[SRG/_WR6V=&7BPZG E45H]_/"Y UX?6Q#:+3V7^&"E,^X?,D? MY4KFUC_/3!E0T6!0/9! [2W?>[3L2L[ZR[^K&??]7RL^;:]N MKW\:I\.1P<_+:#^MO_G\<6-[8_U3L5I?*];_[\V_5^OOUHLW6YN;&Y\^;6S5 M'W$*_$Y3^&I!&+7V>^U6K5A;?K-<4"RX><1A7P6]FX>]=Y?_;IW%"/'+.2+^ MMUL?-XN%]S$C>$#P&&F1N9@BVLHE&8,HX 179D6BQ MWUNCF%),,$'E#Y*!#M*R1S"'$!NOUMH>GMKJ;9\>@W0H-8M'4N%._J&[ISM? MO=S=_MC8/%K_L?MU]VCSK'E0?[<)SV\VMD"GW3GZTJP?_@4J7%;K=KZ'=U]X M^/??S5W:_.X.CYOU=QNG.]M_->&-H%^OXYVS=;[U%=[S[N_&[E<8 ZAP=5#K MZDU]4C_\ &/>8?ES6=\6BVB9!*M-N0#F!LWFAG<,$:8Q2\%SZL/2"L'H0ZF8 M7>[(RA/EC<<9ZXM-V_E6;+7BR[F4]Z-"^^IW=%DJ?2=Q?R\M0BX#Y]Y'B[A- M93A7"NCQ258+1E&N&=/UM6D?+TV*G+_">_.[N[^MV9)R":8/A1_ZM@-3:YY^ MC,?M3F^I2.W.D>W!"TYZKU+C) ;4Z_07$RW?-MR[SW+S;!4^-[_MKFWD]X#Q MO ]_F@<[VZLG@(1D<^VO0S">R=;:YO">+_ NTBTU RZVO'[\!LX#$R3OF>-<2+] MYX^?/J_6MXOMK0+4R&W0%0O"BJV/!1$OPLMBZVVQ_>_U8D3#O- N5]]LYZ^) M8?R&U;J_VM\ B['5>T55:3L\AA1XV^X4O8-8_.><&XMC>% [%!&&%F:A$KTO MW[?>"FNVS.@<08$ OT%'\,Z#?!L*]A2=1MM!L;60J/#[.M3FVC=1WUX'76KS MQ^;9-[Z'%;8R.VJ-RVU"+!;(2 ':E%0QZ)"/.8FEE;_[K5@P7"OR^M]9F9JU M?7HW#7WKXPUZTVPU%F.6!1>_I[!0)J:AL'!YM\=6"LL$;+<.C*^1/7VW:RS) M-KN+K++LY+)&,*:MM56^\_4+W+-^NG/V[0Q4F+/-KYN@EFS@,IAR<<^YRG+< MV#G\+?'/MX& W ]KVWX=;VW50839/=LX N X_YF!*!K1QE65[?4\FHJ.3 M"27I3&XC09#U7"/&@DHBZ8!-6EII/Q.59?OC:OW31JF8S%1G>0PG\X+I2;T+ M$#A7E/(1E"+_UVO?;U)SX*]XTSXZ:G2[>3:I 9*TU3]RL3--K6^]U6OT3M_" MR^KENQ82*R?F#"-[*6 A. \H>.]!?>,2.9,S&DCD(C(PV+A96L&PFAQ3R>96 MB7N2SF-Z-T?^U-GE8]QO=#/R].KPS?-F&;87 O6Y-B=R/)&^Q>)-M %<&:.'3O]O-4M6L%1LMO[QPWN47ZR?6]TKJR#'O MS@55%+9;=(^C;Z0&V.R-5M'H=0M_4%KT+^=^6K_K-)\K=_7/[#26S3\V"8@#Y+0[Q\-Y&_SO;_7MC\V=HP]L<_LSKK^#<1R];>ZN?8%QO#W8 M^;I)P$8D._0&-_C1!U)_]Z6QN^9/ZML?,%P#WWWY5O_ZY7#S*]Q[]OET\^S+ MX3MA9:0.B&MM< " W>0+5*I?0%@P'+Z)=6EF+3?O#=N*MTN#7 M1N58[D?%"K]FA6U[LI$-.I!7OF2'!;8%9DWC&R,T_GDO,LUS6 >(.B>9YM9[ M-K&<::J=)E@G3_S2BM; QQ+87Y*Y4\)SE^4"%N U=X&L[U3'/8[C6YH^-)R M;Z<_7>>/E<8H(I>7=O9MJW%6?G[YC '@Q<;RQ^5/R\7ZT7&S?1H[Y6J->H1UE!HS9;A42RN$85)\@LUL@X'SJ=>)L3<_-MI\T=,;^'&K ML]W^L9B*X0.HZ7!]+TC.6#ZQ1D,.?@8>D.9.(&E9C-@S"JK=T@H04O$6K&/? MZ/IK@8/:]'VT\@:X&]:NU;!7-W-F>_F^#9O5W&T<#TRVY[11I+[VC=6W\S&H M'9*/C2IG81VY0A@GA3A.L&DB_Z6=4B2(0#*D&TX(6300WX[-Y5?%BRE258;O MU4ZTSX^.KKISQ9Y2+EB7^UJ;E,O)Y<8K)DE$G!0A8NPI8V#"8'R5C%Y.D^__ M:8,J_OZ@W:KB5#D%<4\[;Y43&I&4FV1Q;9$E)B!*J8;U))):V"7*<@M-JA:- MXU\, ;Y6@(QN]K.E5IPUCH&B0JP5MA6*7FS&XTP.PQCIZ)46.'EXZ9A;_G_^ MI2E1K[O%<0'C.>D[7Y&9,%CHG""MB,"HZM MT(%R0:FW44DC8ZRB6_?([(.?U\5>2D)23B6BB3O$!4A8DXQ "4*V3OH'C;;+<[%9E5 M]OG/B.QL3T@E&+4)UBP$Q)/W2#,IX".S,JC ,-9+*WEW=]J=;_>STR>Y8Y6= M?I]]Q7LB*1.]" B4:E (26X&@3U!2BKK+.<>MN;V?9W9MCYCD_WJGM$]J4.( M04BPV0D OLFG!F+"B(20/-5"6B?RR4M,[GY:8$Z _<5;8%>04/4R.:93##]> MZO6I>'-@6_LQ%)\R?Q?_V&ZO&"1RWYXB.# N M8@>F<=SO=/LY^:?7+N"*4OLC](5[F8V0G*JZZGNO%J^6 V/+!-_M%.;]OF/* M3#Q7AIAE0^Z6*_/X@^5T65#Y*(D]1XT0FG'V[#/(IF_T!D5BHO4'A6_:;O>1 M8[N/NQP=6WHM/IT>N7;S1?>Q ]V/NACU82YE21KQQ)->T6TW&V&\6LQB+,[/=#02*#5>)8F5X2X9K7A@,#MIN"3:\U_H M:$.1=DJH*]ES(36SX9$I"O?0C]\VR_'5#_([-[_^W=S,+M2S';%[N'Y6W]X_ MVX&Y7#DR=;C[;N-L]QW,)?>VH>MP_\[)SM%GT."^G=4/FT>;VYMD:ZW>V,QC MO$QO.]M6C MYTZ#Z'"7OIGB4Q8*Q?EVS#1%='#0=MZ4&R,Q92QW-?>"&VD<=A3P@WK.1+36 M5,K-A GX=$2YP5MK .>6%_, M 5Q?7OQ?A"P+G(_^#AXP9Z<&9L%.]U>-'LA.E6IT7UZZ4(UP_7!GSU/!'.4* MI9 3;.!'9,K#,#%ZZD",&V\&JM'RUT]S1M"/I>[_4@>:D(BH=* )DOV8#B0< MB%\'PB,%!09!SBRUC@7$HM<&6V^8%@_0@>YZT.&10@8;K9 /:L3"G1;^(,+4 MCG*UQQ\'L3P-D\,#EWE*KXH7Y&5Q8+ME$8A0V&83OLV1D1QP^$^_D<,-O7;A MXO ">.A%Q('E:,N@",DP[C 2KCA?SQR+R%_G(B1%@&];^^6EQYWH8^F-)+0H M"WUUBQ?PO"RDNWV0X]V#=C[$?%YKHW< @GE\\"#DQT=9%K(H;Q[.X>7K,H/K M!1W,T0$[P??N$&:0KR\OA9OR*(;/R=5^NN4@RD'F2)'!1;"GW>5Y"8L#O9X9O;7]@6VNKIYMG&[E/S=D>B"OB%;!PI)8C MKIT'.68C"E@G[K'%'/.EE9W8O19LOHB"S:PF5.O&(TY/RQ#S=Q M+#*L?XS[_4%[C>(3VBY>_,^_B%2O*:/+PPMZ!XVR(,5Q+D@Q;0$P&/K%N"\ M/G9?EO ]??P>6>&\P$,X?][XC?<$UM(8YI'5%FQZF7CNAQ<1,8$('V0R.E7X M/8+?%7S?_1#Q8;_;:Z33A4!TP$);-&$NL;#> Z)GN XE1'7R:8,;?UL 0Z ; MO@"@M$7W"*0!O*ASKC%F;Q:LP^DR:..Q?'^(J=$J<\2[&9'SV00*4[EE%.77 MY/7Y9=6KAU'! MPN0[4;9,^._E._WTL]>^@9//]TYW"W43]K-NKOUOGNUPVV<[AZ MND,W^,YV\UO]Z_J/S:.KY9^.C^IG'N;R=Z-^M,' EL([VPD8QY(NK=1O4AUG M7DM[KEG^I)(//UF=3[?I]L^;:*8.H^6Z_]7OPIN[W2?8(6EVN'D>&]P@F]L? M]H1)F/L@4=38(ZZY0899CHQ.RD?MDT[X;AV2[J@6W ,LIG/IPD/0.FS!?D:> M_4[[1^^@ J"9 -#YJK\K%_W-8,TK(/I=(!I)4MC 6]L[>](':AT)R'(7$/<* M(R>Q0,KXP)VR5"=Y#R":]ZR$5&;5W:\<9P(#]98>C^>/H^P<^N@>QV3QG^N(% ML'(9FA@T+K@>( #N&89M=V#8SS,@-I.@]:>\+S^1\!47?Z-[2DD2A/)(,BIS M!86$G,(,86HE=8XG34SVM\Q="/NW"S*OE,6?YQR&MJ_J!Z%H]WNEU,[B>\@[ M;\N<#)#3_59CP#EE#C\8UF/T,B7WFFH,PM_52^:NMR5.,\UNH?H=#NH>$#P6P!6P2> MA9\7QYUN;G\3N6[0YN%GOK6VP_9XBC*QF!!1FB!.&$7&&8^PDP$[L-.# H[C MK ;H5M/ZXB3K^6:O# YJ=&\_ZM$*]R003:)T"@ W.,D!:BV7S,M N /(Q896 M!#*3.K3^=/-P=2](RU/."@U!:,2CS?6E' %$3C;;5MRZM+1"B*DIJ6I:R5\3 MR%]7"*3\:K6_W^_V$=C\OS-A)V#'WU<_MU^$[>5Z5X_; X'C5B8MUW7:SW[O]EMDWQ;I9HI$K)O[(WWFT)6CJ_YZ!SZ0?;C\AUHOV&;(+YO;+-'_:TN_3'N%@'0AQ=\ZO+=>NB MI#2U11FH*(!_PXX=K_I@Z'?R53 F.S=C*0XZ64K\ZT[;LUW"!<#+GW_8A9W$ MFRP<6[UN.8<;R'8.>\Y=K/OEV!<7RO6RXGKBV5.:+!LV^10RN0R20>HQ7V@!ENPL0IOO$:)H*F>!\X)!AV9?7C M=K%1H.+M1GVU_F9C]9\"E/^MCYNKN6_W#2CYD'(BUY6HB24IW6GWIR6?;M_] M*;[QP;O/EE8V>O&H(,OWVN9J8Z:],<"6;R\B.V6MWZ-;5):I[-(-^D\G3V[V MUL74475:?,5OV:O)JPD5%TYK&V5I+(38ZN:*BC.V>"8T@>+-HHZ\W2KU![NH MX^\M,-'\99LVEYW^=!!C)7861>S(.10[OSXZ4,FGA,[G5)(E16[$;"RGRRC4K*FFQ$-*BW"PY;^*B\MG<=Q\I772!,9S! M8LN+/(DKXL)VRR:,/RK]>3$0,6\AP0]#Q KFIB6NR#!R1Y]NY([.?&-N2C+Z MC8W9M"V[7R+?14OMM4;7][O=G*R;-=W5EFV>=ALE,%[&^;+<&AP!R]=\C-U^ M$[!S+E*M?F,5*I_)XF%^WC=&*\R?R\TQ[!STV=,%_<7=F0_Y>&VC5Z9XEP . MOVB>?\[XWVQW^SEQW[IVOU=LVLZWV"L^-KK?*G!<"' L=UE4Z#B?NP//&*(C MK]!Q_G8F.X0[L/@E,K[OM'T,&0PKZ%L(Z"NW\'[05R5QSS")F^7<^DZOV,AI MW%O;_U[_^-LIW%6B]ESRGZPRM>=W9_Z)^[8YD&IE=XA*K"V*6(/-$ZS2Z.=T M=\PYZ*U6J#=_6Y-=%\5;ZWOM3@5XBP)XI@*\^=T=0I]^5&]Q=^9S:U"S*99Y M;K8YJ,&R_I]^HWS@^=\OC^D.5L(+'!8''O,VY)E,%CW.Y.Z**?\WO MSJS%9,N$A<_'.:LWMAKMS@@L5A"X(! H*@BG.[ M.WP(>K("O?G;F?63@X9K5/51%@;K^'VQ;KI93!5'C>U./F(.:V=[E=&T0#P% MNZ9_6F?C3EV^Z$4SCGMT\)BCF^[TQ&=7%IY.HBR\E&SI_*ZJ,/Q\UE1_+H7A M[\3FKGW/Z[^K'G:*^M;U>?%Q_M_IQ;:/^KGB[]?$K_(C^V=KZ M__+G3]NKV^N;Z_7M3_,\J4%WL=^#WI'A'_:[O48Z?21(W#YH=(O_]&T'EK!Y M.FQ17;1;Q=MVYZ@@&'TH7O3R-4L7OWB9>TWZ9C^K.+6R$V0^0-9L')6GR]JM M&LSAHM1"2?ME*[J#:,MDU&+I\D#R_WO04>2Q([VUI>&H8&U2N_/#=@)JMMO? MA@THS\>3A]MHE0,ZBK:5OX7'G+>@I&KUO'/>2 ;%JN_EWQ+#6"WWL[%'99/, M6EZ96"R-7[GTYJY4?R^OS7/^+5W_2[%[]I=\Y_V>YWAK]\ M68 "T2U++\'7MMOM'^4&HOVL;A>#YD+P>C=LWUWDYF2]N ^K5ROB]SR'VJ#Q MZ 4MM"]IH5R-VZE@N=@^B-V?75%X8$47026 3XW4@)&YTW(7^X-4FJNW ON M< >FW3\=7?%\QX]V;GVZY&*S 0//A+H4@>6/X%WEAWQ.TS>.SS_&D^.8]PU^ M;&0!$,H?CYNVI'%0 T_S/S\:S6;Y^W:6$< CY8=.^_#\WN-.#(WAS[G_5J/5 MC_ S+-E2%QBV&:P%"*,#F' WUO)X&YVB%?<'9 !7MTM/ZG?;:0S6MACV M@;6=4L:.S+M<55CWX=*UVN6F=LK"K0,2];T^D.7YEN4IE"2;5P(>#V1=A$9* M\+K4:1\5@X48O/5ZLZA?(NGB(/#/"1$>8!O#!I\E$E\B+MS?= M5EZ2']KOPFZ>EKOJ\JZWN\.]_P$"P)8GD<^)/=R!"QNM[^UFOJMH]8\<$ 9P M7J?1_08972/9O.HEU0[F#!L ]Y<[TRD:1\?- M2P3YZ8S/UZ2<9#G<\7D.1=S-8G?PZC1(@88=ZOI.P\4PE,'#$UF Z(,<]E?% MTFC*]/)2\:G$!=CHDO&/VITX%%T7 X)?CX_G?!V WDLX'D!+V1DZ(W)_?*&/ M2TD#[>I2YST I#G-I'[^Y/QE"8BCRSL$NG.F^-6:?HV#->C9;R4N MM1WP?;EH9?/KXUS8ZK*+=3GZVQ]7N^C/F^7U<.QYMKD5=N,RXE0[Y[ 1:572 MWH]&1MIXXN-Q+S\CS]KE#IS_Z3VSC1Q0%:P .SVMS,) 3$--CL\OH0 MCV.KA&;?Z/C^4>Y,Z>,(W&0F&^Y V\,6#XEY2#SWI.4R MJ+)%=LP.F#-O5-$88-0(U,]B\GFCX(G=G+P-8B-#^0/F=8[[(Y,8&]$(DS<& M_<9+S2[=>@.\H=MW78"C/#H83L19 M>P,'RDEN\W:!LF/I.E?1YHYL=>F;OSET(F;09?WF"0_/RQG*7TQ7 MCD?H8GMM?N[WN$HJ;\0+_=$:W-.JXVCQGL2;U M8B,K/.T^/"-T+\RFLNEXJ7V!?G+^Z:C=!UYZ>3[#A>E JZ;3*Y;09:QOO_5G MC_WY=QS+Z0R6/5)GVT=N5ZOO5 ;H[WXK%@S72EN;8GH9S'Y*K7OOMA9KTV]A*O^;TRV\F5W> M#$,IMMS*5[^UEU>F_5O[,.UG3(@=B_)?-N^;FKL^9*W1YQ^RP_V[;99.KZO[ M>Y_IXV(1"/J_'C3%UU<34N=J;G\V3G*FZ-O.(&^@Z+<:O8_92=+OAJ72>0JC M+W_12$*XQ#E3UF,>0K*8$6,)MI9R:KG>V\BZ%98,+Q4A^L:1;7;_=PD!1[3L M4;.V7%SYVO] M6WUM]VB'?J:;9QYOTMWFSN';;YO;^WQK>X-O'C8/=\Y63^I?]$F]88[\T=O6 MUM&'T\TUSS:_?OFVLUV'[S_0^MEGOOOU[;?=PQVR>?CA;//K9[&U[4__81\/ M=HY.FEN'ZR=U^'YG>_>H?O;QV];V!QC/)M]ZM]N$\?S87=LYV5P+!YO;;P_. M[X%W]7?I9[FYO4YVOGX\J!_ML/J[#Z*^]NUT\VR?[QY]_K&Y_=>W^N'ZCSI= M/]G\^C;5W^"3?[;7>YN?\$E]^\.>\#P!G7*$I5*(8Z^032HA&R(FWB42G5]: M(8S6F&%__C%.'RO_\R\B\>N',,0YY-V#,28IPBMX>J+P9+R-S'B#*0X\)B#> M*)T5F"E)38J^A"="*",5/,T7/)V-PA,APA-,#)(T!,0#D4A'JY'S@M'H,1;2 M+*TH78-]G2-TFI!BOQC*X$8KQ^K;G=-:T8J]6Q5\>K_IWXBV"PU)D]*8+M:[ M'GL5\DP,>3Z-*T:!B.@9TXA3FA"//B(MF$ NL>1YGW#_ MM/2BNYK#SYYK)Z5(5%P[):X=TQ=XBE)Z*I#GDH Y$QFR%',D)8E8$R&2Y,"U MO,;%@ZV9"7+MLW(>O>_$8]L(97)UJQM'4B\O\J[MS_V^/P.ENQIN"PU*DU(E MAENQ/M@)L'/*>B\#K_O0<5MAU<2PJG'%]4)]$!%;)&(TB!LID8W8HTB)B\'K MD#@&VP84##)'ILVD8R?/GI'5I'2/"IFF M@TRGXUJ&%0+@*%I$N'2('_O]8,JSL)HFYP$9+/[[IFWUP&A:/U__ MRDT[0:#:NI)U0A+CE.F(%-,:<2\ J*2W2%J*B;#:1)65$E'3K/)]/&$NGISO MH^+BF7#QF+HA)+9:1X*<#09Q)W*(5 $%1Z\M%L[YY$LN-HS.$1<_AZSK83VO MUG[1C+:L<0'?H79"96&6!_L^GC8J34JWN-B$?_(>?,R#V4J?N[&TABI8FA@L M7LY>"P&76&: M[=8^RG4+JW2-62D4EQ'=>KOE*W?J9!%H)*E2%,E& YI$C7(S1_9-Y:685T6B8M^IL^_I"/O&Q"DV"J.8,S.X M%A8YRQ.RSCM/@]**Q*457F,/S^">/_?$(B5EW*P_3#$H.W?K_>;_)/! MX,EFG52@.SG071_7F:1G5%B3D,#69>]+0)JS@(*GR@=M.?8$S#:&:Y@]6&M: MI'R3"LXJ.)M28DT%9Q.%LU$=4GE*.!B!*&!E$(@:@;3$%@7MK*:6>.\#F(": MUKBJ4FKFI6[4/PWK&LVRU'LM%W$LQY:K&+[OQ!0[N3K\IU[;?QNTF,D_';2; ML.;=W%.%J-?%6DP-W[@]_^8.ZS6RBPRV*K3[>0"WU_-ZA*)4]QWBK M:EZ24%6TZDF<.USUOBQL6AS;TUR=M"I5]4QJP4S,=AP2T/L!_53IS!-7OCZ, MVY+6*/1$\6ABQE^% M1]/'HU%CT"IO?) "24H"XLD[9 CER 4:K0PA!L;+E 3&JVI4CZ?E=?KQLKI$ ME>8X [4HK_B(S5TAT<21Z/.X9F2T=\$S@KRQ G$N/#*!P$=OG21$)IZ3HSBN M:8;G*#FJRG&<7U6BXN$9\/"H-B&$(%Q8CCR.#G&F09&(//]%E*&"6L%S@B.N M23%/>T=NXN[N0^A_UK/J,J26KB]<#AH?EU7QN]@S?]+LP]=LYAZ;0" MI8F#TLZX8J&)"D0X@WP4(H?O);*<:Q0-)]SX%)262RN$UH02U3&(,981HA /'G0,2@PRE$7DL(LJ< 1V)C4JU1RQ\[/R6%P] MJ]D<#5X/LX0K+\9L#VM6$#4]B/)7#EEH[6+$"E$?".($!^2T$\C8P!@S@?C$ MEE983>E)E:>J/!ESR,?3.:U9\?%4^7A4U6!,$,ZQ1(0K4#62B+D8ID72>>L4 M8XFGF/E8B'GR2#XK;\;66)'M$3VC[5"G+N 3G[5YP5ADD?J48$ M1 /B#H-AXPP#)8(IHA6(%&V75K1X@LDA%8=.Y71F%0"9,ON.:@R:,>(-=NAR?,O9/2 M("KNG3;WCFD/4FN&N4(8YP9]L*;(!(-15-P1I57@ 91_@FOJR3H<%J2\PX0= M#L^U&/_$E(S*QID>2AU>*2$5HM#$FH!8+H_+38C($GII=4##]=AA]52WQDBG,I$*8*Ý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